ASSI,CUB,ASSUBCELFRAC,ASTI,TISI,Desc,Ti,ASORG,DI,BAFO,ASSST,CONFISC,SI,SASI,CHEI,CI,VARI
7524,Intermediate,,Kidney,2113.0,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618647,,
7525,Intermediate,,Kidney,2113.0,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618648,,
7526,Intermediate,,Kidney,2113.0,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618649,,
7527,Intermediate,,Liver,2107.0,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618650,,
7528,Intermediate,,Liver,2107.0,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618651,,
7529,Intermediate,,Liver,2107.0,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL876497,,
7530,Intermediate,,Lung,2048.0,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618652,,
7531,Intermediate,,Lung,2048.0,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618653,,
7532,Intermediate,,Lung,2048.0,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618654,,
7533,Intermediate,,,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,50597,Rattus norvegicus,6351,BAO_0000218,,1,1,,CHEMBL618655,,
7534,Intermediate,,,,Compound was tested for solubility in water,50597,Rattus norvegicus,1465,BAO_0000218,,1,1,,CHEMBL618656,,
7535,Intermediate,,,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),22229,,5182,BAO_0000100,,0,1,,CHEMBL618657,,
7536,Intermediate,,,,Solubility was determined,50597,Rattus norvegicus,17847,BAO_0000218,,1,1,,CHEMBL618658,,
7537,Intermediate,,,,solubility in water (ug/mL) at 37 degree C.,50597,Rattus norvegicus,15339,BAO_0000218,,1,1,,CHEMBL618659,,
7538,Intermediate,,,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,50597,Rattus norvegicus,5202,BAO_0000218,,1,1,,CHEMBL618660,,
7539,Intermediate,,,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,50597,Rattus norvegicus,1088,BAO_0000218,,1,1,,CHEMBL618661,,
7540,Intermediate,,,,Half life in rats,50597,Rattus norvegicus,3169,BAO_0000218,,1,1,,CHEMBL873807,,
7541,Intermediate,,,,Half life in Dawley rat,50597,Rattus norvegicus,5353,BAO_0000218,,1,1,,CHEMBL618662,,
7542,Intermediate,,,,Half life period after 3 mg/kg iv administration,50597,Rattus norvegicus,2864,BAO_0000218,,1,1,,CHEMBL618663,,
7543,Intermediate,,,,Half life period after 3 mg/kg iv administration in rat,50597,Rattus norvegicus,2864,BAO_0000218,,1,1,,CHEMBL618664,,
7544,Intermediate,,,,Half life period after 3 mg/kg iv administration in the rat,50597,Rattus norvegicus,2864,BAO_0000218,,1,1,,CHEMBL618665,,
7545,Intermediate,,,,Half life period in female Sprague-Dawley rats,50597,Rattus norvegicus,6362,BAO_0000218,,1,1,,CHEMBL876498,,
7546,Intermediate,,,,Half life period in rat,50597,Rattus norvegicus,6249,BAO_0000218,,1,1,,CHEMBL618666,,
7547,Intermediate,,,,Half-life in rats was determined,50597,Rattus norvegicus,3169,BAO_0000218,,1,1,,CHEMBL620440,,
7548,Intermediate,,,,Half-life in rats with metabolic oxidation,50597,Rattus norvegicus,3169,BAO_0000218,,1,1,,CHEMBL620441,,
7549,Intermediate,,,,Half-life in rats,50597,Rattus norvegicus,3169,BAO_0000218,,1,1,,CHEMBL620442,,
7550,Intermediate,,,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,50597,Rattus norvegicus,17260,BAO_0000218,,1,1,,CHEMBL620443,,
7551,Intermediate,,,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,50597,Rattus norvegicus,17260,BAO_0000218,,1,1,,CHEMBL620444,,
7552,Intermediate,,,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,50597,Rattus norvegicus,17260,BAO_0000218,,1,1,,CHEMBL620445,,
7553,Intermediate,,,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,50597,Rattus norvegicus,17260,BAO_0000218,,1,1,,CHEMBL620446,,
7554,Intermediate,,Plasma,1969.0,Biological half-life measured in plasma of rat,50597,Rattus norvegicus,2879,BAO_0000218,,1,1,,CHEMBL620447,,
7555,Intermediate,,Plasma,1969.0,Biological half-life measured in plasma of rat; 22-25,50597,Rattus norvegicus,2879,BAO_0000218,,1,1,,CHEMBL621129,,
7556,Intermediate,,Plasma,1969.0,Biological half-life measured in plasma of rat; 9-16,50597,Rattus norvegicus,2879,BAO_0000218,,1,1,,CHEMBL621130,,
7557,Intermediate,,,,Compound was evaluated for its half life when administered intravenously in rat,50597,Rattus norvegicus,3184,BAO_0000218,,1,1,,CHEMBL873808,,
7558,Intermediate,,,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,50597,Rattus norvegicus,4891,BAO_0000218,,1,1,,CHEMBL876598,,
7559,Intermediate,,,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,50597,Rattus norvegicus,429,BAO_0000218,,1,1,,CHEMBL621131,,
7560,Intermediate,,,,Half life (T1/2) after oral administration in rat,50597,Rattus norvegicus,5656,BAO_0000218,,1,1,,CHEMBL621132,,
7561,Intermediate,,,,Half life of compound after iv administration of 20 mg/kg dose in rat,50597,Rattus norvegicus,4413,BAO_0000218,,1,1,,CHEMBL621133,,
7562,Expert,,,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,50597,Rattus norvegicus,3598,BAO_0000218,,1,1,,CHEMBL621312,,
7563,Intermediate,,,,Half life of compound was determined in rat,50597,Rattus norvegicus,17267,BAO_0000218,,1,1,,CHEMBL621313,,
7564,Intermediate,,Blood,178.0,Half life of compound was determined in rat blood,50597,Rattus norvegicus,4727,BAO_0000218,,1,1,,CHEMBL621314,,
7565,Intermediate,,,,Half life at 1 mg/kg was determined in rat,50597,Rattus norvegicus,17651,BAO_0000218,,1,1,,CHEMBL621315,,
7566,Intermediate,,,,Half life at 10 mg/kg was determined in rat,50597,Rattus norvegicus,17651,BAO_0000218,,1,1,,CHEMBL621316,,
7567,Intermediate,,,,Half life in rats,50597,Rattus norvegicus,401,BAO_0000218,,1,1,,CHEMBL621317,,
7568,Intermediate,,,,Half life in rats in hours,50597,Rattus norvegicus,4942,BAO_0000218,,1,1,,CHEMBL621318,,
7569,Intermediate,,,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,50597,Rattus norvegicus,17735,BAO_0000218,,1,1,,CHEMBL621319,,
7570,Intermediate,,,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,50597,Rattus norvegicus,6056,BAO_0000218,,1,1,,CHEMBL621377,,
7571,Intermediate,,,,Half life was determined,50597,Rattus norvegicus,5213,BAO_0000218,,1,1,,CHEMBL621378,,
7572,Intermediate,,,,Half life after i.v. administration,50597,Rattus norvegicus,6616,BAO_0000218,,1,1,,CHEMBL876599,,
7573,Intermediate,,,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,50597,Rattus norvegicus,5937,BAO_0000218,,1,1,,CHEMBL621379,,
7574,Intermediate,,Plasma,1969.0,Half life in rat plasma,50597,Rattus norvegicus,5819,BAO_0000218,,1,1,,CHEMBL621380,,
7575,Intermediate,,Plasma,1969.0,Half life in rat plasma; Not detected,50597,Rattus norvegicus,5819,BAO_0000218,,1,1,,CHEMBL621381,,
7576,Intermediate,,,,Half life in rats,50597,Rattus norvegicus,6803,BAO_0000218,,1,1,,CHEMBL618515,,
7577,Intermediate,,,,Half life period of compound was determined after peroral administration,50597,Rattus norvegicus,17804,BAO_0000218,,1,1,,CHEMBL618516,,
7578,Intermediate,,,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,50597,Rattus norvegicus,17804,BAO_0000218,,1,1,,CHEMBL618517,,
7579,Intermediate,,,,Half life period in rat,50597,Rattus norvegicus,5948,BAO_0000218,,1,1,,CHEMBL618518,,
7580,Intermediate,,,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,50597,Rattus norvegicus,1916,BAO_0000218,,1,1,,CHEMBL618519,,
7581,Intermediate,,,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,50597,Rattus norvegicus,1916,BAO_0000218,,1,1,,CHEMBL618698,,
7582,Intermediate,,,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,50597,Rattus norvegicus,1916,BAO_0000218,,1,1,,CHEMBL618862,,
7583,Intermediate,,,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,50597,Rattus norvegicus,4890,BAO_0000218,,1,1,,CHEMBL618863,,
7584,Intermediate,,,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,50597,Rattus norvegicus,17764,BAO_0000218,,1,1,,CHEMBL618864,,
7585,Intermediate,,,,Half life time in rat the dose of 2 mg/kg,50597,Rattus norvegicus,4727,BAO_0000218,,1,1,,CHEMBL618865,,
7586,Intermediate,,,,Half-life 24 hr after 10 mg/kg iv administration in rats,50597,Rattus norvegicus,17509,BAO_0000218,,1,1,,CHEMBL618866,,
7587,Intermediate,,,,Half-life 24 hr after 2 mg/kg iv administration in rats,50597,Rattus norvegicus,17509,BAO_0000218,,1,1,,CHEMBL618867,,
7588,Intermediate,,,,Half-life consistent with the observed metabolic steady state in rats,50597,Rattus norvegicus,6597,BAO_0000218,,1,1,,CHEMBL875828,,
7589,Intermediate,,,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,50597,Rattus norvegicus,17735,BAO_0000218,,1,1,,CHEMBL618868,,
7590,Intermediate,,,,Half-life for oxidative metabolic stability was determined using male human,50597,Rattus norvegicus,6597,BAO_0000218,,1,1,,CHEMBL618869,,
7591,Intermediate,,,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",50597,Rattus norvegicus,17670,BAO_0000218,,1,1,,CHEMBL618870,,
7592,Intermediate,,Plasma,1969.0,Half-life in rat plasma,50597,Rattus norvegicus,1696,BAO_0000218,,1,1,,CHEMBL618871,,
7593,Intermediate,,Plasma,1969.0,Half-life in rat plasma was determined,50597,Rattus norvegicus,1742,BAO_0000218,,1,1,,CHEMBL618872,,
7594,Intermediate,,,,Half-life in rats was determined,50597,Rattus norvegicus,17800,BAO_0000218,,1,1,,CHEMBL873816,,
7595,Autocuration,,,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,22224,,12923,BAO_0000218,,0,1,,CHEMBL618873,,
7596,Autocuration,,,,Area under curve after oral dose of 0.1 mg//kg,22224,,11954,BAO_0000019,,0,1,,CHEMBL621602,,
7597,Autocuration,,,,Area under curve after oral dose of 0.3 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL621603,,
7598,Autocuration,,,,Area under curve after oral dose of 1 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL621604,,
7599,Autocuration,,,,Area under curve after oral dose of 10 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL621605,,
7600,Autocuration,,,,Area under curve after oral dose of 23.4 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL621606,,
7601,Autocuration,,,,Area under curve after oral dose of 3 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL621607,,
7602,Autocuration,,,,Area under curve after oral dose of 3.87 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL621608,,
7603,Autocuration,,,,Area under curve was determined,22224,,5237,BAO_0000019,,0,1,,CHEMBL621609,,
7604,Autocuration,,,,Area under curve at a dose of 10 mg/kg,22224,,4026,BAO_0000218,,0,1,,CHEMBL621610,,
7605,Intermediate,,,,Area under curve was determined; ND=No data,50597,Rattus norvegicus,5237,BAO_0000218,,1,1,,CHEMBL621611,,
7606,Intermediate,,,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL621612,,
7607,Intermediate,,,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL622308,,
7608,Intermediate,,,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL622309,,
7609,Intermediate,,,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL622310,,
7610,Intermediate,,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL622311,,
7611,Intermediate,,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL622312,,
7612,Intermediate,,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL622931,,
7613,Intermediate,,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL622932,,
7614,Intermediate,,Plasma,1969.0,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL622736,,
7615,Intermediate,,Plasma,1969.0,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL622737,,
7616,Intermediate,,Plasma,1969.0,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL622738,,
7617,Intermediate,,Plasma,1969.0,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL622739,,
7618,Intermediate,,Plasma,1969.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL622740,,
7619,Intermediate,,Plasma,1969.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL622741,,
7620,Intermediate,,Plasma,1969.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL622742,,
7621,Intermediate,,Plasma,1969.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL622743,,
7622,Intermediate,,Plasma,1969.0,AUC in mice,50594,Mus musculus,11637,BAO_0000218,,1,1,,CHEMBL622744,,
7623,Autocuration,,,,Area under curve was measured from the graph obtained from concentration Vs time,22224,,11149,BAO_0000019,,0,1,,CHEMBL624134,,
7624,Autocuration,,,,Area under curve value of compound per hour after oral administration,22224,,10016,BAO_0000019,,0,1,,CHEMBL624135,,
7625,Intermediate,,,,Area under curve was determined after oral administration in rats,50597,Rattus norvegicus,17796,BAO_0000218,,1,1,,CHEMBL624136,,
7626,Intermediate,,,,Area under curve was determined after oral administration in rats; No data,50597,Rattus norvegicus,17796,BAO_0000218,,1,1,,CHEMBL624137,,
7627,Intermediate,,,,Area under curve was determined after oral administration in rats;No data,50597,Rattus norvegicus,17796,BAO_0000218,,1,1,,CHEMBL624320,,
7628,Intermediate,,,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,50588,Canis lupus familiaris,12923,BAO_0000218,,1,1,,CHEMBL624321,,
7629,Intermediate,,,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL624322,,
7630,Intermediate,,,,Area under curve was determined for the compound after iv dose of 5.06 in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL624323,,
7631,Intermediate,,,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL624324,,
7632,Intermediate,,,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL624325,,
7633,Intermediate,,,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL624326,,
7634,Intermediate,,,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL624327,,
7635,Intermediate,,,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL624328,,
7636,Intermediate,,,,Area under curve was determined in Dogs after peroral administration,50588,Canis lupus familiaris,14169,BAO_0000218,,1,1,,CHEMBL627848,,
7637,Intermediate,,,,Area under curve was determined in Rats after peroral administration,50597,Rattus norvegicus,14169,BAO_0000218,,1,1,,CHEMBL627849,,
7638,Intermediate,,,,Area under curve was determined in carotid blood of rat when administered intradermally,50597,Rattus norvegicus,14258,BAO_0000218,,1,1,,CHEMBL627850,,
7639,Intermediate,,,,Area under curve was determined in portal blood of rat when administered intradermally,50597,Rattus norvegicus,14258,BAO_0000218,,1,1,,CHEMBL627851,,
7640,Intermediate,,,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,50594,Mus musculus,15011,BAO_0000218,,1,1,,CHEMBL627852,,
7641,Intermediate,,,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,50594,Mus musculus,15011,BAO_0000218,,1,1,,CHEMBL627853,,
7642,Intermediate,,,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),50594,Mus musculus,15011,BAO_0000218,,1,1,,CHEMBL627854,,
7643,Intermediate,,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,50594,Mus musculus,15011,BAO_0000218,,1,1,,CHEMBL627855,,
7644,Intermediate,,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),50594,Mus musculus,15011,BAO_0000218,,1,1,,CHEMBL627856,,
7645,Intermediate,,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,50594,Mus musculus,15011,BAO_0000218,,1,1,,CHEMBL875339,,
7646,Intermediate,,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),50594,Mus musculus,15011,BAO_0000218,,1,1,,CHEMBL627857,,
7647,Intermediate,,Spleen,2106.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL627858,,
7648,Intermediate,,Blood,178.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627859,,
7649,Intermediate,,Brain,955.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627860,,
7650,Intermediate,,Heart,948.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627019,,
7651,Intermediate,,Liver,2107.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627020,,
7652,Intermediate,,Lung,2048.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627021,,
7653,Intermediate,,Muscle tissue,2385.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627022,,
7654,Intermediate,,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627023,,
7655,Intermediate,,Spleen,2106.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627024,,
7656,Intermediate,,Thyroid gland,2046.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627025,,
7657,Intermediate,,Kidney,2113.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627026,,
7658,Intermediate,,Blood,178.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627027,,
7659,Intermediate,,Brain,955.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627028,,
7660,Intermediate,,Heart,948.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627029,,
7661,Intermediate,,Kidney,2113.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627030,,
7662,Intermediate,,Liver,2107.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627031,,
7663,Intermediate,,Lung,2048.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627032,,
7664,Intermediate,,Muscle tissue,2385.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627033,,
7665,Intermediate,,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627034,,
7666,Intermediate,,Spleen,2106.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627035,,
7667,Intermediate,,Thyroid gland,2046.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627036,,
7668,Intermediate,,Blood,178.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL875340,,
7669,Intermediate,,Heart,948.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627037,,
7670,Intermediate,,Kidney,2113.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627038,,
7671,Intermediate,,Liver,2107.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627039,,
7672,Intermediate,,Muscle tissue,2385.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL627040,,
7673,Intermediate,,Spleen,2106.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL624663,,
7674,Intermediate,,Thyroid gland,2046.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL625963,,
7675,Intermediate,,Brain,955.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL876799,,
7676,Intermediate,,Lung,2048.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL626133,,
7677,Intermediate,,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL626134,,
7678,Intermediate,,,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,50597,Rattus norvegicus,6295,BAO_0000218,,1,1,,CHEMBL626135,,
7679,Intermediate,,,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,50597,Rattus norvegicus,6296,BAO_0000218,,1,1,,CHEMBL626136,,
7680,Intermediate,,,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,50597,Rattus norvegicus,6296,BAO_0000218,,1,1,,CHEMBL626137,,
7681,Intermediate,,,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,50597,Rattus norvegicus,6295,BAO_0000218,,1,1,,CHEMBL626138,,
7682,Intermediate,,,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,50597,Rattus norvegicus,6296,BAO_0000218,,1,1,,CHEMBL626139,,
7683,Intermediate,,,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,50597,Rattus norvegicus,17260,BAO_0000218,,1,1,,CHEMBL626140,,
7684,Intermediate,,,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,50597,Rattus norvegicus,17260,BAO_0000218,,1,1,,CHEMBL626141,,
7685,Intermediate,,,,C24h in rat p.o. at 20 mg/kg concentration,50597,Rattus norvegicus,17686,BAO_0000218,,1,1,,CHEMBL626142,,
7686,Intermediate,,Muscle tissue,2385.0,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627930,,
7687,Intermediate,,Muscle tissue,2385.0,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627931,,
7688,Intermediate,,Muscle tissue,2385.0,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627932,,
7689,Intermediate,,Spleen,2106.0,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627933,,
7690,Intermediate,,Spleen,2106.0,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627934,,
7691,Intermediate,,Spleen,2106.0,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627935,,
7692,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627936,,
7693,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627937,,
7694,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627938,,
7695,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627939,,
7696,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627940,,
7697,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627941,,
7698,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL876800,,
7699,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627942,,
7700,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627943,,
7701,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627944,,
7702,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627945,,
7703,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL628584,,
7704,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of GdDTPA at 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL628585,,
7705,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL628586,,
7706,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of GdDTPA at 30 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL628587,,
7707,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL628588,,
7708,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL628589,,
7709,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL625304,,
7710,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL625305,,
7711,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL625306,,
7712,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL625307,,
7713,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL625308,,
7714,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627740,,
7715,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627741,,
7716,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627742,,
7717,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627743,,
7718,Intermediate,,Blood,178.0,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627744,,
7719,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627745,,
7720,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627746,,
7721,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627747,,
7722,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL876810,,
7723,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627748,,
7724,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627749,,
7725,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL627750,,
7726,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618728,,
7727,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618729,,
7728,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of GdDTPA at 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618730,,
7729,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618731,,
7730,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of GdDTPA at 30 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618732,,
7731,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618733,,
7732,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618734,,
7733,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618735,,
7734,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL876602,,
7735,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618736,,
7736,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618737,,
7737,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618738,,
7738,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618739,,
7739,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618740,,
7740,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618741,,
7741,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618742,,
7742,Intermediate,,Bone,10000001.0,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL618743,,
7743,Intermediate,,Plasma,1969.0,Half-life from rat plasma at a single oral dose of 25 mg/kg,50597,Rattus norvegicus,17752,BAO_0000218,,1,1,,CHEMBL618744,,
7744,Intermediate,,,,Half-life in male rat,50597,Rattus norvegicus,5610,BAO_0000218,,1,1,,CHEMBL618745,,
7745,Intermediate,,,,Half-life in rat after peroral administration at 10 mg/kg concentration,50597,Rattus norvegicus,5939,BAO_0000218,,1,1,,CHEMBL620479,,
7746,Intermediate,,,,Half-life in rat after peroral administration at 5 mg/kg concentration,50597,Rattus norvegicus,5939,BAO_0000218,,1,1,,CHEMBL620480,,
7747,Intermediate,,,,Half-life in rat at a dose of 3 mg/kg,50597,Rattus norvegicus,17771,BAO_0000218,,1,1,,CHEMBL620481,,
7748,Intermediate,,,,Half-life was evaluated in rats,50597,Rattus norvegicus,1974,BAO_0000218,,1,1,,CHEMBL620482,,
7749,Intermediate,,,,Half-life was measured in rat,50597,Rattus norvegicus,4239,BAO_0000218,,1,1,,CHEMBL876603,,
7750,Intermediate,,,,Half-life period for the compound was determined in rats at 50 mg/kg dose,50597,Rattus norvegicus,6681,BAO_0000218,,1,1,,CHEMBL620483,,
7751,Intermediate,,,,Half-life period in rats after intravenous administration at 5 mg/kg,50597,Rattus norvegicus,17752,BAO_0000218,,1,1,,CHEMBL620484,,
7752,Intermediate,,,,Half-life period in rat at 10 mg/kg,50597,Rattus norvegicus,6046,BAO_0000218,,1,1,,CHEMBL620485,,
7753,Intermediate,,,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL620486,,
7754,Intermediate,,,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL620487,,
7755,Intermediate,,,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL620488,,
7756,Intermediate,,,,Half-life time in rat the dose of 2 mg/kg,50597,Rattus norvegicus,4727,BAO_0000218,,1,1,,CHEMBL620489,,
7757,Intermediate,,,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,50597,Rattus norvegicus,1088,BAO_0000218,,1,1,,CHEMBL620490,,
7758,Intermediate,,,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,50597,Rattus norvegicus,5610,BAO_0000218,,1,1,,CHEMBL620491,,
7759,Intermediate,,Plasma,1969.0,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",50597,Rattus norvegicus,3032,BAO_0000218,,1,1,,CHEMBL876604,,
7760,Intermediate,,,,Oral half life was determined,50597,Rattus norvegicus,5199,BAO_0000218,,1,1,,CHEMBL620492,,
7761,Intermediate,,,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",50597,Rattus norvegicus,14941,BAO_0000218,,1,1,,CHEMBL620493,,
7762,Intermediate,,,,Pharmacokinetic property (t1/2) in rat,50597,Rattus norvegicus,4408,BAO_0000218,,1,1,,CHEMBL620494,,
7763,Intermediate,,Plasma,1969.0,Plasma elimination half-life was determined,50597,Rattus norvegicus,2552,BAO_0000218,,1,1,,CHEMBL620495,,
7764,Intermediate,,Plasma,1969.0,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,50597,Rattus norvegicus,5199,BAO_0000218,,1,1,,CHEMBL620496,,
7765,Intermediate,,Plasma,1969.0,Plasma half life was observed after intravenous administration in rat,50597,Rattus norvegicus,15662,BAO_0000218,,1,1,,CHEMBL620497,,
7766,Intermediate,,Plasma,1969.0,Plasma half-life was determined,50597,Rattus norvegicus,1465,BAO_0000218,,1,1,,CHEMBL620498,,
7767,Intermediate,,Plasma,1969.0,Plasma half-life following oral administration in Fisher rats,50597,Rattus norvegicus,1446,BAO_0000218,,1,1,,CHEMBL620499,,
7768,Intermediate,,Plasma,1969.0,Plasma half-life in rat,50597,Rattus norvegicus,6824,BAO_0000218,,1,1,,CHEMBL620500,,
7769,Intermediate,,Plasma,1969.0,Plasmatic Half-life after intravenous administration to rat,50597,Rattus norvegicus,17533,BAO_0000218,,1,1,,CHEMBL873809,,
7770,Intermediate,,,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,50597,Rattus norvegicus,5979,BAO_0000218,,1,1,,CHEMBL620501,,
7771,Intermediate,,,,Terminal half life after intravenous administration (1 mg/kg) in rat,50597,Rattus norvegicus,4689,BAO_0000218,,1,1,,CHEMBL620502,,
7772,Intermediate,,,,Terminal half life in Rat at a oral dose of 5 mg/kg,50597,Rattus norvegicus,4689,BAO_0000218,,1,1,,CHEMBL620503,,
7773,Intermediate,,,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,50597,Rattus norvegicus,2463,BAO_0000218,,1,1,,CHEMBL620504,,
7774,Intermediate,,,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,50597,Rattus norvegicus,4883,BAO_0000218,,1,1,,CHEMBL876605,,
7775,Intermediate,,,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,50597,Rattus norvegicus,4883,BAO_0000218,,1,1,,CHEMBL620505,,
7776,Intermediate,,Plasma,1969.0,plasma half life was observed after intravenous administration in rat,50597,Rattus norvegicus,15662,BAO_0000218,,1,1,,CHEMBL873811,,
7777,Expert,,,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,50597,Rattus norvegicus,3598,BAO_0000218,,1,1,,CHEMBL624016,,
7778,Intermediate,,,,Half life of compound determined in rat,50597,Rattus norvegicus,4576,BAO_0000218,,1,1,,CHEMBL624017,,
7779,Intermediate,,,,Mean residence time determined in rat,50597,Rattus norvegicus,4576,BAO_0000218,,1,1,,CHEMBL624018,,
7780,Intermediate,,,,Plasma half life determined in rat,50597,Rattus norvegicus,4576,BAO_0000218,,1,1,,CHEMBL624019,,
7781,Intermediate,,Brain,955.0,Compound was evaluated for Tmax in brain after intravenous administration in male rats,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL624020,,
7782,Intermediate,,,,Compound was evaluated for pharmacokinetic parameter maximum time period,50597,Rattus norvegicus,4891,BAO_0000218,,1,1,,CHEMBL624201,,
7783,Intermediate,,,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,50597,Rattus norvegicus,429,BAO_0000218,,1,1,,CHEMBL872528,,
7784,Intermediate,,,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL624202,,
7785,Intermediate,,,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL624203,,
7786,Intermediate,,,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL624350,,
7787,Intermediate,,,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL621320,,
7788,Intermediate,,,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,50597,Rattus norvegicus,17582,BAO_0000218,,1,1,,CHEMBL621321,,
7789,Intermediate,,,,Maximum time (Tmax) required to reach Cmax in rats,50597,Rattus norvegicus,4026,BAO_0000218,,1,1,,CHEMBL621322,,
7790,Intermediate,,,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,50597,Rattus norvegicus,4890,BAO_0000218,,1,1,,CHEMBL621323,,
7791,Intermediate,,,,Maximum time of clearance of compound in rats after peroral administration,50597,Rattus norvegicus,6571,BAO_0000218,,1,1,,CHEMBL621324,,
7792,Intermediate,,,,Maximum time at the dose of 2 mg/kg in rat,50597,Rattus norvegicus,4727,BAO_0000218,,1,1,,CHEMBL621325,,
7793,Intermediate,,Plasma,1969.0,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,50597,Rattus norvegicus,17651,BAO_0000218,,1,1,,CHEMBL875837,,
7794,Intermediate,,Plasma,1969.0,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,50597,Rattus norvegicus,17651,BAO_0000218,,1,1,,CHEMBL621326,,
7795,Intermediate,,,,Tmax in Guinea pig (PO dose),50597,Rattus norvegicus,14465,BAO_0000218,,1,1,,CHEMBL621327,,
7796,Intermediate,,,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",50597,Rattus norvegicus,14941,BAO_0000218,,1,1,,CHEMBL621328,,
7797,Intermediate,,,,Pharmacokinetic parameter (Tmax) in rat,50597,Rattus norvegicus,5960,BAO_0000218,,1,1,,CHEMBL621329,,
7798,Intermediate,,,,Pharmacokinetic parameter (Tmax) was estimated,50597,Rattus norvegicus,5022,BAO_0000218,,1,1,,CHEMBL621330,,
7799,Intermediate,,,,Pharmacokinetic property (Tmax) in rat,50597,Rattus norvegicus,4408,BAO_0000218,,1,1,,CHEMBL621331,,
7800,Intermediate,,,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,50597,Rattus norvegicus,5983,BAO_0000218,,1,1,,CHEMBL621332,,
7801,Intermediate,,,,T max in Rat at a oral dose of 5 mg/kg,50597,Rattus norvegicus,4689,BAO_0000218,,1,1,,CHEMBL621333,,
7802,Intermediate,,,,T max was determined at 10 mg/kg po dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL621334,,
7803,Intermediate,,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),50594,Mus musculus,15011,BAO_0000218,,1,1,,CHEMBL621335,,
7804,Intermediate,,,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,50588,Canis lupus familiaris,14180,BAO_0000218,,1,1,,CHEMBL621336,,
7805,Intermediate,,,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,50597,Rattus norvegicus,14180,BAO_0000218,,1,1,,CHEMBL621337,,
7806,Intermediate,,,,Area under curve was measured after i.v. administration into Beagle dog.,50588,Canis lupus familiaris,14599,BAO_0000218,,1,1,,CHEMBL621338,,
7807,Intermediate,,,,Area under curve was measured after iv administration into Beagle dog,50588,Canis lupus familiaris,14599,BAO_0000218,,1,1,,CHEMBL875838,,
7808,Intermediate,,,,Area under curve was measured after po administration into Beagle dog,50588,Canis lupus familiaris,14599,BAO_0000218,,1,1,,CHEMBL621339,,
7809,Intermediate,,,,Area under curve was measured after po administration into Beagle dog.,50588,Canis lupus familiaris,14599,BAO_0000218,,1,1,,CHEMBL621340,,
7810,Autocuration,,,,Area under curve was measured at peroral dose of 3 mg/kg,22224,,15675,BAO_0000218,,0,1,,CHEMBL621341,,
7811,Autocuration,,,,Area under curve was measured by using concentration Vs time,22224,,12706,BAO_0000019,,0,1,,CHEMBL621342,,
7812,Autocuration,,,,Area under curve was measured by using concentration Vs time; not tested,22224,,12706,BAO_0000019,,0,1,,CHEMBL621343,,
7813,Intermediate,,,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),50594,Mus musculus,9750,BAO_0000218,,1,1,,CHEMBL621344,,
7814,Intermediate,,,,Area under curve(AUC) was measured in mice after oral administration.,50594,Mus musculus,9750,BAO_0000218,,1,1,,CHEMBL621345,,
7815,Autocuration,,,,Area under curve(AUC) value of the compound,22224,,14691,BAO_0000019,,0,1,,CHEMBL621346,,
7816,Autocuration,,,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,22224,,14691,BAO_0000218,,0,1,,CHEMBL621347,,
7817,Intermediate,,,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,50588,Canis lupus familiaris,14691,BAO_0000218,,1,1,,CHEMBL621348,,
7818,Autocuration,,Blood,178.0,Area under curve(carotid artery) was determined by the availability in blood,22224,,2939,BAO_0000019,,0,1,,CHEMBL621349,,
7819,Autocuration,,Blood,178.0,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,22224,,2939,BAO_0000019,,0,1,,CHEMBL621350,,
7820,Autocuration,,Blood,178.0,Area under curve(carotid artery) was determined by the availability in blood; No data,22224,,2939,BAO_0000019,,0,1,,CHEMBL875839,,
7821,Autocuration,,Blood,178.0,Area under curve(portal vein) was determined by the availability in blood,22224,,2939,BAO_0000019,,0,1,,CHEMBL620211,,
7822,Autocuration,,Blood,178.0,Area under curve(portal vein) was determined by the availability in blood; ND means no data,22224,,2939,BAO_0000019,,0,1,,CHEMBL620212,,
7823,Autocuration,,Blood,178.0,Area under curve(portal vein) was determined by the availability in blood; No data,22224,,2939,BAO_0000019,,0,1,,CHEMBL620213,,
7824,Intermediate,,Plasma,1969.0,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",50797,Macaca mulatta,9552,BAO_0000218,,1,1,,CHEMBL620214,,
7825,Intermediate,,Plasma,1969.0,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",50797,Macaca mulatta,9552,BAO_0000218,,1,1,,CHEMBL620215,,
7826,Intermediate,,Plasma,1969.0,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,50797,Macaca mulatta,9552,BAO_0000218,,1,1,,CHEMBL620216,,
7827,Intermediate,,Plasma,1969.0,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",50588,Canis lupus familiaris,9552,BAO_0000218,,1,1,,CHEMBL620888,,
7828,Intermediate,,Plasma,1969.0,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",50588,Canis lupus familiaris,9552,BAO_0000218,,1,1,,CHEMBL620889,,
7829,Autocuration,,Plasma,1969.0,Area under plasma concentration vs time curve observed in rats for 0-3 h,22224,,9552,BAO_0000019,,0,1,,CHEMBL620890,,
7830,Intermediate,,Plasma,1969.0,Area under plasma time curve determined in male rat,50597,Rattus norvegicus,11911,BAO_0000218,,1,1,,CHEMBL620891,,
7831,Autocuration,,,,Area under the MAP curve measured over 5 min.,22224,,16618,BAO_0000019,,0,1,,CHEMBL620892,,
7832,Intermediate,,,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,50594,Mus musculus,14387,BAO_0000218,,1,1,,CHEMBL621079,,
7833,Intermediate,,,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,50594,Mus musculus,14387,BAO_0000218,,1,1,,CHEMBL621080,,
7834,Intermediate,,,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,50588,Canis lupus familiaris,12836,BAO_0000218,,1,1,,CHEMBL621081,,
7835,Intermediate,,,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,100712,Cricetinae,12836,BAO_0000218,,1,1,,CHEMBL621082,,
7836,Intermediate,,,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,50597,Rattus norvegicus,12836,BAO_0000218,,1,1,,CHEMBL621083,,
7837,Intermediate,,,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,50588,Canis lupus familiaris,14339,BAO_0000218,,1,1,,CHEMBL621084,,
7838,Intermediate,,,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,50588,Canis lupus familiaris,14339,BAO_0000218,,1,1,,CHEMBL621085,,
7839,Intermediate,,,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,50588,Canis lupus familiaris,14339,BAO_0000218,,1,1,,CHEMBL621086,,
7840,Intermediate,,,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),50588,Canis lupus familiaris,10524,BAO_0000218,,1,1,,CHEMBL621087,,
7841,Intermediate,,,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),50588,Canis lupus familiaris,9994,BAO_0000218,,1,1,,CHEMBL622607,,
7842,Intermediate,,,,Serum AUC in marmosets (IV dose),50588,Canis lupus familiaris,11325,BAO_0000218,,1,1,,CHEMBL622608,,
7843,Autocuration,,,,Area under the curve after intravenous administration at a dose of 10 umol/kg,22224,,12536,BAO_0000019,,0,1,,CHEMBL624481,,
7844,Autocuration,,,,Area under the curve after intravenous administration at a dose of 2 umol/kg,22224,,12536,BAO_0000019,,0,1,,CHEMBL624482,,
7845,Autocuration,,,,Area under the curve after intravenous administration at a dose of 4 umol/kg,22224,,12536,BAO_0000019,,0,1,,CHEMBL624483,,
7846,Autocuration,,,,Area under the curve after intravenous administration at a dose of 40 umol/kg,22224,,12536,BAO_0000019,,0,1,,CHEMBL624484,,
7847,Autocuration,,,,Area under the curve after intravenous administration at a dose of 5 umol/kg,22224,,12536,BAO_0000019,,0,1,,CHEMBL624485,,
7848,Intermediate,,,,Area under the curve for fumarate salt was evaluated in F344 Rats.,50597,Rattus norvegicus,15556,BAO_0000218,,1,1,,CHEMBL624486,,
7849,Autocuration,,,,Area under the curve for the compound was calculated.,22224,,2809,BAO_0000019,,0,1,,CHEMBL624487,,
7850,Autocuration,,,,Area under the curve in concentration/ time,22224,,9511,BAO_0000019,,0,1,,CHEMBL624488,,
7851,Intermediate,,,,Area under the curve administered intraintestinal in rats.,50597,Rattus norvegicus,12818,BAO_0000218,,1,1,,CHEMBL624489,,
7852,Intermediate,,,,Area under the curve administered intravenously in rats.,50597,Rattus norvegicus,12818,BAO_0000218,,1,1,,CHEMBL625184,,
7853,Autocuration,,,,Area under the curve during intravenous administration,22224,,15118,BAO_0000019,,0,1,,CHEMBL625185,,
7854,Autocuration,,,,Area under the curve during intravenous administration; Not determined,22224,,15118,BAO_0000019,,0,1,,CHEMBL875954,,
7855,Autocuration,,,,Area under the curve during systemic administration,22224,,15118,BAO_0000019,,0,1,,CHEMBL625186,,
7856,Autocuration,,,,Area under the curve during systemic administration; Not determined,22224,,15118,BAO_0000019,,0,1,,CHEMBL625187,,
7857,Autocuration,,,,Area under the curve was calculated for the compound.,22224,,2632,BAO_0000019,,0,1,,CHEMBL625188,,
7858,Intermediate,,,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,50588,Canis lupus familiaris,14346,BAO_0000218,,1,1,,CHEMBL625189,,
7859,Intermediate,,,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,50588,Canis lupus familiaris,14346,BAO_0000218,,1,1,,CHEMBL625190,,
7860,Intermediate,,,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL621733,,
7861,Intermediate,,,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL621734,,
7862,Intermediate,,,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,50597,Rattus norvegicus,11149,BAO_0000218,,1,1,,CHEMBL621735,,
7863,Intermediate,,Plasma,1969.0,Clearance of the drug was measured in the plasma of rat; No data,50597,Rattus norvegicus,17796,BAO_0000218,,1,1,,CHEMBL621736,,
7864,Intermediate,,Plasma,1969.0,The pharmacokinetic parameter plasma clearance in vivo in rats,50597,Rattus norvegicus,5247,BAO_0000218,,1,1,,CHEMBL621737,,
7865,Intermediate,,,,Plasma clearance at the dose of 2 mg/kg in rat,50597,Rattus norvegicus,4727,BAO_0000218,,1,1,,CHEMBL621738,,
7866,Intermediate,,,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,50597,Rattus norvegicus,5654,BAO_0000218,,1,1,,CHEMBL622806,,
7867,Intermediate,,,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,50597,Rattus norvegicus,5654,BAO_0000218,,1,1,,CHEMBL623519,,
7868,Intermediate,,,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,50597,Rattus norvegicus,17260,BAO_0000218,,1,1,,CHEMBL623520,,
7869,Intermediate,,,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,50597,Rattus norvegicus,17065,BAO_0000218,,1,1,,CHEMBL623521,,
7870,Intermediate,,,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,50597,Rattus norvegicus,17671,BAO_0000218,,1,1,,CHEMBL623522,,
7871,Intermediate,,,,Clearance rate in rat,50597,Rattus norvegicus,6672,BAO_0000218,,1,1,,CHEMBL623523,,
7872,Intermediate,,,,Clearance rate in rat,50597,Rattus norvegicus,6673,BAO_0000218,,1,1,,CHEMBL623690,,
7873,Intermediate,,,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL623691,,
7874,Intermediate,,,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL623692,,
7875,Intermediate,,,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL623693,,
7876,Intermediate,,,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL623694,,
7877,Intermediate,,,,Clearance of compound after iv administration of 20 mg/kg dose in rat,50597,Rattus norvegicus,4413,BAO_0000218,,1,1,,CHEMBL623695,,
7878,Intermediate,,,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL623696,,
7879,Intermediate,,,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL623697,,
7880,Intermediate,,Plasma,1969.0,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,22224,Macaca mulatta,5005,BAO_0000218,,0,1,,CHEMBL623698,,
7881,Intermediate,,Plasma,1969.0,Compound was tested for its plasma clearance rate in Sprague Dawley rats,22224,Rattus norvegicus,5005,BAO_0000218,,0,1,,CHEMBL623699,,
7882,Intermediate,,,,Mean (%CV) PK parameters for CL(mL/min/kg).,50597,Rattus norvegicus,15765,BAO_0000218,,1,1,,CHEMBL623700,,
7883,Intermediate,,,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,50597,Rattus norvegicus,3747,BAO_0000218,,1,1,,CHEMBL623701,,
7884,Intermediate,,Plasma,1969.0,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,50597,Rattus norvegicus,16366,BAO_0000218,,1,1,,CHEMBL623702,,
7885,Intermediate,,,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,50597,Rattus norvegicus,4199,BAO_0000218,,1,1,,CHEMBL623703,,
7886,Intermediate,,,,Plasma clearance in rat was determined,50597,Rattus norvegicus,17267,BAO_0000218,,1,1,,CHEMBL623704,,
7887,Intermediate,,,,Plasma clearance in rat after administration of 2 mg/kg iv,50597,Rattus norvegicus,6535,BAO_0000218,,1,1,,CHEMBL623705,,
7888,Intermediate,,,,Plasma clearance in rat after administration of 2 mg/kg iv,50597,Rattus norvegicus,6535,BAO_0000218,,1,1,,CHEMBL623706,,
7889,Intermediate,,,,Plasma clearance was determined,50597,Rattus norvegicus,5041,BAO_0000218,,1,1,,CHEMBL623707,,
7890,Intermediate,,,,Plasma clearance in rat,50597,Rattus norvegicus,5960,BAO_0000218,,1,1,,CHEMBL623708,,
7891,Intermediate,,,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,50597,Rattus norvegicus,5937,BAO_0000218,,1,1,,CHEMBL623709,,
7892,Intermediate,,,,Plasma clearance in rat by iv administration,50597,Rattus norvegicus,5871,BAO_0000218,,1,1,,CHEMBL623710,,
7893,Intermediate,,,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,50597,Rattus norvegicus,5874,BAO_0000218,,1,1,,CHEMBL623711,,
7894,Intermediate,,,,Plasma clearance in rat p.o.,50597,Rattus norvegicus,6504,BAO_0000218,,1,1,,CHEMBL623712,,
7895,Intermediate,,,,Plasma clearance in rats,50597,Rattus norvegicus,6803,BAO_0000218,,1,1,,CHEMBL623713,,
7896,Intermediate,,,,Plasma clearance was determined; ND denotes no data,50597,Rattus norvegicus,5041,BAO_0000218,,1,1,,CHEMBL623714,,
7897,Intermediate,,,,Plasma clearance was determined; ND denotes not determined,50597,Rattus norvegicus,5041,BAO_0000218,,1,1,,CHEMBL623715,,
7898,Intermediate,,,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,50597,Rattus norvegicus,1916,BAO_0000218,,1,1,,CHEMBL623716,,
7899,Intermediate,,,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,50597,Rattus norvegicus,5199,BAO_0000218,,1,1,,CHEMBL622980,,
7900,Intermediate,,,,Plasma administration to rats,50597,Rattus norvegicus,16367,BAO_0000218,,1,1,,CHEMBL622981,,
7901,Intermediate,,,,Plasma clearance of the compound in female Sprague-Dawley rats,50597,Rattus norvegicus,6362,BAO_0000218,,1,1,,CHEMBL622982,,
7902,Intermediate,,,,Plasma clearance was observed after intravenous administration in rat,50597,Rattus norvegicus,15662,BAO_0000218,,1,1,,CHEMBL622983,,
7903,Intermediate,,,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,50597,Rattus norvegicus,6215,BAO_0000218,,1,1,,CHEMBL622984,,
7904,Intermediate,,,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,50597,Rattus norvegicus,1466,BAO_0000218,,1,1,,CHEMBL622985,,
7905,Intermediate,,Plasma,1969.0,plasma clearance was observed after intravenous administration in rat,50597,Rattus norvegicus,15662,BAO_0000218,,1,1,,CHEMBL623631,,
7906,Intermediate,,,,In vivo CL/F determined,50597,Rattus norvegicus,4723,BAO_0000218,,1,1,,CHEMBL623632,,
7907,Intermediate,,Plasma,1969.0,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL623633,,
7908,Intermediate,,Plasma,1969.0,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL623634,,
7909,Intermediate,,,,Compound was tested for the lower blood clearance in rat,50597,Rattus norvegicus,5213,BAO_0000218,,1,1,,CHEMBL623635,,
7910,Intermediate,,,,Evaluated for the low clearance in rat (in vivo),50597,Rattus norvegicus,4687,BAO_0000218,,1,1,,CHEMBL621195,,
7911,Intermediate,,,,Pharmacokinetic property (CLb)of the compound was determined in rat,50597,Rattus norvegicus,3371,BAO_0000218,,1,1,,CHEMBL621196,,
7912,Intermediate,,,,Rapid clearance after intravenous administration in rat was determined,50597,Rattus norvegicus,4690,BAO_0000218,,1,1,,CHEMBL875287,,
7913,Intermediate,,,,Clearance measured in rat,50597,Rattus norvegicus,5702,BAO_0000218,,1,1,,CHEMBL621197,,
7914,Intermediate,,Plasma,1969.0,Compound was evaluated for plasma clearance in rat,50597,Rattus norvegicus,740,BAO_0000218,,1,1,,CHEMBL621198,,
7915,Intermediate,,Plasma,1969.0,Low plasma clearance was calculated in rat,50597,Rattus norvegicus,4853,BAO_0000218,,1,1,,CHEMBL621199,,
7916,Intermediate,,,,Pharmacokinetic property (Clp) in rat,50597,Rattus norvegicus,5789,BAO_0000218,,1,1,,CHEMBL621200,,
7917,Intermediate,,,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,50597,Rattus norvegicus,4527,BAO_0000218,,1,1,,CHEMBL621201,,
7918,Intermediate,,,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,50597,Rattus norvegicus,4527,BAO_0000218,,1,1,,CHEMBL621202,,
7919,Intermediate,,,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL621203,,
7920,Intermediate,,,,Plasma clearance after IV dosing at 1 mg/kg in rat,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL621204,,
7921,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621205,,
7922,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621206,,
7923,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621207,,
7924,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621208,,
7925,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621209,,
7926,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL876484,,
7927,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621210,,
7928,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621211,,
7929,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621212,,
7930,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of GdDTPA at 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621213,,
7931,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621214,,
7932,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of GdDTPA at 30 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621215,,
7933,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621216,,
7934,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621217,,
7935,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621218,,
7936,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621219,,
7937,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621220,,
7938,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621221,,
7939,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621222,,
7940,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621223,,
7941,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL876485,,
7942,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621224,,
7943,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621225,,
7944,Intermediate,,Heart,948.0,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621226,,
7945,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621227,,
7946,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621228,,
7947,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621229,,
7948,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621230,,
7949,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621231,,
7950,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621232,,
7951,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621233,,
7952,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621234,,
7953,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621235,,
7954,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621236,,
7955,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621237,,
7956,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL876486,,
7957,Intermediate,,Intestine,160.0,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622436,,
7958,Intermediate,,Intestine,160.0,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622437,,
7959,Intermediate,,Intestine,160.0,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622438,,
7960,Intermediate,,Liver,2107.0,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622439,,
7961,Intermediate,,Liver,2107.0,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622440,,
7962,Intermediate,,Liver,2107.0,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622441,,
7963,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622442,,
7964,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622443,,
7965,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622444,,
7966,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622445,,
7967,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622446,,
7968,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622447,,
7969,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622448,,
7970,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622449,,
7971,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622450,,
7972,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622451,,
7973,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of GdDTPA at 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622452,,
7974,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622453,,
7975,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of GdDTPA at 30 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622454,,
7976,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL622455,,
7977,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL876024,,
7978,Intermediate,,,,T max was determined at 3 mg/kg po dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL622456,,
7979,Intermediate,,,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL622457,,
7980,Intermediate,,,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL622458,,
7981,Intermediate,,,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,50597,Rattus norvegicus,15022,BAO_0000218,,1,1,,CHEMBL622459,,
7982,Intermediate,,,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,50597,Rattus norvegicus,15022,BAO_0000218,,1,1,,CHEMBL873343,,
7983,Intermediate,,,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,50597,Rattus norvegicus,15022,BAO_0000218,,1,1,,CHEMBL622460,,
7984,Intermediate,,Plasma,1969.0,Time for maximum plasma concentration determined in rat,50597,Rattus norvegicus,4576,BAO_0000218,,1,1,,CHEMBL622461,,
7985,Intermediate,,Plasma,1969.0,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,50597,Rattus norvegicus,6681,BAO_0000218,,1,1,,CHEMBL622462,,
7986,Intermediate,,,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL622463,,
7987,Intermediate,,,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL622464,,
7988,Intermediate,,,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL622465,,
7989,Intermediate,,,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL622466,,
7990,Intermediate,,,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL622467,,
7991,Intermediate,,Plasma,1969.0,Time of maximum plasma concentration in rat,50597,Rattus norvegicus,6824,BAO_0000218,,1,1,,CHEMBL622468,,
7992,Intermediate,,Plasma,1969.0,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL876025,,
7993,Intermediate,,Plasma,1969.0,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL622469,,
7994,Intermediate,,Plasma,1969.0,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL622470,,
7995,Intermediate,,,,Time required to reach maximum concentration (Cmax) after oral administration in rat,50597,Rattus norvegicus,15662,BAO_0000218,,1,1,,CHEMBL622471,,
7996,Intermediate,,Plasma,1969.0,Time required to reach maximum concentration in rat plasma,50597,Rattus norvegicus,1742,BAO_0000218,,1,1,,CHEMBL622472,,
7997,Intermediate,,Plasma,1969.0,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,50597,Rattus norvegicus,2774,BAO_0000218,,1,1,,CHEMBL622473,,
7998,Intermediate,,Plasma,1969.0,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,50597,Rattus norvegicus,5199,BAO_0000218,,1,1,,CHEMBL624282,,
7999,Intermediate,,Plasma,1969.0,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,50597,Rattus norvegicus,12873,BAO_0000218,,1,1,,CHEMBL624283,,
8000,Intermediate,,Plasma,1969.0,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,50597,Rattus norvegicus,12873,BAO_0000218,,1,1,,CHEMBL624284,,
8001,Intermediate,,Plasma,1969.0,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,50597,Rattus norvegicus,1916,BAO_0000218,,1,1,,CHEMBL624285,,
8002,Intermediate,,,,Time to reach Cmax after oral administration to rats,50597,Rattus norvegicus,16367,BAO_0000218,,1,1,,CHEMBL624286,,
8003,Intermediate,,,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,50597,Rattus norvegicus,16366,BAO_0000218,,1,1,,CHEMBL624287,,
8004,Intermediate,,,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,50597,Rattus norvegicus,216,BAO_0000218,,1,1,,CHEMBL624288,,
8005,Intermediate,,Plasma,1969.0,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,50597,Rattus norvegicus,6410,BAO_0000218,,1,1,,CHEMBL624289,,
8006,Intermediate,,Plasma,1969.0,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,50597,Rattus norvegicus,6410,BAO_0000218,,1,1,,CHEMBL873344,,
8007,Intermediate,,,,Tmax after peroral administration (10 mg/kg) was determined in rat,50597,Rattus norvegicus,6215,BAO_0000218,,1,1,,CHEMBL619623,,
8008,Expert,,,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,50597,Rattus norvegicus,3598,BAO_0000218,,1,1,,CHEMBL621399,,
8009,Intermediate,,,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,50597,Rattus norvegicus,4527,BAO_0000218,,1,1,,CHEMBL621400,,
8010,Intermediate,,,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",50597,Rattus norvegicus,17670,BAO_0000218,,1,1,,CHEMBL621401,,
8011,Intermediate,,,,Tmax was determined,50597,Rattus norvegicus,1465,BAO_0000218,,1,1,,CHEMBL621402,,
8012,Intermediate,,,,Tmax was determined,50597,Rattus norvegicus,2552,BAO_0000218,,1,1,,CHEMBL621403,,
8013,Intermediate,,,,Tmax after oral administration in rat,50597,Rattus norvegicus,5656,BAO_0000218,,1,1,,CHEMBL621121,,
8014,Intermediate,,,,Tmax after peroral administration in rats at 2.4 uM/kg,50597,Rattus norvegicus,17764,BAO_0000218,,1,1,,CHEMBL872525,,
8015,Intermediate,,,,Tmax in male rat,50597,Rattus norvegicus,5610,BAO_0000218,,1,1,,CHEMBL621122,,
8016,Intermediate,,,,Tmax in rat at 10 mg/kg,50597,Rattus norvegicus,6046,BAO_0000218,,1,1,,CHEMBL621123,,
8017,Intermediate,,,,Tmax in rat by po administration at a dose of 40 mg/kg,50597,Rattus norvegicus,5874,BAO_0000218,,1,1,,CHEMBL621124,,
8018,Intermediate,,,,Tmax in rats,50597,Rattus norvegicus,17596,BAO_0000218,,1,1,,CHEMBL621125,,
8019,Intermediate,,,,Tmax was measured in rats after peroral administration at 5 mg/kg,50597,Rattus norvegicus,17804,BAO_0000218,,1,1,,CHEMBL621126,,
8020,Intermediate,,,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,50597,Rattus norvegicus,1908,BAO_0000218,,1,1,,CHEMBL621127,,
8021,Intermediate,,,,Tmax value after administration of 20 mg/Kg oral dose in rat,50597,Rattus norvegicus,2959,BAO_0000218,,1,1,,CHEMBL621128,,
8022,Intermediate,,,,Tmax value at a dose of 10 mg/kg in male SD rats,50597,Rattus norvegicus,6757,BAO_0000218,,1,1,,CHEMBL618263,,
8023,Intermediate,,,,Tmax value at a dose of 100 mg/kg in male SD rats,50597,Rattus norvegicus,6757,BAO_0000218,,1,1,,CHEMBL618264,,
8024,Intermediate,,,,Tmax value at a dose of 50 mg/kg in male SD rats,50597,Rattus norvegicus,6757,BAO_0000218,,1,1,,CHEMBL618265,,
8025,Intermediate,,Plasma,1969.0,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,50597,Rattus norvegicus,4186,BAO_0000218,,1,1,,CHEMBL618266,,
8026,Intermediate,,,,time required to reach maximum concentration (Cmax) after oral administration in rat,50597,Rattus norvegicus,15662,BAO_0000218,,1,1,,CHEMBL618267,,
8027,Intermediate,,Urine,1088.0,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),50597,Rattus norvegicus,429,BAO_0000218,,1,1,,CHEMBL618450,,
8028,Intermediate,,Urine,1088.0,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),50597,Rattus norvegicus,429,BAO_0000218,,1,1,,CHEMBL618451,,
8029,Intermediate,,,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,50597,Rattus norvegicus,5546,BAO_0000218,,1,1,,CHEMBL618452,,
8030,Intermediate,,Urine,1088.0,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,50597,Rattus norvegicus,3173,BAO_0000218,,1,1,,CHEMBL618453,,
8031,Intermediate,,Urine,1088.0,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,50597,Rattus norvegicus,3173,BAO_0000218,,1,1,,CHEMBL618454,,
8032,Intermediate,,Urine,1088.0,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,50597,Rattus norvegicus,3173,BAO_0000218,,1,1,,CHEMBL618455,,
8033,Intermediate,,,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,50597,Rattus norvegicus,4257,BAO_0000218,,1,1,,CHEMBL618456,,
8034,Intermediate,,,,Compound distribution in rat tissues was determined,50597,Rattus norvegicus,6011,BAO_0000218,,1,1,,CHEMBL618457,,
8035,Intermediate,,,,Volume of distribution was evaluated in rat,50597,Rattus norvegicus,5472,BAO_0000218,,1,1,,CHEMBL618458,,
8036,Intermediate,,,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL618459,,
8037,Intermediate,,,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL876733,,
8038,Intermediate,,,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,50588,Canis lupus familiaris,14346,BAO_0000218,,1,1,,CHEMBL618460,,
8039,Intermediate,,,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL618461,,
8040,Autocuration,,,,Area under the curve was determined after oral administration (300 uM/Kg),22224,,15469,BAO_0000019,,0,1,,CHEMBL618462,,
8041,Intermediate,,,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL618463,,
8042,Intermediate,,,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL618464,,
8043,Intermediate,,,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL618465,,
8044,Intermediate,,,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL618466,,
8045,Intermediate,,,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL618467,,
8046,Intermediate,,,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL618468,,
8047,Intermediate,,Plasma,1969.0,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,50588,Canis lupus familiaris,12935,BAO_0000218,,1,1,,CHEMBL618469,,
8048,Intermediate,,Plasma,1969.0,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,50588,Canis lupus familiaris,12935,BAO_0000218,,1,1,,CHEMBL618470,,
8049,Autocuration,,,,Plasma drug AUC in rat (PO dose),22224,,14813,BAO_0000218,,0,1,,CHEMBL618471,,
8050,Intermediate,,,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,50594,Mus musculus,15792,BAO_0000218,,1,1,,CHEMBL618472,,
8051,Autocuration,,,,Area under was determined at a dose of 30 mg/kg,22224,,3579,BAO_0000218,,0,1,,CHEMBL618473,,
8052,Intermediate,,,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,50506,Mustela putorius furo,12487,BAO_0000218,,1,1,,CHEMBL621699,,
8053,Intermediate,,,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,50597,Rattus norvegicus,12487,BAO_0000218,,1,1,,CHEMBL621700,,
8054,Intermediate,,,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,50597,Rattus norvegicus,12487,BAO_0000218,,1,1,,CHEMBL621701,,
8055,Intermediate,,,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,50506,Mustela putorius furo,12487,BAO_0000218,,1,1,,CHEMBL621702,,
8056,Intermediate,,,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,50588,Canis lupus familiaris,12487,BAO_0000218,,1,1,,CHEMBL621703,,
8057,Intermediate,,,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,50588,Canis lupus familiaris,12487,BAO_0000218,,1,1,,CHEMBL621704,,
8058,Intermediate,,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",50597,Rattus norvegicus,12902,BAO_0000218,,1,1,,CHEMBL624259,,
8059,Intermediate,,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",50597,Rattus norvegicus,12902,BAO_0000218,,1,1,,CHEMBL624260,,
8060,Intermediate,,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",50597,Rattus norvegicus,12902,BAO_0000218,,1,1,,CHEMBL624430,,
8061,Intermediate,,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",50597,Rattus norvegicus,12902,BAO_0000218,,1,1,,CHEMBL624431,,
8062,Intermediate,,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",50597,Rattus norvegicus,12902,BAO_0000218,,1,1,,CHEMBL624432,,
8063,Intermediate,,,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",50597,Rattus norvegicus,12902,BAO_0000218,,1,1,,CHEMBL624433,,
8064,Intermediate,,,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",50597,Rattus norvegicus,12902,BAO_0000218,,1,1,,CHEMBL624434,,
8065,Intermediate,,,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",50597,Rattus norvegicus,12902,BAO_0000218,,1,1,,CHEMBL624435,,
8066,Intermediate,,,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,50594,Mus musculus,12745,BAO_0000218,,1,1,,CHEMBL618570,,
8067,Intermediate,,,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),50594,Mus musculus,12745,BAO_0000218,,1,1,,CHEMBL618571,,
8068,Intermediate,,,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,50594,Mus musculus,12745,BAO_0000218,,1,1,,CHEMBL618572,,
8069,Intermediate,,,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),50594,Mus musculus,12745,BAO_0000218,,1,1,,CHEMBL618573,,
8070,Intermediate,,,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,50594,Mus musculus,12745,BAO_0000218,,1,1,,CHEMBL619267,,
8071,Intermediate,,,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),50594,Mus musculus,12745,BAO_0000218,,1,1,,CHEMBL619431,,
8072,Intermediate,,,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,50594,Mus musculus,12745,BAO_0000218,,1,1,,CHEMBL619432,,
8073,Intermediate,,,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),50594,Mus musculus,12745,BAO_0000218,,1,1,,CHEMBL619433,,
8074,Autocuration,,Plasma,1969.0,AUC in mice after oral dose (50 mg/kg),22224,,13298,BAO_0000218,,0,1,,CHEMBL619434,,
8075,Intermediate,,Serum,1977.0,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,50594,Mus musculus,12226,BAO_0000218,,1,1,,CHEMBL619435,,
8076,Autocuration,,Plasma,1969.0,AUC (0-4 hr) ug/ml/h,22224,,12634,BAO_0000019,,0,1,,CHEMBL619436,,
8077,Intermediate,,,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,50597,Rattus norvegicus,14810,BAO_0000218,,1,1,,CHEMBL619437,,
8078,Autocuration,,,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,22224,,13889,BAO_0000218,,0,1,,CHEMBL619438,,
8079,Intermediate,,,,Compound was evaluated for Area under curve in mice,50594,Mus musculus,10018,BAO_0000218,,1,1,,CHEMBL619439,,
8080,Intermediate,,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,50597,Rattus norvegicus,8758,BAO_0000218,,1,1,,CHEMBL619440,,
8081,Autocuration,,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,22224,,8758,BAO_0000218,,0,1,,CHEMBL619441,,
8082,Intermediate,,,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,50597,Rattus norvegicus,8758,BAO_0000218,,1,1,,CHEMBL619442,,
8083,Autocuration,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,22224,,2249,BAO_0000019,,0,1,,CHEMBL875156,,
8084,Autocuration,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,22224,,2249,BAO_0000019,,0,1,,CHEMBL619443,,
8085,Autocuration,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,22224,,2249,BAO_0000019,,0,1,,CHEMBL619444,,
8086,Autocuration,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,22224,,2249,BAO_0000019,,0,1,,CHEMBL623464,,
8087,Intermediate,,,,Compound was evaluated for area under curve when administered through oral route in mouse,50594,Mus musculus,15115,BAO_0000218,,1,1,,CHEMBL623465,,
8088,Intermediate,,,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL623466,,
8089,Intermediate,,,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL623467,,
8090,Intermediate,,,,Plasma clearance in rat,50597,Rattus norvegicus,6249,BAO_0000218,,1,1,,CHEMBL623468,,
8091,Intermediate,,,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,50597,Rattus norvegicus,2463,BAO_0000218,,1,1,,CHEMBL622660,,
8092,Intermediate,,,,Plasma clearance rate in Sprague-Dawley rats,50597,Rattus norvegicus,4969,BAO_0000218,,1,1,,CHEMBL622661,,
8093,Intermediate,,,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,50597,Rattus norvegicus,17720,BAO_0000218,,1,1,,CHEMBL622662,,
8094,Intermediate,,,,Pharmacokinetic property (total body clearance) in rat,50597,Rattus norvegicus,3457,BAO_0000218,,1,1,,CHEMBL622663,,
8095,Intermediate,,,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,50597,Rattus norvegicus,5983,BAO_0000218,,1,1,,CHEMBL622664,,
8096,Intermediate,,,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,50597,Rattus norvegicus,6295,BAO_0000218,,1,1,,CHEMBL622665,,
8097,Intermediate,,,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,50597,Rattus norvegicus,6296,BAO_0000218,,1,1,,CHEMBL622666,,
8098,Intermediate,,,,Cl in rat i.v. at 2 mg/kg concentration,50597,Rattus norvegicus,17686,BAO_0000218,,1,1,,CHEMBL621615,,
8099,Intermediate,,,,Clearance of compound after intravenous administration in rats at 24 uM/kg,50597,Rattus norvegicus,17764,BAO_0000218,,1,1,,CHEMBL621616,,
8100,Intermediate,,,,Clearance was determined,50597,Rattus norvegicus,5503,BAO_0000218,,1,1,,CHEMBL621617,,
8101,Intermediate,,,,Clearance by intravenous administration of 3.4 mg/kg in rat,50597,Rattus norvegicus,4368,BAO_0000218,,1,1,,CHEMBL621618,,
8102,Intermediate,,,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,50597,Rattus norvegicus,6005,BAO_0000218,,1,1,,CHEMBL621619,,
8103,Intermediate,,,,Clearance rate after i.v. administration in rats,50597,Rattus norvegicus,5031,BAO_0000218,,1,1,,CHEMBL621620,,
8104,Intermediate,,,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,50597,Rattus norvegicus,4890,BAO_0000218,,1,1,,CHEMBL621786,,
8105,Intermediate,,,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,50597,Rattus norvegicus,5182,BAO_0000218,,1,1,,CHEMBL621787,,
8106,Intermediate,,,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,50597,Rattus norvegicus,5979,BAO_0000218,,1,1,,CHEMBL621788,,
8107,Intermediate,,,,Clearance (Cl) after oral administration in rat,50597,Rattus norvegicus,5656,BAO_0000218,,1,1,,CHEMBL621789,,
8108,Intermediate,,,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,50597,Rattus norvegicus,17804,BAO_0000218,,1,1,,CHEMBL621790,,
8109,Intermediate,,Plasma,1969.0,Compound was tested for plasma clearance in rat,50597,Rattus norvegicus,4839,BAO_0000218,,1,1,,CHEMBL621791,,
8110,Intermediate,Microsomes,,,In vitro microsome metabolism clearance in rat was determined,50597,Rattus norvegicus,5041,BAO_0000218,,1,1,,CHEMBL621792,,
8111,Intermediate,Microsomes,,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,50597,Rattus norvegicus,5041,BAO_0000218,,1,1,,CHEMBL621793,,
8112,Intermediate,,,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL621794,,
8113,Intermediate,,Plasma,1969.0,In vivo plasma clearance was determined,50597,Rattus norvegicus,5496,BAO_0000218,,1,1,,CHEMBL621795,,
8114,Intermediate,,,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,50597,Rattus norvegicus,5739,BAO_0000218,,1,1,,CHEMBL621796,,
8115,Intermediate,,Liver,2107.0,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,50597,Rattus norvegicus,5676,BAO_0000218,,1,1,,CHEMBL621797,401.0,
8116,Intermediate,,,,Pharmacokinetic property (Plasma clearance) was measured in rat,50597,Rattus norvegicus,4239,BAO_0000218,,1,1,,CHEMBL621798,,
8117,Intermediate,,,,Pharmacokinetic property (clearance) in rat i.v.,50597,Rattus norvegicus,5676,BAO_0000218,,1,1,,CHEMBL621799,,
8118,Intermediate,,,,"Plasma Clearance was evaluated in rats, iv",50597,Rattus norvegicus,1918,BAO_0000218,,1,1,,CHEMBL621800,,
8119,Intermediate,,,,Plasma clearance (in vivo) in rats was determined,50597,Rattus norvegicus,17800,BAO_0000218,,1,1,,CHEMBL621801,,
8120,Intermediate,,,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,50597,Rattus norvegicus,6056,BAO_0000218,,1,1,,CHEMBL621802,,
8121,Intermediate,,,,Plasma clearance was determined,50597,Rattus norvegicus,5496,BAO_0000218,,1,1,,CHEMBL618596,,
8122,Intermediate,,,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,50597,Rattus norvegicus,5939,BAO_0000218,,1,1,,CHEMBL618597,,
8123,Intermediate,,,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,50597,Rattus norvegicus,5939,BAO_0000218,,1,1,,CHEMBL618598,,
8124,Intermediate,,,,Plasma clearance in rats,50597,Rattus norvegicus,17752,BAO_0000218,,1,1,,CHEMBL618599,,
8125,Intermediate,,,,Plasma clearance rate determined in rat,50597,Rattus norvegicus,4576,BAO_0000218,,1,1,,CHEMBL618600,,
8126,Intermediate,,,,Plasma clearance was determined in rat,50597,Rattus norvegicus,6011,BAO_0000218,,1,1,,CHEMBL618601,,
8127,Intermediate,,,,Plasma clearance was determined,50597,Rattus norvegicus,5510,BAO_0000218,,1,1,,CHEMBL618602,,
8128,Intermediate,,,,Plasma clearance value in rat,50597,Rattus norvegicus,5948,BAO_0000218,,1,1,,CHEMBL618603,,
8129,Intermediate,,Liver,2107.0,Clearance rate constant using isolated perfused rat liver (IPRL) assay,50597,Rattus norvegicus,6125,BAO_0000218,,1,1,,CHEMBL618604,,
8130,Intermediate,,,,Clearance in rat,50597,Rattus norvegicus,4839,BAO_0000218,,1,1,,CHEMBL618605,,
8131,Intermediate,,,,Total body clearance in rat i.v. at 2 mg/kg concentration,50597,Rattus norvegicus,17686,BAO_0000218,,1,1,,CHEMBL618606,,
8132,Intermediate,,,,Clearance of compound in rats after intravenous administration,50597,Rattus norvegicus,6571,BAO_0000218,,1,1,,CHEMBL618607,,
8133,Intermediate,,,,Clearance after iv administration to rats,50597,Rattus norvegicus,3364,BAO_0000218,,1,1,,CHEMBL618608,,
8134,Intermediate,,,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,50597,Rattus norvegicus,13569,BAO_0000218,,1,1,,CHEMBL618609,,
8135,Intermediate,,,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,50597,Rattus norvegicus,13569,BAO_0000218,,1,1,,CHEMBL618610,,
8136,Intermediate,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,50597,Rattus norvegicus,13569,BAO_0000218,,1,1,,CHEMBL618611,,
8137,Intermediate,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,50597,Rattus norvegicus,13569,BAO_0000218,,1,1,,CHEMBL618612,,
8138,Intermediate,,,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,50597,Rattus norvegicus,13569,BAO_0000218,,1,1,,CHEMBL618613,,
8139,Intermediate,,,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,50597,Rattus norvegicus,13569,BAO_0000218,,1,1,,CHEMBL621076,,
8140,Intermediate,,,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,50597,Rattus norvegicus,13569,BAO_0000218,,1,1,,CHEMBL621077,,
8141,Intermediate,,,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",50597,Rattus norvegicus,17670,BAO_0000218,,1,1,,CHEMBL621078,,
8142,Intermediate,,,,Clearance in rat,50597,Rattus norvegicus,5970,BAO_0000218,,1,1,,CHEMBL621251,,
8143,Intermediate,,,,Clearance in rat after oral administration at 10 mg/kg,50597,Rattus norvegicus,6495,BAO_0000218,,1,1,,CHEMBL621252,,
8144,Intermediate,,,,Clearance in rat.,50597,Rattus norvegicus,4590,BAO_0000218,,1,1,,CHEMBL621253,,
8145,Intermediate,,,,Clearance rate following an oral dose of 20 mg/kg in rats,50597,Rattus norvegicus,6193,BAO_0000218,,1,1,,CHEMBL621254,,
8146,Intermediate,,,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,50597,Rattus norvegicus,2832,BAO_0000218,,1,1,,CHEMBL621255,,
8147,Intermediate,,Plasma,1969.0,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,50597,Rattus norvegicus,1052,BAO_0000218,,1,1,,CHEMBL621256,,
8148,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621257,,
8149,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621258,,
8150,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621259,,
8151,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621260,,
8152,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL876494,,
8153,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621261,,
8154,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621262,,
8155,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621263,,
8156,Intermediate,,Liver,2107.0,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621264,,
8157,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621265,,
8158,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621266,,
8159,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621267,,
8160,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621268,,
8161,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621269,,
8162,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621270,,
8163,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621271,,
8164,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621272,,
8165,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621273,,
8166,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621274,,
8167,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL876495,,
8168,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621275,,
8169,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621276,,
8170,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621277,,
8171,Intermediate,,Intestine,160.0,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621278,,
8172,Intermediate,,Intestine,160.0,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621279,,
8173,Intermediate,,Intestine,160.0,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621280,,
8174,Intermediate,,Spleen,2106.0,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621281,,
8175,Intermediate,,Spleen,2106.0,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621282,,
8176,Intermediate,,Spleen,2106.0,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621283,,
8177,Intermediate,,Spleen,2106.0,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621284,,
8178,Intermediate,,Spleen,2106.0,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621285,,
8179,Intermediate,,Spleen,2106.0,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621286,,
8180,Intermediate,,Spleen,2106.0,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL623220,,
8181,Intermediate,,Spleen,2106.0,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL623221,,
8182,Intermediate,,Spleen,2106.0,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL876029,,
8183,Intermediate,,Stomach,945.0,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL623222,,
8184,Intermediate,,Stomach,945.0,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL623223,,
8185,Intermediate,,Stomach,945.0,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,50597,Rattus norvegicus,9866,BAO_0000218,,1,1,,CHEMBL621445,,
8186,Intermediate,,Blood,178.0,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621446,,
8187,Intermediate,,Blood,178.0,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621447,,
8188,Intermediate,,Blood,178.0,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL619681,,
8189,Intermediate,,Blood,178.0,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL619682,,
8190,Intermediate,,Blood,178.0,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL619683,,
8191,Intermediate,,Brain,955.0,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL619684,,
8192,Intermediate,,Brain,955.0,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL619685,,
8193,Intermediate,,Brain,955.0,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL619686,,
8194,Intermediate,,Brain,955.0,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL619687,,
8195,Intermediate,,Brain,955.0,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL619688,,
8196,Intermediate,,Heart,948.0,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL619689,,
8197,Intermediate,,Heart,948.0,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL619690,,
8198,Intermediate,,Heart,948.0,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL619691,,
8199,Intermediate,,,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,50597,Rattus norvegicus,6062,BAO_0000218,,1,1,,CHEMBL619692,,
8200,Expert,,,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,50597,Rattus norvegicus,3598,BAO_0000218,,1,1,,CHEMBL619693,,
8201,Intermediate,,,,Vc value after IV dose at a dose of 5 mg/kg in rats.,50597,Rattus norvegicus,1908,BAO_0000218,,1,1,,CHEMBL619694,,
8202,Intermediate,,,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,50597,Rattus norvegicus,17596,BAO_0000218,,1,1,,CHEMBL619695,,
8203,Intermediate,,,,Compound was evaluated for pharmacokinetic parameter volume of distribution,50597,Rattus norvegicus,4891,BAO_0000218,,1,1,,CHEMBL619696,,
8204,Intermediate,,,,Compound was evaluated for volume of distribution in rat,50597,Rattus norvegicus,740,BAO_0000218,,1,1,,CHEMBL619697,,
8205,Intermediate,,,,Steady state volume distribution was determined; steady state(ss),50597,Rattus norvegicus,16366,BAO_0000218,,1,1,,CHEMBL619698,,
8206,Intermediate,,,,Steady state volume of distribution after iv administration to rats,50597,Rattus norvegicus,3364,BAO_0000218,,1,1,,CHEMBL619699,,
8207,Intermediate,,,,Steady state volume of distribution dosing at 3 mg/kg iv,50597,Rattus norvegicus,2552,BAO_0000218,,1,1,,CHEMBL619700,,
8208,Intermediate,,,,The compound was evaluated for volume of distribution in rat,50597,Rattus norvegicus,406,BAO_0000218,,1,1,,CHEMBL619701,,
8209,Intermediate,,,,The compound was tested for volume of distribution in rat,50597,Rattus norvegicus,12500,BAO_0000218,,1,1,,CHEMBL619702,,
8210,Intermediate,,,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,50597,Rattus norvegicus,12500,BAO_0000218,,1,1,,CHEMBL620335,,
8211,Intermediate,,,,Volume distribution (VD) after oral administration in rat,50597,Rattus norvegicus,5656,BAO_0000218,,1,1,,CHEMBL620336,,
8212,Intermediate,,,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,50597,Rattus norvegicus,17671,BAO_0000218,,1,1,,CHEMBL620337,,
8213,Intermediate,,,,Volume distribution in rat,50597,Rattus norvegicus,1094,BAO_0000218,,1,1,,CHEMBL620520,,
8214,Intermediate,,,,Volume distribution in rat,50597,Rattus norvegicus,5833,BAO_0000218,,1,1,,CHEMBL620521,,
8215,Intermediate,,,,Volume distribution in rat after peroral administration at 10 mg/kg,50597,Rattus norvegicus,5939,BAO_0000218,,1,1,,CHEMBL875825,,
8216,Intermediate,,,,Volume distribution in rat after peroral administration at 5 mg/kg,50597,Rattus norvegicus,5939,BAO_0000218,,1,1,,CHEMBL620522,,
8217,Intermediate,,,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,50597,Rattus norvegicus,6005,BAO_0000218,,1,1,,CHEMBL620523,,
8218,Intermediate,,,,Volume of distribution in rat.,50597,Rattus norvegicus,1696,BAO_0000218,,1,1,,CHEMBL620524,,
8219,Intermediate,,,,Volume of distribution in rat,50597,Rattus norvegicus,6672,BAO_0000218,,1,1,,CHEMBL620525,,
8220,Intermediate,,,,Volume of distribution in rat,50597,Rattus norvegicus,6673,BAO_0000218,,1,1,,CHEMBL620526,,
8221,Intermediate,,,,Volume of distribution in rat by iv administration,50597,Rattus norvegicus,5871,BAO_0000218,,1,1,,CHEMBL620527,,
8222,Intermediate,,,,Volume of distribution in rats,50597,Rattus norvegicus,6803,BAO_0000218,,1,1,,CHEMBL620528,,
8223,Intermediate,,,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,50597,Rattus norvegicus,5199,BAO_0000218,,1,1,,CHEMBL620529,,
8224,Intermediate,,,,Volume distribution at the dose of 2 mg/kg in rat,50597,Rattus norvegicus,4727,BAO_0000218,,1,1,,CHEMBL620530,,
8225,Intermediate,,,,Steady state volume of distribution was determined,50597,Rattus norvegicus,16367,BAO_0000218,,1,1,,CHEMBL620531,,
8226,Intermediate,,,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,22224,Macaca mulatta,5005,BAO_0000218,,0,1,,CHEMBL620532,,
8227,Intermediate,,,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,22224,Rattus norvegicus,5005,BAO_0000218,,0,1,,CHEMBL620533,,
8228,Intermediate,,,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,22224,Rattus norvegicus,5005,BAO_0000218,,0,1,,CHEMBL620534,,
8229,Intermediate,,,,Mean (%CV) PK parameters for Vdss(mL/kg).,50597,Rattus norvegicus,15765,BAO_0000218,,1,1,,CHEMBL620535,,
8230,Intermediate,,,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL875826,,
8231,Intermediate,,,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL620536,,
8232,Intermediate,,,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL620537,,
8233,Intermediate,,,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL618526,,
8234,Intermediate,,,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,50597,Rattus norvegicus,5739,BAO_0000218,,1,1,,CHEMBL618527,,
8235,Intermediate,,,,Pharmacokinetic property (Vdss) in rat,50597,Rattus norvegicus,5789,BAO_0000218,,1,1,,CHEMBL618528,,
8236,Intermediate,,,,Pharmacokinetic property (vdss) was measured in rat,50597,Rattus norvegicus,4239,BAO_0000218,,1,1,,CHEMBL618529,,
8237,Intermediate,,,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,50597,Rattus norvegicus,4709,BAO_0000218,,1,1,,CHEMBL618530,,
8238,Intermediate,,,,Volume of distribution in rat,50597,Rattus norvegicus,6642,BAO_0000218,,1,1,,CHEMBL618531,,
8239,Intermediate,,,,The pharmacokinetic parameter volume of distribution in vivo in rats,50597,Rattus norvegicus,5247,BAO_0000218,,1,1,,CHEMBL618532,,
8240,Intermediate,,,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,50597,Rattus norvegicus,17720,BAO_0000218,,1,1,,CHEMBL618533,,
8241,Intermediate,,,,Vdss in rat i.v. at 2 mg/kg concentration,50597,Rattus norvegicus,17686,BAO_0000218,,1,1,,CHEMBL618534,,
8242,Intermediate,,,,Volume distribution after intravenous administration (1 mg/kg) in rat,50597,Rattus norvegicus,4689,BAO_0000218,,1,1,,CHEMBL618535,,
8243,Intermediate,,,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,50597,Rattus norvegicus,5654,BAO_0000218,,1,1,,CHEMBL618536,,
8244,Intermediate,,,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,50597,Rattus norvegicus,5654,BAO_0000218,,1,1,,CHEMBL618537,,
8245,Intermediate,,,,Volume distribution at a dose of 10 uM/kg in rat was determined,50597,Rattus norvegicus,4527,BAO_0000218,,1,1,,CHEMBL618538,,
8246,Intermediate,,,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,50597,Rattus norvegicus,4521,BAO_0000218,,1,1,,CHEMBL618539,,
8247,Intermediate,,,,Volume distribution was calculated in rat,50597,Rattus norvegicus,6057,BAO_0000218,,1,1,,CHEMBL618540,,
8248,Intermediate,,,,Volume distribution was determined,50597,Rattus norvegicus,5510,BAO_0000218,,1,1,,CHEMBL618541,,
8249,Intermediate,,,,Volume of distribution after intravenous administration was evaluated in rat,50597,Rattus norvegicus,2938,BAO_0000218,,1,1,,CHEMBL618542,,
8250,Intermediate,,,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,50597,Rattus norvegicus,6679,BAO_0000218,,1,1,,CHEMBL622544,,
8251,Intermediate,,,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL622545,,
8252,Intermediate,,,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL622546,,
8253,Intermediate,,,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL622547,,
8254,Intermediate,,,,Volume of distribution in steady state was determined in rat,50597,Rattus norvegicus,5145,BAO_0000218,,1,1,,CHEMBL622548,,
8255,Intermediate,,,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,50597,Rattus norvegicus,6467,BAO_0000218,,1,1,,CHEMBL622549,,
8256,Intermediate,,,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,50597,Rattus norvegicus,6467,BAO_0000218,,1,1,,CHEMBL622550,,
8257,Intermediate,,,,Compound was evaluated for area under curve when administered through oral route to mouse,50594,Mus musculus,15115,BAO_0000218,,1,1,,CHEMBL622551,,
8258,Intermediate,,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,50597,Rattus norvegicus,8758,BAO_0000218,,1,1,,CHEMBL622552,,
8259,Intermediate,,,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,50597,Rattus norvegicus,8758,BAO_0000218,,1,1,,CHEMBL622553,,
8260,Autocuration,,,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,22224,,8267,BAO_0000218,,0,1,,CHEMBL622554,,
8261,Intermediate,,,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,50588,Canis lupus familiaris,8267,BAO_0000218,,1,1,,CHEMBL622555,,
8262,Intermediate,,,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,50594,Mus musculus,14239,BAO_0000218,,1,1,,CHEMBL622556,,
8263,Intermediate,,,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,50594,Mus musculus,14239,BAO_0000218,,1,1,,CHEMBL622557,,
8264,Intermediate,,Blood,178.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,50594,Mus musculus,10754,BAO_0000218,,1,1,,CHEMBL622558,,
8265,Intermediate,,Blood,178.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,50594,Mus musculus,10754,BAO_0000218,,1,1,,CHEMBL622559,,
8266,Intermediate,,,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,50588,Canis lupus familiaris,10754,BAO_0000218,,1,1,,CHEMBL622560,,
8267,Intermediate,,,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,50597,Rattus norvegicus,14681,BAO_0000218,,1,1,,CHEMBL622561,,
8268,Intermediate,,,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,50597,Rattus norvegicus,14681,BAO_0000218,,1,1,,CHEMBL622562,,
8269,Intermediate,,,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,50597,Rattus norvegicus,14681,BAO_0000218,,1,1,,CHEMBL622563,,
8270,Autocuration,,,,Concentration of compound in Central nervous system,22224,,13118,BAO_0000019,,0,1,,CHEMBL622564,,
8271,Autocuration,,,,Concentration of compound in Central nervous system; Not detectable,22224,,13118,BAO_0000019,,0,1,,CHEMBL622565,,
8272,Intermediate,,,,"Concentration of diester in the blood, following oral administration in mice",50594,Mus musculus,13318,BAO_0000218,,1,1,,CHEMBL622566,,
8273,Intermediate,,,,"Concentration of monoester in the blood, following oral administration in mice",50594,Mus musculus,13318,BAO_0000218,,1,1,,CHEMBL624515,,
8274,Intermediate,,,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,50594,Mus musculus,13318,BAO_0000218,,1,1,,CHEMBL624516,,
8275,Autocuration,,,,Evaluated for Pharmacokinetic property: Area under the curve,22224,,15692,BAO_0000019,,0,1,,CHEMBL624517,,
8276,Intermediate,,,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL624518,,
8277,Intermediate,,,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL624519,,
8278,Intermediate,,,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL624520,,
8279,Intermediate,,,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL624521,,
8280,Intermediate,,,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL624522,,
8281,Intermediate,,,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL624523,,
8282,Intermediate,,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL624409,,
8283,Intermediate,,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL624410,,
8284,Intermediate,,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL624411,,
8285,Intermediate,,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL623531,,
8286,Intermediate,,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL623532,,
8287,Intermediate,,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL623533,,
8288,Intermediate,,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL623534,,
8289,Intermediate,,,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL623535,,
8290,Intermediate,,,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL623536,,
8291,Intermediate,,,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL623537,,
8292,Intermediate,,,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL623538,,
8293,Intermediate,,,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL623539,,
8294,Intermediate,,,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL623540,,
8295,Intermediate,,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL623541,,
8296,Intermediate,,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL623542,,
8297,Intermediate,,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL623543,,
8298,Intermediate,,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL623544,,
8299,Intermediate,,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL623545,,
8300,Intermediate,,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL623546,,
8301,Intermediate,,Plasma,1969.0,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,50597,Rattus norvegicus,5408,BAO_0000218,,1,1,,CHEMBL623547,,
8302,Intermediate,,,,High i.v. clearance in Dawley rats,50597,Rattus norvegicus,6827,BAO_0000218,,1,1,,CHEMBL623548,,
8303,Intermediate,Microsomes,Liver,2107.0,In vitro clearance in rat liver microsomes,50597,Rattus norvegicus,17538,BAO_0000218,,1,1,,CHEMBL623549,,
8304,Intermediate,Microsomes,Liver,2107.0,Intrinsic clearance in rat liver microsomes was determined,50597,Rattus norvegicus,6331,BAO_0000218,,1,1,,CHEMBL623550,,
8305,Intermediate,,Liver,2107.0,Intrinsic clearance in rat hepatocytes was determined,50597,Rattus norvegicus,5948,BAO_0000218,,1,1,,CHEMBL875276,401.0,
8306,Intermediate,,,,Plasma Clearance was determined,50597,Rattus norvegicus,4026,BAO_0000218,,1,1,,CHEMBL621872,,
8307,Intermediate,,,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,50597,Rattus norvegicus,6647,BAO_0000218,,1,1,,CHEMBL621873,,
8308,Intermediate,,,,Plasma clearance in rat.,50597,Rattus norvegicus,1696,BAO_0000218,,1,1,,CHEMBL621874,,
8309,Intermediate,,,,Plasma clearance in rats,50597,Rattus norvegicus,6597,BAO_0000218,,1,1,,CHEMBL621875,,
8310,Intermediate,,,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,50597,Rattus norvegicus,347,BAO_0000218,,1,1,,CHEMBL621876,,
8311,Intermediate,,,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,50597,Rattus norvegicus,16423,BAO_0000218,,1,1,,CHEMBL621877,,
8312,Intermediate,,,,Plasma clearance was measured in rat,50597,Rattus norvegicus,2879,BAO_0000218,,1,1,,CHEMBL621878,,
8313,Intermediate,,,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,50597,Rattus norvegicus,4883,BAO_0000218,,1,1,,CHEMBL621879,,
8314,Intermediate,,Plasma,1969.0,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",50597,Rattus norvegicus,5328,BAO_0000218,,1,1,,CHEMBL621880,,
8315,Intermediate,,,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,50597,Rattus norvegicus,5160,BAO_0000218,,1,1,,CHEMBL621881,,
8316,Intermediate,,,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,50597,Rattus norvegicus,17582,BAO_0000218,,1,1,,CHEMBL621882,,
8317,Intermediate,,,,Total clearance at 1 mg/kg was determined in rat,50597,Rattus norvegicus,17651,BAO_0000218,,1,1,,CHEMBL875283,,
8318,Intermediate,,,,Total clearance at 10 mg/kg was determined in rat,50597,Rattus norvegicus,17651,BAO_0000218,,1,1,,CHEMBL621883,,
8319,Intermediate,,,,Clearance in rat,50597,Rattus norvegicus,6596,BAO_0000218,,1,1,,CHEMBL621884,,
8320,Intermediate,,,,Plasma clearance rate determined in rats,50597,Rattus norvegicus,4796,BAO_0000218,,1,1,,CHEMBL621885,,
8321,Intermediate,,,,Clearance of compound in rat was evaluated,50597,Rattus norvegicus,6850,BAO_0000218,,1,1,,CHEMBL621886,,
8322,Intermediate,,Plasma,1969.0,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,50597,Rattus norvegicus,5932,BAO_0000218,,1,1,,CHEMBL621887,,
8323,Intermediate,,,,Pharmacokinetic property (blood clearance) in rat,50597,Rattus norvegicus,3371,BAO_0000218,,1,1,,CHEMBL621888,,
8324,Intermediate,,,,Plasma clearance in rat,50597,Rattus norvegicus,2083,BAO_0000218,,1,1,,CHEMBL621889,,
8325,Intermediate,,,,Plasma clearance in rats,50597,Rattus norvegicus,4942,BAO_0000218,,1,1,,CHEMBL621890,,
8326,Intermediate,Microsomes,Liver,2107.0,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,50597,Rattus norvegicus,6838,BAO_0000218,,1,1,,CHEMBL621891,,
8327,Intermediate,,,,Clearance in Dawley rat,50597,Rattus norvegicus,5353,BAO_0000218,,1,1,,CHEMBL621892,,
8328,Intermediate,,,,Clearance rat,50597,Rattus norvegicus,6641,BAO_0000218,,1,1,,CHEMBL621893,,
8329,Intermediate,,,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),50597,Rattus norvegicus,6641,BAO_0000218,,1,1,,CHEMBL621894,,
8330,Intermediate,,,,Clearance rat; Not determined,50597,Rattus norvegicus,6641,BAO_0000218,,1,1,,CHEMBL621895,,
8331,Intermediate,,,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,50597,Rattus norvegicus,6444,BAO_0000218,,1,1,,CHEMBL875284,,
8332,Intermediate,,,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,50597,Rattus norvegicus,6444,BAO_0000218,,1,1,,CHEMBL618699,,
8333,Intermediate,,,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,50597,Rattus norvegicus,6444,BAO_0000218,,1,1,,CHEMBL618700,,
8334,Intermediate,,,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,50597,Rattus norvegicus,6211,BAO_0000218,,1,1,,CHEMBL618701,,
8335,Intermediate,,Plasma,1969.0,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",50597,Rattus norvegicus,12873,BAO_0000218,,1,1,,CHEMBL876600,,
8336,Intermediate,,,,Clearance of compound in rat after 1 mg/kg i.v. administration,50597,Rattus norvegicus,6570,BAO_0000218,,1,1,,CHEMBL618702,,
8337,Intermediate,,,,Compound was evaluated for Hepatic clearance in rat,50597,Rattus norvegicus,3341,BAO_0000218,,1,1,,CHEMBL618703,,
8338,Intermediate,,,,In vivo clearance after 5 mg/kg dose,50597,Rattus norvegicus,4891,BAO_0000218,,1,1,,CHEMBL618704,,
8339,Intermediate,,Plasma,1969.0,Compound was tested for plasma clearance in rats,50597,Rattus norvegicus,1094,BAO_0000218,,1,1,,CHEMBL618705,,
8340,Intermediate,,,,Hepatic clearance after intravenous administration was evaluated in rat,50597,Rattus norvegicus,2938,BAO_0000218,,1,1,,CHEMBL618706,,
8341,Intermediate,,,,Lower clearance in rat (i.v.) at 0.5 mpk,50597,Rattus norvegicus,17853,BAO_0000218,,1,1,,CHEMBL618707,,
8342,Intermediate,,Plasma,1969.0,Pharmacokinetic parameter expressed as plasma clearance in rat,50597,Rattus norvegicus,6049,BAO_0000218,,1,1,,CHEMBL618708,,
8343,Intermediate,,,,Pharmacokinetic property (Clp) in rat,50597,Rattus norvegicus,5789,BAO_0000218,,1,1,,CHEMBL618709,,
8344,Intermediate,,,,Plasma clearance in Sprague-Dawley rats,50597,Rattus norvegicus,4514,BAO_0000218,,1,1,,CHEMBL618710,,
8345,Intermediate,,,,Plasma clearance (Clp) in rat,50597,Rattus norvegicus,6448,BAO_0000218,,1,1,,CHEMBL618711,,
8346,Intermediate,,,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,50597,Rattus norvegicus,6062,BAO_0000218,,1,1,,CHEMBL618712,,
8347,Intermediate,,,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,50597,Rattus norvegicus,5710,BAO_0000218,,1,1,,CHEMBL618713,,
8348,Intermediate,,,,Plasma clearance after intravenous administration of 1 mg/kg in rat,50597,Rattus norvegicus,4709,BAO_0000218,,1,1,,CHEMBL618714,,
8349,Intermediate,,,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,50597,Rattus norvegicus,4521,BAO_0000218,,1,1,,CHEMBL618715,,
8350,Intermediate,,,,Plasma clearance in rat was determined,50597,Rattus norvegicus,1742,BAO_0000218,,1,1,,CHEMBL618716,,
8351,Intermediate,,,,Plasma clearance measured in rat,50597,Rattus norvegicus,6057,BAO_0000218,,1,1,,CHEMBL876601,,
8352,Intermediate,,,,Plasma clearance was calculated in rat,50597,Rattus norvegicus,6057,BAO_0000218,,1,1,,CHEMBL618717,,
8353,Intermediate,,,,Plasma clearance in rat,50597,Rattus norvegicus,5145,BAO_0000218,,1,1,,CHEMBL618718,,
8354,Intermediate,,,,Plasma clearance in rat,50597,Rattus norvegicus,5833,BAO_0000218,,1,1,,CHEMBL618719,,
8355,Intermediate,,,,Plasma clearance in rat,50597,Rattus norvegicus,6453,BAO_0000218,,1,1,,CHEMBL618720,,
8356,Intermediate,,,,Plasma clearance in rat,50597,Rattus norvegicus,6640,BAO_0000218,,1,1,,CHEMBL618721,,
8357,Intermediate,,,,Plasma clearance in rats,50597,Rattus norvegicus,6305,BAO_0000218,,1,1,,CHEMBL621477,,
8358,Intermediate,,,,Plasma clearance in rat,50597,Rattus norvegicus,6642,BAO_0000218,,1,1,,CHEMBL621478,,
8359,Intermediate,,,,Plasma clearance was evaluated in rat,50597,Rattus norvegicus,5472,BAO_0000218,,1,1,,CHEMBL621479,,
8360,Intermediate,,,,Plasma clearance was evaluated in rat; Not tested,50597,Rattus norvegicus,5472,BAO_0000218,,1,1,,CHEMBL621480,,
8361,Intermediate,,,,Plasma clearance rate was determined for the compound in rat,50597,Rattus norvegicus,5144,BAO_0000218,,1,1,,CHEMBL621481,,
8362,Intermediate,,,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL621482,,
8363,Intermediate,,,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL621483,,
8364,Intermediate,,,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL621484,,
8365,Intermediate,,Heart,948.0,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621485,,
8366,Intermediate,,Heart,948.0,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621486,,
8367,Intermediate,,Intestine,160.0,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621487,,
8368,Intermediate,,Intestine,160.0,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621488,,
8369,Intermediate,,Intestine,160.0,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621489,,
8370,Intermediate,,Intestine,160.0,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621490,,
8371,Intermediate,,Intestine,160.0,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621491,,
8372,Intermediate,,Kidney,2113.0,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621492,,
8373,Intermediate,,Kidney,2113.0,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621493,,
8374,Intermediate,,Kidney,2113.0,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621494,,
8375,Intermediate,,Kidney,2113.0,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621495,,
8376,Intermediate,,Kidney,2113.0,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621496,,
8377,Intermediate,,Liver,2107.0,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621497,,
8378,Intermediate,,Liver,2107.0,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621498,,
8379,Intermediate,,Liver,2107.0,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL621499,,
8380,Intermediate,,Liver,2107.0,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL618634,,
8381,Intermediate,,Liver,2107.0,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL618635,,
8382,Intermediate,,Lung,2048.0,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL618636,,
8383,Intermediate,,Lung,2048.0,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL619737,,
8384,Intermediate,,Lung,2048.0,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL619738,,
8385,Intermediate,,Lung,2048.0,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL624329,,
8386,Intermediate,,Lung,2048.0,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL624330,,
8387,Intermediate,,Muscle tissue,2385.0,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL624331,,
8388,Intermediate,,Muscle tissue,2385.0,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL624332,,
8389,Intermediate,,Muscle tissue,2385.0,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL624333,,
8390,Intermediate,,Muscle tissue,2385.0,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL624334,,
8391,Intermediate,,Muscle tissue,2385.0,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL624335,,
8392,Intermediate,,Spleen,2106.0,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620016,,
8393,Intermediate,,Spleen,2106.0,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620169,,
8394,Intermediate,,Spleen,2106.0,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620170,,
8395,Intermediate,,Spleen,2106.0,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620171,,
8396,Intermediate,,Spleen,2106.0,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620172,,
8397,Intermediate,,Stomach,945.0,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620173,,
8398,Intermediate,,Stomach,945.0,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620174,,
8399,Intermediate,,Stomach,945.0,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620175,,
8400,Intermediate,,Stomach,945.0,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620176,,
8401,Intermediate,,Stomach,945.0,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620177,,
8402,Intermediate,,Cerebellum,2037.0,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620178,,
8403,Intermediate,,Cerebellum,2037.0,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620179,,
8404,Intermediate,,,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620180,,
8405,Intermediate,,,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,50597,Rattus norvegicus,6570,BAO_0000218,,1,1,,CHEMBL620181,,
8406,Intermediate,,,,Volume of distribution of compound in rats after intravenous administration,50597,Rattus norvegicus,6571,BAO_0000218,,1,1,,CHEMBL620182,,
8407,Intermediate,,,,Volume of distribution in rat,50597,Rattus norvegicus,6453,BAO_0000218,,1,1,,CHEMBL620183,,
8408,Intermediate,,,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,50597,Rattus norvegicus,6444,BAO_0000218,,1,1,,CHEMBL620184,,
8409,Intermediate,,,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,50597,Rattus norvegicus,6444,BAO_0000218,,1,1,,CHEMBL620185,,
8410,Intermediate,,,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,50597,Rattus norvegicus,6444,BAO_0000218,,1,1,,CHEMBL620186,,
8411,Intermediate,,,,Volume of distribution was determined in Dawley rat,50597,Rattus norvegicus,5353,BAO_0000218,,1,1,,CHEMBL620187,,
8412,Intermediate,,,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL620188,,
8413,Intermediate,,,,Volume of distribution was reported in Sprague-Dawley rat,50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL620189,,
8414,Intermediate,,,,Volumes of distribution in rat after peroral administration,50597,Rattus norvegicus,6641,BAO_0000218,,1,1,,CHEMBL620190,,
8415,Intermediate,,,,Volumes of distribution in rat after po administration,50597,Rattus norvegicus,6641,BAO_0000218,,1,1,,CHEMBL620191,,
8416,Intermediate,,,,Volumes of distribution in rat after po administration; Not determined,50597,Rattus norvegicus,6641,BAO_0000218,,1,1,,CHEMBL620192,,
8417,Intermediate,,,,Pharmacokinetic property (Volume) in rat i.v.,50597,Rattus norvegicus,5676,BAO_0000218,,1,1,,CHEMBL620193,,
8418,Intermediate,,,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,50597,Rattus norvegicus,6410,BAO_0000218,,1,1,,CHEMBL620194,,
8419,Intermediate,,,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",50597,Rattus norvegicus,17670,BAO_0000218,,1,1,,CHEMBL876730,,
8420,Intermediate,,,,Volume distribution in rat after oral administration at 10 mg/kg,50597,Rattus norvegicus,6495,BAO_0000218,,1,1,,CHEMBL620195,,
8421,Intermediate,,,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,50597,Rattus norvegicus,5408,BAO_0000218,,1,1,,CHEMBL620196,,
8422,Intermediate,,,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,50597,Rattus norvegicus,4883,BAO_0000218,,1,1,,CHEMBL620197,,
8423,Intermediate,,,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,50597,Rattus norvegicus,6647,BAO_0000218,,1,1,,CHEMBL620198,,
8424,Intermediate,,,,Volume of distribution in rats,50597,Rattus norvegicus,6495,BAO_0000218,,1,1,,CHEMBL620199,,
8425,Intermediate,,,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL620200,,
8426,Intermediate,,,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL620201,,
8427,Intermediate,,,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL620202,,
8428,Intermediate,,,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL620203,,
8429,Intermediate,,,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL620204,,
8430,Intermediate,,,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL620205,,
8431,Intermediate,,,,Pharmacokinetic parameter (Vss) in rat,50597,Rattus norvegicus,5960,BAO_0000218,,1,1,,CHEMBL624664,,
8432,Intermediate,,,,Pharmacokinetic property (Volume) in rat i.v.,50597,Rattus norvegicus,5676,BAO_0000218,,1,1,,CHEMBL624665,,
8433,Intermediate,,,,Pharmacokinetic property (Vss) in rat,50597,Rattus norvegicus,5948,BAO_0000218,,1,1,,CHEMBL624666,,
8434,Intermediate,,,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,50597,Rattus norvegicus,5979,BAO_0000218,,1,1,,CHEMBL624667,,
8435,Intermediate,,,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL624668,,
8436,Intermediate,,,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL624669,,
8437,Intermediate,,,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL624670,,
8438,Intermediate,,,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL624671,,
8439,Intermediate,,,,Steady state volume distribution in rat,50597,Rattus norvegicus,6448,BAO_0000218,,1,1,,CHEMBL624672,,
8440,Intermediate,,Plasma,1969.0,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",50597,Rattus norvegicus,12873,BAO_0000218,,1,1,,CHEMBL624673,,
8441,Intermediate,,,,Steady state volume of distribution determined in rat,50597,Rattus norvegicus,4576,BAO_0000218,,1,1,,CHEMBL624674,,
8442,Intermediate,,,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,50597,Rattus norvegicus,17582,BAO_0000218,,1,1,,CHEMBL624675,,
8443,Intermediate,,,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,50597,Rattus norvegicus,1466,BAO_0000218,,1,1,,CHEMBL621728,,
8444,Intermediate,,,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,50597,Rattus norvegicus,5182,BAO_0000218,,1,1,,CHEMBL621729,,
8445,Intermediate,,,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,50597,Rattus norvegicus,5182,BAO_0000218,,1,1,,CHEMBL621730,,
8446,Intermediate,,,,Volume distribution in rat after administration of 2 mg/kg iv,50597,Rattus norvegicus,6535,BAO_0000218,,1,1,,CHEMBL621731,,
8447,Intermediate,,,,Volume distribution in rat after administration of 2 mg/kg iv,50597,Rattus norvegicus,6535,BAO_0000218,,1,1,,CHEMBL621732,,
8448,Intermediate,,,,Volume in steady state distribution value was determined,50597,Rattus norvegicus,5041,BAO_0000218,,1,1,,CHEMBL621908,,
8449,Intermediate,,,,Volume in steady state distribution value was determined; ND denotes no data,50597,Rattus norvegicus,5041,BAO_0000218,,1,1,,CHEMBL875347,,
8450,Intermediate,,,,Volume in steady state distribution value was determined; ND denotes not determined,50597,Rattus norvegicus,5041,BAO_0000218,,1,1,,CHEMBL621909,,
8451,Intermediate,,,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,50597,Rattus norvegicus,17065,BAO_0000218,,1,1,,CHEMBL621910,,
8452,Intermediate,,,,Volume of distribution at steady state was evaluated in rats,50597,Rattus norvegicus,6597,BAO_0000218,,1,1,,CHEMBL621911,,
8453,Intermediate,,,,Volume of distribution at steady state was observed after intravenous administration in rat,50597,Rattus norvegicus,15662,BAO_0000218,,1,1,,CHEMBL621912,,
8454,Intermediate,,,,Volume of distribution in steady state was determined in rat,50597,Rattus norvegicus,6485,BAO_0000218,,1,1,,CHEMBL621913,,
8455,Intermediate,,,,Volume of distribution in steady state was determined in rat,50597,Rattus norvegicus,17655,BAO_0000218,,1,1,,CHEMBL621914,,
8456,Intermediate,,,,Volume of distribution after i.v. administration,50597,Rattus norvegicus,6616,BAO_0000218,,1,1,,CHEMBL621915,,
8457,Intermediate,,,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,50597,Rattus norvegicus,1916,BAO_0000218,,1,1,,CHEMBL621916,,
8458,Intermediate,,Liver,2107.0,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL621917,,
8459,Intermediate,,Liver,2107.0,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL621918,,
8460,Intermediate,,Spleen,2106.0,Biodistribution of compound (oxidized form) in spleen tissue,50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL621919,,
8461,Intermediate,,Spleen,2106.0,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL621920,,
8462,Intermediate,,Spleen,2106.0,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL621921,,
8463,Intermediate,,Spleen,2106.0,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL622401,,
8464,Intermediate,,Spleen,2106.0,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL875348,,
8465,Intermediate,,Spleen,2106.0,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL622402,,
8466,Intermediate,,Blood,178.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL622403,,
8467,Intermediate,,Blood,178.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL622404,,
8468,Intermediate,,Brain,955.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL622405,,
8469,Intermediate,,Brain,955.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL622406,,
8470,Intermediate,,Brain,955.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL622407,,
8471,Intermediate,,Heart,948.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL622408,,
8472,Intermediate,,Heart,948.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL622409,,
8473,Intermediate,,Heart,948.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL622410,,
8474,Intermediate,,Kidney,2113.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL622411,,
8475,Intermediate,,Kidney,2113.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL627864,,
8476,Intermediate,,Kidney,2113.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL627865,,
8477,Intermediate,,Liver,2107.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL627866,,
8478,Intermediate,,Liver,2107.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL627751,,
8479,Intermediate,,Spleen,2106.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL627752,,
8480,Intermediate,,Spleen,2106.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL627753,,
8481,Intermediate,,Spleen,2106.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",50594,Mus musculus,16438,BAO_0000218,,1,1,,CHEMBL627754,,
8482,Intermediate,,,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,50594,Mus musculus,12467,BAO_0000218,,1,1,,CHEMBL627755,,
8483,Intermediate,,Brain,955.0,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL627756,,
8484,Intermediate,,Brain,955.0,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL627757,,
8485,Intermediate,,Brain,955.0,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL627758,,
8486,Intermediate,,Brain,955.0,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL627759,,
8487,Intermediate,,Brain,955.0,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL627760,,
8488,Intermediate,,Brain,955.0,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL627761,,
8489,Intermediate,,Heart,948.0,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL876811,,
8490,Intermediate,,Heart,948.0,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL627762,,
8491,Intermediate,,Heart,948.0,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL627763,,
8492,Intermediate,,Heart,948.0,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL627764,,
8493,Intermediate,,Heart,948.0,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL627765,,
8494,Intermediate,,Heart,948.0,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL627766,,
8495,Intermediate,,Kidney,2113.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL627767,,
8496,Intermediate,,Kidney,2113.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL627768,,
8497,Intermediate,,Kidney,2113.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL628422,,
8498,Intermediate,,Kidney,2113.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL628423,,
8499,Intermediate,,,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,50597,Rattus norvegicus,5089,BAO_0000218,,1,1,,CHEMBL628424,,
8500,Intermediate,,,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,50597,Rattus norvegicus,5089,BAO_0000218,,1,1,,CHEMBL628425,,
8501,Intermediate,,,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,50597,Rattus norvegicus,4257,BAO_0000218,,1,1,,CHEMBL628426,,
8502,Intermediate,,,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,50597,Rattus norvegicus,6679,BAO_0000218,,1,1,,CHEMBL628427,,
8503,Intermediate,,,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,50597,Rattus norvegicus,5546,BAO_0000218,,1,1,,CHEMBL626938,,
8504,Intermediate,,,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,50597,Rattus norvegicus,6141,BAO_0000218,,1,1,,CHEMBL626939,,
8505,Intermediate,,,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL626940,,
8506,Intermediate,,,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL626941,,
8507,Intermediate,,,,Plasma clearance was reported in Sprague-Dawley rat,50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL626942,,
8508,Intermediate,,,,Plasma clearance after intravenous administration (1 mg/kg) in rat,50597,Rattus norvegicus,4689,BAO_0000218,,1,1,,CHEMBL876812,,
8509,Intermediate,,,,Plasma clearance of compound in rats was evaluated,50597,Rattus norvegicus,6848,BAO_0000218,,1,1,,CHEMBL626943,,
8510,Intermediate,,,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,50597,Rattus norvegicus,6848,BAO_0000218,,1,1,,CHEMBL626944,,
8511,Intermediate,,,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,50597,Rattus norvegicus,6467,BAO_0000218,,1,1,,CHEMBL626945,,
8512,Intermediate,,,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,50597,Rattus norvegicus,6467,BAO_0000218,,1,1,,CHEMBL626946,,
8513,Intermediate,,,,Plasma clearance rate in Sprague-Dawley rats,50597,Rattus norvegicus,4956,BAO_0000218,,1,1,,CHEMBL626856,,
8514,Intermediate,,,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),50597,Rattus norvegicus,5529,BAO_0000218,,1,1,,CHEMBL626857,,
8515,Intermediate,,Plasma,1969.0,The compound was evaluated for plasma clearance in rat,50597,Rattus norvegicus,406,BAO_0000218,,1,1,,CHEMBL626858,,
8516,Intermediate,,Plasma,1969.0,Total plasma clearance in rat,50597,Rattus norvegicus,17655,BAO_0000218,,1,1,,CHEMBL627018,,
8517,Intermediate,,Blood,178.0,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,50597,Rattus norvegicus,3293,BAO_0000218,,1,1,,CHEMBL625331,,
8518,Intermediate,,Blood,178.0,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,50597,Rattus norvegicus,4075,BAO_0000218,,1,1,,CHEMBL625332,,
8519,Intermediate,,,,C max was determined at 10 mg/kg po dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL877590,,
8520,Intermediate,,,,C max was determined at 3 mg/kg po dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL625333,,
8521,Intermediate,,,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,50597,Rattus norvegicus,17594,BAO_0000218,,1,1,,CHEMBL625334,,
8522,Intermediate,,,,Cmax after single intravenous bolus of 1 mg/kg in rats,50597,Rattus norvegicus,17594,BAO_0000218,,1,1,,CHEMBL625335,,
8523,Intermediate,,,,Cmax of compound at 5 mg/kg after po administration was determined in rat,50597,Rattus norvegicus,4762,BAO_0000218,,1,1,,CHEMBL625336,,
8524,Intermediate,,,,Cmax 24 hr after 10 mg/kg oral administration in rats,50597,Rattus norvegicus,17509,BAO_0000218,,1,1,,CHEMBL625337,,
8525,Intermediate,,,,Cmax 24 hr after 2 mg/kg oral administration in rats,50597,Rattus norvegicus,17509,BAO_0000218,,1,1,,CHEMBL625338,,
8526,Intermediate,,Plasma,1969.0,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,50597,Rattus norvegicus,1466,BAO_0000218,,1,1,,CHEMBL625339,,
8527,Intermediate,,,,Cmax in rat after administration of 2 mg/kg iv,50597,Rattus norvegicus,6535,BAO_0000218,,1,1,,CHEMBL625340,,
8528,Intermediate,,,,Cmax in rat after administration of 2 mg/kg iv,50597,Rattus norvegicus,6535,BAO_0000218,,1,1,,CHEMBL625341,,
8529,Intermediate,,,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,50597,Rattus norvegicus,3169,BAO_0000218,,1,1,,CHEMBL622687,,
8530,Intermediate,,Plasma,1969.0,Cmax wa determined in rat plasma at 30 mg/kg after po administration,50597,Rattus norvegicus,6515,BAO_0000218,,1,1,,CHEMBL622688,,
8531,Intermediate,,Blood,178.0,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,50597,Rattus norvegicus,11149,BAO_0000218,,1,1,,CHEMBL622689,,
8532,Intermediate,,Blood,178.0,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,50597,Rattus norvegicus,11149,BAO_0000218,,1,1,,CHEMBL620295,,
8533,Intermediate,,,,Cmax after 10 mg/kg oral administration in rat,50597,Rattus norvegicus,17858,BAO_0000218,,1,1,,CHEMBL620296,,
8534,Intermediate,,,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL620297,,
8535,Intermediate,,,,Cmax after IV dosing at 1 mg/kg in rat; no data,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL620298,,
8536,Intermediate,,,,Cmax after oral administration at 20 mpk in rats,50597,Rattus norvegicus,4426,BAO_0000218,,1,1,,CHEMBL620299,,
8537,Intermediate,,,,Cmax after oral administration at 20 mpk in rats; Not performed.,50597,Rattus norvegicus,4426,BAO_0000218,,1,1,,CHEMBL620300,,
8538,Intermediate,,,,Cmax after oral administration at 20 mpk in rats d; Not performed.,50597,Rattus norvegicus,4426,BAO_0000218,,1,1,,CHEMBL620301,,
8539,Intermediate,,,,Cmax after oral administration in rat,50597,Rattus norvegicus,5656,BAO_0000218,,1,1,,CHEMBL620302,,
8540,Intermediate,,,,Cmax after oral administration at a dose of 2 mg/kg in rat,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL620303,,
8541,Intermediate,,,,Cmax after oral administration at a dose of 4 mg/kg in rat,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL620304,,
8542,Intermediate,,,,Cmax in rats after 20 mg/kg oral dose,50597,Rattus norvegicus,6113,BAO_0000218,,1,1,,CHEMBL620305,,
8543,Intermediate,,,,Cmax after peroral administration in rats at 2.4 uM/kg,50597,Rattus norvegicus,17764,BAO_0000218,,1,1,,CHEMBL620306,,
8544,Intermediate,,,,Cmax at the dose of 2 mg/Kg administered perorally in rats,50597,Rattus norvegicus,4756,BAO_0000218,,1,1,,CHEMBL620307,,
8545,Intermediate,,,,Cmax at the dose of 5 mg/Kg administered perorally in rats,50597,Rattus norvegicus,4756,BAO_0000218,,1,1,,CHEMBL620308,,
8546,Intermediate,,,,Cmax by administering at 20 mg/kg p.o. in rats,50597,Rattus norvegicus,6402,BAO_0000218,,1,1,,CHEMBL620309,,
8547,Intermediate,,,,Cmax in male rat,50597,Rattus norvegicus,5610,BAO_0000218,,1,1,,CHEMBL620310,,
8548,Intermediate,,,,Cmax in rat,50597,Rattus norvegicus,5207,BAO_0000218,,1,1,,CHEMBL620311,,
8549,Intermediate,,,,Cmax in rat,50597,Rattus norvegicus,6011,BAO_0000218,,1,1,,CHEMBL620312,,
8550,Intermediate,,,,Cmax in rat,50597,Rattus norvegicus,6504,BAO_0000218,,1,1,,CHEMBL620313,,
8551,Intermediate,,,,Cmax in rat at 10 mg/kg,50597,Rattus norvegicus,6046,BAO_0000218,,1,1,,CHEMBL620314,,
8552,Intermediate,,,,Cmax in rat at the dose of 1 mg/kg i.v.,50597,Rattus norvegicus,6504,BAO_0000218,,1,1,,CHEMBL620315,,
8553,Intermediate,,,,Cmax in rat by po administration at a dose of 40 mg/kg,50597,Rattus norvegicus,5874,BAO_0000218,,1,1,,CHEMBL620316,,
8554,Intermediate,,,,Cmax in rat p.o. at 20 mg/kg concentration,50597,Rattus norvegicus,17686,BAO_0000218,,1,1,,CHEMBL620317,,
8555,Intermediate,,,,Cmax in rats,50597,Rattus norvegicus,5836,BAO_0000218,,1,1,,CHEMBL620318,,
8556,Intermediate,,,,Cmax in rats,50597,Rattus norvegicus,17596,BAO_0000218,,1,1,,CHEMBL620319,,
8557,Intermediate,,,,Cmax was evaluated after 20 uM/kg of peroral administration,50597,Rattus norvegicus,16423,BAO_0000218,,1,1,,CHEMBL620320,,
8558,Intermediate,,,,Cmax was measured in rats after peroral administration at 3 mg/kg,50597,Rattus norvegicus,17804,BAO_0000218,,1,1,,CHEMBL620321,,
8559,Intermediate,,,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,50597,Rattus norvegicus,1908,BAO_0000218,,1,1,,CHEMBL620322,,
8560,Intermediate,,,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620323,,
8561,Intermediate,,Frontal cortex,1870.0,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620324,,
8562,Intermediate,,Frontal cortex,1870.0,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620325,,
8563,Intermediate,,Hippocampus,10000000.0,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620326,,
8564,Intermediate,,Hippocampus,10000000.0,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620327,,
8565,Intermediate,,,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620328,,
8566,Intermediate,,,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620329,,
8567,Intermediate,,Midbrain,1891.0,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620330,,
8568,Intermediate,,Midbrain,1891.0,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL875286,,
8569,Intermediate,,,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620331,,
8570,Intermediate,,,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620332,,
8571,Intermediate,,Striatum,2435.0,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620333,,
8572,Intermediate,,Striatum,2435.0,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,50597,Rattus norvegicus,13950,BAO_0000218,,1,1,,CHEMBL620334,,
8573,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621015,,
8574,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621016,,
8575,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621191,,
8576,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621192,,
8577,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621193,,
8578,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621194,,
8579,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624204,,
8580,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624205,,
8581,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624206,,
8582,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624207,,
8583,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624208,,
8584,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624209,,
8585,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624210,,
8586,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624211,,
8587,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624212,,
8588,Intermediate,,Blood,178.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624213,,
8589,Intermediate,,Blood,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL876611,,
8590,Intermediate,,Blood,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624214,,
8591,Intermediate,,Blood,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624215,,
8592,Intermediate,,Blood,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624216,,
8593,Intermediate,,Blood,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624217,,
8594,Intermediate,,Blood,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624218,,
8595,Intermediate,,Blood,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624219,,
8596,Intermediate,,Blood,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624220,,
8597,Intermediate,,Blood,178.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624221,,
8598,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624222,,
8599,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624223,,
8600,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624224,,
8601,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624225,,
8602,Intermediate,,,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,50597,Rattus norvegicus,17764,BAO_0000218,,1,1,,CHEMBL622420,,
8603,Intermediate,,,,Volume of steady state distribution after i.v. administration in rats,50597,Rattus norvegicus,5031,BAO_0000218,,1,1,,CHEMBL622421,,
8604,Intermediate,,,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,50597,Rattus norvegicus,6215,BAO_0000218,,1,1,,CHEMBL622422,,
8605,Intermediate,,,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,50597,Rattus norvegicus,17671,BAO_0000218,,1,1,,CHEMBL622423,,
8606,Intermediate,,,,Vss was determined,50597,Rattus norvegicus,17752,BAO_0000218,,1,1,,CHEMBL622424,,
8607,Intermediate,,,,Vss in rat,50597,Rattus norvegicus,6596,BAO_0000218,,1,1,,CHEMBL622425,,
8608,Intermediate,,,,Vss was evaluated after 10 uM/kg of intra arterial administration,50597,Rattus norvegicus,16423,BAO_0000218,,1,1,,CHEMBL876612,,
8609,Intermediate,,,,volume of distribution at steady state was observed after intravenous administration in rat,50597,Rattus norvegicus,15662,BAO_0000218,,1,1,,CHEMBL622426,,
8610,Intermediate,,,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,50597,Rattus norvegicus,6062,BAO_0000218,,1,1,,CHEMBL622427,,
8611,Intermediate,,,,Pharmacokinetic (PK) parameter Vz in rat,50597,Rattus norvegicus,5874,BAO_0000218,,1,1,,CHEMBL622428,,
8612,Intermediate,,,,Volume distribution in rats,50597,Rattus norvegicus,4942,BAO_0000218,,1,1,,CHEMBL622429,,
8613,Intermediate,,,,Volume of distribution in rat; No data,50597,Rattus norvegicus,17796,BAO_0000218,,1,1,,CHEMBL622430,,
8614,Intermediate,,,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,50597,Rattus norvegicus,4890,BAO_0000218,,1,1,,CHEMBL622431,,
8615,Intermediate,,Ileum,2116.0,% absorption predicted from in vitro rat ileum transport studies,50597,Rattus norvegicus,15765,BAO_0000218,,1,1,,CHEMBL622432,,
8616,Intermediate,,,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,50597,Rattus norvegicus,13569,BAO_0000218,,1,1,,CHEMBL622433,,
8617,Intermediate,,,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,50597,Rattus norvegicus,13569,BAO_0000218,,1,1,,CHEMBL622434,,
8618,Intermediate,,,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,50597,Rattus norvegicus,13569,BAO_0000218,,1,1,,CHEMBL622435,,
8619,Intermediate,,,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),50597,Rattus norvegicus,13569,BAO_0000218,,1,1,,CHEMBL618748,,
8620,Intermediate,,,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,50597,Rattus norvegicus,13569,BAO_0000218,,1,1,,CHEMBL618749,,
8621,Intermediate,,,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,50597,Rattus norvegicus,13569,BAO_0000218,,1,1,,CHEMBL618750,,
8622,Intermediate,,,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,50597,Rattus norvegicus,13569,BAO_0000218,,1,1,,CHEMBL618751,,
8623,Intermediate,,,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,50597,Rattus norvegicus,13569,BAO_0000218,,1,1,,CHEMBL618752,,
8624,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,4576,BAO_0000218,,1,1,,CHEMBL618753,,
8625,Intermediate,,Plasma,1969.0,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,50597,Rattus norvegicus,750,BAO_0000218,,1,1,,CHEMBL618754,,
8626,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,750,BAO_0000218,,1,1,,CHEMBL618755,,
8627,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,4590,BAO_0000218,,1,1,,CHEMBL618756,,
8628,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,1716,BAO_0000218,,1,1,,CHEMBL618757,,
8629,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,1974,BAO_0000218,,1,1,,CHEMBL618758,,
8630,Intermediate,,,,Oral bioavailability in rat (dose 30 mg/kg),50597,Rattus norvegicus,4502,BAO_0000218,,1,1,,CHEMBL621088,,
8631,Intermediate,,,,Pharmacokinetic property (cLogP) in rat,50597,Rattus norvegicus,3371,BAO_0000218,,1,1,,CHEMBL621089,,
8632,Intermediate,,Blood,178.0,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,50597,Rattus norvegicus,9099,BAO_0000218,,1,1,,CHEMBL621090,,
8633,Intermediate,,Blood,178.0,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,50597,Rattus norvegicus,9099,BAO_0000218,,1,1,,CHEMBL621091,,
8634,Intermediate,,,,Clearance in rat.,50597,Rattus norvegicus,4590,BAO_0000218,,1,1,,CHEMBL876731,,
8635,Intermediate,,,,Compound was evaluated for its clearance when administered intravenously in rat,50597,Rattus norvegicus,3184,BAO_0000218,,1,1,,CHEMBL621092,,
8636,Intermediate,,,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,50597,Rattus norvegicus,16456,BAO_0000218,,1,1,,CHEMBL621093,,
8637,Intermediate,,,,Blood: Brain distribution ratio is determined in rat,50597,Rattus norvegicus,4199,BAO_0000218,,1,1,,CHEMBL621094,,
8638,Intermediate,,,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,50597,Rattus norvegicus,4199,BAO_0000218,,1,1,,CHEMBL621095,,
8639,Intermediate,,,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,50597,Rattus norvegicus,4199,BAO_0000218,,1,1,,CHEMBL621096,,
8640,Intermediate,,Kidney,2113.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL621097,,
8641,Intermediate,,,,Percent dose excreted in 0-48 hours administered ip to male rat,50597,Rattus norvegicus,7449,BAO_0000218,,1,1,,CHEMBL621098,,
8642,Intermediate,,Cerebellum,2037.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL621099,,
8643,Intermediate,,Cerebellum,2037.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL621100,,
8644,Intermediate,,Cerebellum,2037.0,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL621101,,
8645,Intermediate,,Cerebellum,2037.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL621102,,
8646,Intermediate,,Cerebellum,2037.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL876732,,
8647,Intermediate,,,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL621103,,
8648,Intermediate,,,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL621104,,
8649,Intermediate,,,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL621105,,
8650,Intermediate,,,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL621106,,
8651,Intermediate,,,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL621107,,
8652,Intermediate,,,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL621108,,
8653,Intermediate,,,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL621109,,
8654,Intermediate,,Kidney,2113.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL621110,,
8655,Intermediate,,Kidney,2113.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL621111,,
8656,Intermediate,,Liver,2107.0,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL622541,,
8657,Intermediate,,Liver,2107.0,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL622542,,
8658,Intermediate,,Liver,2107.0,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL622543,,
8659,Intermediate,,Liver,2107.0,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL624412,,
8660,Intermediate,,Liver,2107.0,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL624413,,
8661,Intermediate,,Liver,2107.0,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL624414,,
8662,Intermediate,,Lung,2048.0,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL624415,,
8663,Intermediate,,Lung,2048.0,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL624416,,
8664,Intermediate,,Lung,2048.0,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL624417,,
8665,Intermediate,,Lung,2048.0,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL624418,,
8666,Intermediate,,Lung,2048.0,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL624419,,
8667,Intermediate,,Lung,2048.0,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL624420,,
8668,Intermediate,,Muscle tissue,2385.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL624421,,
8669,Intermediate,,Muscle tissue,2385.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL624422,,
8670,Intermediate,,Muscle tissue,2385.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL624423,,
8671,Intermediate,,Muscle tissue,2385.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL625123,,
8672,Intermediate,,Muscle tissue,2385.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL625124,,
8673,Intermediate,,Muscle tissue,2385.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL625125,,
8674,Intermediate,,Zone of skin,14.0,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL625126,,
8675,Intermediate,,Zone of skin,14.0,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL626947,,
8676,Intermediate,,Zone of skin,14.0,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL626948,,
8677,Intermediate,,Zone of skin,14.0,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL626949,,
8678,Intermediate,,Zone of skin,14.0,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL626950,,
8679,Intermediate,,Zone of skin,14.0,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL626951,,
8680,Intermediate,,Spleen,2106.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL626952,,
8681,Intermediate,,Spleen,2106.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL626953,,
8682,Intermediate,,Spleen,2106.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL626954,,
8683,Intermediate,,Spleen,2106.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL626955,,
8684,Intermediate,,Spleen,2106.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL626956,,
8685,Intermediate,,Spleen,2106.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL626957,,
8686,Intermediate,,Blood,178.0,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL626958,,
8687,Intermediate,,Blood,178.0,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL626959,,
8688,Intermediate,,Blood,178.0,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL626960,,
8689,Intermediate,,Blood,178.0,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL626961,,
8690,Intermediate,,Blood,178.0,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL627589,,
8691,Intermediate,,Blood,178.0,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),50594,Mus musculus,17208,BAO_0000218,,1,1,,CHEMBL627590,,
8692,Intermediate,,,,Time taken for EC90 was determined when tested in mouse,50594,Mus musculus,3132,BAO_0000218,,1,1,,CHEMBL627591,,
8693,Intermediate,,,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,50594,Mus musculus,3132,BAO_0000218,,1,1,,CHEMBL627592,,
8694,Intermediate,,,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),50594,Mus musculus,16597,BAO_0000218,,1,1,,CHEMBL627593,,
8695,Intermediate,,,,Half life in mice,50594,Mus musculus,5727,BAO_0000218,,1,1,,CHEMBL627594,,
8696,Intermediate,,,,Half life period in mouse after 10 mg/Kg dose,50594,Mus musculus,5302,BAO_0000218,,1,1,,CHEMBL876813,,
8697,Intermediate,,,,Half life period in mouse after 10 mg/kg dose,50594,Mus musculus,5302,BAO_0000218,,1,1,,CHEMBL627595,,
8698,Intermediate,,,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,50594,Mus musculus,6348,BAO_0000218,,1,1,,CHEMBL627596,,
8699,Intermediate,,,,Cmax value at 5 mg/kg po was determined in rat,50597,Rattus norvegicus,5964,BAO_0000218,,1,1,,CHEMBL627597,,
8700,Intermediate,,,,Cmax value evaluated in rat,50597,Rattus norvegicus,6078,BAO_0000218,,1,1,,CHEMBL627598,,
8701,Intermediate,,Brain,955.0,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,50597,Rattus norvegicus,5206,BAO_0000218,,1,1,,CHEMBL627599,,
8702,Intermediate,,,,Cmax value after administration of 20 mg/Kg oral dose in rat,50597,Rattus norvegicus,2959,BAO_0000218,,1,1,,CHEMBL627600,,
8703,Intermediate,,,,Cmax value at 1 mg/kg po in rat,50597,Rattus norvegicus,5964,BAO_0000218,,1,1,,CHEMBL627601,,
8704,Intermediate,,,,Cmax value at 5 mg/kg po in rat,50597,Rattus norvegicus,5964,BAO_0000218,,1,1,,CHEMBL627776,,
8705,Intermediate,,,,Cmax value at a dose of 10 mg/kg in male SD rats,50597,Rattus norvegicus,6757,BAO_0000218,,1,1,,CHEMBL627777,,
8706,Intermediate,,,,Cmax value at a dose of 100 mg/kg in male SD rats,50597,Rattus norvegicus,6757,BAO_0000218,,1,1,,CHEMBL627778,,
8707,Intermediate,,,,Cmax value at a dose of 50 mg/kg in male SD rats,50597,Rattus norvegicus,6757,BAO_0000218,,1,1,,CHEMBL627779,,
8708,Intermediate,,,,Cmax value in rats at 10 mg/kg,50597,Rattus norvegicus,17617,BAO_0000218,,1,1,,CHEMBL876814,,
8709,Intermediate,,,,Cmax value was evaluated in rats at a dose of 20 mg/kg,50597,Rattus norvegicus,1445,BAO_0000218,,1,1,,CHEMBL627780,,
8710,Intermediate,,,,Cmax value was determined after peroral administration of 20 mg/kg in rat,50597,Rattus norvegicus,6082,BAO_0000218,,1,1,,CHEMBL627781,,
8711,Intermediate,,,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,50597,Rattus norvegicus,1446,BAO_0000218,,1,1,,CHEMBL627782,,
8712,Intermediate,,Plasma,1969.0,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,50597,Rattus norvegicus,5407,BAO_0000218,,1,1,,CHEMBL627783,,
8713,Intermediate,,Plasma,1969.0,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,50597,Rattus norvegicus,2690,BAO_0000218,,1,1,,CHEMBL627784,,
8714,Intermediate,,,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL627785,,
8715,Intermediate,,,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL627786,,
8716,Intermediate,,Plasma,1969.0,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,50597,Rattus norvegicus,4891,BAO_0000218,,1,1,,CHEMBL627787,,
8717,Intermediate,,Plasma,1969.0,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,50597,Rattus norvegicus,2807,BAO_0000218,,1,1,,CHEMBL627788,,
8718,Intermediate,,Plasma,1969.0,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,50597,Rattus norvegicus,2807,BAO_0000218,,1,1,,CHEMBL626579,,
8719,Intermediate,,Plasma,1969.0,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,50597,Rattus norvegicus,2807,BAO_0000218,,1,1,,CHEMBL626580,,
8720,Intermediate,,,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,50597,Rattus norvegicus,3634,BAO_0000218,,1,1,,CHEMBL876815,,
8721,Intermediate,,Plasma,1969.0,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,50597,Rattus norvegicus,1881,BAO_0000218,,1,1,,CHEMBL626581,,
8722,Intermediate,,Plasma,1969.0,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,50597,Rattus norvegicus,1881,BAO_0000218,,1,1,,CHEMBL626582,,
8723,Intermediate,,,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,50597,Rattus norvegicus,429,BAO_0000218,,1,1,,CHEMBL626583,,
8724,Intermediate,,,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL626205,,
8725,Intermediate,,,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL626206,,
8726,Intermediate,,,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL626207,,
8727,Intermediate,,,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL623882,,
8728,Intermediate,,,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,50597,Rattus norvegicus,17582,BAO_0000218,,1,1,,CHEMBL623883,,
8729,Intermediate,,,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,50597,Rattus norvegicus,17582,BAO_0000218,,1,1,,CHEMBL623884,,
8730,Intermediate,,Plasma,1969.0,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",50597,Rattus norvegicus,3032,BAO_0000218,,1,1,,CHEMBL623885,,
8731,Intermediate,,Plasma,1969.0,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,50597,Rattus norvegicus,6295,BAO_0000218,,1,1,,CHEMBL623886,,
8732,Intermediate,,,,Maximal concentration in rat was determined,50597,Rattus norvegicus,6619,BAO_0000218,,1,1,,CHEMBL623887,,
8733,Intermediate,,,,Maximal concentration after i.v. administration,50597,Rattus norvegicus,6616,BAO_0000218,,1,1,,CHEMBL623888,,
8734,Intermediate,,Plasma,1969.0,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,50597,Rattus norvegicus,3249,BAO_0000218,,1,1,,CHEMBL623889,,
8735,Intermediate,,Plasma,1969.0,Maximal plasma concentration in rat after oral administration at 50 mg/kg,50597,Rattus norvegicus,17791,BAO_0000218,,1,1,,CHEMBL623890,,
8736,Intermediate,,Plasma,1969.0,Cmax in rat plasma after oral dose (50 mg/Kg),50597,Rattus norvegicus,17791,BAO_0000218,,1,1,,CHEMBL623891,,
8737,Intermediate,,Plasma,1969.0,Maximal plasma concentration was determined.,50597,Rattus norvegicus,1360,BAO_0000218,,1,1,,CHEMBL623892,,
8738,Intermediate,,Plasma,1969.0,Maximal plasma drug concentration was determined,50597,Rattus norvegicus,2552,BAO_0000218,,1,1,,CHEMBL623893,,
8739,Intermediate,,,,Maximal concentration in rats after peroral administration,50597,Rattus norvegicus,6571,BAO_0000218,,1,1,,CHEMBL877616,,
8740,Intermediate,,,,Maximum concentration in rat after 2 mg/kg peroral administration,50597,Rattus norvegicus,6570,BAO_0000218,,1,1,,CHEMBL623894,,
8741,Intermediate,,Plasma,1969.0,Maximum concentration in rat plasma after 5 mg/kg oral gavage,50597,Rattus norvegicus,6567,BAO_0000218,,1,1,,CHEMBL623895,,
8742,Intermediate,,,,Maximum concentration of compound in rat was evaluated.,50597,Rattus norvegicus,3031,BAO_0000218,,1,1,,CHEMBL623896,,
8743,Intermediate,,,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,50597,Rattus norvegicus,3436,BAO_0000218,,1,1,,CHEMBL623897,,
8744,Intermediate,,,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,50597,Rattus norvegicus,3436,BAO_0000218,,1,1,,CHEMBL623898,,
8745,Intermediate,,,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,50597,Rattus norvegicus,2083,BAO_0000218,,1,1,,CHEMBL623899,,
8746,Intermediate,,,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,50597,Rattus norvegicus,3436,BAO_0000218,,1,1,,CHEMBL623900,,
8747,Intermediate,,,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,50597,Rattus norvegicus,4527,BAO_0000218,,1,1,,CHEMBL623901,,
8748,Intermediate,,,,Maximum concentration was evaluated in rats,50597,Rattus norvegicus,1974,BAO_0000218,,1,1,,CHEMBL623902,,
8749,Intermediate,,Cerebrospinal fluid,1359.0,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,50597,Rattus norvegicus,3307,BAO_0000218,,1,1,,CHEMBL623903,,
8750,Intermediate,,Plasma,1969.0,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,50597,Rattus norvegicus,3307,BAO_0000218,,1,1,,CHEMBL623904,,
8751,Intermediate,,Plasma,1969.0,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,50597,Rattus norvegicus,1916,BAO_0000218,,1,1,,CHEMBL877617,,
8752,Intermediate,,,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,50597,Rattus norvegicus,1500,BAO_0000218,,1,1,,CHEMBL623905,,
8753,Intermediate,,,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,50597,Rattus norvegicus,1500,BAO_0000218,,1,1,,CHEMBL623906,,
8754,Intermediate,,Plasma,1969.0,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,50597,Rattus norvegicus,4186,BAO_0000218,,1,1,,CHEMBL623907,,
8755,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623908,,
8756,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623909,,
8757,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623910,,
8758,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623911,,
8759,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623912,,
8760,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624616,,
8761,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624617,,
8762,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624618,,
8763,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624619,,
8764,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624794,,
8765,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624795,,
8766,Intermediate,,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623921,,
8767,Intermediate,,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623922,,
8768,Intermediate,,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623923,,
8769,Intermediate,,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623924,,
8770,Intermediate,,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623925,,
8771,Intermediate,,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623926,,
8772,Intermediate,,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623927,,
8773,Intermediate,,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623928,,
8774,Intermediate,,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623929,,
8775,Intermediate,,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623930,,
8776,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623931,,
8777,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622165,,
8778,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621249,,
8779,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621250,,
8780,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621448,,
8781,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621449,,
8782,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621450,,
8783,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621451,,
8784,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621452,,
8785,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621453,,
8786,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621454,,
8787,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621455,,
8788,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621456,,
8789,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625145,,
8790,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL875847,,
8791,Intermediate,,Brain,955.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625146,,
8792,Intermediate,,Brain,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL625147,,
8793,Intermediate,,Brain,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL625148,,
8794,Intermediate,,Brain,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL625149,,
8795,Intermediate,,Brain,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625150,,
8796,Intermediate,,Brain,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625151,,
8797,Intermediate,,Brain,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625152,,
8798,Intermediate,,Brain,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625153,,
8799,Intermediate,,Brain,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625154,,
8800,Intermediate,,Brain,955.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625155,,
8801,Intermediate,,,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL625156,,
8802,Intermediate,,,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624354,,
8803,Intermediate,,Hippocampus,10000000.0,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624355,,
8804,Intermediate,,Hippocampus,10000000.0,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624356,,
8805,Intermediate,,Hippocampus,10000000.0,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624357,,
8806,Intermediate,,Hippocampus,10000000.0,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624358,,
8807,Intermediate,,Striatum,2435.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624359,,
8808,Intermediate,,Striatum,2435.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624360,,
8809,Intermediate,,Striatum,2435.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624361,,
8810,Intermediate,,Striatum,2435.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624362,,
8811,Intermediate,,Striatum,2435.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624363,,
8812,Intermediate,,Blood,178.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624364,,
8813,Intermediate,,Blood,178.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624365,,
8814,Intermediate,,Blood,178.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624366,,
8815,Intermediate,,Blood,178.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624367,,
8816,Intermediate,,Brain,955.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624368,,
8817,Intermediate,,Brain,955.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624369,,
8818,Intermediate,,Brain,955.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624370,,
8819,Intermediate,,Brain,955.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL625069,,
8820,Intermediate,,Brain,955.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL625070,,
8821,Intermediate,,Heart,948.0,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL626051,,
8822,Intermediate,,Heart,948.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL626052,,
8823,Intermediate,,Heart,948.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL626053,,
8824,Intermediate,,Heart,948.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL626054,,
8825,Intermediate,,Heart,948.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL626055,,
8826,Intermediate,,Kidney,2113.0,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL626056,,
8827,Intermediate,,Kidney,2113.0,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL626057,,
8828,Intermediate,,Kidney,2113.0,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL625193,,
8829,Intermediate,,Kidney,2113.0,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL625194,,
8830,Intermediate,,Liver,2107.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL625195,,
8831,Intermediate,,Liver,2107.0,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL625196,,
8832,Intermediate,,Liver,2107.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL625197,,
8833,Intermediate,,Liver,2107.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL625198,,
8834,Intermediate,,Liver,2107.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL627929,,
8835,Intermediate,,Lung,2048.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL627074,,
8836,Intermediate,,Lung,2048.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL627075,,
8837,Intermediate,,Lung,2048.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL627076,,
8838,Intermediate,,Lung,2048.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL627077,,
8839,Intermediate,,Lung,2048.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL627078,,
8840,Intermediate,,Muscle tissue,2385.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL627079,,
8841,Intermediate,,,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,50594,Mus musculus,4573,BAO_0000218,,1,1,,CHEMBL873824,,
8842,Intermediate,,Plasma,1969.0,Half life in mouse plasma was determined at dose 25 mg/kg,50594,Mus musculus,3132,BAO_0000218,,1,1,,CHEMBL627080,,
8843,Intermediate,,,,Half life was determined,50594,Mus musculus,17718,BAO_0000218,,1,1,,CHEMBL627081,,
8844,Intermediate,,,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,50594,Mus musculus,17728,BAO_0000218,,1,1,,CHEMBL627082,,
8845,Intermediate,,,,Half-life in male mice after 1 mg/kg intravenous dose,50594,Mus musculus,5961,BAO_0000218,,1,1,,CHEMBL627083,,
8847,Intermediate,,Plasma,1969.0,Half life in mice plasma,50594,Mus musculus,17731,BAO_0000218,,1,1,,CHEMBL627085,,
8848,Intermediate,,,,Half life in mouse,50594,Mus musculus,17592,BAO_0000218,,1,1,,CHEMBL627086,,
8849,Intermediate,,Plasma,1969.0,Half life in mouse plasma at dose 25 mg/kg,50594,Mus musculus,3132,BAO_0000218,,1,1,,CHEMBL627087,,
8850,Intermediate,,,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,50594,Mus musculus,17729,BAO_0000218,,1,1,,CHEMBL627088,,
8851,Intermediate,,,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,50594,Mus musculus,17729,BAO_0000218,,1,1,,CHEMBL627089,,
8852,Intermediate,,,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,50594,Mus musculus,17729,BAO_0000218,,1,1,,CHEMBL627090,,
8853,Intermediate,,,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),50594,Mus musculus,3277,BAO_0000218,,1,1,,CHEMBL627091,,
8854,Intermediate,,,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",50594,Mus musculus,3760,BAO_0000218,,1,1,,CHEMBL627092,,
8855,Intermediate,,,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",50594,Mus musculus,3760,BAO_0000218,,1,1,,CHEMBL876785,,
8856,Intermediate,,,,Half-life by iv administration in mouse,50594,Mus musculus,2862,BAO_0000218,,1,1,,CHEMBL627093,,
8857,Intermediate,,,,Half-life by oral administration in mouse,50594,Mus musculus,2862,BAO_0000218,,1,1,,CHEMBL627094,,
8858,Intermediate,,,,Half-life in mice,50594,Mus musculus,5980,BAO_0000218,,1,1,,CHEMBL627095,,
8859,Intermediate,,Brain,955.0,Half-life using mouse brain homogenate,50594,Mus musculus,6159,BAO_0000218,,1,1,,CHEMBL627096,,
8860,Intermediate,,,,Half-life was measured in mice,50594,Mus musculus,6254,BAO_0000218,,1,1,,CHEMBL627097,,
8861,Intermediate,,,,Half-life was measured in mouse after an iv dose of 1 mg/kg,50594,Mus musculus,6062,BAO_0000218,,1,1,,CHEMBL627098,,
8862,Intermediate,,Blood,178.0,Half-life period was determined in mouse blood,50594,Mus musculus,1574,BAO_0000218,,1,1,,CHEMBL627099,,
8863,Intermediate,,Brain,955.0,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",50594,Mus musculus,56,BAO_0000218,,1,1,,CHEMBL627100,,
8864,Intermediate,,Plasma,1969.0,Plasma half life in mouse,50594,Mus musculus,993,BAO_0000218,,1,1,,CHEMBL627101,,
8865,Intermediate,,,,Stability of the peptide in the presence of mouse serum,50594,Mus musculus,6652,BAO_0000218,,1,1,,CHEMBL627102,,
8866,Intermediate,,,,Terminal half life of compound was determined in mouse,50594,Mus musculus,17852,BAO_0000218,,1,1,,CHEMBL627103,,
8867,Intermediate,,,,Terminal half life was evaluated in mice after intravenous administration,50594,Mus musculus,2675,BAO_0000218,,1,1,,CHEMBL627104,,
8868,Intermediate,,,,Terminal half life was evaluated in mice after oral administration,50594,Mus musculus,2675,BAO_0000218,,1,1,,CHEMBL627105,,
8869,Intermediate,,,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,50594,Mus musculus,499,BAO_0000218,,1,1,,CHEMBL876786,,
8870,Intermediate,,,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,50594,Mus musculus,499,BAO_0000218,,1,1,,CHEMBL873825,,
8871,Intermediate,,,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,50594,Mus musculus,499,BAO_0000218,,1,1,,CHEMBL627106,,
8872,Intermediate,,,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,50594,Mus musculus,14239,BAO_0000218,,1,1,,CHEMBL626336,,
8873,Intermediate,,,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",50594,Mus musculus,5506,BAO_0000218,,1,1,,CHEMBL877462,,
8874,Intermediate,,,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",50594,Mus musculus,5506,BAO_0000218,,1,1,,CHEMBL626337,,
8875,Intermediate,,,,Half life after intraperitoneal administration of 100 mg/kg in mice,50594,Mus musculus,17734,BAO_0000218,,1,1,,CHEMBL626338,,
8876,Intermediate,,,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,50594,Mus musculus,17728,BAO_0000218,,1,1,,CHEMBL626339,,
8877,Intermediate,,,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,50594,Mus musculus,17728,BAO_0000218,,1,1,,CHEMBL626340,,
8878,Intermediate,,,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,50594,Mus musculus,17728,BAO_0000218,,1,1,,CHEMBL625377,,
8879,Intermediate,,,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,50594,Mus musculus,17728,BAO_0000218,,1,1,,CHEMBL625378,,
8880,Intermediate,,,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,50594,Mus musculus,17728,BAO_0000218,,1,1,,CHEMBL625379,,
8881,Autocuration,Microsomes,,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),22224,Sus scrofa,14294,BAO_0000251,,0,1,,CHEMBL625380,,
8882,Autocuration,Microsomes,,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),22224,Sus scrofa,14294,BAO_0000251,,0,1,,CHEMBL625381,,
8883,Autocuration,,,,Stability to porcine renal DHP-I,22224,Sus scrofa,6056,BAO_0000019,,0,1,,CHEMBL625382,,
8884,Autocuration,,,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,22224,Sus scrofa,1317,BAO_0000218,,0,1,,CHEMBL873828,,
8885,Autocuration,,,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,22224,Sus scrofa,1317,BAO_0000218,,0,1,,CHEMBL625383,,
8886,Autocuration,,,,Half-life of the parent prodrug in porcine esterase solution,22224,Sus scrofa,5229,BAO_0000019,,0,1,,CHEMBL625384,,
8887,Autocuration,,,,"First order rate constant, k was determined in in pig liver Esterase",22224,Sus scrofa,4231,BAO_0000019,,0,1,,CHEMBL625385,,
8888,Autocuration,,Liver,2107.0,Half life of the in pig liver Esterase,22224,Sus scrofa,4231,BAO_0000221,,0,1,,CHEMBL625386,,
8889,Autocuration,,Liver,2107.0,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,22224,Sus scrofa,5318,BAO_0000221,,0,1,,CHEMBL623571,,
8890,Autocuration,,Liver,2107.0,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,22224,Sus scrofa,5318,BAO_0000221,,0,1,,CHEMBL623572,,
8891,Autocuration,,Liver,2107.0,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,22224,Sus scrofa,5318,BAO_0000221,,0,1,,CHEMBL623573,,
8892,Autocuration,,Liver,2107.0,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,22224,Sus scrofa,3305,BAO_0000221,,0,1,,CHEMBL623574,,
8893,Autocuration,,Liver,2107.0,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,22224,Sus scrofa,3305,BAO_0000221,,0,1,,CHEMBL623575,,
8894,Autocuration,,Liver,2107.0,Half-life in the presence of pig liver esterase(PLE) was evaluated.,22224,Sus scrofa,2842,BAO_0000221,,0,1,,CHEMBL623749,,
8895,Autocuration,,Liver,2107.0,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,22224,Sus scrofa,2842,BAO_0000221,,0,1,,CHEMBL623750,,
8896,Autocuration,,Liver,2107.0,Half-life in vitro in pig liver,22224,Sus scrofa,889,BAO_0000221,,0,1,,CHEMBL623751,,
8897,Autocuration,,Liver,2107.0,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,22224,Sus scrofa,1904,BAO_0000221,,0,1,,CHEMBL623752,,
8898,Intermediate,,Plasma,1969.0,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,50597,Rattus norvegicus,4186,BAO_0000218,,1,1,,CHEMBL623753,,
8899,Intermediate,,Plasma,1969.0,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,50597,Rattus norvegicus,2774,BAO_0000218,,1,1,,CHEMBL623754,,
8900,Intermediate,,Plasma,1969.0,Maximum concentration in rat plasma was determined,50597,Rattus norvegicus,1742,BAO_0000218,,1,1,,CHEMBL623755,,
8901,Intermediate,,,,Maximum concentration in rats,50597,Rattus norvegicus,3169,BAO_0000218,,1,1,,CHEMBL623756,,
8902,Intermediate,,,,Maximum concentration in rats at 1-2 hours,50597,Rattus norvegicus,3169,BAO_0000218,,1,1,,CHEMBL623757,,
8903,Intermediate,,,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,50597,Rattus norvegicus,2081,BAO_0000218,,1,1,,CHEMBL623758,,
8904,Intermediate,,Brain,955.0,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,50597,Rattus norvegicus,3307,BAO_0000218,,1,1,,CHEMBL623759,,
8905,Intermediate,,,,Maximum concentration at the dose of 2 mg/kg in rat,50597,Rattus norvegicus,4727,BAO_0000218,,1,1,,CHEMBL623760,,
8906,Intermediate,,,,Maximum concentration was evaluated in rats,50597,Rattus norvegicus,6597,BAO_0000218,,1,1,,CHEMBL623761,,
8907,Intermediate,,Plasma,1969.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL623762,,
8908,Intermediate,,Plasma,1969.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL877594,,
8909,Intermediate,,Plasma,1969.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL623763,,
8910,Intermediate,,Plasma,1969.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL623764,,
8911,Intermediate,,Plasma,1969.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL623765,,
8912,Intermediate,,Blood,178.0,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,50597,Rattus norvegicus,2591,BAO_0000218,,1,1,,CHEMBL623766,,
8913,Intermediate,,Blood,178.0,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,50597,Rattus norvegicus,2591,BAO_0000218,,1,1,,CHEMBL623767,,
8914,Intermediate,,Blood,178.0,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,50597,Rattus norvegicus,2591,BAO_0000218,,1,1,,CHEMBL623768,,
8915,Intermediate,,Plasma,1969.0,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL623769,,
8916,Intermediate,,Plasma,1969.0,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL623770,,
8917,Intermediate,,Plasma,1969.0,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL623771,,
8918,Intermediate,,Plasma,1969.0,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL623772,,
8919,Intermediate,,Plasma,1969.0,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL623773,,
8920,Intermediate,,Plasma,1969.0,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL623774,,
8921,Intermediate,,Plasma,1969.0,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL623775,,
8922,Intermediate,,,,Cmax in rat (PO dose),50597,Rattus norvegicus,14465,BAO_0000218,,1,1,,CHEMBL623776,,
8923,Intermediate,,Plasma,1969.0,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,50597,Rattus norvegicus,4723,BAO_0000218,,1,1,,CHEMBL622191,,
8924,Intermediate,,Plasma,1969.0,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,50597,Rattus norvegicus,4723,BAO_0000218,,1,1,,CHEMBL622192,,
8925,Intermediate,,Plasma,1969.0,Maximum plasma concentration determined in rat,50597,Rattus norvegicus,4576,BAO_0000218,,1,1,,CHEMBL622193,,
8926,Intermediate,,Plasma,1969.0,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,50597,Rattus norvegicus,12873,BAO_0000218,,1,1,,CHEMBL622194,,
8927,Intermediate,,Plasma,1969.0,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,50597,Rattus norvegicus,12873,BAO_0000218,,1,1,,CHEMBL622195,,
8928,Intermediate,,Plasma,1969.0,Maximum plasma concentration in rat,50597,Rattus norvegicus,6824,BAO_0000218,,1,1,,CHEMBL622196,,
8929,Intermediate,,Plasma,1969.0,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,50597,Rattus norvegicus,17065,BAO_0000218,,1,1,,CHEMBL622197,,
8930,Intermediate,,Plasma,1969.0,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,50597,Rattus norvegicus,2932,BAO_0000218,,1,1,,CHEMBL622198,,
8931,Intermediate,,Plasma,1969.0,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,50597,Rattus norvegicus,2932,BAO_0000218,,1,1,,CHEMBL622199,,
8932,Intermediate,,Plasma,1969.0,Maximum plasma concentration of compound was measured in rat,50597,Rattus norvegicus,2879,BAO_0000218,,1,1,,CHEMBL622200,,
8933,Intermediate,,Plasma,1969.0,Maximum plasma concentration after 20 mg/kg oral administration in rat,50597,Rattus norvegicus,2864,BAO_0000218,,1,1,,CHEMBL622201,,
8934,Intermediate,,Plasma,1969.0,Maximum plasma concentration after oral administration to rats,50597,Rattus norvegicus,16367,BAO_0000218,,1,1,,CHEMBL623990,,
8935,Intermediate,,Plasma,1969.0,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL623991,,
8936,Intermediate,,Plasma,1969.0,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL623992,,
8937,Intermediate,,Plasma,1969.0,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL623993,,
8938,Intermediate,,Plasma,1969.0,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL623994,,
8939,Intermediate,,Plasma,1969.0,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,50597,Rattus norvegicus,17720,BAO_0000218,,1,1,,CHEMBL623995,,
8940,Intermediate,,Plasma,1969.0,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,50597,Rattus norvegicus,17720,BAO_0000218,,1,1,,CHEMBL623996,,
8941,Intermediate,,Plasma,1969.0,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,50597,Rattus norvegicus,17720,BAO_0000218,,1,1,,CHEMBL623997,,
8942,Intermediate,,Plasma,1969.0,Maximum plasma concentration dosed orally in rats,50597,Rattus norvegicus,4516,BAO_0000218,,1,1,,CHEMBL623998,,
8943,Intermediate,,Plasma,1969.0,Maximum plasma concentration dosed orally in rats after 6 hours,50597,Rattus norvegicus,4516,BAO_0000218,,1,1,,CHEMBL623999,,
8944,Intermediate,,Plasma,1969.0,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,50597,Rattus norvegicus,4516,BAO_0000218,,1,1,,CHEMBL624000,,
8945,Intermediate,,Plasma,1969.0,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,50597,Rattus norvegicus,5199,BAO_0000218,,1,1,,CHEMBL624001,,
8946,Intermediate,,Plasma,1969.0,Maximum plasma concentration in rat after po administration,50597,Rattus norvegicus,17538,BAO_0000218,,1,1,,CHEMBL624002,,
8947,Intermediate,,Plasma,1969.0,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL624003,,
8948,Intermediate,,Plasma,1969.0,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL624004,,
8949,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624005,,
8950,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624006,,
8951,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624007,,
8952,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624008,,
8953,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624009,,
8954,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL874387,,
8955,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624010,,
8956,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624011,,
8957,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624012,,
8958,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624013,,
8959,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624736,,
8960,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624737,,
8961,Intermediate,,Heart,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624738,,
8962,Intermediate,,Heart,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624739,,
8963,Intermediate,,Heart,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL624740,,
8964,Intermediate,,Heart,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624896,,
8965,Intermediate,,Heart,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624897,,
8966,Intermediate,,Heart,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624108,,
8967,Intermediate,,Heart,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624109,,
8968,Intermediate,,Heart,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624110,,
8969,Intermediate,,Heart,948.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624111,,
8970,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624112,,
8971,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL624113,,
8972,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL619709,,
8973,Intermediate,,Heart,948.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL619710,,
8974,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL619711,,
8975,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL619712,,
8976,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL619713,,
8977,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL619714,,
8978,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL619715,,
8979,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL619716,,
8980,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL619717,,
8981,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL619718,,
8982,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL619719,,
8983,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL875329,,
8984,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL619720,,
8985,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL619721,,
8986,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL619722,,
8987,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL619723,,
8988,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL619724,,
8989,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL619725,,
8990,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL619726,,
8991,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL619727,,
8992,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL619728,,
8993,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL619729,,
8994,Intermediate,,Muscle tissue,2385.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL619730,,
8995,Intermediate,,Muscle tissue,2385.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL619731,,
8996,Intermediate,,Muscle tissue,2385.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL619732,,
8997,Intermediate,,Muscle tissue,2385.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL619733,,
8998,Intermediate,,Muscle tissue,2385.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL619734,,
8999,Intermediate,,Zone of skin,14.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL619735,,
9000,Intermediate,,Zone of skin,14.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL875330,,
9001,Intermediate,,Zone of skin,14.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL628465,,
9002,Intermediate,,Zone of skin,14.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL628466,,
9003,Intermediate,,Zone of skin,14.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL628467,,
9004,Intermediate,,Spleen,2106.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL628468,,
9005,Intermediate,,Spleen,2106.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL628469,,
9006,Intermediate,,Spleen,2106.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL628470,,
9007,Intermediate,,Spleen,2106.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL628471,,
9008,Intermediate,,Spleen,2106.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL628472,,
9009,Intermediate,,Thyroid gland,2046.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL625191,,
9010,Intermediate,,Thyroid gland,2046.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL625192,,
9011,Intermediate,,Thyroid gland,2046.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL875337,,
9012,Intermediate,,Thyroid gland,2046.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL626341,,
9013,Intermediate,,Thyroid gland,2046.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL626342,,
9014,Intermediate,,Liver,2107.0,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL621943,,
9015,Intermediate,,,,Half life in rats,50597,Rattus norvegicus,3748,BAO_0000218,,1,1,,CHEMBL621944,,
9016,Intermediate,,,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,50597,Rattus norvegicus,15765,BAO_0000218,,1,1,,CHEMBL621945,,
9017,Intermediate,,,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),50597,Rattus norvegicus,4871,BAO_0000218,,1,1,,CHEMBL621946,,
9018,Intermediate,,,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,50597,Rattus norvegicus,4871,BAO_0000218,,1,1,,CHEMBL621947,,
9019,Intermediate,,,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),50597,Rattus norvegicus,4872,BAO_0000218,,1,1,,CHEMBL621948,,
9020,Intermediate,,,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,50597,Rattus norvegicus,4872,BAO_0000218,,1,1,,CHEMBL621949,,
9021,Intermediate,,,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),50597,Rattus norvegicus,5413,BAO_0000218,,1,1,,CHEMBL621950,,
9022,Intermediate,,,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,50597,Rattus norvegicus,5413,BAO_0000218,,1,1,,CHEMBL621951,,
9023,Intermediate,,Blood,178.0,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,50597,Rattus norvegicus,15272,BAO_0000218,,1,1,,CHEMBL621952,,
9024,Intermediate,,Liver,2107.0,Stability (%) in rat liver microsomes,50597,Rattus norvegicus,4689,BAO_0000218,,1,1,,CHEMBL621953,,
9025,Intermediate,,,,Area under curve was calculated after intravenous administration,50597,Rattus norvegicus,6057,BAO_0000218,,1,1,,CHEMBL621954,,
9026,Intermediate,,,,Area under the curve was calculated after iv administration in rat,50597,Rattus norvegicus,6057,BAO_0000218,,1,1,,CHEMBL621955,,
9027,Intermediate,,,,Area under the curve was calculated in rat after peroral administration,50597,Rattus norvegicus,6057,BAO_0000218,,1,1,,CHEMBL621956,,
9028,Intermediate,,,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,50597,Rattus norvegicus,6211,BAO_0000218,,1,1,,CHEMBL621957,,
9029,Intermediate,,,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,50597,Rattus norvegicus,5710,BAO_0000218,,1,1,,CHEMBL621958,,
9030,Intermediate,,,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,50597,Rattus norvegicus,5710,BAO_0000218,,1,1,,CHEMBL621959,,
9031,Intermediate,,,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,50597,Rattus norvegicus,17853,BAO_0000218,,1,1,,CHEMBL621960,,
9032,Intermediate,,,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,50597,Rattus norvegicus,17853,BAO_0000218,,1,1,,CHEMBL621961,,
9033,Intermediate,,,,p value of the compound,50597,Rattus norvegicus,15765,BAO_0000218,,1,1,,CHEMBL621962,,
9034,Intermediate,,,,p value of the compound,50597,Rattus norvegicus,15765,BAO_0000218,,1,1,,CHEMBL876787,,
9035,Intermediate,,,,p value of the compound,50597,Rattus norvegicus,15765,BAO_0000218,,1,1,,CHEMBL621963,,
9036,Intermediate,,Stomach,945.0,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),50597,Rattus norvegicus,6175,BAO_0000218,,1,1,,CHEMBL622637,,
9037,Intermediate,,Stomach,945.0,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),50597,Rattus norvegicus,6175,BAO_0000218,,1,1,,CHEMBL622638,,
9038,Intermediate,,Stomach,945.0,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),50597,Rattus norvegicus,6175,BAO_0000218,,1,1,,CHEMBL626561,,
9039,Autocuration,,,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),22224,Oryctolagus cuniculus,7991,BAO_0000019,,0,1,,CHEMBL626562,,
9040,Autocuration,,,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),22224,Oryctolagus cuniculus,429,BAO_0000218,,0,1,,CHEMBL626563,,
9041,Autocuration,,,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),22224,Oryctolagus cuniculus,429,BAO_0000218,,0,1,,CHEMBL626564,,
9042,Autocuration,,,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,22224,Oryctolagus cuniculus,6253,BAO_0000218,,0,1,,CHEMBL626565,,
9043,Autocuration,,,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,22224,Oryctolagus cuniculus,6253,BAO_0000218,,0,1,,CHEMBL626566,,
9044,Autocuration,,,,Clearance rate in rabbits,22224,Oryctolagus cuniculus,3615,BAO_0000218,,0,1,,CHEMBL626567,,
9045,Autocuration,,,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,22224,Oryctolagus cuniculus,4059,BAO_0000218,,0,1,,CHEMBL626568,,
9046,Autocuration,,,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,22224,Oryctolagus cuniculus,5124,BAO_0000218,,0,1,,CHEMBL626569,,
9047,Autocuration,,,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,22224,Oryctolagus cuniculus,5124,BAO_0000218,,0,1,,CHEMBL626570,,
9048,Autocuration,,,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,22224,Oryctolagus cuniculus,5124,BAO_0000218,,0,1,,CHEMBL626571,,
9049,Autocuration,,,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,22224,Oryctolagus cuniculus,429,BAO_0000218,,0,1,,CHEMBL626572,,
9050,Autocuration,,Plasma,1969.0,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,22224,Oryctolagus cuniculus,4059,BAO_0000218,,0,1,,CHEMBL626573,,
9051,Autocuration,Microsomes,Liver,2107.0,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,22224,Oryctolagus cuniculus,9659,BAO_0000251,,0,1,,CHEMBL626574,,
9052,Autocuration,Microsomes,Liver,2107.0,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,22224,Oryctolagus cuniculus,9659,BAO_0000251,,0,1,,CHEMBL626575,,
9053,Autocuration,,,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,22224,Oryctolagus cuniculus,3639,BAO_0000218,,0,1,,CHEMBL626576,,
9054,Autocuration,,,,Dose at which bioavailability of perorally administered compound was tested in rabbit,22224,Oryctolagus cuniculus,3639,BAO_0000218,,0,1,,CHEMBL626577,,
9055,Autocuration,,,,The compound was tested for its bioavailability in rabbit (by oral dosage).,22224,Oryctolagus cuniculus,3639,BAO_0000218,,0,1,,CHEMBL626578,,
9056,Autocuration,,,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,22224,Oryctolagus cuniculus,5124,BAO_0000218,,0,1,,CHEMBL625263,,
9057,Autocuration,,,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,22224,Oryctolagus cuniculus,5124,BAO_0000218,,0,1,,CHEMBL625264,,
9058,Autocuration,,,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,22224,Oryctolagus cuniculus,5124,BAO_0000218,,0,1,,CHEMBL625265,,
9059,Autocuration,Microsomes,,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),22224,Oryctolagus cuniculus,14294,BAO_0000251,,0,1,,CHEMBL625266,,
9060,Autocuration,Microsomes,,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),22224,Oryctolagus cuniculus,14294,BAO_0000251,,0,1,,CHEMBL876796,,
9061,Autocuration,,,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,22224,Oryctolagus cuniculus,429,BAO_0000218,,0,1,,CHEMBL625267,,
9062,Autocuration,,Plasma,1969.0,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,22224,Oryctolagus cuniculus,5124,BAO_0000218,,0,1,,CHEMBL625268,,
9063,Autocuration,,Plasma,1969.0,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,22224,Oryctolagus cuniculus,5124,BAO_0000218,,0,1,,CHEMBL625269,,
9064,Autocuration,,Plasma,1969.0,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,22224,Oryctolagus cuniculus,5124,BAO_0000218,,0,1,,CHEMBL624689,,
9065,Autocuration,,,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,22224,Oryctolagus cuniculus,429,BAO_0000218,,0,1,,CHEMBL624690,,
9066,Autocuration,,Urine,1088.0,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),22224,Oryctolagus cuniculus,429,BAO_0000218,,0,1,,CHEMBL624691,,
9067,Autocuration,,Urine,1088.0,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),22224,Oryctolagus cuniculus,429,BAO_0000218,,0,1,,CHEMBL624692,,
9068,Autocuration,,,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,22224,Oryctolagus cuniculus,4059,BAO_0000218,,0,1,,CHEMBL624693,,
9069,Autocuration,,,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,22224,Oryctolagus cuniculus,4137,BAO_0000218,,0,1,,CHEMBL624694,,
9070,Autocuration,,,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,22224,Oryctolagus cuniculus,11672,BAO_0000221,,0,1,,CHEMBL877596,,
9071,Autocuration,,,,Time within which only 10% of the drug was degraded,22224,Oryctolagus cuniculus,12886,BAO_0000019,,0,1,,CHEMBL624695,,
9072,Autocuration,,Liver,2107.0,Half life period in rabbit liver homogenate,22224,Oryctolagus cuniculus,3853,BAO_0000221,,0,1,,CHEMBL624696,,
9073,Autocuration,,,,Half life value in rabbits,22224,Oryctolagus cuniculus,3615,BAO_0000019,,0,1,,CHEMBL624697,,
9074,Autocuration,,Blood,178.0,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,22224,Oryctolagus cuniculus,6253,BAO_0000218,,0,1,,CHEMBL624698,,
9075,Autocuration,,Blood,178.0,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,22224,Oryctolagus cuniculus,6253,BAO_0000218,,0,1,,CHEMBL624699,,
9076,Autocuration,,,,Half-life period in rabbits following intravenous administration at 2 mg/kg,22224,Oryctolagus cuniculus,6077,BAO_0000218,,0,1,,CHEMBL624700,,
9077,Intermediate,,Plasma,1969.0,AUC 0-8 hr value in rats at 10 mg/kg,50597,Rattus norvegicus,17617,BAO_0000218,,1,1,,CHEMBL622903,,
9078,Intermediate,,Plasma,1969.0,AUC after administration at 2000 mg/kg/day in rats,50597,Rattus norvegicus,17594,BAO_0000218,,1,1,,CHEMBL622904,,
9079,Intermediate,,Plasma,1969.0,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,50597,Rattus norvegicus,6149,BAO_0000218,,1,1,,CHEMBL622905,,
9080,Intermediate,,Plasma,1969.0,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,50597,Rattus norvegicus,17260,BAO_0000218,,1,1,,CHEMBL622906,,
9081,Intermediate,,Plasma,1969.0,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,50597,Rattus norvegicus,17260,BAO_0000218,,1,1,,CHEMBL622907,,
9082,Intermediate,,Plasma,1969.0,AUC in rat after oral administration at 10.5 mg/kg dose,50597,Rattus norvegicus,6644,BAO_0000218,,1,1,,CHEMBL622908,,
9083,Intermediate,,Plasma,1969.0,AUC in rat after oral administration at 11.2 mg/kg dose,50597,Rattus norvegicus,6644,BAO_0000218,,1,1,,CHEMBL622909,,
9084,Intermediate,,Plasma,1969.0,AUC in rat after oral administration at 9.7 mg/kg dose,50597,Rattus norvegicus,6644,BAO_0000218,,1,1,,CHEMBL622910,,
9085,Intermediate,,Brain,955.0,AUC in rat brain after oral administration at 10 mg/kg,50597,Rattus norvegicus,6495,BAO_0000218,,1,1,,CHEMBL622911,,
9086,Intermediate,,Plasma,1969.0,AUC in rat p.o.,50597,Rattus norvegicus,6504,BAO_0000218,,1,1,,CHEMBL622912,,
9087,Intermediate,,Plasma,1969.0,AUC in rat p.o. at 20 mg/kg concentration,50597,Rattus norvegicus,17686,BAO_0000218,,1,1,,CHEMBL622913,,
9088,Intermediate,,Plasma,1969.0,AUC in rat plasma after oral administration at 10 mg/kg,50597,Rattus norvegicus,6495,BAO_0000218,,1,1,,CHEMBL622914,,
9089,Intermediate,,Plasma,1969.0,AUC in rats,50597,Rattus norvegicus,216,BAO_0000218,,1,1,,CHEMBL622915,,
9090,Intermediate,,Plasma,1969.0,AUC value after IV dose at a dose of 5 mg/kg in rats.,50597,Rattus norvegicus,1908,BAO_0000218,,1,1,,CHEMBL622916,,
9091,Intermediate,,Plasma,1969.0,AUC value after oral dose at a dose of 10 mg/kg in rats.,50597,Rattus norvegicus,1908,BAO_0000218,,1,1,,CHEMBL622917,,
9092,Intermediate,,Plasma,1969.0,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL622918,,
9093,Intermediate,,Plasma,1969.0,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,50597,Rattus norvegicus,216,BAO_0000218,,1,1,,CHEMBL622919,,
9094,Intermediate,,Plasma,1969.0,Maximum plasma concentration was evaluated in rat,50597,Rattus norvegicus,6049,BAO_0000218,,1,1,,CHEMBL622920,,
9095,Intermediate,,Plasma,1969.0,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,50597,Rattus norvegicus,2463,BAO_0000218,,1,1,,CHEMBL622921,,
9096,Intermediate,,Plasma,1969.0,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,50597,Rattus norvegicus,6679,BAO_0000218,,1,1,,CHEMBL622922,,
9097,Intermediate,,Plasma,1969.0,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,50597,Rattus norvegicus,6681,BAO_0000218,,1,1,,CHEMBL622923,,
9098,Intermediate,,Plasma,1969.0,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,50597,Rattus norvegicus,4890,BAO_0000218,,1,1,,CHEMBL877604,,
9099,Intermediate,,Plasma,1969.0,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,50597,Rattus norvegicus,6410,BAO_0000218,,1,1,,CHEMBL622924,,
9100,Intermediate,,Plasma,1969.0,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,50597,Rattus norvegicus,6410,BAO_0000218,,1,1,,CHEMBL622925,,
9101,Intermediate,,Plasma,1969.0,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,50597,Rattus norvegicus,16366,BAO_0000218,,1,1,,CHEMBL622926,,
9102,Intermediate,,Plasma,1969.0,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,50597,Rattus norvegicus,6227,BAO_0000218,,1,1,,CHEMBL623625,,
9103,Expert,,Plasma,1969.0,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,50597,Rattus norvegicus,3598,BAO_0000218,,1,1,,CHEMBL623626,,
9104,Intermediate,,Plasma,1969.0,Maximum plasma drug concentration was determined,50597,Rattus norvegicus,1465,BAO_0000218,,1,1,,CHEMBL623627,,
9105,Intermediate,,,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,50597,Rattus norvegicus,4368,BAO_0000218,,1,1,,CHEMBL623628,,
9106,Intermediate,,Plasma,1969.0,Mean peak plasma concentration was observed after intravenous administration in rat,50597,Rattus norvegicus,15662,BAO_0000218,,1,1,,CHEMBL623629,,
9107,Intermediate,,Plasma,1969.0,Mean peak plasma concentration was observed after oral administration in rat,50597,Rattus norvegicus,15662,BAO_0000218,,1,1,,CHEMBL623630,,
9108,Intermediate,,,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,50597,Rattus norvegicus,5355,BAO_0000218,,1,1,,CHEMBL623804,,
9109,Intermediate,,,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,50597,Rattus norvegicus,5355,BAO_0000218,,1,1,,CHEMBL623805,,
9110,Intermediate,,Plasma,1969.0,Peak oral plasma concentration was determined in rats by oral administration,50597,Rattus norvegicus,1567,BAO_0000218,,1,1,,CHEMBL623806,,
9111,Intermediate,,Plasma,1969.0,Peak plasma concentration (Cmax) was determined,50597,Rattus norvegicus,4026,BAO_0000218,,1,1,,CHEMBL623807,,
9112,Intermediate,,Plasma,1969.0,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,50597,Rattus norvegicus,6193,BAO_0000218,,1,1,,CHEMBL623808,,
9113,Intermediate,,Plasma,1969.0,Peak plasma concentration (Cmax) in rats,50597,Rattus norvegicus,4026,BAO_0000218,,1,1,,CHEMBL623809,,
9114,Intermediate,,Plasma,1969.0,Peak plasma concentration at 1 mg/kg peroral administration,50597,Rattus norvegicus,6485,BAO_0000218,,1,1,,CHEMBL623810,,
9115,Intermediate,,Plasma,1969.0,Peak plasma concentration in rat,50597,Rattus norvegicus,17655,BAO_0000218,,1,1,,CHEMBL623811,,
9116,Intermediate,,Plasma,1969.0,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",50597,Rattus norvegicus,14941,BAO_0000218,,1,1,,CHEMBL623812,,
9117,Intermediate,,,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,50597,Rattus norvegicus,5394,BAO_0000218,,1,1,,CHEMBL877605,,
9118,Intermediate,,,,Pharmacokinetic property (Cmax) in rat,50597,Rattus norvegicus,4408,BAO_0000218,,1,1,,CHEMBL623813,,
9119,Intermediate,,,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,50597,Rattus norvegicus,5983,BAO_0000218,,1,1,,CHEMBL623814,,
9120,Intermediate,,,,Cmax in rat after 3mg/kg oral dose,50597,Rattus norvegicus,4878,BAO_0000218,,1,1,,CHEMBL623815,,
9121,Intermediate,,,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,50597,Rattus norvegicus,5862,BAO_0000218,Sprague-Dawley,1,1,,CHEMBL623816,,
9122,Intermediate,,,,Cmax in rats after 20 mg/kg oral dose,50597,Rattus norvegicus,4517,BAO_0000218,,1,1,,CHEMBL623145,,
9123,Intermediate,,Plasma,1969.0,Cmax in rat plasma after 30mg/kg oral dose,50597,Rattus norvegicus,5932,BAO_0000218,,1,1,,CHEMBL623146,,
9124,Intermediate,,Plasma,1969.0,Plasma concentration after oral administration of 100 mg/kg to rats,50597,Rattus norvegicus,5436,BAO_0000218,,1,1,,CHEMBL623147,,
9125,Intermediate,,Brain,955.0,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL623042,,
9126,Intermediate,,,,Tested for the Cmax in rat at 10 mg/kg per orally,50597,Rattus norvegicus,4950,BAO_0000218,,1,1,,CHEMBL623043,,
9127,Intermediate,,,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL623044,,
9128,Intermediate,,,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL623045,,
9129,Intermediate,,,,Bioavailability as oral Cmax in rats at 30 mins,50597,Rattus norvegicus,3360,BAO_0000218,,1,1,,CHEMBL623046,,
9130,Intermediate,,,,Bioavailability as oral Cmax in rats at 6hr,50597,Rattus norvegicus,3360,BAO_0000218,,1,1,,CHEMBL623226,,
9131,Intermediate,,,,The maximum concentration of compound was measured at the dose of 100 umol/kg,50597,Rattus norvegicus,15022,BAO_0000218,,1,1,,CHEMBL623227,,
9132,Intermediate,,,,The maximum concentration of compound was measured at the dose of 300 umol/kg,50597,Rattus norvegicus,15022,BAO_0000218,,1,1,,CHEMBL623228,,
9133,Intermediate,,,,The maximum concentration of compound was measured at the dose of 30 umol/kg,50597,Rattus norvegicus,15022,BAO_0000218,,1,1,,CHEMBL623229,,
9134,Intermediate,,Plasma,1969.0,The maximum plasma levels for the compounds were determined by LC-MS.,50597,Rattus norvegicus,5160,BAO_0000218,,1,1,,CHEMBL623230,,
9135,Intermediate,,Plasma,1969.0,mean peak plasma concentration was observed after intravenous administration in rat,50597,Rattus norvegicus,15662,BAO_0000218,,1,1,,CHEMBL623231,,
9136,Intermediate,,Plasma,1969.0,mean peak plasma concentration was observed after oral administration in rat,50597,Rattus norvegicus,15662,BAO_0000218,,1,1,,CHEMBL623232,,
9137,Intermediate,,,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,50597,Rattus norvegicus,4709,BAO_0000218,,1,1,,CHEMBL623233,,
9138,Intermediate,,,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,50597,Rattus norvegicus,3535,BAO_0000218,,1,1,,CHEMBL623234,,
9139,Intermediate,,,,Concentration in plasma (portal) following oral dose in rats at 1 hr,50597,Rattus norvegicus,3535,BAO_0000218,,1,1,,CHEMBL623235,,
9140,Intermediate,,,,Concentration in plasma (portal) following oral dose in rats at 2 hr,50597,Rattus norvegicus,3535,BAO_0000218,,1,1,,CHEMBL623236,,
9141,Intermediate,,,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,50597,Rattus norvegicus,3535,BAO_0000218,,1,1,,CHEMBL623237,,
9142,Intermediate,,,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,50597,Rattus norvegicus,3535,BAO_0000218,,1,1,,CHEMBL623238,,
9143,Intermediate,,,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,50597,Rattus norvegicus,3535,BAO_0000218,,1,1,,CHEMBL623239,,
9144,Intermediate,,Plasma,1969.0,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,22224,Rattus norvegicus,5005,BAO_0000218,,0,1,,CHEMBL623240,,
9145,Intermediate,,Hypothalamus,1898.0,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",50597,Rattus norvegicus,6326,BAO_0000218,,1,1,,CHEMBL623241,,
9146,Intermediate,,Hypothalamus,1898.0,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",50597,Rattus norvegicus,6326,BAO_0000218,,1,1,,CHEMBL623242,,
9147,Intermediate,,,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",50597,Rattus norvegicus,6326,BAO_0000218,,1,1,,CHEMBL874394,,
9148,Intermediate,,,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",50597,Rattus norvegicus,6326,BAO_0000218,,1,1,,CHEMBL623243,,
9149,Intermediate,,,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,50597,Rattus norvegicus,17411,BAO_0000218,,1,1,,CHEMBL623244,,
9150,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623245,,
9151,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623246,,
9152,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623247,,
9153,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623248,,
9154,Intermediate,,Kidney,2113.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623249,,
9155,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL625072,,
9156,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL625073,,
9157,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL625074,,
9158,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL625075,,
9159,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL625076,,
9160,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL625077,,
9161,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL625078,,
9162,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL874395,,
9163,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625079,,
9164,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625080,,
9165,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625081,,
9166,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625082,,
9167,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625083,,
9168,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625084,,
9169,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625085,,
9170,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL625086,,
9171,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL625087,,
9172,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL625088,,
9173,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622205,,
9174,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622206,,
9175,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622207,,
9176,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622366,,
9177,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622367,,
9178,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL875331,,
9179,Intermediate,,Liver,2107.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622368,,
9180,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622369,,
9181,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622370,,
9182,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622371,,
9183,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622372,,
9184,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622373,,
9185,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622374,,
9186,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622375,,
9187,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622376,,
9188,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622377,,
9189,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622378,,
9190,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622379,,
9191,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622380,,
9192,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622381,,
9193,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622382,,
9194,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622383,,
9195,Intermediate,,Stomach,945.0,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),50597,Rattus norvegicus,6175,BAO_0000218,,1,1,,CHEMBL875332,,
9196,Intermediate,,Stomach,945.0,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),50597,Rattus norvegicus,6175,BAO_0000218,,1,1,,CHEMBL622384,,
9197,Intermediate,,Stomach,945.0,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),50597,Rattus norvegicus,6175,BAO_0000218,,1,1,,CHEMBL622385,,
9198,Intermediate,,Stomach,945.0,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),50597,Rattus norvegicus,6175,BAO_0000218,,1,1,,CHEMBL622386,,
9199,Intermediate,,,,The compound was tested for the plasma binding in rat,50597,Rattus norvegicus,10839,BAO_0000218,,1,1,,CHEMBL622387,,
9200,Intermediate,,,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",50597,Rattus norvegicus,16459,BAO_0000218,,1,1,,CHEMBL622388,,
9201,Intermediate,,,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",50597,Rattus norvegicus,16459,BAO_0000218,,1,1,,CHEMBL622389,,
9202,Intermediate,,,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",50597,Rattus norvegicus,16459,BAO_0000218,,1,1,,CHEMBL622390,,
9203,Intermediate,,,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),50597,Rattus norvegicus,16459,BAO_0000218,,1,1,,CHEMBL622391,,
9204,Intermediate,,,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),50597,Rattus norvegicus,16459,BAO_0000218,,1,1,,CHEMBL622392,,
9205,Intermediate,,,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),50597,Rattus norvegicus,16459,BAO_0000218,,1,1,,CHEMBL622393,,
9206,Intermediate,,,,Plasma level at 2 hr after administration of the compound,50597,Rattus norvegicus,3278,BAO_0000218,,1,1,,CHEMBL622394,,
9207,Intermediate,,,,plasma level at 2 hr after administration of the compound,50597,Rattus norvegicus,3278,BAO_0000218,,1,1,,CHEMBL622395,,
9208,Intermediate,,Serum,1977.0,Stability in rat serum measured as % recovery at 1 min,50597,Rattus norvegicus,4684,BAO_0000218,,1,1,,CHEMBL622396,,
9209,Intermediate,,Serum,1977.0,Stability in rat serum measured as % recovery at 10 min,50597,Rattus norvegicus,4684,BAO_0000218,,1,1,,CHEMBL624894,,
9210,Intermediate,,Serum,1977.0,Stability in rat serum measured as % recovery at 10 mins,50597,Rattus norvegicus,4684,BAO_0000218,,1,1,,CHEMBL624895,,
9211,Intermediate,,Serum,1977.0,Stability in rat serum measured as % recovery at 2 hr,50597,Rattus norvegicus,4684,BAO_0000218,,1,1,,CHEMBL624058,,
9212,Intermediate,,Serum,1977.0,Stability in rat serum measured as % recovery at 3 min,50597,Rattus norvegicus,4684,BAO_0000218,,1,1,,CHEMBL624059,,
9213,Intermediate,,Serum,1977.0,Stability in rat serum measured as % recovery at 3 mins,50597,Rattus norvegicus,4684,BAO_0000218,,1,1,,CHEMBL624060,,
9214,Intermediate,,Serum,1977.0,Stability in rat serum measured as % recovery at 5 min,50597,Rattus norvegicus,4684,BAO_0000218,,1,1,,CHEMBL624061,,
9215,Intermediate,,Serum,1977.0,Stability in rat serum measured as % recovery at 5 mins,50597,Rattus norvegicus,4684,BAO_0000218,,1,1,,CHEMBL624062,,
9216,Intermediate,,,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,50597,Rattus norvegicus,16456,BAO_0000218,,1,1,,CHEMBL624063,,
9217,Intermediate,,,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,50597,Rattus norvegicus,16456,BAO_0000218,,1,1,,CHEMBL624064,,
9218,Intermediate,,Plasma,1969.0,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,50597,Rattus norvegicus,723,BAO_0000218,,1,1,,CHEMBL624065,,
9219,Intermediate,,Plasma,1969.0,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,50597,Rattus norvegicus,723,BAO_0000218,,1,1,,CHEMBL624066,,
9220,Intermediate,,,,Half life tested in mature male rat at a dose of 30 mg/kg,50597,Rattus norvegicus,5160,BAO_0000218,,1,1,,CHEMBL877490,,
9221,Intermediate,,,,Half life after intravenous administration of 1 mg/kg in rat,50597,Rattus norvegicus,4709,BAO_0000218,,1,1,,CHEMBL874442,,
9222,Intermediate,,,,Half life period after administration (30 mg/kg) in rat,50597,Rattus norvegicus,5633,BAO_0000218,,1,1,,CHEMBL626890,,
9223,Intermediate,,,,Half life period in rat after 5 mg/Kg dose,50597,Rattus norvegicus,5302,BAO_0000218,,1,1,,CHEMBL626891,,
9224,Intermediate,,,,Half life period in rat after 5 mg/kg dose,50597,Rattus norvegicus,5302,BAO_0000218,,1,1,,CHEMBL626892,,
9225,Intermediate,,,,Half life period was determined,50597,Rattus norvegicus,17791,BAO_0000218,,1,1,,CHEMBL626893,,
9226,Intermediate,,,,Half life period was evaluated in rat,50597,Rattus norvegicus,17791,BAO_0000218,,1,1,,CHEMBL626894,,
9227,Intermediate,,,,Half life period was evaluated in rat; 0.5-1.0,50597,Rattus norvegicus,17791,BAO_0000218,,1,1,,CHEMBL626895,,
9228,Intermediate,,,,Half life period was evaluated in rat; 5.9-7.5,50597,Rattus norvegicus,17791,BAO_0000218,,1,1,,CHEMBL626896,,
9229,Intermediate,,Plasma,1969.0,Half-life in rat plasma,50597,Rattus norvegicus,14512,BAO_0000218,,1,1,,CHEMBL626897,,
9230,Intermediate,,,,Half-life time in rat was determined,50597,Rattus norvegicus,6230,BAO_0000218,,1,1,,CHEMBL626898,,
9231,Intermediate,,,,Terminal half-life after iv administration to rats,50597,Rattus norvegicus,3364,BAO_0000218,,1,1,,CHEMBL626899,,
9232,Intermediate,,,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,50597,Rattus norvegicus,6874,BAO_0000218,,1,1,,CHEMBL626900,,
9233,Intermediate,,,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,50597,Rattus norvegicus,857,BAO_0000218,,1,1,,CHEMBL626901,,
9234,Intermediate,,,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),50597,Rattus norvegicus,858,BAO_0000218,,1,1,,CHEMBL626902,,
9235,Intermediate,,,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),50597,Rattus norvegicus,858,BAO_0000218,,1,1,,CHEMBL626903,,
9236,Intermediate,,,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,50597,Rattus norvegicus,5355,BAO_0000218,,1,1,,CHEMBL874443,,
9237,Intermediate,,,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,50597,Rattus norvegicus,5355,BAO_0000218,,1,1,,CHEMBL626904,,
9238,Intermediate,,,,Half life in rats,50597,Rattus norvegicus,6305,BAO_0000218,,1,1,,CHEMBL626905,,
9239,Intermediate,,Plasma,1969.0,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,50597,Rattus norvegicus,13501,BAO_0000218,,1,1,,CHEMBL873830,,
9240,Intermediate,,,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,50597,Rattus norvegicus,17594,BAO_0000218,,1,1,,CHEMBL626906,,
9241,Intermediate,,Plasma,1969.0,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,50597,Rattus norvegicus,4186,BAO_0000218,,1,1,,CHEMBL631076,,
9242,Intermediate,,Plasma,1969.0,Biological half-life was measured in plasma of rats,50597,Rattus norvegicus,2932,BAO_0000218,,1,1,,CHEMBL631077,,
9243,Intermediate,,,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,50597,Rattus norvegicus,17065,BAO_0000218,,1,1,,CHEMBL631078,,
9244,Intermediate,,,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,50597,Rattus norvegicus,15765,BAO_0000218,,1,1,,CHEMBL631079,,
9245,Intermediate,,,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,50597,Rattus norvegicus,2713,BAO_0000218,,1,1,,CHEMBL631080,,
9246,Intermediate,,,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL631081,,
9247,Intermediate,,,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL631239,,
9248,Intermediate,,Plasma,1969.0,Compound was evaluated for plasma half life in rat,50597,Rattus norvegicus,740,BAO_0000218,,1,1,,CHEMBL631240,,
9249,Intermediate,,Plasma,1969.0,AUC value at a dose of 5 mg/kg (p.o.) in rats,50597,Rattus norvegicus,6597,BAO_0000218,,1,1,,CHEMBL631241,,
9250,Intermediate,,Plasma,1969.0,AUC value after administration of 20 mg/Kg oral dose in rat,50597,Rattus norvegicus,2959,BAO_0000218,,1,1,,CHEMBL631242,,
9251,Intermediate,,Plasma,1969.0,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,50597,Rattus norvegicus,17594,BAO_0000218,,1,1,,CHEMBL631243,,
9252,Intermediate,,Plasma,1969.0,AUC0-96 after administration at 50 mg/kg,50597,Rattus norvegicus,17596,BAO_0000218,,1,1,,CHEMBL874444,,
9253,Intermediate,,Plasma,1969.0,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,50597,Rattus norvegicus,17594,BAO_0000218,,1,1,,CHEMBL631244,,
9254,Intermediate,,,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",50597,Rattus norvegicus,3293,BAO_0000218,,1,1,,CHEMBL631245,,
9255,Intermediate,,,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,50597,Rattus norvegicus,6757,BAO_0000218,,1,1,,CHEMBL627162,,
9256,Intermediate,,,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,50597,Rattus norvegicus,6757,BAO_0000218,,1,1,,CHEMBL627163,,
9257,Intermediate,,,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,50597,Rattus norvegicus,6757,BAO_0000218,,1,1,,CHEMBL627164,,
9258,Intermediate,,Kidney,2113.0,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,50597,Rattus norvegicus,5979,BAO_0000218,,1,1,,CHEMBL627165,,
9259,Intermediate,,,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,50597,Rattus norvegicus,5979,BAO_0000218,,1,1,,CHEMBL627166,,
9260,Intermediate,,,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,50597,Rattus norvegicus,5979,BAO_0000218,,1,1,,CHEMBL627167,,
9261,Intermediate,,,,Area under curve (AUC) at a dose of 30 mg/kg in rats,50597,Rattus norvegicus,4026,BAO_0000218,,1,1,,CHEMBL627822,,
9262,Intermediate,,,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,50597,Rattus norvegicus,5355,BAO_0000218,,1,1,,CHEMBL627823,,
9263,Intermediate,,,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,50597,Rattus norvegicus,5355,BAO_0000218,,1,1,,CHEMBL627824,,
9264,Intermediate,,,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,50597,Rattus norvegicus,5355,BAO_0000218,,1,1,,CHEMBL627825,,
9265,Intermediate,,,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,50597,Rattus norvegicus,5633,BAO_0000218,,1,1,,CHEMBL627826,,
9266,Intermediate,,,,Area under curve (Pharmacokinetic property) was determined,50597,Rattus norvegicus,1716,BAO_0000218,,1,1,,CHEMBL627827,,
9267,Intermediate,,,,Area under curve (Pharmacokinetic property) of the compound; Not determined,50597,Rattus norvegicus,1716,BAO_0000218,,1,1,,CHEMBL627828,,
9268,Intermediate,,,,Area under curve after intravenous administration (1 mg/kg) in rat,50597,Rattus norvegicus,4689,BAO_0000218,,1,1,,CHEMBL627829,,
9269,Intermediate,,,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,50597,Rattus norvegicus,4527,BAO_0000218,,1,1,,CHEMBL627830,,
9270,Intermediate,,,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,50597,Rattus norvegicus,4527,BAO_0000218,,1,1,,CHEMBL627831,,
9271,Intermediate,,,,Area under curve in male SD rats was observed after oral administration in rat,50597,Rattus norvegicus,15662,BAO_0000218,,1,1,,CHEMBL627832,,
9272,Intermediate,,,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,50597,Rattus norvegicus,4413,BAO_0000218,,1,1,,CHEMBL627833,,
9273,Expert,,,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,50597,Rattus norvegicus,3598,BAO_0000218,,1,1,,CHEMBL627834,,
9274,Expert,,,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,50597,Rattus norvegicus,3598,BAO_0000218,,1,1,,CHEMBL628004,,
9275,Intermediate,,,,Area under curve at 5 mg/kg po was determined in rat,50597,Rattus norvegicus,5964,BAO_0000218,,1,1,,CHEMBL628005,,
9276,Intermediate,,,,Area under curve in Rat at a oral dose of 5 mg/kg,50597,Rattus norvegicus,4689,BAO_0000218,,1,1,,CHEMBL628006,,
9277,Intermediate,,,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,50597,Rattus norvegicus,4186,BAO_0000218,,1,1,,CHEMBL628007,,
9278,Intermediate,,,,Area under curve was determined,50597,Rattus norvegicus,5510,BAO_0000218,,1,1,,CHEMBL625676,,
9279,Intermediate,,,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,50597,Rattus norvegicus,17858,BAO_0000218,,1,1,,CHEMBL631309,,
9280,Intermediate,,,,Area under curve after intravenous administration at 3 mg/kg,50597,Rattus norvegicus,17804,BAO_0000218,,1,1,,CHEMBL631310,,
9281,Intermediate,,,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,50597,Rattus norvegicus,6106,BAO_0000218,,1,1,,CHEMBL631311,,
9282,Intermediate,,,,Area under curve at 4 hr in rat,50597,Rattus norvegicus,5964,BAO_0000218,,1,1,,CHEMBL631312,,
9283,Intermediate,,,,Area under curve at a dose of 30 mg/kg,50597,Rattus norvegicus,4026,BAO_0000218,,1,1,,CHEMBL631313,,
9284,Intermediate,,,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,50597,Rattus norvegicus,4756,BAO_0000218,,1,1,,CHEMBL631314,,
9285,Intermediate,,,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,50597,Rattus norvegicus,4756,BAO_0000218,,1,1,,CHEMBL631315,,
9286,Intermediate,,,,Area under curve for a 2-mpk po dose in SD rats,50597,Rattus norvegicus,5862,BAO_0000218,,1,1,,CHEMBL631316,,
9287,Intermediate,,,,Area under curve in SD rats,50597,Rattus norvegicus,5862,BAO_0000218,,1,1,,CHEMBL631317,,
9288,Intermediate,,,,Area under curve in rat after oral administration at 13 mg/kg dose,50597,Rattus norvegicus,6644,BAO_0000218,,1,1,,CHEMBL874471,,
9289,Intermediate,,,,Area under curve in rat by po administration at 0-24 hr,50597,Rattus norvegicus,5871,BAO_0000218,,1,1,,CHEMBL631318,,
9290,Intermediate,,Plasma,1969.0,Area under curve in rat plasma,50597,Rattus norvegicus,5919,BAO_0000218,,1,1,,CHEMBL631319,,
9291,Intermediate,,,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,50597,Rattus norvegicus,5939,BAO_0000218,,1,1,,CHEMBL631320,,
9292,Intermediate,,,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,50597,Rattus norvegicus,5939,BAO_0000218,,1,1,,CHEMBL631321,,
9293,Intermediate,,,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,50597,Rattus norvegicus,10,BAO_0000218,,1,1,,CHEMBL631322,,
9294,Intermediate,,,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,50597,Rattus norvegicus,11149,BAO_0000218,,1,1,,CHEMBL631323,,
9295,Intermediate,,,,Area under curve value in rat at a dose of 5 mg/kg,50597,Rattus norvegicus,5302,BAO_0000218,,1,1,,CHEMBL631324,,
9296,Intermediate,,,,Area under curve was determined after oral administration in rats,50597,Rattus norvegicus,17796,BAO_0000218,,1,1,,CHEMBL631325,,
9297,Intermediate,,,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,50597,Rattus norvegicus,4890,BAO_0000218,,1,1,,CHEMBL631326,,
9298,Intermediate,,,,Area under curve was determined after peroral administration in rat,50597,Rattus norvegicus,6011,BAO_0000218,,1,1,,CHEMBL631327,,
9299,Intermediate,,,,Area under curve was determined at a dose 30 mpk administered orally.,50597,Rattus norvegicus,5375,BAO_0000218,,1,1,,CHEMBL631328,,
9300,Intermediate,,,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,50597,Rattus norvegicus,17764,BAO_0000218,,1,1,,CHEMBL631329,,
9301,Intermediate,,,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,50597,Rattus norvegicus,4368,BAO_0000218,,1,1,,CHEMBL627217,,
9302,Intermediate,,,,Area under curve was determined in male rat,50597,Rattus norvegicus,5610,BAO_0000218,,1,1,,CHEMBL626352,,
9303,Intermediate,,,,Area under curve was determined in rat after PO administration,50597,Rattus norvegicus,5833,BAO_0000218,,1,1,,CHEMBL626353,,
9304,Intermediate,,,,Area under curve was determined in rat after a 3 mg/kg of oral dose,50597,Rattus norvegicus,4257,BAO_0000218,,1,1,,CHEMBL626354,,
9305,Intermediate,,,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,50597,Rattus norvegicus,5937,BAO_0000218,,1,1,,CHEMBL626355,,
9306,Intermediate,,,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,50597,Rattus norvegicus,5932,BAO_0000218,,1,1,,CHEMBL626356,,
9307,Intermediate,,,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,50597,Rattus norvegicus,5932,BAO_0000218,,1,1,,CHEMBL626357,,
9308,Intermediate,,,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,50597,Rattus norvegicus,17411,BAO_0000218,,1,1,,CHEMBL626358,,
9309,Intermediate,,,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,50597,Rattus norvegicus,17411,BAO_0000218,,1,1,,CHEMBL626359,,
9310,Intermediate,,Plasma,1969.0,Peak plasma concentration in rat at a dose of 3 mg/kg,50597,Rattus norvegicus,17771,BAO_0000218,,1,1,,CHEMBL626360,,
9311,Intermediate,,,,Plasma concentration at 2 hr in rats was evaluated.,50597,Rattus norvegicus,1628,BAO_0000218,,1,1,,CHEMBL626361,,
9312,Intermediate,,,,Plasma concentration at 2 hr in rats was evaluated; Not available,50597,Rattus norvegicus,1628,BAO_0000218,,1,1,,CHEMBL626362,,
9313,Intermediate,,,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,50597,Rattus norvegicus,17411,BAO_0000218,,1,1,,CHEMBL626363,,
9314,Intermediate,,,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL626970,,
9315,Intermediate,,,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL626971,,
9316,Intermediate,,Plasma,1969.0,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL626972,,
9317,Intermediate,,Plasma,1969.0,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL626973,,
9318,Intermediate,,Plasma,1969.0,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL626974,,
9319,Intermediate,,Plasma,1969.0,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL874592,,
9320,Intermediate,,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,50597,Rattus norvegicus,5510,BAO_0000218,,1,1,,CHEMBL626975,,
9321,Intermediate,,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,50597,Rattus norvegicus,5510,BAO_0000218,,1,1,,CHEMBL626976,,
9322,Intermediate,,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,50597,Rattus norvegicus,5510,BAO_0000218,,1,1,,CHEMBL626977,,
9323,Intermediate,,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,50597,Rattus norvegicus,5510,BAO_0000218,,1,1,,CHEMBL626978,,
9324,Intermediate,,,,PK study was carried to determine the relative absorption ranking in rat.,50597,Rattus norvegicus,16427,BAO_0000218,,1,1,,CHEMBL626979,,
9325,Intermediate,,Plasma,1969.0,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,50597,Rattus norvegicus,4689,BAO_0000218,,1,1,,CHEMBL626980,,
9326,Intermediate,,Blood,178.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL626981,,
9327,Intermediate,,Blood,178.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL626982,,
9328,Intermediate,,Blood,178.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL626983,,
9329,Intermediate,,Blood,178.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622522,,
9330,Intermediate,,Blood,178.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622523,,
9331,Intermediate,,Blood,178.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622524,,
9332,Intermediate,,Brain,955.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622525,,
9333,Intermediate,,Brain,955.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622526,,
9334,Intermediate,,Brain,955.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL619849,,
9335,Intermediate,,Brain,955.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL619850,,
9336,Intermediate,,Brain,955.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL623864,,
9337,Intermediate,,Brain,955.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL623865,,
9338,Intermediate,,Heart,948.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL623866,,
9339,Intermediate,,Heart,948.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL623867,,
9340,Intermediate,,Heart,948.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL877615,,
9341,Intermediate,,Heart,948.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL623868,,
9342,Intermediate,,Heart,948.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL623869,,
9343,Intermediate,,Heart,948.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL623870,,
9344,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623871,,
9345,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623872,,
9346,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622129,,
9347,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622130,,
9348,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622131,,
9349,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622132,,
9350,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622133,,
9351,Intermediate,,Lung,2048.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622134,,
9352,Intermediate,,Lung,2048.0,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622135,,
9353,Intermediate,,Lung,2048.0,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622136,,
9354,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622137,,
9355,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622138,,
9356,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623017,,
9357,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623018,,
9358,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623019,,
9359,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623020,,
9360,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623021,,
9361,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623022,,
9362,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623023,,
9363,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623024,,
9364,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623025,,
9365,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL620545,,
9366,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL620546,,
9367,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL620547,,
9368,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL620548,,
9369,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL620549,,
9370,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL620550,,
9371,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL620551,,
9372,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL620552,,
9373,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL620553,,
9374,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL620554,,
9375,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL875845,,
9376,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL620555,,
9377,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL620556,,
9378,Intermediate,,Muscle tissue,2385.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL620557,,
9379,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL620558,,
9380,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL620559,,
9381,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622939,,
9382,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622940,,
9383,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622941,,
9384,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622942,,
9385,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622943,,
9386,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622944,,
9387,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622945,,
9388,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622946,,
9389,Intermediate,,,,Compound was evaluated for terminal half life in rat,50597,Rattus norvegicus,3341,BAO_0000218,,1,1,,CHEMBL622947,,
9390,Intermediate,,Plasma,1969.0,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,50597,Rattus norvegicus,3634,BAO_0000218,,1,1,,CHEMBL622948,,
9391,Intermediate,,Plasma,1969.0,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,50597,Rattus norvegicus,3634,BAO_0000218,,1,1,,CHEMBL622949,,
9392,Intermediate,,,,Compound was tested for its half life in rat,50597,Rattus norvegicus,4839,BAO_0000218,,1,1,,CHEMBL622950,,
9393,Intermediate,,Plasma,1969.0,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,22224,Macaca mulatta,5005,BAO_0000218,,0,1,,CHEMBL622951,,
9394,Intermediate,,Plasma,1969.0,Compound was tested for its plasma half life in Sprague Dawley rats,22224,Rattus norvegicus,5005,BAO_0000366,,0,1,,CHEMBL622952,,
9395,Intermediate,,Plasma,1969.0,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,22224,Rattus norvegicus,5005,BAO_0000366,,0,1,,CHEMBL622953,,
9396,Intermediate,,Plasma,1969.0,Compound was tested for plasma half-life period in rat,50597,Rattus norvegicus,1094,BAO_0000218,,1,1,,CHEMBL873818,,
9397,Intermediate,,,,Elimination half life after i.v. administration of compound in rats,50597,Rattus norvegicus,5031,BAO_0000218,,1,1,,CHEMBL622954,,
9398,Intermediate,,,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL622955,,
9399,Intermediate,,,,Elimination half-life after IV dosing at 1 mg/kg in rat,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL875229,,
9400,Intermediate,,,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL622956,,
9401,Intermediate,,,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL622957,,
9402,Intermediate,,Brain,955.0,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,50597,Rattus norvegicus,5408,BAO_0000218,,1,1,,CHEMBL622958,,
9403,Intermediate,,Plasma,1969.0,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,50597,Rattus norvegicus,5408,BAO_0000218,,1,1,,CHEMBL622959,,
9404,Intermediate,,Brain,955.0,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,50597,Rattus norvegicus,5408,BAO_0000218,,1,1,,CHEMBL622960,,
9405,Intermediate,,Plasma,1969.0,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,50597,Rattus norvegicus,5408,BAO_0000218,,1,1,,CHEMBL622961,,
9406,Intermediate,,,,Evaluated for the half life in rat (in vivo),50597,Rattus norvegicus,4687,BAO_0000218,,1,1,,CHEMBL622962,,
9407,Intermediate,,,,Hafl life in rat,50597,Rattus norvegicus,6640,BAO_0000218,,1,1,,CHEMBL622963,,
9408,Intermediate,,,,Hafl life rat,50597,Rattus norvegicus,6640,BAO_0000218,,1,1,,CHEMBL622964,,
9409,Intermediate,,,,Hafl life rat,50597,Rattus norvegicus,6641,BAO_0000218,,1,1,,CHEMBL622965,,
9410,Intermediate,,,,Hafl life rat; Not determined,50597,Rattus norvegicus,6640,BAO_0000218,,1,1,,CHEMBL622966,,
9411,Intermediate,,,,Hafl life rat; Not determined,50597,Rattus norvegicus,6641,BAO_0000218,,1,1,,CHEMBL622967,,
9412,Intermediate,,Kidney,2113.0,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,50597,Rattus norvegicus,17411,BAO_0000218,,1,1,,CHEMBL622968,,
9413,Intermediate,,Liver,2107.0,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,50597,Rattus norvegicus,17411,BAO_0000218,,1,1,,CHEMBL622969,,
9414,Intermediate,,Lung,2048.0,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,50597,Rattus norvegicus,17411,BAO_0000218,,1,1,,CHEMBL875327,,
9415,Intermediate,,,,Half life in rat after 1 mg/kg i.v. administration,50597,Rattus norvegicus,6570,BAO_0000218,,1,1,,CHEMBL628638,,
9416,Intermediate,,,,Half life in rat after 2 mg/kg peroral administration,50597,Rattus norvegicus,6570,BAO_0000218,,1,1,,CHEMBL628639,,
9417,Intermediate,,,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,50597,Rattus norvegicus,17411,BAO_0000218,,1,1,,CHEMBL625840,,
9418,Intermediate,,,,Half life of 10 mg/kg oral dose determined in rats,50597,Rattus norvegicus,4722,BAO_0000218,,1,1,,CHEMBL625841,,
9419,Intermediate,,,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL625842,,
9420,Intermediate,,,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL625843,,
9421,Intermediate,,,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL625844,,
9422,Intermediate,,,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL873822,,
9423,Intermediate,,,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL625845,,
9424,Intermediate,,,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL627059,,
9425,Intermediate,,,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL627060,,
9426,Intermediate,,,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL627061,,
9427,Intermediate,,,,Half life of compound at 5 mg/kg after po administration was determined in rat,50597,Rattus norvegicus,4762,BAO_0000218,,1,1,,CHEMBL627709,,
9428,Intermediate,,,,Half life of compound determined after intravenous administration to rat,50597,Rattus norvegicus,5327,BAO_0000218,,1,1,,CHEMBL627710,,
9429,Intermediate,,,,Half life of compound was determined in rat,50597,Rattus norvegicus,4847,BAO_0000218,,1,1,,CHEMBL627711,,
9430,Intermediate,,Plasma,1969.0,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,50597,Rattus norvegicus,17720,BAO_0000218,,1,1,,CHEMBL627712,,
9431,Intermediate,,,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,50597,Rattus norvegicus,4723,BAO_0000218,,1,1,,CHEMBL627713,,
9432,Intermediate,,,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,50597,Rattus norvegicus,4723,BAO_0000218,,1,1,,CHEMBL627714,,
9433,Intermediate,,,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,22224,Macaca fascicularis,4256,BAO_0000218,,0,1,,CHEMBL627889,,
9434,Intermediate,,,,Half life determined in rat by intravenous administration,22224,Rattus norvegicus,4256,BAO_0000218,,0,1,,CHEMBL627890,,
9435,Intermediate,,,,Half life determined in rats after iv administration,50597,Rattus norvegicus,4722,BAO_0000218,,1,1,,CHEMBL627891,,
9436,Intermediate,,Plasma,1969.0,Half life in rat plasma after administration of 2 mg/kg iv,50597,Rattus norvegicus,6535,BAO_0000218,,1,1,,CHEMBL627892,,
9437,Intermediate,,Plasma,1969.0,Half life in rat plasma after administration of 2 mg/kg iv,50597,Rattus norvegicus,6535,BAO_0000218,,1,1,,CHEMBL627893,,
9438,Intermediate,,Plasma,1969.0,Half life in rat plasma was determined,50597,Rattus norvegicus,1435,BAO_0000218,,1,1,,CHEMBL627894,,
9439,Intermediate,,Plasma,1969.0,Half life in rat plasma was determined; NA means not applicable,50597,Rattus norvegicus,1435,BAO_0000218,,1,1,,CHEMBL627895,,
9440,Intermediate,,,,Half life in rat was tested,50597,Rattus norvegicus,5206,BAO_0000218,,1,1,,CHEMBL627896,,
9441,Intermediate,,Plasma,1969.0,Half life measured in rat plasma,50597,Rattus norvegicus,6080,BAO_0000218,,1,1,,CHEMBL627897,,
9442,Intermediate,,,,Half life recorded in rats,50597,Rattus norvegicus,4449,BAO_0000218,,1,1,,CHEMBL627898,,
9443,Intermediate,,,,Half life was calculated,50597,Rattus norvegicus,6057,BAO_0000218,,1,1,,CHEMBL627899,,
9444,Intermediate,,,,Half life was calculated in rat,50597,Rattus norvegicus,6057,BAO_0000218,,1,1,,CHEMBL873823,,
9445,Intermediate,,,,Half life was determined,50597,Rattus norvegicus,3747,BAO_0000218,,1,1,,CHEMBL627900,,
9446,Intermediate,,,,Half life after 10 mg/kg oral administration in rat,50597,Rattus norvegicus,17858,BAO_0000218,,1,1,,CHEMBL627901,,
9447,Intermediate,,,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL627902,,
9448,Intermediate,,,,Half life after administering orally a dose of 30 mg/kg,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL627903,,
9449,Intermediate,,,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,50597,Rattus norvegicus,5031,BAO_0000218,,1,1,,CHEMBL627904,,
9450,Intermediate,,,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,50597,Rattus norvegicus,4722,BAO_0000218,,1,1,,CHEMBL627905,,
9451,Intermediate,,,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,50597,Rattus norvegicus,6078,BAO_0000218,,1,1,,CHEMBL627906,,
9452,Intermediate,,,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,50597,Rattus norvegicus,6078,BAO_0000218,,1,1,,CHEMBL627907,,
9453,Intermediate,,,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,50597,Rattus norvegicus,6078,BAO_0000218,,1,1,,CHEMBL876783,,
9454,Intermediate,,,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,50597,Rattus norvegicus,6078,BAO_0000218,,1,1,,CHEMBL627908,,
9455,Intermediate,,,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,50597,Rattus norvegicus,17065,BAO_0000218,,1,1,,CHEMBL627909,,
9456,Intermediate,,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,50597,Rattus norvegicus,1353,BAO_0000218,,1,1,,CHEMBL627910,,
9457,Intermediate,,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),50597,Rattus norvegicus,1353,BAO_0000218,,1,1,,CHEMBL627911,,
9458,Intermediate,,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),50597,Rattus norvegicus,1353,BAO_0000218,,1,1,,CHEMBL627912,,
9459,Intermediate,,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),50597,Rattus norvegicus,1353,BAO_0000218,,1,1,,CHEMBL627913,,
9460,Intermediate,,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),50597,Rattus norvegicus,1353,BAO_0000218,,1,1,,CHEMBL627914,,
9461,Intermediate,,,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,50597,Rattus norvegicus,16423,BAO_0000218,,1,1,,CHEMBL627915,,
9462,Intermediate,,,,Area under the curve was evaluated after 20 uM/kg of peroral administration,50597,Rattus norvegicus,16423,BAO_0000218,,1,1,,CHEMBL627916,,
9463,Intermediate,,,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,50597,Rattus norvegicus,6062,BAO_0000218,,1,1,,CHEMBL627917,,
9464,Intermediate,,,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,50597,Rattus norvegicus,6056,BAO_0000218,,1,1,,CHEMBL627918,,
9465,Intermediate,,,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,50597,Rattus norvegicus,5182,BAO_0000218,,1,1,,CHEMBL627919,,
9466,Intermediate,,,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,50597,Rattus norvegicus,6410,BAO_0000218,,1,1,,CHEMBL627920,,
9467,Intermediate,,,,Area under the curve was evaluated at an oral dose of 30 mg/kg,50597,Rattus norvegicus,6410,BAO_0000218,,1,1,,CHEMBL627921,,
9468,Intermediate,,,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,50597,Rattus norvegicus,4723,BAO_0000218,,1,1,,CHEMBL627922,,
9469,Intermediate,,,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,50597,Rattus norvegicus,4723,BAO_0000218,,1,1,,CHEMBL876784,,
9470,Intermediate,,,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,50597,Rattus norvegicus,4723,BAO_0000218,,1,1,,CHEMBL627923,,
9471,Intermediate,,,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,50597,Rattus norvegicus,4723,BAO_0000218,,1,1,,CHEMBL626208,,
9472,Intermediate,,,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,50597,Rattus norvegicus,4723,BAO_0000218,,1,1,,CHEMBL626209,,
9473,Intermediate,,,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,50597,Rattus norvegicus,4723,BAO_0000218,,1,1,,CHEMBL626210,,
9474,Intermediate,,Plasma,1969.0,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,50597,Rattus norvegicus,2463,BAO_0000218,,1,1,,CHEMBL627994,,
9475,Intermediate,,,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,50597,Rattus norvegicus,4709,BAO_0000218,,1,1,,CHEMBL627995,,
9476,Intermediate,,,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,50597,Rattus norvegicus,4075,BAO_0000218,,1,1,,CHEMBL627996,,
9477,Intermediate,,,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,50597,Rattus norvegicus,5394,BAO_0000218,,1,1,,CHEMBL627997,,
9478,Intermediate,,,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL627998,,
9479,Intermediate,,,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL628640,,
9480,Intermediate,,,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL628641,,
9481,Intermediate,,,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL628642,,
9482,Intermediate,,,,Compound was evaluated for area under the curve expressed as (h*ug/ml),50597,Rattus norvegicus,17791,BAO_0000218,,1,1,,CHEMBL628643,,
9483,Intermediate,,,,Compound was tested for area under curve in rat,50597,Rattus norvegicus,2591,BAO_0000218,,1,1,,CHEMBL628644,,
9484,Intermediate,,,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,50597,Rattus norvegicus,6567,BAO_0000218,,1,1,,CHEMBL628645,,
9485,Intermediate,,,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,50597,Rattus norvegicus,6211,BAO_0000218,,1,1,,CHEMBL628646,,
9486,Intermediate,,,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),50597,Rattus norvegicus,5529,BAO_0000218,,1,1,,CHEMBL628647,,
9487,Intermediate,,,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,50597,Rattus norvegicus,5408,BAO_0000218,,1,1,,CHEMBL628648,,
9488,Intermediate,,,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,50597,Rattus norvegicus,5408,BAO_0000218,,1,1,,CHEMBL625358,,
9489,Intermediate,,,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,50597,Rattus norvegicus,5408,BAO_0000218,,1,1,,CHEMBL625359,,
9490,Intermediate,,,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,50597,Rattus norvegicus,5408,BAO_0000218,,1,1,,CHEMBL625360,,
9491,Intermediate,,,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),50597,Rattus norvegicus,429,BAO_0000218,,1,1,,CHEMBL625361,,
9492,Intermediate,,,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),50597,Rattus norvegicus,429,BAO_0000218,,1,1,,CHEMBL625362,,
9493,Intermediate,,,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),50597,Rattus norvegicus,429,BAO_0000218,,1,1,,CHEMBL625363,,
9494,Intermediate,,,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,50597,Rattus norvegicus,4796,BAO_0000218,,1,1,,CHEMBL625364,,
9495,Intermediate,,,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL625365,,
9496,Intermediate,,,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL625366,,
9497,Intermediate,,,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL625367,,
9498,Intermediate,,Kidney,2113.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL625368,,
9499,Intermediate,,Kidney,2113.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL625369,,
9500,Intermediate,,Kidney,2113.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL625370,,
9501,Intermediate,,Kidney,2113.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL625371,,
9502,Intermediate,,Kidney,2113.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL625372,,
9503,Intermediate,,Kidney,2113.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL625373,,
9504,Intermediate,,Liver,2107.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL625374,,
9505,Intermediate,,Liver,2107.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL877593,,
9506,Intermediate,,Liver,2107.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL625375,,
9507,Intermediate,,Liver,2107.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL625376,,
9508,Intermediate,,Liver,2107.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL621973,,
9509,Intermediate,,Liver,2107.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL621974,,
9510,Intermediate,,Lung,2048.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL621975,,
9511,Intermediate,,Lung,2048.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622166,,
9512,Intermediate,,Lung,2048.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622167,,
9513,Intermediate,,Lung,2048.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622168,,
9514,Intermediate,,Lung,2048.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622169,,
9515,Intermediate,,Lung,2048.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622170,,
9516,Intermediate,,Thyroid gland,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622171,,
9517,Intermediate,,Thyroid gland,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622172,,
9518,Intermediate,,Thyroid gland,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622173,,
9519,Intermediate,,Thyroid gland,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622174,,
9520,Intermediate,,Thyroid gland,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622175,,
9521,Intermediate,,Thyroid gland,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622176,,
9522,Intermediate,,Thyroid gland,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622177,,
9523,Intermediate,,Thyroid gland,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622178,,
9524,Intermediate,,Thyroid gland,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622179,,
9525,Intermediate,,Thyroid gland,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622180,,
9526,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622181,,
9527,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622182,,
9528,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622183,,
9529,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622184,,
9530,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622185,,
9531,Intermediate,,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622186,,
9532,Intermediate,,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622187,,
9533,Intermediate,,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL625002,,
9534,Intermediate,,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622090,,
9535,Intermediate,,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622091,,
9536,Intermediate,,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622092,,
9537,Intermediate,,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622093,,
9538,Intermediate,,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622094,,
9539,Intermediate,,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622095,,
9540,Intermediate,,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622264,,
9541,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622265,,
9542,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622266,,
9543,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622267,,
9544,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622268,,
9545,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622269,,
9546,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL625071,,
9547,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621621,,
9548,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621622,,
9549,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621623,,
9550,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621624,,
9551,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621625,,
9552,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621626,,
9553,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621627,,
9554,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621628,,
9555,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL875328,,
9556,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621629,,
9557,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621630,,
9558,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621631,,
9559,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL621632,,
9560,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621633,,
9561,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621634,,
9562,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621635,,
9563,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621636,,
9564,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621637,,
9565,Intermediate,,Spleen,2106.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL621638,,
9566,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL618883,,
9567,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL618884,,
9568,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL628627,,
9569,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL628628,,
9570,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL628629,,
9571,Intermediate,,,,Half life after administering orally a dose of 3 mg/kg,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL628630,,
9572,Intermediate,,,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL628631,,
9573,Intermediate,,,,Half life after administering intravenously a dose of 1 mg/kg,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL628632,,
9574,Intermediate,,,,Half life after oral dosing in rats,50597,Rattus norvegicus,526,BAO_0000218,,1,1,,CHEMBL628633,,
9575,Intermediate,,,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL628634,,
9576,Intermediate,,,,Half life by intravenous administration of 3.4 mg/kg in rat,50597,Rattus norvegicus,4368,BAO_0000218,,1,1,,CHEMBL627789,,
9577,Intermediate,,,,Half life in rat,50597,Rattus norvegicus,3371,BAO_0000218,,1,1,,CHEMBL627790,,
9578,Intermediate,,,,Half life in rat,50597,Rattus norvegicus,6448,BAO_0000218,,1,1,,CHEMBL627791,,
9579,Intermediate,,,,Half life in rat,50597,Rattus norvegicus,6453,BAO_0000218,,1,1,,CHEMBL627792,,
9580,Intermediate,,,,Half life in rat after intravenous administration of the compound,50597,Rattus norvegicus,4353,BAO_0000218,,1,1,,CHEMBL627793,,
9581,Intermediate,,Plasma,1969.0,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,50597,Rattus norvegicus,4353,BAO_0000218,,1,1,,CHEMBL627794,,
9582,Intermediate,,,,Half life in rat after po administration of the compound,50597,Rattus norvegicus,4353,BAO_0000218,,1,1,,CHEMBL627795,,
9583,Intermediate,,,,Half life in rat after po administration of the compound; ND means Not determined,50597,Rattus norvegicus,4353,BAO_0000218,,1,1,,CHEMBL627796,,
9584,Intermediate,,Plasma,1969.0,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,50597,Rattus norvegicus,4353,BAO_0000218,,1,1,,CHEMBL875335,,
9585,Intermediate,,Plasma,1969.0,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,50597,Rattus norvegicus,4353,BAO_0000218,,1,1,,CHEMBL627797,,
9586,Intermediate,,,,Half life in rat i.v.,50597,Rattus norvegicus,5789,BAO_0000218,,1,1,,CHEMBL627798,,
9587,Intermediate,,,,Half life in rat i.v. at 2 mg/kg concentration,50597,Rattus norvegicus,17686,BAO_0000218,,1,1,,CHEMBL627799,,
9588,Intermediate,,,,Half life in rats,50597,Rattus norvegicus,6495,BAO_0000218,,1,1,,CHEMBL627800,,
9589,Intermediate,,,,Half life in rats after intravenous administration,50597,Rattus norvegicus,484,BAO_0000218,,1,1,,CHEMBL627801,,
9590,Intermediate,,,,Half life in rats at the dose of 1.0 mpk by i.v. administration,50597,Rattus norvegicus,6467,BAO_0000218,,1,1,,CHEMBL627802,,
9591,Expert,,,,Half life in rat,50597,Rattus norvegicus,6642,BAO_0000218,,1,1,,CHEMBL627803,,
9592,Intermediate,,,,Half life was evaluated after intravenous administration to rats,50597,Rattus norvegicus,16367,BAO_0000218,,1,1,,CHEMBL873820,,
9593,Intermediate,,,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),50597,Rattus norvegicus,1369,BAO_0000218,,1,1,,CHEMBL627804,,
9594,Intermediate,,,,Half life was evaluated in rat,50597,Rattus norvegicus,5472,BAO_0000218,,1,1,,CHEMBL627805,,
9595,Intermediate,,,,Half life was evaluated in rat,50597,Rattus norvegicus,6049,BAO_0000218,,1,1,,CHEMBL627806,,
9596,Intermediate,,,,Half life was evaluated in rat; Not tested,50597,Rattus norvegicus,5472,BAO_0000218,,1,1,,CHEMBL627107,,
9597,Intermediate,,,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,50597,Rattus norvegicus,16366,BAO_0000218,,1,1,,CHEMBL627108,,
9598,Intermediate,,,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,50597,Rattus norvegicus,11149,BAO_0000218,,1,1,,CHEMBL627109,,
9599,Intermediate,,Blood,178.0,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,50597,Rattus norvegicus,11149,BAO_0000218,,1,1,,CHEMBL627110,,
9600,Intermediate,,,,Half life was measured in monkey at dose of 10 mg/kg by po administration,22224,Primates,2891,BAO_0000218,,0,1,,CHEMBL627111,,
9601,Intermediate,,,,Half life was measured in monkey at dose of 10 mg/kg by po administration,22224,Primates,2891,BAO_0000218,,0,1,,CHEMBL627112,,
9602,Intermediate,,,,Half life was measured in rat at dose of 30 mg/kg by iv administration,22224,Rattus norvegicus,2891,BAO_0000218,,0,1,,CHEMBL627113,,
9603,Intermediate,,,,Half life was measured in rat at dose of 30 mg/kg by po administration,22224,Rattus norvegicus,2891,BAO_0000218,,0,1,,CHEMBL627114,,
9604,Intermediate,,,,Half life (t1/2) was determined,50597,Rattus norvegicus,4026,BAO_0000218,,1,1,,CHEMBL627115,,
9605,Intermediate,,,,Half life period at a dose of 10 uM/kg in rat was determined,50597,Rattus norvegicus,4527,BAO_0000218,,1,1,,CHEMBL627116,,
9606,Intermediate,,,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,50597,Rattus norvegicus,4527,BAO_0000218,,1,1,,CHEMBL627117,,
9607,Intermediate,,,,Half life period was determined,50597,Rattus norvegicus,5503,BAO_0000218,,1,1,,CHEMBL627118,,
9608,Intermediate,,,,Half life period after intravenous administration at 20 mpk in rats,50597,Rattus norvegicus,4426,BAO_0000218,,1,1,,CHEMBL627119,,
9609,Intermediate,,,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,50597,Rattus norvegicus,4426,BAO_0000218,,1,1,,CHEMBL627120,,
9610,Intermediate,,,,Half life period after intravenous administration in rat,50597,Rattus norvegicus,6109,BAO_0000218,,1,1,,CHEMBL626922,,
9611,Intermediate,,,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,50597,Rattus norvegicus,5654,BAO_0000218,,1,1,,CHEMBL626923,,
9612,Intermediate,,,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,50597,Rattus norvegicus,5654,BAO_0000218,,1,1,,CHEMBL626924,,
9613,Intermediate,,Plasma,1969.0,Half life period in 80% rat plasma at 37 degree Centigrade,50597,Rattus norvegicus,4755,BAO_0000218,,1,1,,CHEMBL626925,,
9614,Intermediate,,,,Half life period in SD rats,50597,Rattus norvegicus,5862,BAO_0000218,,1,1,,CHEMBL626926,,
9615,Intermediate,,Plasma,1969.0,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),50597,Rattus norvegicus,1515,BAO_0000218,,1,1,,CHEMBL626927,,
9616,Intermediate,,Plasma,1969.0,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),50597,Rattus norvegicus,1515,BAO_0000218,,1,1,,CHEMBL626928,,
9617,Intermediate,,Plasma,1969.0,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,50597,Rattus norvegicus,1515,BAO_0000218,,1,1,,CHEMBL626929,,
9618,Intermediate,,Plasma,1969.0,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,50597,Rattus norvegicus,1515,BAO_0000218,,1,1,,CHEMBL626930,,
9619,Intermediate,,,,Half life period in rat,50597,Rattus norvegicus,5960,BAO_0000218,,1,1,,CHEMBL626931,,
9620,Intermediate,,,,Half life period in rat,50597,Rattus norvegicus,6103,BAO_0000218,,1,1,,CHEMBL626932,,
9621,Intermediate,,,,Half life period in rat,50597,Rattus norvegicus,6317,BAO_0000218,,1,1,,CHEMBL626933,,
9622,Intermediate,,,,Half life period in rat after oral administration at 10.5 mg/kg dose,50597,Rattus norvegicus,6644,BAO_0000218,,1,1,,CHEMBL873826,,
9623,Intermediate,,,,Half life period in rat after oral administration at 11.2 mg/kg dose,50597,Rattus norvegicus,6644,BAO_0000218,,1,1,,CHEMBL626934,,
9624,Intermediate,,,,Half life period in rat after oral administration at 13 mg/kg dose,50597,Rattus norvegicus,6644,BAO_0000218,,1,1,,CHEMBL626935,,
9625,Intermediate,,,,Half life period in rat after oral administration at 9.7 mg/kg dose,50597,Rattus norvegicus,6644,BAO_0000218,,1,1,,CHEMBL626936,,
9626,Intermediate,,,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL626937,,
9627,Intermediate,,,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,50597,Rattus norvegicus,6295,BAO_0000218,,1,1,,CHEMBL625906,,
9628,Intermediate,,,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,50597,Rattus norvegicus,6296,BAO_0000218,,1,1,,CHEMBL625907,,
9629,Intermediate,,,,PK study was carried to determine AUC (area under curve) value in rat,50597,Rattus norvegicus,16427,BAO_0000218,,1,1,,CHEMBL625908,,
9630,Intermediate,,,,Pharmacokinetic parameter AUC after intravenous administration to rats,50597,Rattus norvegicus,16367,BAO_0000218,,1,1,,CHEMBL625909,,
9631,Intermediate,,,,Pharmacokinetic parameter AUC after oral administration to rats,50597,Rattus norvegicus,16367,BAO_0000218,,1,1,,CHEMBL625910,,
9632,Intermediate,,,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL625911,,
9633,Intermediate,,,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL625912,,
9634,Intermediate,,,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL626538,,
9635,Intermediate,,,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL876794,,
9636,Intermediate,,,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL626539,,
9637,Intermediate,,,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL626540,,
9638,Intermediate,,,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,50597,Rattus norvegicus,5394,BAO_0000218,,1,1,,CHEMBL626541,,
9639,Intermediate,,,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,50597,Rattus norvegicus,5394,BAO_0000218,,1,1,,CHEMBL626542,,
9640,Intermediate,,,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL626543,,
9641,Intermediate,,,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL626544,,
9642,Intermediate,,,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL626545,,
9643,Intermediate,,,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL626546,,
9644,Intermediate,,,,Pharmacokinetic parameter area under curve was reported,50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL626547,,
9645,Intermediate,,,,Pharmacokinetic property (AUC) in rat,50597,Rattus norvegicus,4408,BAO_0000218,,1,1,,CHEMBL626548,,
9646,Intermediate,,,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,50597,Rattus norvegicus,5983,BAO_0000218,,1,1,,CHEMBL626549,,
9647,Intermediate,,,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,50597,Rattus norvegicus,4397,BAO_0000218,,1,1,,CHEMBL626550,,
9648,Intermediate,,,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,50597,Rattus norvegicus,4397,BAO_0000218,,1,1,,CHEMBL626551,,
9649,Intermediate,,,,Pharmacokinetic property was determined,50597,Rattus norvegicus,5491,BAO_0000218,,1,1,,CHEMBL623777,,
9650,Intermediate,,,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,50597,Rattus norvegicus,5491,BAO_0000218,,1,1,,CHEMBL623778,,
9651,Intermediate,,,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,50597,Rattus norvegicus,5491,BAO_0000218,,1,1,,CHEMBL623779,,
9652,Intermediate,,Plasma,1969.0,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,50597,Rattus norvegicus,4199,BAO_0000218,,1,1,,CHEMBL623780,,
9653,Intermediate,,Plasma,1969.0,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,50597,Rattus norvegicus,4199,BAO_0000218,,1,1,,CHEMBL622015,,
9654,Intermediate,,Plasma,1969.0,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,50597,Rattus norvegicus,4199,BAO_0000218,,1,1,,CHEMBL622016,,
9655,Intermediate,,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",50597,Rattus norvegicus,5173,BAO_0000218,,1,1,,CHEMBL622017,,
9656,Intermediate,,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",50597,Rattus norvegicus,5173,BAO_0000218,,1,1,,CHEMBL622018,,
9657,Intermediate,,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",50597,Rattus norvegicus,5173,BAO_0000218,,1,1,,CHEMBL622019,,
9658,Intermediate,,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",50597,Rattus norvegicus,5173,BAO_0000218,,1,1,,CHEMBL622020,,
9659,Intermediate,,,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,50597,Rattus norvegicus,16366,BAO_0000218,,1,1,,CHEMBL622021,,
9660,Intermediate,,,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,50597,Rattus norvegicus,16366,BAO_0000218,,1,1,,CHEMBL622022,,
9661,Intermediate,,,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,50597,Rattus norvegicus,5327,BAO_0000218,,1,1,,CHEMBL622023,,
9662,Intermediate,,,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,50597,Rattus norvegicus,6681,BAO_0000218,,1,1,,CHEMBL622024,,
9663,Intermediate,,,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),50597,Rattus norvegicus,12873,BAO_0000218,,1,1,,CHEMBL622693,,
9664,Intermediate,,,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),50597,Rattus norvegicus,12873,BAO_0000218,,1,1,,CHEMBL622694,,
9665,Intermediate,,,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL622695,,
9666,Intermediate,,,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL622696,,
9667,Intermediate,,,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL622697,,
9668,Intermediate,,,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",50597,Rattus norvegicus,6619,BAO_0000218,,1,1,,CHEMBL622874,,
9669,Intermediate,,,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",50597,Rattus norvegicus,6619,BAO_0000218,,1,1,,CHEMBL622875,,
9670,Intermediate,,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,50597,Rattus norvegicus,10363,BAO_0000218,,1,1,,CHEMBL622876,,
9671,Intermediate,,,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,50597,Rattus norvegicus,4796,BAO_0000218,,1,1,,CHEMBL622877,,
9672,Intermediate,,,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL622878,,
9673,Intermediate,,Plasma,1969.0,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL622879,,
9674,Intermediate,,,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,50597,Rattus norvegicus,4839,BAO_0000218,,1,1,,CHEMBL877602,,
9675,Intermediate,,,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL622880,,
9676,Intermediate,,,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL622881,,
9677,Intermediate,,,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL622882,,
9678,Intermediate,,,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL622883,,
9679,Intermediate,,Thyroid gland,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622884,,
9680,Intermediate,,Thyroid gland,2046.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",50597,Rattus norvegicus,11450,BAO_0000218,,1,1,,CHEMBL622885,,
9681,Intermediate,,,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,50597,Rattus norvegicus,8151,BAO_0000218,,1,1,,CHEMBL622886,,
9682,Intermediate,,,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,50597,Rattus norvegicus,8151,BAO_0000218,,1,1,,CHEMBL622887,,
9683,Intermediate,,Urine,1088.0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,50597,Rattus norvegicus,8151,BAO_0000218,,1,1,,CHEMBL622888,,
9684,Intermediate,,Blood,178.0,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622889,,
9685,Intermediate,,Blood,178.0,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622890,,
9686,Intermediate,,Blood,178.0,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622891,,
9687,Intermediate,,Blood,178.0,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL877603,,
9688,Intermediate,,Brain,955.0,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622892,,
9689,Intermediate,,Brain,955.0,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622893,,
9690,Intermediate,,Brain,955.0,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622894,,
9691,Intermediate,,Brain,955.0,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622895,,
9692,Intermediate,,Brain,955.0,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622896,,
9693,Intermediate,,Heart,948.0,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622897,,
9694,Intermediate,,Heart,948.0,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622898,,
9695,Intermediate,,Heart,948.0,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622899,,
9696,Intermediate,,Kidney,2113.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622900,,
9697,Intermediate,,Kidney,2113.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624114,,
9698,Intermediate,,Kidney,2113.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624115,,
9699,Intermediate,,Kidney,2113.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624116,,
9700,Intermediate,,Liver,2107.0,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624117,,
9701,Intermediate,,Liver,2107.0,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624118,,
9702,Intermediate,,Liver,2107.0,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624119,,
9703,Intermediate,,Liver,2107.0,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624120,,
9704,Intermediate,,Lung,2048.0,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624121,,
9705,Intermediate,,Lung,2048.0,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624122,,
9706,Intermediate,,Lung,2048.0,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624123,,
9707,Intermediate,,Lung,2048.0,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624124,,
9708,Intermediate,,Muscle tissue,2385.0,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624125,,
9709,Intermediate,,Muscle tissue,2385.0,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624126,,
9710,Intermediate,,Muscle tissue,2385.0,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624127,,
9711,Intermediate,,Muscle tissue,2385.0,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624128,,
9712,Intermediate,,Zone of skin,14.0,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624129,,
9713,Intermediate,,Zone of skin,14.0,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL624130,,
9714,Intermediate,,Zone of skin,14.0,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622340,,
9715,Intermediate,,Zone of skin,14.0,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622341,,
9716,Intermediate,,Intestine,160.0,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622342,,
9717,Intermediate,,Intestine,160.0,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622343,,
9718,Intermediate,,Intestine,160.0,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622344,,
9719,Intermediate,,Intestine,160.0,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622345,,
9720,Intermediate,,Spleen,2106.0,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622346,,
9721,Intermediate,,Spleen,2106.0,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622347,,
9722,Intermediate,,Spleen,2106.0,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622348,,
9723,Intermediate,,Spleen,2106.0,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622349,,
9724,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622350,,
9725,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622351,,
9726,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622352,,
9727,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622353,,
9728,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622354,,
9729,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622355,,
9730,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622356,,
9731,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622357,,
9732,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622358,,
9733,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL622359,,
9734,Intermediate,,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL874393,,
9735,Intermediate,,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622872,,
9736,Intermediate,,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL622873,,
9737,Intermediate,,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL623047,,
9738,Intermediate,,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623048,,
9739,Intermediate,,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623049,,
9740,Intermediate,,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623050,,
9741,Intermediate,,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623051,,
9742,Intermediate,,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL623052,,
9743,Intermediate,,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL626343,,
9744,Intermediate,,,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL626344,,
9745,Intermediate,,,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL626345,,
9746,Intermediate,,,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL626346,,
9747,Intermediate,,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL626347,,
9748,Intermediate,,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL626348,,
9749,Intermediate,,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,50597,Rattus norvegicus,16434,BAO_0000218,,1,1,,CHEMBL626349,,
9750,Intermediate,,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL626350,,
9751,Intermediate,,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL626351,,
9752,Intermediate,,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL627650,,
9753,Intermediate,,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL627651,,
9754,Intermediate,,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL627652,,
9755,Intermediate,,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,50597,Rattus norvegicus,16435,BAO_0000218,,1,1,,CHEMBL627653,,
9756,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL627654,,
9757,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL627835,,
9758,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL627836,,
9759,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL627837,,
9760,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL627838,,
9761,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL875338,,
9762,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL627839,,
9763,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL627840,,
9764,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL627841,,
9765,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL627842,,
9766,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL627843,,
9767,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL627844,,
9768,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL627845,,
9769,Intermediate,,,,Half life period in rat by iv administration at a dose of 3 mg/kg,50597,Rattus norvegicus,5874,BAO_0000218,,1,1,,CHEMBL627846,,
9770,Intermediate,,Plasma,1969.0,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),50597,Rattus norvegicus,1515,BAO_0000218,,1,1,,CHEMBL627847,,
9771,Intermediate,,Plasma,1969.0,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),50597,Rattus norvegicus,1515,BAO_0000218,,1,1,,CHEMBL873821,,
9772,Intermediate,,Plasma,1969.0,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,50597,Rattus norvegicus,1515,BAO_0000218,,1,1,,CHEMBL626079,,
9773,Intermediate,,Plasma,1969.0,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,50597,Rattus norvegicus,1515,BAO_0000218,,1,1,,CHEMBL626080,,
9774,Intermediate,,Plasma,1969.0,Half life period was evaluated in rat plasma,50597,Rattus norvegicus,5491,BAO_0000218,,1,1,,CHEMBL626081,,
9775,Intermediate,,Plasma,1969.0,Half life period was evaluated in rat plasma; Not tested,50597,Rattus norvegicus,5491,BAO_0000218,,1,1,,CHEMBL875344,,
9776,Intermediate,,,,Half life period was evaluated in rats,50597,Rattus norvegicus,1918,BAO_0000218,,1,1,,CHEMBL626082,,
9777,Intermediate,,,,"Half life period was evaluated in rats, iv",50597,Rattus norvegicus,1918,BAO_0000218,,1,1,,CHEMBL626250,,
9778,Intermediate,,,,Half life period after intravenous administration at 5 mg/kg in rat,50597,Rattus norvegicus,6113,BAO_0000218,,1,1,,CHEMBL626251,,
9779,Intermediate,,,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,50597,Rattus norvegicus,5546,BAO_0000218,,1,1,,CHEMBL626252,,
9780,Intermediate,,,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,50597,Rattus norvegicus,5553,BAO_0000218,,1,1,,CHEMBL626253,,
9781,Intermediate,,Plasma,1969.0,Half life stability of compound was evaluated in rat plasma,50597,Rattus norvegicus,4188,BAO_0000218,,1,1,,CHEMBL626254,,
9782,Intermediate,,,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,50597,Rattus norvegicus,6215,BAO_0000218,,1,1,,CHEMBL626255,,
9783,Intermediate,,,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,50597,Rattus norvegicus,6141,BAO_0000218,,1,1,,CHEMBL626256,,
9784,Intermediate,,,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,50597,Rattus norvegicus,5182,BAO_0000218,,1,1,,CHEMBL626257,,
9785,Intermediate,,,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,50597,Rattus norvegicus,5182,BAO_0000218,,1,1,,CHEMBL626258,,
9786,Intermediate,,,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,50597,Rattus norvegicus,5710,BAO_0000218,,1,1,,CHEMBL626259,,
9787,Intermediate,,,,Half in rat i.v.,50597,Rattus norvegicus,5789,BAO_0000218,,1,1,,CHEMBL626260,,
9788,Intermediate,,,,Half period in rat after intravenous administration,50597,Rattus norvegicus,6011,BAO_0000218,,1,1,,CHEMBL875345,,
9789,Intermediate,,,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,50597,Rattus norvegicus,17594,BAO_0000218,,1,1,,CHEMBL626261,,
9790,Intermediate,,Liver,2107.0,Half-life measured in in vitro Cathepsin B assay in rat liver,50597,Rattus norvegicus,12357,BAO_0000218,,1,1,,CHEMBL626262,,
9791,Intermediate,,,,Half-life of compound was determined in rats,50597,Rattus norvegicus,5210,BAO_0000218,,1,1,,CHEMBL626263,,
9792,Intermediate,,,,Half-life at 10 mg/kg in rat upon intravenous administration,50597,Rattus norvegicus,17596,BAO_0000218,,1,1,,CHEMBL625270,,
9793,Intermediate,,,,Half-life determined in rat,50597,Rattus norvegicus,6672,BAO_0000218,,1,1,,CHEMBL625271,,
9794,Intermediate,,,,Half-life determined in rat,50597,Rattus norvegicus,6673,BAO_0000218,,1,1,,CHEMBL625272,,
9795,Intermediate,,Brain,955.0,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL625273,,
9796,Intermediate,,Plasma,1969.0,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",50597,Rattus norvegicus,3741,BAO_0000218,,1,1,,CHEMBL625274,,
9797,Intermediate,,,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,50597,Rattus norvegicus,17671,BAO_0000218,,1,1,,CHEMBL625275,,
9798,Intermediate,,Plasma,1969.0,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL625276,,
9799,Intermediate,,Plasma,1969.0,Half-life in rat plasma,50597,Rattus norvegicus,17537,BAO_0000218,,1,1,,CHEMBL625277,,
9800,Intermediate,,Plasma,1969.0,Half-life in rat plasma was determined,50597,Rattus norvegicus,4965,BAO_0000218,,1,1,,CHEMBL625278,,
9801,Intermediate,,Plasma,1969.0,Half-life in rat plasma; Not tested,50597,Rattus norvegicus,17537,BAO_0000218,,1,1,,CHEMBL625279,,
9802,Intermediate,,Serum,1977.0,Half-life in rat serum,50597,Rattus norvegicus,6124,BAO_0000218,,1,1,,CHEMBL625280,,
9803,Intermediate,,Serum,1977.0,Half-life in rat serum; na is not available,50597,Rattus norvegicus,6124,BAO_0000218,,1,1,,CHEMBL876797,,
9804,Intermediate,,,,Half-life was calculated in rat,50597,Rattus norvegicus,6078,BAO_0000218,,1,1,,CHEMBL625281,,
9805,Intermediate,,Plasma,1969.0,Half-life was calculated in rat plasma,50597,Rattus norvegicus,17668,BAO_0000218,,1,1,,CHEMBL873827,,
9806,Intermediate,,,,Half-life was determined,50597,Rattus norvegicus,3185,BAO_0000218,,1,1,,CHEMBL625282,,
9807,Intermediate,,,,Half-life was determined,50597,Rattus norvegicus,4883,BAO_0000218,,1,1,,CHEMBL625283,,
9808,Intermediate,,,,Half-life after administration of 20 mg/Kg oral dose in rat,50597,Rattus norvegicus,2959,BAO_0000218,,1,1,,CHEMBL625284,,
9809,Intermediate,,,,Half-life after administration of 3.2 mg/kg intravenously in male rat,50597,Rattus norvegicus,4029,BAO_0000218,,1,1,,CHEMBL625285,,
9810,Intermediate,,,,Half-life after intravenous administration in female rat,50597,Rattus norvegicus,4029,BAO_0000218,,1,1,,CHEMBL625286,,
9811,Intermediate,,,,Half-life after intravenous administration in male rat,50597,Rattus norvegicus,4029,BAO_0000218,,1,1,,CHEMBL625287,,
9812,Intermediate,,,,Half-life after intravenous dose in rat,50597,Rattus norvegicus,6180,BAO_0000218,,1,1,,CHEMBL625288,,
9813,Intermediate,,Liver,2107.0,Half-life in a rat liver homogenate preparation,50597,Rattus norvegicus,1557,BAO_0000218,,1,1,,CHEMBL625289,,
9814,Intermediate,,Plasma,1969.0,Half-life in plasma of rat,50597,Rattus norvegicus,12500,BAO_0000218,,1,1,,CHEMBL625290,,
9815,Intermediate,,Plasma,1969.0,Half-life in plasma of rat at dose of 3-10 mgkg,50597,Rattus norvegicus,12500,BAO_0000218,,1,1,,CHEMBL876798,,
9816,Intermediate,,,,Half-life in rat,50597,Rattus norvegicus,5064,BAO_0000218,,1,1,,CHEMBL625291,,
9817,Intermediate,,,,Half-life in rat,50597,Rattus norvegicus,5145,BAO_0000218,,1,1,,CHEMBL625292,,
9818,Intermediate,,,,Half-life in rat,50597,Rattus norvegicus,5147,BAO_0000218,,1,1,,CHEMBL625293,,
9819,Intermediate,,,,Half-life in rat,50597,Rattus norvegicus,5833,BAO_0000218,,1,1,,CHEMBL622832,,
9820,Intermediate,,,,Half-life in rat,50597,Rattus norvegicus,6596,BAO_0000218,,1,1,,CHEMBL622833,,
9821,Intermediate,,,,Half-life in rat,50597,Rattus norvegicus,17655,BAO_0000218,,1,1,,CHEMBL622834,,
9822,Intermediate,,,,Half-life in rat after oral administration at 10 mg/kg,50597,Rattus norvegicus,6495,BAO_0000218,,1,1,,CHEMBL622835,,
9823,Intermediate,,,,Half-life in rat after po administration at a dose of 10 mg/kg,50597,Rattus norvegicus,17538,BAO_0000218,,1,1,,CHEMBL622836,,
9824,Intermediate,,,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,50597,Rattus norvegicus,17538,BAO_0000218,,1,1,,CHEMBL622837,,
9825,Intermediate,,,,Half-life in rat at 3 mg/kg dose administered intravenously,50597,Rattus norvegicus,10,BAO_0000218,,1,1,,CHEMBL622838,,
9826,Intermediate,,Brain,955.0,Half-life in rat brain homogenate,50597,Rattus norvegicus,17669,BAO_0000218,,1,1,,CHEMBL622839,,
9827,Intermediate,,Plasma,1969.0,Half-life in rat plasma,50597,Rattus norvegicus,17065,BAO_0000218,,1,1,,CHEMBL622840,,
9828,Intermediate,,,,Half-life in rats,50597,Rattus norvegicus,4333,BAO_0000218,,1,1,,CHEMBL622841,,
9829,Intermediate,,,,Half-life in Dawley rats,50597,Rattus norvegicus,6827,BAO_0000218,,1,1,,CHEMBL622842,,
9830,Intermediate,,Plasma,1969.0,Half-life in vitro in rat plasma,50597,Rattus norvegicus,889,BAO_0000218,,1,1,,CHEMBL622843,,
9831,Intermediate,,Plasma,1969.0,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,50597,Rattus norvegicus,889,BAO_0000218,,1,1,,CHEMBL622844,,
9832,Intermediate,,,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",50597,Rattus norvegicus,3747,BAO_0000218,,1,1,,CHEMBL622845,,
9833,Intermediate,,,,The area under the curve of compound was measured at the dose of 100 umol/kg,50597,Rattus norvegicus,15022,BAO_0000218,,1,1,,CHEMBL622846,,
9834,Intermediate,,,,The area under the curve of compound was measured at the dose of 300 umol/kg,50597,Rattus norvegicus,15022,BAO_0000218,,1,1,,CHEMBL622847,,
9835,Intermediate,,,,The area under the curve of compound was measured at the dose of 30 umol/kg,50597,Rattus norvegicus,15022,BAO_0000218,,1,1,,CHEMBL622848,,
9836,Intermediate,,,,Bioavailability as oral AUC in rats,50597,Rattus norvegicus,3360,BAO_0000218,,1,1,,CHEMBL622849,,
9837,Intermediate,,Plasma,1969.0,The plasma concentration versus time curve (AUC) was determined,50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL622850,,
9838,Intermediate,,,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,50597,Rattus norvegicus,17411,BAO_0000218,,1,1,,CHEMBL876807,,
9839,Intermediate,,,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,50597,Rattus norvegicus,17411,BAO_0000218,,1,1,,CHEMBL622851,,
9840,Intermediate,,,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,50597,Rattus norvegicus,17411,BAO_0000218,,1,1,,CHEMBL622852,,
9841,Intermediate,,,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,50597,Rattus norvegicus,6570,BAO_0000218,,1,1,,CHEMBL622853,,
9842,Intermediate,,,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,50597,Rattus norvegicus,6570,BAO_0000218,,1,1,,CHEMBL622854,,
9843,Intermediate,,,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,50597,Rattus norvegicus,17411,BAO_0000218,,1,1,,CHEMBL622855,,
9844,Intermediate,,Plasma,1969.0,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",50597,Rattus norvegicus,14941,BAO_0000218,,1,1,,CHEMBL622856,,
9845,Intermediate,,Plasma,1969.0,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",50597,Rattus norvegicus,14941,BAO_0000218,,1,1,,CHEMBL622857,,
9846,Intermediate,,Plasma,1969.0,AUC in rat after po administration at a dose of 10 mg/kg,50597,Rattus norvegicus,17538,BAO_0000218,,1,1,,CHEMBL622858,,
9847,Intermediate,,Plasma,1969.0,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,50597,Rattus norvegicus,17752,BAO_0000218,,1,1,,CHEMBL622859,,
9848,Intermediate,,,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,50597,Rattus norvegicus,17509,BAO_0000218,,1,1,,CHEMBL622860,,
9849,Intermediate,,,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,50597,Rattus norvegicus,17509,BAO_0000218,,1,1,,CHEMBL622861,,
9850,Intermediate,,,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,50597,Rattus norvegicus,17509,BAO_0000218,,1,1,,CHEMBL622862,,
9851,Intermediate,,,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,50597,Rattus norvegicus,17509,BAO_0000218,,1,1,,CHEMBL622863,,
9852,Intermediate,,,,Area under curve value 6 hr after po administration in rat,50597,Rattus norvegicus,17509,BAO_0000218,,1,1,,CHEMBL623817,,
9853,Intermediate,,,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL623818,,
9854,Intermediate,,,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL623819,,
9855,Intermediate,,,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL623820,,
9856,Intermediate,,,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL623821,,
9857,Intermediate,,Plasma,1969.0,AUC normalized for dose (AUCN) in rat,50597,Rattus norvegicus,6642,BAO_0000218,,1,1,,CHEMBL623822,,
9858,Intermediate,,,,Area under curve in rat after p.o. administration,50597,Rattus norvegicus,6640,BAO_0000218,,1,1,,CHEMBL623823,,
9859,Intermediate,,,,Area under curve in rat after p.o. administration,50597,Rattus norvegicus,6641,BAO_0000218,,1,1,,CHEMBL623824,,
9860,Intermediate,,,,Area under curve in rat after p.o. administration; Not determined,50597,Rattus norvegicus,6641,BAO_0000218,,1,1,,CHEMBL623825,,
9861,Intermediate,,,,Area under curve in rat after peroral administration,50597,Rattus norvegicus,6641,BAO_0000218,,1,1,,CHEMBL622070,,
9862,Intermediate,,,,Area under curve (carotid artery) value of the compound,50597,Rattus norvegicus,3603,BAO_0000218,,1,1,,CHEMBL622071,,
9863,Intermediate,,,,Bioavailability expressed as the area under curve of rat carotid artery,50597,Rattus norvegicus,3550,BAO_0000218,,1,1,,CHEMBL622072,,
9864,Intermediate,,,,Area under curve in male SD rats was observed after intravenous administration in rat,50597,Rattus norvegicus,15662,BAO_0000218,,1,1,,CHEMBL622073,,
9865,Intermediate,,,,Area under curve of the compound was determined,50597,Rattus norvegicus,17720,BAO_0000218,,1,1,,CHEMBL622074,,
9866,Intermediate,,,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,50597,Rattus norvegicus,5407,BAO_0000218,,1,1,,CHEMBL622075,,
9867,Intermediate,,Plasma,1969.0,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,50597,Rattus norvegicus,17752,BAO_0000218,,1,1,,CHEMBL622076,,
9868,Intermediate,,Plasma,1969.0,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,50597,Rattus norvegicus,17752,BAO_0000218,,1,1,,CHEMBL622077,,
9869,Intermediate,,,,Area under curve (portal vein) value of the compound,50597,Rattus norvegicus,3603,BAO_0000218,,1,1,,CHEMBL622078,,
9870,Intermediate,,,,Bioavailability expressed as the area under curve of rat portal vein,50597,Rattus norvegicus,3550,BAO_0000218,,1,1,,CHEMBL622079,,
9871,Intermediate,,Plasma,1969.0,Area Under plasma concentration time curve in rat upon peroral administration,50597,Rattus norvegicus,17655,BAO_0000218,,1,1,,CHEMBL622080,,
9872,Intermediate,,,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,50597,Rattus norvegicus,17582,BAO_0000218,,1,1,,CHEMBL877612,,
9873,Intermediate,,,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,50597,Rattus norvegicus,17582,BAO_0000218,,1,1,,CHEMBL622081,,
9874,Intermediate,,,,Compound was evaluated for oral bioavailability in rats,50597,Rattus norvegicus,17791,BAO_0000218,,1,1,,CHEMBL622082,,
9875,Intermediate,,,,Compound was evaluated for oral bioavailability in rats after iv administration,50597,Rattus norvegicus,17791,BAO_0000218,,1,1,,CHEMBL622083,,
9876,Intermediate,,,,Compound was evaluated for oral bioavailability in rats; 30-80,50597,Rattus norvegicus,17791,BAO_0000218,,1,1,,CHEMBL622084,,
9877,Intermediate,,,,Compound was evaluated for oral bioavailability in rats; 50-60,50597,Rattus norvegicus,17791,BAO_0000218,,1,1,,CHEMBL622085,,
9878,Intermediate,,,,Compound was evaluated for oral bioavailability in rats; no data,50597,Rattus norvegicus,17791,BAO_0000218,,1,1,,CHEMBL622086,,
9879,Intermediate,,,,Compound was evaluated for oral bioavailability in rats; peptide,50597,Rattus norvegicus,17791,BAO_0000218,,1,1,,CHEMBL622087,,
9880,Intermediate,,Blood,178.0,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL622088,,
9881,Intermediate,,Blood,178.0,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL622089,,
9882,Intermediate,,Blood,178.0,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL623685,,
9883,Intermediate,,Blood,178.0,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL623686,,
9884,Intermediate,,Stomach,945.0,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL623687,,
9885,Intermediate,,Stomach,945.0,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL623688,,
9886,Intermediate,,Stomach,945.0,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL623689,,
9887,Intermediate,,Stomach,945.0,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622485,,
9888,Intermediate,,Thyroid gland,2046.0,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622486,,
9889,Intermediate,,Thyroid gland,2046.0,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL877613,,
9890,Intermediate,,Thyroid gland,2046.0,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622487,,
9891,Intermediate,,Thyroid gland,2046.0,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622488,,
9892,Intermediate,,Heart,948.0,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622489,,
9893,Intermediate,,Urine,1088.0,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,50597,Rattus norvegicus,6899,BAO_0000218,,1,1,,CHEMBL622490,,
9894,Intermediate,,Urine,1088.0,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,50597,Rattus norvegicus,6899,BAO_0000218,,1,1,,CHEMBL622491,,
9895,Intermediate,,Liver,2107.0,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,50597,Rattus norvegicus,6899,BAO_0000218,,1,1,,CHEMBL622492,,
9896,Intermediate,,Urine,1088.0,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,50597,Rattus norvegicus,6899,BAO_0000218,,1,1,,CHEMBL622493,,
9897,Intermediate,,Urine,1088.0,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,50597,Rattus norvegicus,6899,BAO_0000218,,1,1,,CHEMBL622494,,
9898,Intermediate,,Muscle tissue,2385.0,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",50597,Rattus norvegicus,8677,BAO_0000218,,1,1,,CHEMBL622495,,
9899,Intermediate,,,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,50597,Rattus norvegicus,6899,BAO_0000218,,1,1,,CHEMBL622496,,
9900,Intermediate,,Urine,1088.0,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,50597,Rattus norvegicus,6899,BAO_0000218,,1,1,,CHEMBL622497,,
9901,Intermediate,,,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,50597,Rattus norvegicus,2189,BAO_0000218,,1,1,,CHEMBL622498,,
9902,Intermediate,,Urine,1088.0,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,50597,Rattus norvegicus,2189,BAO_0000218,,1,1,,CHEMBL624918,,
9903,Intermediate,,Urine,1088.0,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,50597,Rattus norvegicus,2189,BAO_0000218,,1,1,,CHEMBL624919,,
9904,Intermediate,,Blood,178.0,Biodistribution of compound in rat blood after 5 min of administration,50597,Rattus norvegicus,10839,BAO_0000218,,1,1,,CHEMBL624920,,
9905,Intermediate,,Blood,178.0,Biodistribution of compound in rat blood after 5 min of administration.,50597,Rattus norvegicus,10839,BAO_0000218,,1,1,,CHEMBL624921,,
9906,Intermediate,,Brain,955.0,Biodistribution of compound in rat brain after 5 min of administration,50597,Rattus norvegicus,10839,BAO_0000218,,1,1,,CHEMBL624922,,
9907,Intermediate,,Heart,948.0,Biodistribution of compound in rat heart after 5 min of administration,50597,Rattus norvegicus,10839,BAO_0000218,,1,1,,CHEMBL624923,,
9908,Intermediate,,Heart,948.0,Biodistribution of compound in rat heart after 5 min of administration.,50597,Rattus norvegicus,10839,BAO_0000218,,1,1,,CHEMBL624924,,
9909,Intermediate,,Kidney,2113.0,Biodistribution of compound in rat kidney after 5 min of administration,50597,Rattus norvegicus,10839,BAO_0000218,,1,1,,CHEMBL624925,,
9910,Intermediate,,Kidney,2113.0,Biodistribution of compound in rat kidney after 5 min of administration.,50597,Rattus norvegicus,10839,BAO_0000218,,1,1,,CHEMBL624926,,
9911,Intermediate,,Liver,2107.0,Biodistribution of compound in rat liver after 5 min of administration,50597,Rattus norvegicus,10839,BAO_0000218,,1,1,,CHEMBL624927,,
9912,Intermediate,,Liver,2107.0,Biodistribution of compound in rat liver after 5 min of administration.,50597,Rattus norvegicus,10839,BAO_0000218,,1,1,,CHEMBL874402,,
9913,Intermediate,,Lung,2048.0,Biodistribution of compound in rat lung after 5 min of administration,50597,Rattus norvegicus,10839,BAO_0000218,,1,1,,CHEMBL624928,,
9914,Intermediate,,Lung,2048.0,Biodistribution of compound in rat lung after 5 min of administration.,50597,Rattus norvegicus,10839,BAO_0000218,,1,1,,CHEMBL624929,,
9915,Intermediate,,Muscle tissue,2385.0,Biodistribution of compound in rat muscle after 5 min of administration,50597,Rattus norvegicus,10839,BAO_0000218,,1,1,,CHEMBL624930,,
9916,Intermediate,,Muscle tissue,2385.0,Biodistribution of compound in rat muscle after 5 min of administration.,50597,Rattus norvegicus,10839,BAO_0000218,,1,1,,CHEMBL624931,,
9917,Intermediate,,Heart,948.0,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,50597,Rattus norvegicus,4043,BAO_0000218,,1,1,,CHEMBL624932,,
9918,Intermediate,,Heart,948.0,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,50597,Rattus norvegicus,4043,BAO_0000218,,1,1,,CHEMBL624933,,
9919,Intermediate,,Liver,2107.0,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,50597,Rattus norvegicus,4043,BAO_0000218,,1,1,,CHEMBL624934,,
9920,Intermediate,,Liver,2107.0,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,50597,Rattus norvegicus,4043,BAO_0000218,,1,1,,CHEMBL624935,,
9921,Intermediate,,,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,50597,Rattus norvegicus,4043,BAO_0000218,,1,1,,CHEMBL624936,,
9922,Intermediate,,,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,50597,Rattus norvegicus,4043,BAO_0000218,,1,1,,CHEMBL624937,,
9923,Intermediate,,Spleen,2106.0,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,50597,Rattus norvegicus,4043,BAO_0000218,,1,1,,CHEMBL624938,,
9924,Intermediate,,Spleen,2106.0,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,50597,Rattus norvegicus,4043,BAO_0000218,,1,1,,CHEMBL624939,,
9925,Intermediate,,,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,50597,Rattus norvegicus,4043,BAO_0000218,,1,1,,CHEMBL624940,,
9926,Intermediate,,,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,50597,Rattus norvegicus,4043,BAO_0000218,,1,1,,CHEMBL874403,,
9927,Intermediate,,,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,50597,Rattus norvegicus,1446,BAO_0000218,,1,1,,CHEMBL624941,,
9928,Intermediate,,Urine,1088.0,Dose required to lower urine osmolality to 300 mOsm/kg in rat,50597,Rattus norvegicus,9971,BAO_0000218,,1,1,,CHEMBL624942,,
9929,Intermediate,,Urine,1088.0,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,50597,Rattus norvegicus,9971,BAO_0000218,,1,1,,CHEMBL624943,,
9930,Intermediate,,,,% Bioavailability after 1 day of the drug administration in rats,50597,Rattus norvegicus,5765,BAO_0000218,,1,1,,CHEMBL624944,,
9931,Intermediate,,,,% Bioavailability after 4 day of the drug administration in rats,50597,Rattus norvegicus,5765,BAO_0000218,,1,1,,CHEMBL624945,,
9932,Intermediate,,,,Absolute bioavailability was evaluated in rat,50597,Rattus norvegicus,4257,BAO_0000218,,1,1,,CHEMBL624946,,
9933,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624947,,
9934,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624948,,
9935,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624949,,
9936,Intermediate,,Kidney,2113.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL622025,,
9937,Intermediate,,Kidney,2113.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL622026,,
9938,Intermediate,,Kidney,2113.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL622027,,
9939,Intermediate,,Kidney,2113.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL622028,,
9940,Intermediate,,Liver,2107.0,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL622029,,
9941,Intermediate,,Liver,2107.0,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL622208,,
9942,Intermediate,,Liver,2107.0,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL622209,,
9943,Intermediate,,Liver,2107.0,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL622210,,
9944,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL622211,,
9945,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL622212,,
9946,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL622213,,
9947,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL874404,,
9948,Intermediate,,Muscle tissue,2385.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL620452,,
9949,Intermediate,,Muscle tissue,2385.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL620453,,
9950,Intermediate,,Muscle tissue,2385.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL620454,,
9951,Intermediate,,Muscle tissue,2385.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624067,,
9952,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624068,,
9953,Intermediate,,Female gonad,992.0,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624069,,
9954,Intermediate,,Female gonad,992.0,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624070,,
9955,Intermediate,,Female gonad,992.0,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624071,,
9956,Intermediate,,Uterus,995.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624072,,
9957,Intermediate,,Uterus,995.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624073,,
9958,Intermediate,,Uterus,995.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624788,,
9959,Intermediate,,Uterus,995.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624789,,
9960,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624790,,
9961,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624791,,
9962,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624792,,
9963,Intermediate,,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624793,,
9964,Intermediate,,Muscle tissue,2385.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL877491,,
9965,Intermediate,,Muscle tissue,2385.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624957,,
9966,Intermediate,,Muscle tissue,2385.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624958,,
9967,Intermediate,,Muscle tissue,2385.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,50597,Rattus norvegicus,13091,BAO_0000218,,1,1,,CHEMBL624959,,
9968,Intermediate,,,,Dissociation constant was determined,50597,Rattus norvegicus,11977,BAO_0000218,,1,1,,CHEMBL624960,,
9969,Intermediate,,,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",50597,Rattus norvegicus,14941,BAO_0000218,,1,1,,CHEMBL624961,,
9970,Intermediate,,,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL624962,,
9971,Intermediate,,,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL624963,,
9972,Intermediate,,,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,50597,Rattus norvegicus,4755,BAO_0000218,,1,1,,CHEMBL624964,,
9973,Intermediate,,,,LogP value was evaluated in the in situ rat gut perfusion assay,50597,Rattus norvegicus,589,BAO_0000218,,1,1,,CHEMBL624965,,
9974,Intermediate,,,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,50597,Rattus norvegicus,17582,BAO_0000218,,1,1,,CHEMBL624966,,
9975,Intermediate,,,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,50597,Rattus norvegicus,5031,BAO_0000218,,1,1,,CHEMBL624967,,
9976,Intermediate,,,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,50597,Rattus norvegicus,17764,BAO_0000218,,1,1,,CHEMBL624968,,
9977,Intermediate,,,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,50597,Rattus norvegicus,17720,BAO_0000218,,1,1,,CHEMBL624969,,
9978,Expert,,,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,50597,Rattus norvegicus,2862,BAO_0000218,,1,1,,CHEMBL624970,,
9979,Intermediate,,,,Half-life was evaluated after 10 uM/kg of intra arterial administration,50597,Rattus norvegicus,16423,BAO_0000218,,1,1,,CHEMBL624971,,
9980,Intermediate,,,,Half-life was evaluated after 20 uM/kg of peroral administration,50597,Rattus norvegicus,16423,BAO_0000218,,1,1,,CHEMBL624972,,
9981,Intermediate,,,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,50597,Rattus norvegicus,6005,BAO_0000218,,1,1,,CHEMBL624973,,
9982,Intermediate,,Plasma,1969.0,Half-life was evaluated in plasma of rat,50597,Rattus norvegicus,2938,BAO_0000218,,1,1,,CHEMBL624974,,
9983,Intermediate,,,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,50597,Rattus norvegicus,6410,BAO_0000218,,1,1,,CHEMBL624975,,
9984,Intermediate,,,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,50597,Rattus norvegicus,6410,BAO_0000218,,1,1,,CHEMBL877492,,
9985,Intermediate,,,,Half-life was measured in rat after an iv dose of 1 mg/kg,50597,Rattus norvegicus,6062,BAO_0000218,,1,1,,CHEMBL624976,,
9986,Intermediate,,,,Half-life period of compound in rats after peroral administration,50597,Rattus norvegicus,6571,BAO_0000218,,1,1,,CHEMBL624977,,
9987,Intermediate,,Plasma,1969.0,Half-life period of compound was measured in rat plasma.,50597,Rattus norvegicus,3136,BAO_0000218,,1,1,,CHEMBL626848,,
9988,Intermediate,,Plasma,1969.0,Half-life period of compound was measured in rat plasma; ND is not determined,50597,Rattus norvegicus,3136,BAO_0000218,,1,1,,CHEMBL626849,,
9989,Intermediate,,Plasma,1969.0,Half-life period of compound was measured in rat plasma; not determined,50597,Rattus norvegicus,3136,BAO_0000218,,1,1,,CHEMBL626850,,
9990,Intermediate,,,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,50597,Rattus norvegicus,4521,BAO_0000218,,1,1,,CHEMBL626851,,
9991,Intermediate,,,,Half-life period in rat by iv administration,50597,Rattus norvegicus,5871,BAO_0000218,,1,1,,CHEMBL626852,,
9992,Intermediate,,,,Half-life period in rats following intravenous administration at 2 mg/kg,50597,Rattus norvegicus,6077,BAO_0000218,,1,1,,CHEMBL626853,,
9993,Intermediate,,,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,50597,Rattus norvegicus,6679,BAO_0000218,,1,1,,CHEMBL626854,,
9994,Intermediate,,,,Half-life period was determined for the compound in rat,50597,Rattus norvegicus,5144,BAO_0000218,,1,1,,CHEMBL627486,,
9995,Intermediate,,,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",50597,Rattus norvegicus,4498,BAO_0000218,,1,1,,CHEMBL627487,,
9996,Intermediate,,,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",50597,Rattus norvegicus,4498,BAO_0000218,,1,1,,CHEMBL627488,,
9997,Intermediate,,,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,50597,Rattus norvegicus,1908,BAO_0000218,,1,1,,CHEMBL627489,,
9998,Intermediate,,,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,50597,Rattus norvegicus,6211,BAO_0000218,,1,1,,CHEMBL627490,,
9999,Intermediate,,,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),50597,Rattus norvegicus,5529,BAO_0000218,,1,1,,CHEMBL873829,,
10000,Intermediate,,,,Half-life was determined in rat at a dose of 1 mpk i.v.,50597,Rattus norvegicus,6444,BAO_0000218,,1,1,,CHEMBL627655,,
10001,Intermediate,,,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,50597,Rattus norvegicus,6444,BAO_0000218,,1,1,,CHEMBL625994,,
10002,Intermediate,,,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,50597,Rattus norvegicus,6444,BAO_0000218,,1,1,,CHEMBL625995,,
10003,Intermediate,,,,Half-life in rat,50597,Rattus norvegicus,5207,BAO_0000218,,1,1,,CHEMBL625996,,
10004,Intermediate,,Plasma,1969.0,In vitro half life in rat plasma,50597,Rattus norvegicus,530,BAO_0000218,,1,1,,CHEMBL625850,,
10005,Intermediate,,Plasma,1969.0,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",50597,Rattus norvegicus,1116,BAO_0000218,,1,1,,CHEMBL625851,,
10006,Intermediate,,,,In vitro half life in rat,50597,Rattus norvegicus,3219,BAO_0000218,,1,1,,CHEMBL625852,,
10007,Intermediate,,,,In vivo half life period after intravenous administration in rat,50597,Rattus norvegicus,6109,BAO_0000218,,1,1,,CHEMBL625853,,
10008,Intermediate,,,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,50597,Rattus norvegicus,17582,BAO_0000218,,1,1,,CHEMBL625854,,
10009,Intermediate,,,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,50597,Rattus norvegicus,17582,BAO_0000218,,1,1,,CHEMBL874450,,
10010,Intermediate,,,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL625855,,
10011,Intermediate,,,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL625856,,
10012,Intermediate,,,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL625857,,
10013,Intermediate,,,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL873831,,
10014,Intermediate,,,,Longer half-life in rat (i.v.) at 0.5 mpk,50597,Rattus norvegicus,17853,BAO_0000218,,1,1,,CHEMBL625858,,
10015,Intermediate,,,,Longer half-life in rat (p.o.) at 2.0 mpk,50597,Rattus norvegicus,17853,BAO_0000218,,1,1,,CHEMBL625859,,
10016,Intermediate,,,,Pharmacokinetic property (half life) in rat,50597,Rattus norvegicus,3457,BAO_0000218,,1,1,,CHEMBL625860,,
10017,Intermediate,,,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL625861,,
10018,Intermediate,,,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL625862,,
10019,Intermediate,,,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL625863,,
10020,Intermediate,,,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL625864,,
10021,Intermediate,,,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,50597,Rattus norvegicus,5739,BAO_0000218,,1,1,,CHEMBL625865,,
10022,Intermediate,,,,Pharmacokinetic half time was determined intravenously in rats.,50597,Rattus norvegicus,15765,BAO_0000218,,1,1,,CHEMBL625866,,
10023,Intermediate,,Plasma,1969.0,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,50597,Rattus norvegicus,6567,BAO_0000218,,1,1,,CHEMBL625867,,
10024,Intermediate,,Plasma,1969.0,Plasma half life of hydrolysis of the compound,50597,Rattus norvegicus,2448,BAO_0000218,,1,1,,CHEMBL625868,,
10025,Intermediate,,Plasma,1969.0,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,50597,Rattus norvegicus,5423,BAO_0000218,,1,1,,CHEMBL625869,,
10026,Intermediate,,Plasma,1969.0,Plasma half life period was calculated in rat,50597,Rattus norvegicus,4853,BAO_0000218,,1,1,,CHEMBL874451,,
10027,Intermediate,,Plasma,1969.0,Plasma half-life in Sprague-Dawley rats,50597,Rattus norvegicus,4514,BAO_0000218,,1,1,,CHEMBL625870,,
10028,Intermediate,,Plasma,1969.0,Plasma half-life in Sprague-Dawley rats; Not determined,50597,Rattus norvegicus,4514,BAO_0000218,,1,1,,CHEMBL625871,,
10029,Intermediate,,Plasma,1969.0,Plasma half-life in rats,50597,Rattus norvegicus,1500,BAO_0000218,,1,1,,CHEMBL625872,,
10030,Intermediate,,Plasma,1969.0,Plasma half-life in rats; <MQL,50597,Rattus norvegicus,1500,BAO_0000218,,1,1,,CHEMBL625873,,
10031,Intermediate,,Plasma,1969.0,Plasma half-life period (0-8 h) was determined,50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL625874,,
10032,Intermediate,,Plasma,1969.0,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL625875,,
10033,Intermediate,,Plasma,1969.0,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL625876,,
10034,Intermediate,,Plasma,1969.0,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL631258,,
10035,Intermediate,,Plasma,1969.0,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,50597,Rattus norvegicus,4956,BAO_0000218,,1,1,,CHEMBL631259,,
10036,Intermediate,,Plasma,1969.0,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,50597,Rattus norvegicus,4956,BAO_0000218,,1,1,,CHEMBL631260,,
10037,Intermediate,,Blood,178.0,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL631261,,
10038,Intermediate,,Blood,178.0,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL631262,,
10039,Intermediate,,Blood,178.0,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL631263,,
10040,Intermediate,,,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL631264,,
10041,Intermediate,,,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL631265,,
10042,Intermediate,,,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL631266,,
10043,Intermediate,,,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL631267,,
10044,Intermediate,,,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL631268,,
10045,Intermediate,,,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL631269,,
10046,Intermediate,,,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL631270,,
10047,Intermediate,,Heart,948.0,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL631271,,
10048,Intermediate,,Heart,948.0,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL631272,,
10049,Intermediate,,Heart,948.0,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL631273,,
10050,Intermediate,,Heart,948.0,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL631274,,
10051,Intermediate,,Heart,948.0,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL631275,,
10052,Intermediate,,Heart,948.0,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626984,,
10053,Intermediate,,Heart,948.0,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626985,,
10054,Intermediate,,Liver,2107.0,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626986,,
10055,Intermediate,,Liver,2107.0,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626987,,
10056,Intermediate,,Liver,2107.0,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626988,,
10057,Intermediate,,Liver,2107.0,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626989,,
10058,Intermediate,,Liver,2107.0,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626990,,
10059,Intermediate,,Liver,2107.0,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626991,,
10060,Intermediate,,Liver,2107.0,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626992,,
10061,Intermediate,,Lung,2048.0,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626993,,
10062,Intermediate,,Lung,2048.0,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL874593,,
10063,Intermediate,,Lung,2048.0,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626994,,
10064,Intermediate,,Lung,2048.0,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626995,,
10065,Intermediate,,Lung,2048.0,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626190,,
10066,Intermediate,,Lung,2048.0,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626191,,
10067,Intermediate,,Lung,2048.0,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626364,,
10068,Intermediate,,Thyroid gland,2046.0,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626365,,
10069,Intermediate,,Thyroid gland,2046.0,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626366,,
10070,Intermediate,,Thyroid gland,2046.0,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626367,,
10071,Intermediate,,Thyroid gland,2046.0,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626368,,
10072,Intermediate,,Thyroid gland,2046.0,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626369,,
10073,Intermediate,,Thyroid gland,2046.0,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626370,,
10074,Intermediate,,,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",50597,Rattus norvegicus,4498,BAO_0000218,,1,1,,CHEMBL626371,,
10075,Intermediate,,,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",50597,Rattus norvegicus,4498,BAO_0000218,,1,1,,CHEMBL626372,,
10076,Intermediate,,,,Bioavailability after a dose of 10 mg/kg p.o.,50597,Rattus norvegicus,3603,BAO_0000218,,1,1,,CHEMBL626373,,
10077,Intermediate,,,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,50597,Rattus norvegicus,6215,BAO_0000218,,1,1,,CHEMBL626374,,
10078,Intermediate,,,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,50597,Rattus norvegicus,5710,BAO_0000218,,1,1,,CHEMBL626375,,
10079,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),50597,Rattus norvegicus,5710,BAO_0000218,,1,1,,CHEMBL626376,,
10080,Intermediate,,,,Bioavailability in rat po was determined,50597,Rattus norvegicus,5676,BAO_0000218,,1,1,,CHEMBL626377,,
10081,Intermediate,,,,Bioavailability of compound at 10 mg/kg in rat after oral administration,50597,Rattus norvegicus,17667,BAO_0000218,,1,1,,CHEMBL626378,,
10082,Intermediate,,,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,50597,Rattus norvegicus,17667,BAO_0000218,,1,1,,CHEMBL626379,,
10083,Intermediate,,,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),50597,Rattus norvegicus,6848,BAO_0000218,,1,1,,CHEMBL626380,,
10084,Intermediate,,,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),50597,Rattus norvegicus,6848,BAO_0000218,,1,1,,CHEMBL626381,,
10085,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,17267,BAO_0000218,,1,1,,CHEMBL626382,,
10086,Intermediate,,,,Bioavailability in rat (Sprague-Dawley) (female),50597,Rattus norvegicus,6362,BAO_0000218,,1,1,,CHEMBL626383,,
10087,Intermediate,,,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,50597,Rattus norvegicus,17671,BAO_0000218,,1,1,,CHEMBL874652,,
10088,Intermediate,,,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),50597,Rattus norvegicus,17671,BAO_0000218,,1,1,,CHEMBL626384,,
10089,Intermediate,,,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,50597,Rattus norvegicus,4333,BAO_0000218,,1,1,,CHEMBL626385,,
10090,Intermediate,,,,Bioavailability in rat at an oral dose of 2 mg/kg,50597,Rattus norvegicus,6077,BAO_0000218,,1,1,,CHEMBL626386,,
10091,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,3278,BAO_0000218,,1,1,,CHEMBL626387,,
10092,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,5964,BAO_0000218,,1,1,,CHEMBL626388,,
10093,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,4884,BAO_0000218,,1,1,,CHEMBL626389,,
10094,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,4905,BAO_0000218,,1,1,,CHEMBL626390,,
10095,Intermediate,,,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,50597,Rattus norvegicus,4884,BAO_0000218,,1,1,,CHEMBL626391,,
10096,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,6850,BAO_0000218,,1,1,,CHEMBL626392,,
10097,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,2864,BAO_0000218,,1,1,,CHEMBL626393,,
10098,Intermediate,,,,Bioavailability was determined in rat,50597,Rattus norvegicus,5780,BAO_0000218,,1,1,,CHEMBL623026,,
10099,Intermediate,,,,Bioavailability,50597,Rattus norvegicus,1465,BAO_0000218,,1,1,,CHEMBL623027,,
10100,Intermediate,,,,Bioavailability,50597,Rattus norvegicus,5199,BAO_0000218,,1,1,,CHEMBL623028,,
10101,Intermediate,,,,Bioavailability in rat after 1 day dosing,50597,Rattus norvegicus,5765,BAO_0000218,,1,1,,CHEMBL623029,,
10102,Intermediate,,,,Bioavailability in rat after 4 day dosing,50597,Rattus norvegicus,5765,BAO_0000218,,1,1,,CHEMBL623030,,
10103,Intermediate,,,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL623031,,
10104,Intermediate,,,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL623032,,
10105,Intermediate,,,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL623033,,
10106,Intermediate,,,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,50597,Rattus norvegicus,6518,BAO_0000218,,1,1,,CHEMBL623034,,
10107,Intermediate,,,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,50597,Rattus norvegicus,2083,BAO_0000218,,1,1,,CHEMBL623035,,
10108,Intermediate,,,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,50597,Rattus norvegicus,17260,BAO_0000218,,1,1,,CHEMBL623036,,
10109,Intermediate,,,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),50597,Rattus norvegicus,4956,BAO_0000218,,1,1,,CHEMBL623037,,
10110,Intermediate,,,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,50597,Rattus norvegicus,4368,BAO_0000218,,1,1,,CHEMBL623038,,
10111,Intermediate,,Plasma,1969.0,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,50597,Rattus norvegicus,17752,BAO_0000218,,1,1,,CHEMBL874385,,
10112,Intermediate,,,,Bioavailability in rat (Fisher) (fasted),50597,Rattus norvegicus,1446,BAO_0000218,,1,1,,CHEMBL623039,,
10113,Intermediate,,,,Bioavailability in monkey after po administration of 10 mg/kg dose,22224,Primates,2891,BAO_0000218,,0,1,,CHEMBL623040,,
10114,Intermediate,,,,Oral bioavailability in monkey (dose 10 mg/kg),22224,Primates,2891,BAO_0000218,,0,1,,CHEMBL623041,,
10115,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,6672,BAO_0000218,,1,1,,CHEMBL623741,,
10116,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,6673,BAO_0000218,,1,1,,CHEMBL623742,,
10117,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,17655,BAO_0000218,,1,1,,CHEMBL623743,,
10118,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,17796,BAO_0000218,,1,1,,CHEMBL623744,,
10119,Intermediate,,,,Bioavailability in rat (dose 2.0 mg/kg p.o.),50597,Rattus norvegicus,17853,BAO_0000218,,1,1,,CHEMBL623745,,
10120,Intermediate,,,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),50597,Rattus norvegicus,4521,BAO_0000218,,1,1,,CHEMBL623746,,
10121,Intermediate,,,,Oral bioavailability in rat (dose 5 mg/kg p.o.),50597,Rattus norvegicus,4940,BAO_0000218,,1,1,,CHEMBL623747,,
10122,Intermediate,,,,Bioavailability in rat after po administration of 30 mg/kg dose,22224,Rattus norvegicus,2891,BAO_0000218,,0,1,,CHEMBL623748,,
10123,Intermediate,,,,Bioavailability in rat after po administration of 30 mg/kg dose,22224,Rattus norvegicus,2891,BAO_0000218,,0,1,,CHEMBL623916,,
10124,Intermediate,,,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,50597,Rattus norvegicus,4521,BAO_0000218,,1,1,,CHEMBL623917,,
10125,Intermediate,,,,Bioavailability in rat (dose 2 mg/kg i.v.),50597,Rattus norvegicus,17686,BAO_0000218,,1,1,,CHEMBL623918,,
10126,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,17796,BAO_0000218,,1,1,,CHEMBL874386,,
10127,Intermediate,,Plasma,1969.0,Bioavailability in rat; Only traces detected in rat plasma,50597,Rattus norvegicus,17796,BAO_0000218,,1,1,,CHEMBL623919,,
10128,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,5064,BAO_0000218,,1,1,,CHEMBL623920,,
10129,Intermediate,,,,Bioavailability upon oral administration of compound,50597,Rattus norvegicus,5147,BAO_0000218,,1,1,,CHEMBL623148,,
10130,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),50597,Rattus norvegicus,1916,BAO_0000218,,1,1,,CHEMBL623149,,
10131,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,6049,BAO_0000218,,1,1,,CHEMBL623150,,
10132,Intermediate,,,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",50597,Rattus norvegicus,1445,BAO_0000218,,1,1,,CHEMBL623151,,
10133,Intermediate,,,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",50597,Rattus norvegicus,1445,BAO_0000218,,1,1,,CHEMBL623152,,
10134,Expert,,,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,50597,Rattus norvegicus,2862,BAO_0000218,,1,1,,CHEMBL623153,,
10135,Expert,,,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,50597,Rattus norvegicus,2862,BAO_0000218,,1,1,,CHEMBL623154,,
10136,Intermediate,,,,In vitro and metabolic stability was determined,50597,Rattus norvegicus,4194,BAO_0000218,,1,1,,CHEMBL623155,,
10137,Intermediate,,,,In vitro metabolic stability in rat hepatocytes,50597,Rattus norvegicus,4194,BAO_0000218,,1,1,,CHEMBL623156,,
10138,Intermediate,,,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,50597,Rattus norvegicus,5486,BAO_0000218,,1,1,,CHEMBL623157,,
10139,Intermediate,,Liver,2107.0,Metabolic rate for compound was observed in rat hepatocytes,50597,Rattus norvegicus,17582,BAO_0000218,,1,1,,CHEMBL623158,401.0,
10140,Intermediate,,,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,50597,Rattus norvegicus,5600,BAO_0000218,,1,1,,CHEMBL623159,,
10141,Intermediate,,,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),50597,Rattus norvegicus,14294,BAO_0000218,,1,1,,CHEMBL874390,,
10142,Intermediate,,,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),50597,Rattus norvegicus,14294,BAO_0000218,,1,1,,CHEMBL623160,,
10143,Intermediate,,,,Metabolism of compound in rat S9 microsomes; Trace,50597,Rattus norvegicus,14294,BAO_0000218,,1,1,,CHEMBL623161,,
10144,Intermediate,,,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,50597,Rattus norvegicus,17847,BAO_0000218,,1,1,,CHEMBL623162,,
10145,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623163,,
10146,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623164,,
10147,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623165,,
10148,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623166,,
10149,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL624983,,
10150,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL624984,,
10151,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL624985,,
10152,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL622970,,
10153,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL622971,,
10154,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL622972,,
10155,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL622973,,
10156,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL622974,,
10157,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL622975,,
10158,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL622976,,
10159,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL622977,,
10160,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL624351,,
10161,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL624352,,
10162,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL624353,,
10163,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL622397,,
10164,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL622398,,
10165,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL622399,,
10166,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL622400,,
10167,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL628428,,
10168,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL628590,,
10169,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL628591,,
10170,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL628592,,
10171,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL628593,,
10172,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL875333,,
10173,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL628594,,
10174,Intermediate,,Plasma,1969.0,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,50597,Rattus norvegicus,4969,BAO_0000218,,1,1,,CHEMBL628595,,
10175,Intermediate,,Plasma,1969.0,Stability in rat plasma was determined,50597,Rattus norvegicus,6737,BAO_0000218,,1,1,,CHEMBL628596,,
10176,Intermediate,,Plasma,1969.0,Stability in rat plasma was determined; ND= no data,50597,Rattus norvegicus,6737,BAO_0000218,,1,1,,CHEMBL628597,,
10177,Intermediate,,Plasma,1969.0,Tested for plasma half life period in rat (0-8 hr),50597,Rattus norvegicus,5089,BAO_0000218,,1,1,,CHEMBL628598,,
10178,Intermediate,,Plasma,1969.0,Tested for plasma half life period in rat (0-8 hr); Not determined,50597,Rattus norvegicus,5089,BAO_0000218,,1,1,,CHEMBL628599,,
10179,Intermediate,,,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,50597,Rattus norvegicus,1466,BAO_0000218,,1,1,,CHEMBL628600,,
10180,Intermediate,,,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,50597,Rattus norvegicus,1466,BAO_0000218,,1,1,,CHEMBL628601,,
10181,Intermediate,,,,Tested for the half life in rat,50597,Rattus norvegicus,4950,BAO_0000218,,1,1,,CHEMBL628602,,
10182,Intermediate,,,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,50597,Rattus norvegicus,2412,BAO_0000218,,1,1,,CHEMBL628603,,
10183,Intermediate,,,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,50597,Rattus norvegicus,2412,BAO_0000218,,1,1,,CHEMBL628604,,
10184,Intermediate,,,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,50597,Rattus norvegicus,2412,BAO_0000218,,1,1,,CHEMBL628605,,
10185,Intermediate,,,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,50597,Rattus norvegicus,2412,BAO_0000218,,1,1,,CHEMBL628606,,
10186,Intermediate,,,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,50597,Rattus norvegicus,2412,BAO_0000218,,1,1,,CHEMBL628607,,
10187,Intermediate,,,,The biological half life the compound was measured at the dose of 100 umol/kg,50597,Rattus norvegicus,15022,BAO_0000218,,1,1,,CHEMBL628608,,
10188,Intermediate,,,,The biological half life the compound was measured at the dose of 30 umol/kg,50597,Rattus norvegicus,15022,BAO_0000218,,1,1,,CHEMBL628609,,
10189,Intermediate,,Plasma,1969.0,The compound was evaluated for plasma half life period in rat,50597,Rattus norvegicus,406,BAO_0000218,,1,1,,CHEMBL628610,,
10190,Intermediate,,,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL873819,,
10191,Intermediate,,,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL628611,,
10192,Intermediate,,,,The pharmacokinetic parameter half-life period in vivo in rats,50597,Rattus norvegicus,5247,BAO_0000218,,1,1,,CHEMBL628612,,
10193,Intermediate,,,,"The pharmacokinetic property, Half-life was determined",50597,Rattus norvegicus,5041,BAO_0000218,,1,1,,CHEMBL628613,,
10194,Intermediate,,,,"The pharmacokinetic property, Half-life in rat in vivo",50597,Rattus norvegicus,5041,BAO_0000218,,1,1,,CHEMBL628614,,
10195,Intermediate,,,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",50597,Rattus norvegicus,5041,BAO_0000218,,1,1,,CHEMBL628615,,
10196,Intermediate,,,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",50597,Rattus norvegicus,5041,BAO_0000218,,1,1,,CHEMBL628616,,
10197,Intermediate,,Plasma,1969.0,The plasma half life period in rats,50597,Rattus norvegicus,3918,BAO_0000218,,1,1,,CHEMBL627924,,
10198,Intermediate,,Liver,2107.0,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,50597,Rattus norvegicus,2906,BAO_0000218,,1,1,,CHEMBL627925,,
10199,Intermediate,,,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,50597,Rattus norvegicus,6467,BAO_0000218,,1,1,,CHEMBL627926,,
10200,Intermediate,,,,t1/2 (apparent elimination)of the compound was determined,50597,Rattus norvegicus,5510,BAO_0000218,,1,1,,CHEMBL627927,,
10201,Intermediate,,,,t1/2 value in rat,50597,Rattus norvegicus,3788,BAO_0000218,,1,1,,CHEMBL627928,,
10202,Intermediate,,,,Half life in rat,50597,Rattus norvegicus,17796,BAO_0000218,,1,1,,CHEMBL627539,,
10203,Intermediate,,Plasma,1969.0,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",50597,Rattus norvegicus,12873,BAO_0000218,,1,1,,CHEMBL876790,,
10204,Intermediate,,,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,50597,Rattus norvegicus,5983,BAO_0000218,,1,1,,CHEMBL858186,,
10205,Intermediate,,,,Half-life period in fasted rats,50597,Rattus norvegicus,15765,BAO_0000218,,1,1,,CHEMBL627540,,
10206,Intermediate,,,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL627541,,
10207,Intermediate,,,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL627715,,
10208,Intermediate,,,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,50597,Rattus norvegicus,429,BAO_0000218,,1,1,,CHEMBL627716,,
10209,Intermediate,,,,Maximum time required to achieve Cmax was determined in rat,50597,Rattus norvegicus,17655,BAO_0000218,,1,1,,CHEMBL627717,,
10210,Intermediate,,,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL627718,,
10211,Intermediate,,,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL627719,,
10212,Intermediate,,,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL627720,,
10213,Intermediate,,,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,50597,Rattus norvegicus,6570,BAO_0000218,,1,1,,CHEMBL627721,,
10214,Intermediate,,,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,50597,Rattus norvegicus,6570,BAO_0000218,,1,1,,CHEMBL627722,,
10215,Intermediate,,,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL627723,,
10216,Intermediate,,,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL626058,,
10217,Intermediate,,,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL626059,,
10218,Intermediate,,,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL626060,,
10219,Intermediate,,Plasma,1969.0,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,50597,Rattus norvegicus,17720,BAO_0000218,,1,1,,CHEMBL626061,,
10220,Intermediate,,,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,50597,Rattus norvegicus,4723,BAO_0000218,,1,1,,CHEMBL876791,,
10221,Intermediate,,,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,50597,Rattus norvegicus,4723,BAO_0000218,,1,1,,CHEMBL626062,,
10222,Intermediate,,,,Tmax at the dose of 2 mg/Kg administered perorally in rats,50597,Rattus norvegicus,4756,BAO_0000218,,1,1,,CHEMBL626063,,
10223,Intermediate,,,,Tmax at the dose of 5 mg/Kg administered perorally in rats,50597,Rattus norvegicus,4756,BAO_0000218,,1,1,,CHEMBL626064,,
10224,Intermediate,,Plasma,1969.0,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,50597,Rattus norvegicus,17720,BAO_0000218,,1,1,,CHEMBL626065,,
10225,Intermediate,,Plasma,1969.0,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,50597,Rattus norvegicus,17720,BAO_0000218,,1,1,,CHEMBL626066,,
10226,Intermediate,,,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,50597,Rattus norvegicus,1466,BAO_0000218,,1,1,,CHEMBL626067,,
10227,Intermediate,,,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,50597,Rattus norvegicus,7449,BAO_0000218,,1,1,,CHEMBL626068,,
10228,Intermediate,,,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,50597,Rattus norvegicus,7449,BAO_0000218,,1,1,,CHEMBL626069,,
10229,Intermediate,,,,Percent total excretion of 3-methoxyacetaminophen glucuronide,50597,Rattus norvegicus,7449,BAO_0000218,,1,1,,CHEMBL626070,,
10230,Intermediate,,,,Percent total excretion of N-methoxyacetaminophen glucuronide,50597,Rattus norvegicus,7449,BAO_0000218,,1,1,,CHEMBL626071,,
10231,Intermediate,,,,Percent total excretion of N-methoxyacetaminophen sulfate,50597,Rattus norvegicus,7449,BAO_0000218,,1,1,,CHEMBL626072,,
10232,Intermediate,,,,Percent total excretion of acetaminophen,50597,Rattus norvegicus,7449,BAO_0000218,,1,1,,CHEMBL626073,,
10233,Intermediate,,Thyroid gland,2046.0,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",50597,Rattus norvegicus,7768,BAO_0000218,,1,1,,CHEMBL626741,,
10234,Intermediate,,,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",50597,Rattus norvegicus,17655,BAO_0000218,,1,1,,CHEMBL626742,,
10235,Intermediate,,,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,50597,Rattus norvegicus,17735,BAO_0000218,,1,1,,CHEMBL626743,,
10236,Intermediate,,,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,50597,Rattus norvegicus,5960,BAO_0000218,,1,1,,CHEMBL876792,,
10237,Intermediate,,,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,50597,Rattus norvegicus,17735,BAO_0000218,,1,1,,CHEMBL626744,,
10238,Intermediate,,,,Compound was tested for antidiuretic activity in rats,50597,Rattus norvegicus,7116,BAO_0000218,,1,1,,CHEMBL626745,,
10239,Intermediate,,Plasma,1969.0,AUC in rat after 3mg/kg oral dose,50597,Rattus norvegicus,4878,BAO_0000218,,1,1,,CHEMBL626746,,
10240,Intermediate,,,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,50597,Rattus norvegicus,5939,BAO_0000218,,1,1,,CHEMBL626747,,
10241,Intermediate,,,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,50597,Rattus norvegicus,5939,BAO_0000218,,1,1,,CHEMBL626748,,
10242,Intermediate,,,,Bioavailability administered orally at a dose of 10 mg/kg to rats,50597,Rattus norvegicus,16367,BAO_0000218,,1,1,,CHEMBL626749,,
10243,Intermediate,,,,Oral Bioavailability was determined,50597,Rattus norvegicus,16366,BAO_0000218,,1,1,,CHEMBL626750,,
10244,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,4426,BAO_0000218,,1,1,,CHEMBL626751,,
10245,Intermediate,,,,Oral bioavailability in rat; Not performed.,50597,Rattus norvegicus,4426,BAO_0000218,,1,1,,CHEMBL626913,,
10246,Intermediate,,,,Bioavailability,50597,Rattus norvegicus,5041,BAO_0000218,,1,1,,CHEMBL626914,,
10247,Intermediate,,,,Bioavailability was determined; ND denotes no data,50597,Rattus norvegicus,5041,BAO_0000218,,1,1,,CHEMBL626915,,
10248,Intermediate,,,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,50597,Rattus norvegicus,1500,BAO_0000218,,1,1,,CHEMBL626916,,
10249,Intermediate,,,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,50597,Rattus norvegicus,1500,BAO_0000218,,1,1,,CHEMBL626917,,
10250,Intermediate,,,,Binding towards rat plasma protein at 10 uM,50597,Rattus norvegicus,17409,BAO_0000218,,1,1,,CHEMBL626918,,
10251,Intermediate,,,,Binding towards rat plasma protein at 100 uM,50597,Rattus norvegicus,17409,BAO_0000218,,1,1,,CHEMBL626919,,
10252,Intermediate,,,,Bioavailability in rat (dose 20 mg/kg p.o.),50597,Rattus norvegicus,2959,BAO_0000218,,1,1,,CHEMBL626920,,
10253,Intermediate,,,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,50597,Rattus norvegicus,13501,BAO_0000218,,1,1,,CHEMBL621976,,
10254,Intermediate,,,,Bioavailability in rat after 5 mg/kg oral gavage,50597,Rattus norvegicus,6567,BAO_0000218,,1,1,,CHEMBL877599,,
10255,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,6571,BAO_0000218,,1,1,,CHEMBL621977,,
10256,Intermediate,,,,Bioavailability in rat (dose 1 mg/kg i.v.),50597,Rattus norvegicus,6715,BAO_0000218,,1,1,,CHEMBL621978,,
10257,Intermediate,,,,Bioavailability in rat (dose 3 mg/kg p.o.),50597,Rattus norvegicus,6715,BAO_0000218,,1,1,,CHEMBL621979,,
10258,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,2932,BAO_0000218,,1,1,,CHEMBL621980,,
10259,Intermediate,,,,Bioavailability of the compound in rats after administration of 30 mg/kg,50597,Rattus norvegicus,4171,BAO_0000218,,1,1,,CHEMBL621981,,
10260,Intermediate,,,,Bioavailability after administration of 10 mg/kg in rats,50597,Rattus norvegicus,17509,BAO_0000218,,1,1,,CHEMBL621982,,
10261,Intermediate,,,,Bioavailability after administration of 2 mg/kg in rats,50597,Rattus norvegicus,17509,BAO_0000218,,1,1,,CHEMBL882953,,
10262,Intermediate,,,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,50597,Rattus norvegicus,4527,BAO_0000218,,1,1,,CHEMBL621983,,
10263,Intermediate,,,,Bioavailability in dogs was determined; high,50597,Rattus norvegicus,4026,BAO_0000218,,1,1,,CHEMBL621984,,
10264,Intermediate,,,,Bioavailability in monkey after intravenous administration at 1 mpk,50597,Rattus norvegicus,6659,BAO_0000218,,1,1,,CHEMBL621985,,
10265,Intermediate,,,,Bioavailability in monkey after peroral administration at 10 mpk,50597,Rattus norvegicus,6659,BAO_0000218,,1,1,,CHEMBL621986,,
10266,Intermediate,,,,Bioavailability in rat after intravenous administration at 1 mpk,50597,Rattus norvegicus,6659,BAO_0000218,,1,1,,CHEMBL621987,,
10267,Intermediate,,,,Bioavailability in rat after intravenous administration at 2 mpk,50597,Rattus norvegicus,6659,BAO_0000218,,1,1,,CHEMBL877600,,
10268,Intermediate,,,,Bioavailability in rat after peroral administration at 30 mpk,50597,Rattus norvegicus,6659,BAO_0000218,,1,1,,CHEMBL621988,,
10269,Intermediate,,,,Bioavailability in rat after peroral administration at at 100 mpk,50597,Rattus norvegicus,6659,BAO_0000218,,1,1,,CHEMBL621989,,
10270,Intermediate,,,,Bioavailability in rats was evaluated,50597,Rattus norvegicus,6597,BAO_0000218,,1,1,,CHEMBL621990,,
10271,Intermediate,,,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,50597,Rattus norvegicus,1202,BAO_0000218,,1,1,,CHEMBL621991,,
10272,Intermediate,,,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,50597,Rattus norvegicus,1202,BAO_0000218,,1,1,,CHEMBL621992,,
10273,Intermediate,,,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,50597,Rattus norvegicus,1202,BAO_0000218,,1,1,,CHEMBL621993,,
10274,Intermediate,,,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,50597,Rattus norvegicus,1202,BAO_0000218,,1,1,,CHEMBL621994,,
10275,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,5207,BAO_0000218,,1,1,,CHEMBL621995,,
10276,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,5970,BAO_0000218,,1,1,,CHEMBL621996,,
10277,Intermediate,,,,Oral bioavailability in rat (dose 10 mg/kg),50597,Rattus norvegicus,17538,BAO_0000218,,1,1,,CHEMBL621997,,
10278,Intermediate,,,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,50597,Rattus norvegicus,17538,BAO_0000218,,1,1,,CHEMBL621998,,
10279,Intermediate,,,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,50597,Rattus norvegicus,1466,BAO_0000218,,1,1,,CHEMBL621999,,
10280,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,2879,BAO_0000218,,1,1,,CHEMBL622000,,
10281,Intermediate,,,,Bioavailability was measured in rat after oral administration; 2-4,50597,Rattus norvegicus,2879,BAO_0000218,,1,1,,CHEMBL622001,,
10282,Intermediate,,,,Bioavailability was measured in rat after oral administration; 3-7,50597,Rattus norvegicus,2879,BAO_0000218,,1,1,,CHEMBL622002,,
10283,Intermediate,,,,Bioavailability in rat (intraduodenal administration),50597,Rattus norvegicus,3777,BAO_0000218,,1,1,,CHEMBL622003,,
10284,Intermediate,,,,Bioavailability in rat (intraduodenal administration),50597,Rattus norvegicus,3777,BAO_0000218,,1,1,,CHEMBL877601,,
10285,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,3777,BAO_0000218,,1,1,,CHEMBL624871,,
10286,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,3777,BAO_0000218,,1,1,,CHEMBL622004,,
10287,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),50597,Rattus norvegicus,5423,BAO_0000218,,1,1,,CHEMBL882954,,
10288,Intermediate,,,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL622005,,
10289,Intermediate,,,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,50597,Rattus norvegicus,16365,BAO_0000218,,1,1,,CHEMBL622006,,
10290,Intermediate,,,,Bioavailability was measured in rat,50597,Rattus norvegicus,4239,BAO_0000218,,1,1,,CHEMBL622007,,
10291,Intermediate,,,,Bioavailability was reported,50597,Rattus norvegicus,5438,BAO_0000218,,1,1,,CHEMBL622008,,
10292,Intermediate,,,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL622009,,
10293,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL622010,,
10294,Intermediate,,,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,50597,Rattus norvegicus,4199,BAO_0000218,,1,1,,CHEMBL622011,,
10295,Intermediate,,,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),50597,Rattus norvegicus,4199,BAO_0000218,,1,1,,CHEMBL622012,,
10296,Intermediate,,,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),50597,Rattus norvegicus,4199,BAO_0000218,,1,1,,CHEMBL622013,,
10297,Intermediate,,,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,50597,Rattus norvegicus,4890,BAO_0000218,,1,1,,CHEMBL622014,,
10298,Intermediate,,,,Bioavailability was determined at 3 mg/kg po dose in rats,50597,Rattus norvegicus,2792,BAO_0000218,,1,1,,CHEMBL624749,,
10299,Intermediate,,,,Oral bioavailability in rat (dose 2 mg/kg),50597,Rattus norvegicus,5529,BAO_0000218,,1,1,,CHEMBL624750,,
10300,Intermediate,,,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL624751,,
10301,Intermediate,,,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL624752,,
10302,Intermediate,,,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",50597,Rattus norvegicus,6685,BAO_0000218,,1,1,,CHEMBL624753,,
10303,Intermediate,,,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,50597,Rattus norvegicus,6005,BAO_0000218,,1,1,,CHEMBL624754,,
10304,Intermediate,,,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,50597,Rattus norvegicus,6410,BAO_0000218,,1,1,,CHEMBL624755,,
10305,Intermediate,,,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,50597,Rattus norvegicus,6410,BAO_0000218,,1,1,,CHEMBL624756,,
10306,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,6103,BAO_0000218,,1,1,,CHEMBL624757,,
10307,Intermediate,,,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,50597,Rattus norvegicus,6410,BAO_0000218,,1,1,,CHEMBL624758,,
10308,Intermediate,,,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,50597,Rattus norvegicus,6410,BAO_0000218,,1,1,,CHEMBL622270,,
10309,Intermediate,,,,Bioavailability in rat (Sprague-Dawley),50597,Rattus norvegicus,5353,BAO_0000218,,1,1,,CHEMBL622271,,
10310,Intermediate,,,,Bioavailability in rat at the dose of 2 mg/kg,50597,Rattus norvegicus,4727,BAO_0000218,,1,1,,CHEMBL622272,,
10311,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,17804,BAO_0000218,,1,1,,CHEMBL622273,,
10312,Intermediate,,,,Bioavailability in rat (cannulated) (dose 2 mg/kg),50597,Rattus norvegicus,5809,BAO_0000218,,1,1,,CHEMBL622274,,
10313,Intermediate,,,,Bioavailability value of compound in rats was determined after peroral administration,50597,Rattus norvegicus,17804,BAO_0000218,,1,1,,CHEMBL622275,,
10314,Intermediate,,,,Oral bioavailability in rat (dose 20 mg/kg),50597,Rattus norvegicus,3634,BAO_0000218,,1,1,,CHEMBL622276,,
10315,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,3341,BAO_0000218,,1,1,,CHEMBL622277,,
10316,Intermediate,,,,Oral bioavailability in rat (dose 5 mg/kg),50597,Rattus norvegicus,2690,BAO_0000218,,1,1,,CHEMBL622278,,
10317,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,3184,BAO_0000218,,1,1,,CHEMBL622279,,
10318,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,740,BAO_0000218,,1,1,,CHEMBL622280,,
10319,Intermediate,,,,Compound was evaluated for oral bioavailability in rats; 15-27 %,50597,Rattus norvegicus,1806,BAO_0000218,,1,1,,CHEMBL624083,,
10320,Intermediate,,,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,50597,Rattus norvegicus,4891,BAO_0000218,,1,1,,CHEMBL624084,,
10321,Intermediate,,,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),50597,Rattus norvegicus,3634,BAO_0000218,,1,1,,CHEMBL624085,,
10322,Intermediate,,,,Compound was tested for bioavailability in rats,50597,Rattus norvegicus,64,BAO_0000218,,1,1,,CHEMBL624086,,
10323,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,4839,BAO_0000218,,1,1,,CHEMBL624087,,
10324,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,1094,BAO_0000218,,1,1,,CHEMBL624088,,
10325,Intermediate,,,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,22224,Macaca mulatta,5005,BAO_0000218,,0,1,,CHEMBL624089,,
10326,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),22224,Rattus norvegicus,5005,BAO_0000218,,0,1,,CHEMBL624090,,
10327,Intermediate,,,,Evaluated for the bioavailability in rat (in vivo),50597,Rattus norvegicus,4687,BAO_0000218,,1,1,,CHEMBL624091,,
10328,Intermediate,,,,F value of compound in rats was determined after peroral administration,50597,Rattus norvegicus,17804,BAO_0000218,,1,1,,CHEMBL624092,,
10329,Intermediate,,,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL624093,,
10330,Intermediate,,,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL624094,,
10331,Intermediate,,,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL624095,,
10332,Intermediate,,,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,50597,Rattus norvegicus,5974,BAO_0000218,,1,1,,CHEMBL624096,,
10333,Intermediate,,,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",50597,Rattus norvegicus,1088,BAO_0000218,,1,1,,CHEMBL624097,,
10334,Intermediate,,,,Maximum fall in carotid flow in rat,50597,Rattus norvegicus,1742,BAO_0000218,,1,1,,CHEMBL624098,,
10335,Intermediate,,,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,50597,Rattus norvegicus,4689,BAO_0000218,,1,1,,CHEMBL874392,,
10336,Intermediate,,,,Oral bioavailability in rat (dose 5 mg/kg),50597,Rattus norvegicus,2463,BAO_0000218,,1,1,,CHEMBL624099,,
10337,Intermediate,,,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,50597,Rattus norvegicus,5654,BAO_0000218,,1,1,,CHEMBL624100,,
10338,Intermediate,,,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,50597,Rattus norvegicus,5654,BAO_0000218,,1,1,,CHEMBL624101,,
10339,Intermediate,,,,Oral bioavailability in rat (male Wistar),50597,Rattus norvegicus,6874,BAO_0000218,,1,1,,CHEMBL624102,,
10340,Intermediate,,,,Oral bioavailability after administration (30 mg/kg) in rat; good,50597,Rattus norvegicus,5633,BAO_0000218,,1,1,,CHEMBL624103,,
10341,Intermediate,,,,Oral bioavailability at the dose of 2 mg/kg in rat,50597,Rattus norvegicus,5496,BAO_0000218,,1,1,,CHEMBL624104,,
10342,Intermediate,,,,Oral bioavailability determined in rats,50597,Rattus norvegicus,2358,BAO_0000218,,1,1,,CHEMBL624105,,
10343,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),50597,Rattus norvegicus,16456,BAO_0000218,,1,1,,CHEMBL624106,,
10344,Intermediate,,,,Oral bioavailability in rat (dose single 10 mg/kg),50597,Rattus norvegicus,5302,BAO_0000218,,1,1,,CHEMBL624107,,
10345,Intermediate,,,,Oral bioavailability in rat (dose single 10 mg/kg),50597,Rattus norvegicus,5302,BAO_0000218,,1,1,,CHEMBL623943,,
10346,Intermediate,,,,Oral bioavailability in rat (dose 5 mg/kg,50597,Rattus norvegicus,5302,BAO_0000218,,1,1,,CHEMBL623944,,
10347,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623945,,
10348,Intermediate,,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623946,,
10349,Intermediate,,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623947,,
10350,Intermediate,,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623948,,
10351,Intermediate,,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623949,,
10352,Intermediate,,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623950,,
10353,Intermediate,,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL874398,,
10354,Intermediate,,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623951,,
10355,Intermediate,,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623952,,
10356,Intermediate,,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623953,,
10357,Intermediate,,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623954,,
10358,Intermediate,,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623955,,
10359,Intermediate,,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL623956,,
10360,Intermediate,,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL627807,,
10361,Intermediate,,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL627808,,
10362,Intermediate,,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL627809,,
10363,Intermediate,,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL627810,,
10364,Intermediate,,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL627811,,
10365,Intermediate,,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL627812,,
10366,Intermediate,,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL627813,,
10367,Intermediate,,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL627814,,
10368,Intermediate,,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL875336,,
10369,Intermediate,,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL627815,,
10370,Intermediate,,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL627816,,
10371,Intermediate,,,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL627817,,
10372,Intermediate,,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL627818,,
10373,Intermediate,,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL627819,,
10374,Intermediate,,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL627820,,
10375,Intermediate,,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL627821,,
10376,Intermediate,,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL628464,,
10377,Intermediate,,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL626239,,
10378,Intermediate,,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL626240,,
10379,Intermediate,,,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL626241,,
10380,Intermediate,,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL626242,,
10381,Intermediate,,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL626243,,
10382,Intermediate,,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL626244,,
10383,Intermediate,,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL626907,,
10384,Intermediate,,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL626908,,
10385,Intermediate,,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL626909,,
10386,Intermediate,,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL626910,,
10387,Intermediate,,,,Percent total excretion of acetaminophen cysteine conjugate,50597,Rattus norvegicus,7449,BAO_0000218,,1,1,,CHEMBL875342,,
10388,Intermediate,,,,Percent total excretion of acetaminophen glucuronide,50597,Rattus norvegicus,7449,BAO_0000218,,1,1,,CHEMBL626911,,
10389,Intermediate,,,,Percent total excretion of acetaminophen sulfate,50597,Rattus norvegicus,7449,BAO_0000218,,1,1,,CHEMBL626912,,
10390,Intermediate,,,,Percent total excretion of acetaminophen-mercapturic acid,50597,Rattus norvegicus,7449,BAO_0000218,,1,1,,CHEMBL627065,,
10391,Intermediate,,Urine,1088.0,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,50597,Rattus norvegicus,3172,BAO_0000218,,1,1,,CHEMBL627066,,
10392,Intermediate,,,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,50597,Rattus norvegicus,16456,BAO_0000218,,1,1,,CHEMBL627067,,
10393,Autocuration,,Muscle tissue,2385.0,Biodistribution of compound in rat muscle after 5 min of administration,22224,ratrat,10839,BAO_0000218,,0,1,,CHEMBL627068,,
10394,Autocuration,,Muscle tissue,2385.0,Biodistribution of compound in rat muscle after 5 min of administration.,22224,ratrat,10839,BAO_0000218,,0,1,,CHEMBL627069,,
10395,Autocuration,,,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),22224,Ovis aries,5334,BAO_0000218,,0,1,,CHEMBL627070,,
10396,Autocuration,,,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),22224,Ovis aries,5334,BAO_0000218,,0,1,,CHEMBL627071,,
10397,Autocuration,,,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),22224,Ovis aries,5334,BAO_0000218,,0,1,,CHEMBL627072,,
10398,Autocuration,,,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),22224,Ovis aries,5334,BAO_0000218,,0,1,,CHEMBL627073,,
10399,Autocuration,,,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),22224,Ovis aries,5334,BAO_0000218,,0,1,,CHEMBL625387,,
10400,Autocuration,,,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),22224,Ovis aries,5334,BAO_0000218,,0,1,,CHEMBL625388,,
10401,Autocuration,,Plasma,1969.0,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),22224,Ovis aries,5334,BAO_0000218,,0,1,,CHEMBL625389,,
10402,Autocuration,,Plasma,1969.0,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),22224,Ovis aries,5334,BAO_0000218,,0,1,,CHEMBL875343,,
10403,Intermediate,,,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),50497,Serpentes,1735,BAO_0000218,,1,1,,CHEMBL876795,,
10404,Intermediate,,,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,50497,Serpentes,1469,BAO_0000218,,1,1,,CHEMBL626552,,
10405,Intermediate,,,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,50497,Serpentes,1336,BAO_0000218,,1,1,,CHEMBL626553,,
10406,Autocuration,,Plasma,1969.0,The human biological plasma half life of the compound,22224,Homo sapiens,12403,BAO_0000366,,0,1,,CHEMBL626554,,
10407,Intermediate,,Urine,1088.0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,50597,Rattus norvegicus,8151,BAO_0000218,,1,1,,CHEMBL626555,,
10408,Intermediate,,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,50597,Rattus norvegicus,8004,BAO_0000218,,1,1,,CHEMBL626556,,
10409,Intermediate,,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,50597,Rattus norvegicus,8004,BAO_0000218,,1,1,,CHEMBL626557,,
10410,Intermediate,,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,50597,Rattus norvegicus,8004,BAO_0000218,,1,1,,CHEMBL626558,,
10411,Intermediate,,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,50597,Rattus norvegicus,8004,BAO_0000218,,1,1,,CHEMBL626559,,
10412,Intermediate,,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,50597,Rattus norvegicus,8004,BAO_0000218,,1,1,,CHEMBL626560,,
10413,Intermediate,,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,50597,Rattus norvegicus,8004,BAO_0000218,,1,1,,CHEMBL876803,,
10414,Intermediate,,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,50597,Rattus norvegicus,8004,BAO_0000218,,1,1,,CHEMBL627964,,
10415,Intermediate,,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,50597,Rattus norvegicus,8004,BAO_0000218,,1,1,,CHEMBL627965,,
10416,Intermediate,,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,50597,Rattus norvegicus,8004,BAO_0000218,,1,1,,CHEMBL627966,,
10417,Intermediate,,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,50597,Rattus norvegicus,8004,BAO_0000218,,1,1,,CHEMBL627967,,
10418,Intermediate,,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,50597,Rattus norvegicus,8004,BAO_0000218,,1,1,,CHEMBL627968,,
10419,Intermediate,,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,50597,Rattus norvegicus,8004,BAO_0000218,,1,1,,CHEMBL627969,,
10420,Intermediate,,,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,50597,Rattus norvegicus,8004,BAO_0000218,,1,1,,CHEMBL627970,,
10421,Intermediate,,Blood,178.0,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,50597,Rattus norvegicus,8004,BAO_0000218,,1,1,,CHEMBL627971,,
10422,Intermediate,,Blood,178.0,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,50597,Rattus norvegicus,8004,BAO_0000218,,1,1,,CHEMBL627972,,
10423,Expert,,,,Dissociation constant against binding to human cyclophilin A,180,Homo sapiens,15917,BAO_0000357,,9,1,,CHEMBL856029,,
10424,Expert,,,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,11591,Bos taurus,12396,BAO_0000019,,8,1,,CHEMBL627973,,
10425,Autocuration,,,,-Log C was determined by performing the electroshock minimum test,22224,,7065,BAO_0000019,,0,1,,CHEMBL627974,,
10426,Autocuration,,,,-Log C was determined by performing the foot shock test,22224,,7065,BAO_0000019,,0,1,,CHEMBL627975,,
10427,Autocuration,,,,-Log C was determined by performing the incl screen test,22224,,7065,BAO_0000019,,0,1,,CHEMBL627976,,
10428,Autocuration,,,,-Log C was determined by performing the maximum electroshock test,22224,,7065,BAO_0000019,,0,1,,CHEMBL627977,,
10429,Autocuration,,,,-Log C was determined by performing the pentylenetetrazole test,22224,,7065,BAO_0000019,,0,1,,CHEMBL627978,,
10430,Autocuration,,,,Tested for experimental arotinoid inhibitory dose,22224,,12415,BAO_0000019,,0,1,,CHEMBL627979,,
10431,Autocuration,,,,Negative log transformed activity,22224,,10256,BAO_0000019,,0,1,,CHEMBL876804,,
10432,Autocuration,,,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",22224,,7991,BAO_0000019,,0,1,,CHEMBL627980,,
10433,Intermediate,,,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,50512,Cavia porcellus,14342,BAO_0000218,,1,1,,CHEMBL627981,,
10434,Intermediate,,,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,50512,Cavia porcellus,14342,BAO_0000218,,1,1,,CHEMBL627982,,
10435,Intermediate,,,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,50512,Cavia porcellus,14342,BAO_0000218,,1,1,,CHEMBL627983,,
10436,Intermediate,,Ileum,2116.0,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,50512,Cavia porcellus,14342,BAO_0000218,,1,1,,CHEMBL627984,,
10437,Autocuration,,,,Solubility in water was determined; values expressed as -log,22229,,6047,BAO_0000100,,0,1,,CHEMBL627985,,
10438,Autocuration,,,,Ratio of Kcat to that of Km was determined,22224,,17269,BAO_0000019,,0,1,,CHEMBL627986,,
10439,Autocuration,,,,Observed first order rate constant,22224,,10026,BAO_0000019,,0,1,,CHEMBL627987,,
10440,Autocuration,,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,22224,,14583,BAO_0000019,,0,1,,CHEMBL627988,,
10441,Intermediate,,,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL627989,,
10442,Intermediate,,,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,50597,Rattus norvegicus,2661,BAO_0000218,,1,1,,CHEMBL627990,,
10443,Intermediate,,,,Oral Bioavailability after administration of 10 mg/kg in male rat,50597,Rattus norvegicus,4029,BAO_0000218,,1,1,,CHEMBL876805,,
10444,Intermediate,,,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),50597,Rattus norvegicus,17735,BAO_0000218,,1,1,,CHEMBL627991,,
10445,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,4576,BAO_0000218,,1,1,,CHEMBL627992,,
10446,Intermediate,,,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,50597,Rattus norvegicus,17582,BAO_0000218,,1,1,,CHEMBL627993,,
10447,Intermediate,,,,Oral bioavailability at 1 mg/kg was determined in rat,50597,Rattus norvegicus,17651,BAO_0000218,,1,1,,CHEMBL622817,,
10448,Intermediate,,,,Oral bioavailability at 10 mg/kg was determined in rat,50597,Rattus norvegicus,17651,BAO_0000218,,1,1,,CHEMBL622818,,
10449,Intermediate,,,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",50597,Rattus norvegicus,17670,BAO_0000218,,1,1,,CHEMBL622819,,
10450,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,5045,BAO_0000218,,1,1,,CHEMBL872267,,
10451,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,1696,BAO_0000218,,1,1,,CHEMBL622820,,
10452,Intermediate,,,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,50597,Rattus norvegicus,17764,BAO_0000218,,1,1,,CHEMBL622821,,
10453,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6448,BAO_0000218,,1,1,,CHEMBL622822,,
10454,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6596,BAO_0000218,,1,1,,CHEMBL622823,,
10455,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,17547,BAO_0000218,,1,1,,CHEMBL622824,,
10456,Intermediate,,,,Oral bioavailability in rat at a dose of 3 mg/kg,50597,Rattus norvegicus,17771,BAO_0000218,,1,1,,CHEMBL622825,,
10457,Intermediate,,,,Oral bioavailability in rat after oral administration at 10 mg/kg,50597,Rattus norvegicus,6495,BAO_0000218,,1,1,,CHEMBL622901,,
10458,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,4558,BAO_0000218,,1,1,,CHEMBL622902,,
10459,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,17596,BAO_0000218,,1,1,,CHEMBL621844,,
10460,Intermediate,,,,Oral bioavailability in Dawley rats,50597,Rattus norvegicus,6827,BAO_0000218,,1,1,,CHEMBL621845,,
10461,Intermediate,,,,Oral bioavailability,50597,Rattus norvegicus,4026,BAO_0000218,,1,1,,CHEMBL621846,,
10462,Intermediate,,,,Oral bioavailability in rat (dose 30 mg/kg),50597,Rattus norvegicus,10,BAO_0000218,,1,1,,CHEMBL621847,,
10463,Intermediate,,,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL877609,,
10464,Intermediate,,,,Bioavailability in rat (dose 3 mg/kg i.v.),50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL621848,,
10465,Intermediate,,,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL621849,,
10466,Intermediate,,,,Oral bioavailability in rat (dose 60 mg/kg p.o.),50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL622030,,
10467,Intermediate,,,,Percent oral bioavailability determined in rats,50597,Rattus norvegicus,4796,BAO_0000218,,1,1,,CHEMBL622031,,
10468,Intermediate,,,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,50597,Rattus norvegicus,4883,BAO_0000218,,1,1,,CHEMBL622032,,
10469,Intermediate,,,,The compound was evaluated for bioavailability in rats; 32-51,50597,Rattus norvegicus,2137,BAO_0000218,,1,1,,CHEMBL622033,,
10470,Intermediate,,,,Bioavailability in rat (dose 20 mg/kg p.o.),50597,Rattus norvegicus,2959,BAO_0000218,,1,1,,CHEMBL622034,,
10471,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,1361,BAO_0000218,,1,1,,CHEMBL622035,,
10472,Intermediate,,,,Bioavailability percent in rat at the dose of 2 mg/kg,50597,Rattus norvegicus,4727,BAO_0000218,,1,1,,CHEMBL882966,,
10473,Intermediate,,,,Bioavailability was evaluated after 20 uM/kg of peroral administration,50597,Rattus norvegicus,16423,BAO_0000218,,1,1,,CHEMBL622036,,
10474,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,5206,BAO_0000218,,1,1,,CHEMBL622037,,
10475,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6448,BAO_0000218,,1,1,,CHEMBL622038,,
10476,Intermediate,,,,Bioavailability in rats,50597,Rattus norvegicus,17723,BAO_0000218,,1,1,,CHEMBL622039,,
10477,Intermediate,,Blood,178.0,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622040,,
10478,Intermediate,,Blood,178.0,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622041,,
10479,Intermediate,,Blood,178.0,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622042,,
10480,Intermediate,,Blood,178.0,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622043,,
10481,Intermediate,,Blood,178.0,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622044,,
10482,Intermediate,,Bone,10000001.0,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622045,,
10483,Intermediate,,Bone,10000001.0,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622046,,
10484,Intermediate,,Bone,10000001.0,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622047,,
10485,Intermediate,,Bone,10000001.0,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL877610,,
10486,Intermediate,,Brain,955.0,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622048,,
10487,Intermediate,,Brain,955.0,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622049,,
10488,Intermediate,,Brain,955.0,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622050,,
10489,Intermediate,,Brain,955.0,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622051,,
10490,Intermediate,,,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622052,,
10491,Intermediate,,,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622053,,
10492,Intermediate,,,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622054,,
10493,Intermediate,,,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622055,,
10494,Intermediate,,,,Oral bioavailability in rats was determined; High,50597,Rattus norvegicus,5237,BAO_0000218,,1,1,,CHEMBL622056,,
10495,Intermediate,,,,Oral bioavailability in the rat was determined,50597,Rattus norvegicus,5503,BAO_0000218,,1,1,,CHEMBL622057,,
10496,Intermediate,,,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,50597,Rattus norvegicus,15765,BAO_0000218,,1,1,,CHEMBL628008,,
10497,Intermediate,,,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),50597,Rattus norvegicus,15660,BAO_0000218,,1,1,,CHEMBL622058,,
10498,Intermediate,,,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL622059,,
10499,Intermediate,,,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL622060,,
10500,Intermediate,,,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL622061,,
10501,Intermediate,,,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,50597,Rattus norvegicus,5978,BAO_0000218,,1,1,,CHEMBL622062,,
10502,Intermediate,,,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,50597,Rattus norvegicus,5656,BAO_0000218,,1,1,,CHEMBL622063,,
10503,Expert,,,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,50597,Rattus norvegicus,3598,BAO_0000218,,1,1,,CHEMBL877611,,
10504,Intermediate,,,,Oral bioavailability of compound in Sprague Dawley rats,50597,Rattus norvegicus,4216,BAO_0000218,,1,1,,CHEMBL622064,,
10505,Intermediate,,,,Oral bioavailability of compound in rat,50597,Rattus norvegicus,17839,BAO_0000218,,1,1,,CHEMBL622065,,
10506,Intermediate,,,,Oral bioavailability in rat (dose 2 mg/kg),50597,Rattus norvegicus,6570,BAO_0000218,,1,1,,CHEMBL622066,,
10507,Intermediate,,,,Oral bioavailability of compound in rat was determined,50597,Rattus norvegicus,5334,BAO_0000218,,1,1,,CHEMBL622067,,
10508,Intermediate,,,,Oral bioavailability of compound in rats,50597,Rattus norvegicus,6886,BAO_0000218,,1,1,,CHEMBL622068,,
10509,Intermediate,,,,Oral bioavailability of compound was determined in rats,50597,Rattus norvegicus,5210,BAO_0000218,,1,1,,CHEMBL622069,,
10510,Intermediate,,,,Oral bioavailability at a dose of 30 mg/kg in rats,50597,Rattus norvegicus,4170,BAO_0000218,,1,1,,CHEMBL624796,,
10511,Intermediate,,,,Oral bioavailability in rat (dose 10 mg/kg),50597,Rattus norvegicus,6028,BAO_0000218,,1,1,,CHEMBL624797,,
10512,Intermediate,,,,Oral bioavailability in rat (dose 10 mg/kg),50597,Rattus norvegicus,6028,BAO_0000218,,1,1,,CHEMBL623053,,
10513,Intermediate,,,,Oral bioavailability evaluated in rat,50597,Rattus norvegicus,6078,BAO_0000218,,1,1,,CHEMBL623054,,
10514,Intermediate,,,,Oral bioavailability in fasted rat,50597,Rattus norvegicus,6168,BAO_0000218,,1,1,,CHEMBL623055,,
10515,Intermediate,,,,Oral bioavailability in fed rat,50597,Rattus norvegicus,6168,BAO_0000218,,1,1,,CHEMBL623056,,
10516,Intermediate,,,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),50597,Rattus norvegicus,5160,BAO_0000218,,1,1,,CHEMBL623057,,
10517,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6057,BAO_0000218,,1,1,,CHEMBL623058,,
10518,Intermediate,,,,Oral bioavailability in rat (dose 10 mg/kg p.o.),50597,Rattus norvegicus,6535,BAO_0000218,,1,1,,CHEMBL623059,,
10519,Intermediate,,,,Oral bioavailability in rat after administration of 10 mg/kg po,50597,Rattus norvegicus,6535,BAO_0000218,,1,1,,CHEMBL623060,,
10520,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,4194,BAO_0000218,,1,1,,CHEMBL623061,,
10521,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6230,BAO_0000218,,1,1,,CHEMBL623062,,
10522,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6619,BAO_0000218,,1,1,,CHEMBL623063,,
10523,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,17607,BAO_0000218,,1,1,,CHEMBL623064,,
10524,Intermediate,,,,Oral bioavailability in ratrs,50597,Rattus norvegicus,4942,BAO_0000218,,1,1,,CHEMBL623065,,
10525,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,4942,BAO_0000218,,1,1,,CHEMBL623066,,
10526,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6646,BAO_0000218,,1,1,,CHEMBL623067,,
10527,Intermediate,,,,Oral bioavailability in rats was determined; High,50597,Rattus norvegicus,5237,BAO_0000218,,1,1,,CHEMBL623068,,
10528,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6646,BAO_0000218,,1,1,,CHEMBL623069,,
10529,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,4449,BAO_0000218,,1,1,,CHEMBL623070,,
10530,Intermediate,,,,Oral bioavailability was calculated in rat,50597,Rattus norvegicus,6057,BAO_0000218,,1,1,,CHEMBL623071,,
10531,Intermediate,,,,Oral bioavailability,50597,Rattus norvegicus,2552,BAO_0000218,,1,1,,CHEMBL623072,,
10532,Intermediate,,,,Oral bioavailability,50597,Rattus norvegicus,5496,BAO_0000218,,1,1,,CHEMBL623073,,
10533,Intermediate,,,,Oral bioavailability,50597,Rattus norvegicus,6484,BAO_0000218,,1,1,,CHEMBL623074,,
10534,Intermediate,,,,Oral bioavailability,50597,Rattus norvegicus,6485,BAO_0000218,,1,1,,CHEMBL623075,,
10535,Intermediate,,,,Oral bioavailability after i.v. administration,50597,Rattus norvegicus,6616,BAO_0000218,,1,1,,CHEMBL623076,,
10536,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),50597,Rattus norvegicus,4969,BAO_0000218,,1,1,,CHEMBL623077,,
10537,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley),50597,Rattus norvegicus,5862,BAO_0000218,,1,1,,CHEMBL623078,,
10538,Intermediate,,,,Oral bioavailability in Sprague-Dawley rats,50597,Rattus norvegicus,4514,BAO_0000218,,1,1,,CHEMBL623079,,
10539,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),50597,Rattus norvegicus,4514,BAO_0000218,,1,1,,CHEMBL623080,,
10540,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),50597,Rattus norvegicus,4514,BAO_0000218,,1,1,,CHEMBL623081,,
10541,Intermediate,,,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,50597,Rattus norvegicus,5546,BAO_0000218,,1,1,,CHEMBL623082,,
10542,Intermediate,,,,Oral bioavailability in fasted rat,50597,Rattus norvegicus,6168,BAO_0000218,,1,1,,CHEMBL874400,,
10543,Intermediate,,,,Oral bioavailability in fed rat,50597,Rattus norvegicus,6168,BAO_0000218,,1,1,,CHEMBL623083,,
10544,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,3624,BAO_0000218,,1,1,,CHEMBL623084,,
10545,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,5213,BAO_0000218,,1,1,,CHEMBL623085,,
10546,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,5496,BAO_0000218,,1,1,,CHEMBL623086,,
10547,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,5553,BAO_0000218,,1,1,,CHEMBL623087,,
10548,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,5833,BAO_0000218,,1,1,,CHEMBL623088,,
10549,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,5836,BAO_0000218,,1,1,,CHEMBL623089,,
10550,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,5865,BAO_0000218,,1,1,,CHEMBL623090,,
10551,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,5960,BAO_0000218,,1,1,,CHEMBL623091,,
10552,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6249,BAO_0000218,,1,1,,CHEMBL623092,,
10553,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6448,BAO_0000218,,1,1,,CHEMBL623093,,
10554,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6453,BAO_0000218,,1,1,,CHEMBL874401,,
10555,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6640,BAO_0000218,,1,1,,CHEMBL623094,,
10556,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,17607,BAO_0000218,,1,1,,CHEMBL623095,,
10557,Intermediate,,,,Oral bioavailability in rat after peroral administration at 10 mg/kg,50597,Rattus norvegicus,5939,BAO_0000218,,1,1,,CHEMBL623096,,
10558,Intermediate,,,,Oral bioavailability in rat after peroral administration at 5 mg/kg,50597,Rattus norvegicus,5939,BAO_0000218,,1,1,,CHEMBL624913,,
10559,Intermediate,,,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),50597,Rattus norvegicus,6281,BAO_0000218,,1,1,,CHEMBL624914,,
10560,Intermediate,,,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,50597,Rattus norvegicus,5874,BAO_0000218,,1,1,,CHEMBL624915,,
10561,Intermediate,,,,Oral bioavailability in rat; Not measured,50597,Rattus norvegicus,5213,BAO_0000218,,1,1,,CHEMBL624916,,
10562,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,4964,BAO_0000218,,1,1,,CHEMBL624917,,
10563,Intermediate,,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,50597,Rattus norvegicus,11020,BAO_0000218,,1,1,,CHEMBL625157,,
10564,Intermediate,,Liver,2107.0,In vitro metabolic potential in rat liver microsomes,50597,Rattus norvegicus,6251,BAO_0000218,,1,1,,CHEMBL625158,,
10565,Intermediate,,,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",50597,Rattus norvegicus,1568,BAO_0000218,,1,1,,CHEMBL625159,,
10566,Intermediate,,,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",50597,Rattus norvegicus,3032,BAO_0000218,,1,1,,CHEMBL625160,,
10567,Intermediate,,,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,50597,Rattus norvegicus,3748,BAO_0000218,,1,1,,CHEMBL625161,,
10568,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,401,BAO_0000218,,1,1,,CHEMBL625162,,
10569,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6512,BAO_0000218,,1,1,,CHEMBL625163,,
10570,Intermediate,,,,Oral bioavailability in rats at 10 mg/kg,50597,Rattus norvegicus,17617,BAO_0000218,,1,1,,CHEMBL625164,,
10571,Intermediate,,,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,50597,Rattus norvegicus,6679,BAO_0000218,,1,1,,CHEMBL625165,,
10572,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6742,BAO_0000218,,1,1,,CHEMBL625166,,
10573,Intermediate,,,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,50597,Rattus norvegicus,589,BAO_0000218,,1,1,,CHEMBL625167,,
10574,Intermediate,,,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,50597,Rattus norvegicus,589,BAO_0000218,,1,1,,CHEMBL625168,,
10575,Intermediate,,,,Plasma clearance of the compound,50597,Rattus norvegicus,3185,BAO_0000218,,1,1,,CHEMBL625169,,
10576,Intermediate,,,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,50597,Rattus norvegicus,17596,BAO_0000218,,1,1,,CHEMBL626264,,
10577,Intermediate,,,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,50597,Rattus norvegicus,2713,BAO_0000218,,1,1,,CHEMBL626265,,
10578,Intermediate,,Plasma,1969.0,The compound was tested for plasma clearance in rat,50597,Rattus norvegicus,12500,BAO_0000218,,1,1,,CHEMBL626266,,
10579,Intermediate,,Plasma,1969.0,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,50597,Rattus norvegicus,12500,BAO_0000218,,1,1,,CHEMBL626267,,
10580,Intermediate,,,,Plasma concentration upon oral administration of 1 mg/Kg in rats,50597,Rattus norvegicus,2713,BAO_0000218,,1,1,,CHEMBL626268,,
10581,Intermediate,,,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,50597,Rattus norvegicus,1446,BAO_0000218,,1,1,,CHEMBL626269,,
10582,Intermediate,,,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,50597,Rattus norvegicus,6227,BAO_0000218,,1,1,,CHEMBL626270,,
10583,Intermediate,,,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,50597,Rattus norvegicus,4709,BAO_0000218,,1,1,,CHEMBL626271,,
10584,Intermediate,,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",50597,Rattus norvegicus,5510,BAO_0000218,,1,1,,CHEMBL626272,,
10585,Intermediate,,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",50597,Rattus norvegicus,5510,BAO_0000218,,1,1,,CHEMBL626273,,
10586,Intermediate,,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",50597,Rattus norvegicus,5510,BAO_0000218,,1,1,,CHEMBL875346,,
10587,Intermediate,,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",50597,Rattus norvegicus,5510,BAO_0000218,,1,1,,CHEMBL626274,,
10588,Intermediate,,,,Compound was tested for protein binding in rat plasma,50597,Rattus norvegicus,4514,BAO_0000218,,1,1,,CHEMBL626275,,
10589,Intermediate,,,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,50597,Rattus norvegicus,2713,BAO_0000218,,1,1,,CHEMBL624646,,
10590,Intermediate,,,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,50597,Rattus norvegicus,2713,BAO_0000218,,1,1,,CHEMBL624647,,
10591,Intermediate,,Liver,2107.0,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,50597,Rattus norvegicus,5340,BAO_0000218,,1,1,,CHEMBL624648,,
10592,Intermediate,,,,Area under curve ratio was determined (po/iv) in rat,50597,Rattus norvegicus,12058,BAO_0000218,,1,1,,CHEMBL624649,,
10593,Intermediate,,,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL624650,,
10594,Intermediate,,,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL624651,,
10595,Intermediate,,,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL624652,,
10596,Intermediate,,,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,50597,Rattus norvegicus,6495,BAO_0000218,,1,1,,CHEMBL624653,,
10597,Intermediate,,,,Ratio of AUCbrain to AUCplasma,50597,Rattus norvegicus,6078,BAO_0000218,,1,1,,CHEMBL624654,,
10598,Intermediate,,,,Ratio of brain to plasma,50597,Rattus norvegicus,5656,BAO_0000218,,1,1,,CHEMBL624655,,
10599,Intermediate,,,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL624656,,
10600,Intermediate,,,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL624657,,
10601,Intermediate,,,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL624658,,
10602,Intermediate,,,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL624659,,
10603,Intermediate,,,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL624660,,
10604,Intermediate,,,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,50597,Rattus norvegicus,10130,BAO_0000218,,1,1,,CHEMBL624661,,
10605,Intermediate,,,,Steady state brain :blood ratio was determined,50597,Rattus norvegicus,5213,BAO_0000218,,1,1,,CHEMBL624662,,
10606,Intermediate,,,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL625199,,
10607,Intermediate,,,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL625200,,
10608,Intermediate,,,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL625201,,
10609,Intermediate,,,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,50597,Rattus norvegicus,4910,BAO_0000218,,1,1,,CHEMBL625202,,
10610,Intermediate,,,,Percentage recovery after 3h incubation with rat hapatocytes was determined,50597,Rattus norvegicus,2083,BAO_0000218,,1,1,,CHEMBL625203,,
10611,Intermediate,,,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,50597,Rattus norvegicus,2082,BAO_0000218,,1,1,,CHEMBL625204,,
10612,Intermediate,,,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,50597,Rattus norvegicus,2082,BAO_0000218,,1,1,,CHEMBL625205,,
10613,Intermediate,,,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,50597,Rattus norvegicus,6351,BAO_0000218,,1,1,,CHEMBL625206,,
10614,Autocuration,,,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",22224,,14583,BAO_0000019,,0,1,,CHEMBL625207,,
10615,Autocuration,,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,22224,,14583,BAO_0000019,,0,1,,CHEMBL625208,,
10616,Intermediate,,,,In vivo absorption in Caco-2 cell line monolayers was determined,50587,Homo sapiens,4608,BAO_0000218,,1,1,,CHEMBL625209,495.0,
10617,Autocuration,,,,Calculated partition coefficient (clogP),22229,,13668,BAO_0000100,,0,1,,CHEMBL625210,,
10618,Intermediate,,,,Area under curve was determine after peroral administration at 10 mpk in Rat,50597,Rattus norvegicus,5669,BAO_0000218,,1,1,,CHEMBL625211,,
10619,Intermediate,,,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,50797,Macaca mulatta,5669,BAO_0000218,,1,1,,CHEMBL625212,,
10620,Intermediate,,,,Area under curve was determine after peroral administration at 160 mpk in Rat,50597,Rattus norvegicus,5669,BAO_0000218,,1,1,,CHEMBL625213,,
10621,Intermediate,,,,Area under curve was determine after peroral administration at 20 mpk in Rat,50597,Rattus norvegicus,5669,BAO_0000218,,1,1,,CHEMBL625214,,
10622,Intermediate,,,,Area under curve was determine after peroral administration at 50 mpk in Rat,50597,Rattus norvegicus,5669,BAO_0000218,,1,1,,CHEMBL874542,,
10623,Autocuration,,,,Calculated partition coefficient (clogP) (AlogP),22229,,6472,BAO_0000100,,0,1,,CHEMBL625215,,
10624,Autocuration,,,,Activated partial thromboplastin time measured,22224,,15106,BAO_0000019,,0,1,,CHEMBL625216,,
10625,Autocuration,,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),22224,,15207,BAO_0000100,,0,1,,CHEMBL625217,,
10626,Autocuration,,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),22224,,15207,BAO_0000100,,0,1,,CHEMBL625218,,
10627,Intermediate,,Plasma,1969.0,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,50588,Canis lupus familiaris,13941,BAO_0000218,,1,1,,CHEMBL622864,,
10628,Intermediate,,Plasma,1969.0,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,50597,Rattus norvegicus,13941,BAO_0000218,,1,1,,CHEMBL622865,,
10629,Intermediate,,Plasma,1969.0,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,50597,Rattus norvegicus,13941,BAO_0000218,,1,1,,CHEMBL622866,,
10630,Intermediate,,Plasma,1969.0,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,50588,Canis lupus familiaris,13941,BAO_0000218,,1,1,,CHEMBL622867,,
10631,Intermediate,,Plasma,1969.0,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,50512,Cavia porcellus,15240,BAO_0000218,,1,1,,CHEMBL876808,,
10632,Autocuration,,Brain,955.0,AUC in brain,22224,,10655,BAO_0000019,,0,1,,CHEMBL627725,,
10633,Autocuration,,Serum,1977.0,AUC in serum,22224,,10655,BAO_0000019,,0,1,,CHEMBL627726,,
10634,Autocuration,,Plasma,1969.0,AUC was determined,22224,,6504,BAO_0000019,,0,1,,CHEMBL627727,,
10635,Autocuration,,Plasma,1969.0,AUC of the compound.,22224,,10615,BAO_0000019,,0,1,,CHEMBL627728,,
10636,Autocuration,,Plasma,1969.0,AUC value (0-4 hr),22224,,10353,BAO_0000019,,0,1,,CHEMBL627729,,
10637,Autocuration,,Plasma,1969.0,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",22224,,14907,BAO_0000019,,0,1,,CHEMBL627730,,
10638,Autocuration,,Plasma,1969.0,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,22224,,14907,BAO_0000019,,0,1,,CHEMBL627731,,
10639,Autocuration,,Plasma,1969.0,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",22224,,14907,BAO_0000019,,0,1,,CHEMBL627732,,
10640,Autocuration,,Plasma,1969.0,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",22224,,14907,BAO_0000019,,0,1,,CHEMBL627733,,
10641,Intermediate,,Plasma,1969.0,AUC(area under curve) was determined after intravenous administration in rats,50597,Rattus norvegicus,16359,BAO_0000218,,1,1,,CHEMBL627734,,
10642,Intermediate,,Plasma,1969.0,AUC(area under curve) was determined after oral administration in rats,50597,Rattus norvegicus,16359,BAO_0000218,,1,1,,CHEMBL627735,,
10643,Intermediate,,Plasma,1969.0,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,50512,Cavia porcellus,15240,BAO_0000218,,1,1,,CHEMBL627736,,
10644,Intermediate,,Plasma,1969.0,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,50597,Rattus norvegicus,15240,BAO_0000218,,1,1,,CHEMBL876809,,
10645,Autocuration,,,,Area Under Curve after oral dosing of 100 uM/Kg,22224,,15469,BAO_0000019,,0,1,,CHEMBL627737,,
10646,Autocuration,,,,Area Under Curve after oral dosing of 30 uM/Kg,22224,,15469,BAO_0000019,,0,1,,CHEMBL627738,,
10647,Autocuration,,,,Area Under Curve was measured by ploting the graph between concentration verses time,22224,,13520,BAO_0000019,,0,1,,CHEMBL627739,,
10648,Intermediate,,,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,50588,Canis lupus familiaris,17025,BAO_0000218,,1,1,,CHEMBL626143,,
10649,Autocuration,,,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,22224,Simiiformes,17025,BAO_0000218,,0,1,,CHEMBL626144,,
10650,Intermediate,,,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,50592,Oryctolagus cuniculus,17025,BAO_0000218,,1,1,,CHEMBL626145,,
10651,Intermediate,,,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,50597,Rattus norvegicus,17025,BAO_0000218,,1,1,,CHEMBL626146,,
10652,Intermediate,,Blood,178.0,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,50597,Rattus norvegicus,12032,BAO_0000218,,1,1,,CHEMBL626147,,
10653,Autocuration,,,,Area under curve (AUC) was determined,22224,,10291,BAO_0000019,,0,1,,CHEMBL626148,,
10654,Autocuration,,,,Area under curve (AUC) following ip administration at 1 mg/kg,22224,,5767,BAO_0000218,,0,1,,CHEMBL626149,,
10655,Autocuration,,,,Area under curve (AUC) was determined; ND is Not determined,22224,,1434,BAO_0000019,,0,1,,CHEMBL626150,,
10656,Intermediate,,,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,50588,Canis lupus familiaris,14925,BAO_0000218,,1,1,,CHEMBL626151,,
10657,Intermediate,,,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,50588,Canis lupus familiaris,14925,BAO_0000218,,1,1,,CHEMBL626152,,
10658,Intermediate,,,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,50588,Canis lupus familiaris,14925,BAO_0000218,,1,1,,CHEMBL626153,,
10659,Autocuration,,,,Area under curve (AUR) was determined,22224,,1434,BAO_0000019,,0,1,,CHEMBL626154,,
10660,Autocuration,,,,Area under curve at 1 uM/dg administered intravenously,22224,,11883,BAO_0000019,,0,1,,CHEMBL626155,,
10661,Autocuration,,,,Area under curve at 10 uM/dg administered perorally,22224,,11883,BAO_0000019,,0,1,,CHEMBL626156,,
10662,Autocuration,,,,Area under curve at 2 uM/dg administered intravenously,22224,,11883,BAO_0000019,,0,1,,CHEMBL626157,,
10663,Autocuration,,,,Area under curve at 20 uM/dg administered perorally,22224,,11883,BAO_0000019,,0,1,,CHEMBL626158,,
10664,Intermediate,,,,Area under curve at a peroral dose of 3 mg/kg in dog,50588,Canis lupus familiaris,15233,BAO_0000218,,1,1,,CHEMBL626159,,
10665,Intermediate,,,,Area under curve at a peroral dose of 3 mg/kg in rat,50597,Rattus norvegicus,15233,BAO_0000218,,1,1,,CHEMBL626160,,
10666,Intermediate,,,,Area under curve at an iv dose of 1 mg/kg in dog,50588,Canis lupus familiaris,15233,BAO_0000218,,1,1,,CHEMBL626161,,
10667,Intermediate,,,,Area under curve at an iv dose of 1 mg/kg in rat,50597,Rattus norvegicus,15233,BAO_0000218,,1,1,,CHEMBL626162,,
10668,Autocuration,,,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,22224,,12978,BAO_0000019,,0,1,,CHEMBL626163,,
10669,Autocuration,,,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,22224,,12978,BAO_0000019,,0,1,,CHEMBL626164,,
10670,Intermediate,,,,Area under curve measured as conc vs time after intravenous administration to mice.,50594,Mus musculus,11355,BAO_0000218,,1,1,,CHEMBL626165,,
10671,Intermediate,,,,Area under curve measured as conc vs time after peroral administration to mice.,50594,Mus musculus,11355,BAO_0000218,,1,1,,CHEMBL626166,,
10672,Intermediate,,,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,50588,Canis lupus familiaris,12923,BAO_0000218,,1,1,,CHEMBL626167,,
10673,Intermediate,,,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,50588,Canis lupus familiaris,12923,BAO_0000218,,1,1,,CHEMBL626168,,
10674,Intermediate,,,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,50588,Canis lupus familiaris,12923,BAO_0000218,,1,1,,CHEMBL877463,,
10675,Intermediate,,,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,50588,Canis lupus familiaris,12923,BAO_0000218,,1,1,,CHEMBL626169,,
10676,Intermediate,,Heart,948.0,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL626170,,
10677,Intermediate,,Heart,948.0,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL626171,,
10678,Intermediate,,Heart,948.0,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL626172,,
10679,Intermediate,,Heart,948.0,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL626173,,
10680,Intermediate,,Kidney,2113.0,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL626174,,
10681,Intermediate,,Kidney,2113.0,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL626175,,
10682,Intermediate,,Kidney,2113.0,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL626176,,
10683,Intermediate,,Kidney,2113.0,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL626177,,
10684,Intermediate,,Kidney,2113.0,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622499,,
10685,Intermediate,,Liver,2107.0,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622500,,
10686,Intermediate,,Liver,2107.0,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622501,,
10687,Intermediate,,Liver,2107.0,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622502,,
10688,Intermediate,,Liver,2107.0,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL622503,,
10689,Intermediate,,Liver,2107.0,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL877614,,
10690,Intermediate,,Lung,2048.0,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL624839,,
10691,Intermediate,,Lung,2048.0,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL624840,,
10692,Intermediate,,Lung,2048.0,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL624841,,
10693,Intermediate,,Lung,2048.0,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL624842,,
10694,Intermediate,,Muscle tissue,2385.0,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL624843,,
10695,Intermediate,,Muscle tissue,2385.0,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL624844,,
10696,Intermediate,,Muscle tissue,2385.0,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL624845,,
10697,Intermediate,,Muscle tissue,2385.0,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,50597,Rattus norvegicus,17738,BAO_0000218,,1,1,,CHEMBL621904,,
10698,Intermediate,,Blood,178.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL621905,,
10699,Intermediate,,Blood,178.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL874382,,
10700,Intermediate,,Blood,178.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL621906,,
10701,Intermediate,,Brain,955.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL621907,,
10702,Intermediate,,Brain,955.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622096,,
10703,Intermediate,,Brain,955.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622097,,
10704,Intermediate,,Heart,948.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622098,,
10705,Intermediate,,Heart,948.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622099,,
10706,Intermediate,,Heart,948.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622100,,
10707,Intermediate,,Kidney,2113.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622101,,
10708,Intermediate,,Kidney,2113.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622102,,
10709,Intermediate,,Kidney,2113.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622103,,
10710,Intermediate,,Liver,2107.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622104,,
10711,Intermediate,,Liver,2107.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622105,,
10712,Intermediate,,Liver,2107.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622106,,
10713,Intermediate,,Lung,2048.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622107,,
10714,Intermediate,,Lung,2048.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622108,,
10715,Intermediate,,Lung,2048.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622109,,
10716,Intermediate,,Muscle tissue,2385.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622110,,
10717,Intermediate,,Muscle tissue,2385.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622111,,
10718,Intermediate,,Muscle tissue,2385.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL874383,,
10719,Intermediate,,Zone of skin,14.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622112,,
10720,Intermediate,,Zone of skin,14.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622113,,
10721,Intermediate,,Zone of skin,14.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622114,,
10722,Intermediate,,Spleen,2106.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622115,,
10723,Intermediate,,Spleen,2106.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,50597,Rattus norvegicus,11195,BAO_0000218,,1,1,,CHEMBL622116,,
10724,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6193,BAO_0000218,,1,1,,CHEMBL622117,,
10725,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6803,BAO_0000218,,1,1,,CHEMBL622118,,
10726,Intermediate,,,,Oral bioavailability in rats at 6 mg/kg,50597,Rattus norvegicus,6647,BAO_0000218,,1,1,,CHEMBL622119,,
10727,Intermediate,,,,Oral bioavailability in rat (dose 6 mg/kg),50597,Rattus norvegicus,6647,BAO_0000218,,1,1,,CHEMBL622120,,
10728,Intermediate,,,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,50597,Rattus norvegicus,6647,BAO_0000218,,1,1,,CHEMBL622121,,
10729,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6640,BAO_0000218,,1,1,,CHEMBL622122,,
10730,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6641,BAO_0000218,,1,1,,CHEMBL622123,,
10731,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6641,BAO_0000218,,1,1,,CHEMBL622124,,
10732,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,6642,BAO_0000218,,1,1,,CHEMBL622125,,
10733,Intermediate,,,,Oral bioavailability,50597,Rattus norvegicus,5472,BAO_0000218,,1,1,,CHEMBL622126,,
10734,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),50597,Rattus norvegicus,6141,BAO_0000218,,1,1,,CHEMBL620455,,
10735,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,4390,BAO_0000218,,1,1,,CHEMBL620456,,
10736,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,5472,BAO_0000218,,1,1,,CHEMBL620457,,
10737,Intermediate,,,,Oral bioavailability was evaluated; Not tested,50597,Rattus norvegicus,5472,BAO_0000218,,1,1,,CHEMBL620458,,
10738,Intermediate,,,,Oral bioavailability,50597,Rattus norvegicus,5438,BAO_0000218,,1,1,,CHEMBL620459,,
10739,Intermediate,,,,Oral bioavailability in rat by oral dosing,50597,Rattus norvegicus,4883,BAO_0000218,,1,1,,CHEMBL620460,,
10740,Intermediate,,,,Oral bioavailability in rat (dose 10 mg/kg p.o.),50597,Rattus norvegicus,1908,BAO_0000218,,1,1,,CHEMBL620461,,
10741,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley),50597,Rattus norvegicus,4853,BAO_0000218,,1,1,,CHEMBL620462,,
10742,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),50597,Rattus norvegicus,4853,BAO_0000218,,1,1,,CHEMBL620463,,
10743,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),50597,Rattus norvegicus,4853,BAO_0000218,,1,1,,CHEMBL620464,,
10744,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),50597,Rattus norvegicus,4853,BAO_0000218,,1,1,,CHEMBL620465,,
10745,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),50597,Rattus norvegicus,4853,BAO_0000218,,1,1,,CHEMBL620466,,
10746,Intermediate,,,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,50597,Rattus norvegicus,4853,BAO_0000218,,1,1,,CHEMBL620467,,
10747,Intermediate,,,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,50597,Rattus norvegicus,4853,BAO_0000218,,1,1,,CHEMBL620468,,
10748,Intermediate,,,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,50597,Rattus norvegicus,12873,BAO_0000218,,1,1,,CHEMBL620469,,
10749,Intermediate,,,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,50597,Rattus norvegicus,12873,BAO_0000218,,1,1,,CHEMBL620470,,
10750,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,3169,BAO_0000218,,1,1,,CHEMBL620471,,
10751,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6305,BAO_0000218,,1,1,,CHEMBL620472,,
10752,Intermediate,,,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,50597,Rattus norvegicus,4762,BAO_0000218,,1,1,,CHEMBL620473,,
10753,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,17847,BAO_0000218,,1,1,,CHEMBL620474,,
10754,Intermediate,,,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),50597,Rattus norvegicus,6211,BAO_0000218,,1,1,,CHEMBL620475,,
10755,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6011,BAO_0000218,,1,1,,CHEMBL620476,,
10756,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,6317,BAO_0000218,,1,1,,CHEMBL620477,,
10757,Intermediate,,,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,50597,Rattus norvegicus,6644,BAO_0000218,,1,1,,CHEMBL620478,,
10758,Intermediate,,,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,50597,Rattus norvegicus,6644,BAO_0000218,,1,1,,CHEMBL618768,,
10759,Intermediate,,,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,50597,Rattus norvegicus,6644,BAO_0000218,,1,1,,CHEMBL618769,,
10760,Intermediate,,,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,50597,Rattus norvegicus,6644,BAO_0000218,,1,1,,CHEMBL618770,,
10761,Intermediate,,,,Oral bioavailability (dose 20 mg/kg p.o.),50597,Rattus norvegicus,6113,BAO_0000218,,1,1,,CHEMBL618771,,
10762,Intermediate,,,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,50597,Rattus norvegicus,5937,BAO_0000218,,1,1,,CHEMBL618772,,
10763,Intermediate,,,,Oral bioavailability in rat at 10 mg/kg of the compound,50597,Rattus norvegicus,5711,BAO_0000218,,1,1,,CHEMBL618773,,
10764,Intermediate,,,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL875842,,
10765,Intermediate,,,,Bioavailability in rat (dose 3 mg/kg i.v.),50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL618774,,
10766,Intermediate,,,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL618775,,
10767,Intermediate,,,,Oral bioavailability in rat (dose 60 mg/kg p.o.),50597,Rattus norvegicus,17717,BAO_0000218,,1,1,,CHEMBL618776,,
10768,Intermediate,,,,Percent bioavailability (F) in rats after iv administration,50597,Rattus norvegicus,4722,BAO_0000218,,1,1,,CHEMBL618777,,
10769,Intermediate,,,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,50597,Rattus norvegicus,4722,BAO_0000218,,1,1,,CHEMBL618778,,
10770,Intermediate,,,,Bioavailability in rat (dose 5 uM/kg p.o.),50597,Rattus norvegicus,4353,BAO_0000218,,1,1,,CHEMBL618779,,
10771,Intermediate,,,,Oral bioavailability,50597,Rattus norvegicus,15662,BAO_0000218,,1,1,,CHEMBL618780,,
10772,Intermediate,,,,Bioavailability in rat (dose 2 mg/kg p.o.),50597,Rattus norvegicus,4756,BAO_0000218,,1,1,,CHEMBL618781,,
10773,Intermediate,,,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,50597,Rattus norvegicus,4756,BAO_0000218,,1,1,,CHEMBL618782,,
10774,Intermediate,,,,Oral bioavailability in rat (dose 20 mg/kg),50597,Rattus norvegicus,3436,BAO_0000218,,1,1,,CHEMBL618783,,
10775,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,17800,BAO_0000218,,1,1,,CHEMBL618784,,
10776,Intermediate,,,,Percent oral bioavailability evaluated in rat,50597,Rattus norvegicus,15762,BAO_0000218,,1,1,,CHEMBL618785,,
10777,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,5089,BAO_0000218,,1,1,,CHEMBL618786,,
10778,Intermediate,,,,Percent oral bioavailability in rat; Not determined,50597,Rattus norvegicus,5089,BAO_0000218,,1,1,,CHEMBL618787,,
10779,Intermediate,,,,Oral bioavailability in rat,50597,Rattus norvegicus,3185,BAO_0000218,,1,1,,CHEMBL618788,,
10780,Intermediate,,,,Bioavailability in rat,50597,Rattus norvegicus,5145,BAO_0000218,,1,1,,CHEMBL618789,,
10781,Intermediate,,,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),50597,Rattus norvegicus,3457,BAO_0000218,,1,1,,CHEMBL618790,,
10782,Intermediate,,,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),50597,Rattus norvegicus,3457,BAO_0000218,,1,1,,CHEMBL618791,,
10783,Intermediate,,,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,50597,Rattus norvegicus,5983,BAO_0000218,,1,1,,CHEMBL875843,,
10784,Intermediate,,,,Oral bioavailability in rat (dose 20 mg/kg p.o.),50597,Rattus norvegicus,5739,BAO_0000218,,1,1,,CHEMBL618792,,
10785,Intermediate,,,,Cmax at a dose of 30 mg/kg in rat,50597,Rattus norvegicus,3579,BAO_0000218,,1,1,,CHEMBL623395,,
10786,Autocuration,,,,Cmax in monkeys at a dose of 1 mg/kg,22224,Simiiformes,17788,BAO_0000218,,0,1,,CHEMBL623396,,
10787,Intermediate,,,,Cmax in rat,50597,Rattus norvegicus,14956,BAO_0000218,,1,1,,CHEMBL623397,,
10788,Intermediate,,,,Cmax in rats at a dose of 1 mg/kg,50597,Rattus norvegicus,17788,BAO_0000218,,1,1,,CHEMBL623398,,
10789,Intermediate,,,,Cmax was measured in mice after an oral dose of 50 mg/kg.,50594,Mus musculus,9750,BAO_0000218,,1,1,,CHEMBL623399,,
10790,Autocuration,,,,"Cmax value at a dose of 12.7 uM/kg, po",22224,,12767,BAO_0000218,,0,1,,CHEMBL623400,,
10791,Autocuration,,,,"Cmax value at a dose of 6.3 uM/kg, iv",22224,,12767,BAO_0000218,,0,1,,CHEMBL623401,,
10792,Autocuration,,,,"Cmax value at a dose of 7.1 uM/kg, iv",22224,,12767,BAO_0000218,,0,1,,CHEMBL623402,,
10793,Autocuration,,,,Cmax value of compound was determined after 1 hr,22224,,12703,BAO_0000218,,0,1,,CHEMBL623403,,
10794,Autocuration,,,,Cmax value of the compound,22224,,15778,BAO_0000218,,0,1,,CHEMBL623404,,
10795,Intermediate,,,,Cmax value administered intraintestinal in rats.,50597,Rattus norvegicus,12818,BAO_0000218,,1,1,,CHEMBL625997,,
10796,Intermediate,,,,Cmax value administered perorally was determined in rat; Not determined,50597,Rattus norvegicus,14964,BAO_0000218,,1,1,,CHEMBL625998,,
10797,Autocuration,,,,Cmax value at the dose of 2.3 mg/kg,22224,,15808,BAO_0000218,,0,1,,CHEMBL625999,,
10798,Autocuration,,,,Cmax value at the dose of 5 mg/kg,22224,,15808,BAO_0000218,,0,1,,CHEMBL626000,,
10799,Autocuration,,,,Cmax value in the period of 8 hr after dosing. ,22224,,15778,BAO_0000218,,0,1,,CHEMBL626001,,
10800,Autocuration,,,,Cmax value at a oral dose of 20 mg/kg; Not tested,22224,,3715,BAO_0000218,,0,1,,CHEMBL626002,,
10801,Autocuration,,,,Cmax value at a oral dose of 20 mg/kg,22224,,3715,BAO_0000218,,0,1,,CHEMBL626003,,
10802,Intermediate,,,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,50597,Rattus norvegicus,1446,BAO_0000218,,1,1,,CHEMBL626004,,
10803,Intermediate,,,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,50512,Cavia porcellus,15240,BAO_0000218,,1,1,,CHEMBL626005,,
10804,Intermediate,,,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,50597,Rattus norvegicus,15240,BAO_0000218,,1,1,,CHEMBL626006,,
10805,Intermediate,,Plasma,1969.0,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,50597,Rattus norvegicus,14810,BAO_0000218,,1,1,,CHEMBL626007,,
10806,Intermediate,,Plasma,1969.0,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,50594,Mus musculus,14239,BAO_0000218,,1,1,,CHEMBL626008,,
10807,Intermediate,,Liver,2107.0,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,50588,Canis lupus familiaris,12555,BAO_0000218,,1,1,,CHEMBL626009,,
10808,Intermediate,,,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,50588,Canis lupus familiaris,10754,BAO_0000218,,1,1,,CHEMBL626010,,
10809,Intermediate,,Blood,178.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,50594,Mus musculus,10754,BAO_0000218,,1,1,,CHEMBL626011,,
10810,Intermediate,,Blood,178.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,50594,Mus musculus,10754,BAO_0000218,,1,1,,CHEMBL626012,,
10811,Intermediate,,Blood,178.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,50594,Mus musculus,10754,BAO_0000218,,1,1,,CHEMBL626013,,
10812,Intermediate,,Blood,178.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,50594,Mus musculus,10754,BAO_0000218,,1,1,,CHEMBL626014,,
10813,Intermediate,,Blood,178.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,50594,Mus musculus,10754,BAO_0000218,,1,1,,CHEMBL877496,,
10814,Intermediate,,,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,50588,Canis lupus familiaris,14600,BAO_0000218,,1,1,,CHEMBL626015,,
10815,Intermediate,,,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,50588,Canis lupus familiaris,14600,BAO_0000218,,1,1,,CHEMBL626016,,
10816,Intermediate,,,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,50588,Canis lupus familiaris,14600,BAO_0000218,,1,1,,CHEMBL626017,,
10817,Intermediate,,Plasma,1969.0,Bioavailability as maximal plasma concentration in dogs,50588,Canis lupus familiaris,13543,BAO_0000218,,1,1,,CHEMBL626018,,
10818,Intermediate,,Plasma,1969.0,Bioavailability as maximal plasma concentration in dogs,50588,Canis lupus familiaris,13543,BAO_0000218,,1,1,,CHEMBL626692,,
10819,Intermediate,,Plasma,1969.0,Bioavailability as maximal plasma concentration in rats,50597,Rattus norvegicus,13543,BAO_0000218,,1,1,,CHEMBL626693,,
10820,Autocuration,,Plasma,1969.0,Bioavailability as maximal plasma concentration in rats,22224,Rattus norvegicus,13543,BAO_0000218,,0,1,,CHEMBL626694,,
10821,Intermediate,,Blood,178.0,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,50588,Canis lupus familiaris,14600,BAO_0000218,,1,1,,CHEMBL626695,,
10822,Intermediate,,Blood,178.0,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,50588,Canis lupus familiaris,14600,BAO_0000218,,1,1,,CHEMBL626696,,
10823,Intermediate,,Blood,178.0,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,50588,Canis lupus familiaris,14600,BAO_0000218,,1,1,,CHEMBL626697,,
10824,Intermediate,,Blood,178.0,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,50588,Canis lupus familiaris,14600,BAO_0000218,,1,1,,CHEMBL626859,,
10825,Intermediate,,Blood,178.0,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,50588,Canis lupus familiaris,14600,BAO_0000218,,1,1,,CHEMBL626860,,
10826,Intermediate,,Blood,178.0,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,50588,Canis lupus familiaris,14600,BAO_0000218,,1,1,,CHEMBL626861,,
10827,Intermediate,,,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,50597,Rattus norvegicus,14681,BAO_0000218,,1,1,,CHEMBL626296,,
10828,Autocuration,,,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,22224,,15905,BAO_0000218,,0,1,,CHEMBL626297,,
10829,Autocuration,,Plasma,1969.0,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,22224,,15905,BAO_0000218,,0,1,,CHEMBL626298,,
10830,Intermediate,,Plasma,1969.0,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",50597,Rattus norvegicus,13304,BAO_0000218,,1,1,,CHEMBL626299,,
10831,Intermediate,,Plasma,1969.0,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,50597,Rattus norvegicus,15137,BAO_0000218,,1,1,,CHEMBL626300,,
10832,Intermediate,,Plasma,1969.0,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,50597,Rattus norvegicus,15137,BAO_0000218,,1,1,,CHEMBL626301,,
10833,Intermediate,,Plasma,1969.0,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,50597,Rattus norvegicus,15137,BAO_0000218,,1,1,,CHEMBL626962,,
10834,Intermediate,,Plasma,1969.0,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,50597,Rattus norvegicus,15137,BAO_0000218,,1,1,,CHEMBL626963,,
10835,Intermediate,,Plasma,1969.0,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,50597,Rattus norvegicus,15137,BAO_0000218,,1,1,,CHEMBL626964,,
10836,Intermediate,,Plasma,1969.0,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL626965,,
10837,Intermediate,,Plasma,1969.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL626966,,
10838,Intermediate,,Plasma,1969.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL626967,,
10839,Intermediate,,Plasma,1969.0,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL626968,,
10840,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626969,,
10841,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627126,,
10842,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631276,,
10843,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631277,,
10844,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631278,,
10845,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL874457,,
10846,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631279,,
10847,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631280,,
10848,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631281,,
10849,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631968,,
10850,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631969,,
10851,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631970,,
10852,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631971,,
10853,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631972,,
10854,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630435,,
10855,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630436,,
10856,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630437,,
10857,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630438,,
10858,Intermediate,,Heart,948.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630439,,
10859,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630440,,
10860,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630441,,
10861,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630442,,
10862,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625234,,
10863,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625235,,
10864,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625236,,
10865,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625237,,
10866,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626125,,
10867,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626126,,
10868,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626127,,
10869,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626128,,
10870,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626129,,
10871,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626130,,
10872,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626131,,
10873,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626132,,
10874,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626752,,
10875,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626753,,
10876,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626754,,
10877,Intermediate,,Kidney,2113.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626755,,
10878,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626756,,
10879,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626757,,
10880,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626758,,
10881,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626759,,
10882,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL626760,,
10883,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL626394,,
10884,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL626395,,
10885,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL626396,,
10886,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL626397,,
10887,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL626398,,
10888,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL626399,,
10889,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL874653,,
10890,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL626400,,
10891,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL626401,,
10892,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL626402,,
10893,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL626403,,
10894,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL626404,,
10895,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL626405,,
10896,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625529,,
10897,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625530,,
10898,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625531,,
10899,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625532,,
10900,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625533,,
10901,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL875474,,
10902,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625534,,
10903,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625535,,
10904,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625536,,
10905,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625537,,
10906,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625538,,
10907,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625539,,
10908,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625540,,
10909,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625541,,
10910,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625542,,
10911,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625543,,
10912,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625544,,
10913,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL625545,,
10914,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL625546,,
10915,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL625547,,
10916,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL625548,,
10917,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL625549,,
10918,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL625550,,
10919,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL625551,,
10920,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL875475,,
10921,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL625552,,
10922,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL625553,,
10923,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL625554,,
10924,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL625555,,
10925,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL625556,,
10926,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624986,,
10927,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624987,,
10928,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624988,,
10929,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL624989,,
10930,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL624990,,
10931,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL874391,,
10932,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL624991,,
10933,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL624992,,
10934,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL624993,,
10935,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL624994,,
10936,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL624995,,
10937,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL624996,,
10938,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL624997,,
10939,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL624998,,
10940,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL624999,,
10941,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL882955,,
10942,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625000,,
10943,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625001,,
10944,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625089,,
10945,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625090,,
10946,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625091,,
10947,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625092,,
10948,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625093,,
10949,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625094,,
10950,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625095,,
10951,Intermediate,,,,Compound was evaluated for its bioavailability in the dogs,50588,Canis lupus familiaris,2249,BAO_0000218,,1,1,,CHEMBL625096,,
10952,Intermediate,,,,Compound was evaluated for its bioavailability in the rats,50597,Rattus norvegicus,2249,BAO_0000218,,1,1,,CHEMBL625097,,
10953,Autocuration,,,,Compound was evaluated for oral bioavailability,22224,,17515,BAO_0000218,,0,1,,CHEMBL882956,,
10954,Intermediate,,,,Compound was evaluated for percentage of Oral bioavailability in rats,50597,Rattus norvegicus,14541,BAO_0000218,,1,1,,CHEMBL625098,,
10955,Autocuration,,,,Bioavailability in guinea pig,22224,Cavia porcellus,12797,BAO_0000218,,0,1,,CHEMBL625099,,
10956,Intermediate,,,,Compound was evaluated for the oral bioavailability in rat,50597,Rattus norvegicus,12797,BAO_0000218,,1,1,,CHEMBL625100,,
10957,Intermediate,,,,Compound was evaluated for the oral bioavailability in dog,50588,Canis lupus familiaris,12797,BAO_0000218,,1,1,,CHEMBL625101,,
10958,Intermediate,,,,Compound was evaluated for the oral bioavailability in rat,50597,Rattus norvegicus,12797,BAO_0000218,,1,1,,CHEMBL874396,,
10959,Autocuration,,,,Bioavailability in dog (dosed i.v.),22224,Canis lupus familiaris,11727,BAO_0000218,,0,1,,CHEMBL625102,,
10960,Intermediate,,,,Compound was tested for in vivo bioavailability in dog,50588,Canis lupus familiaris,13249,BAO_0000218,,1,1,,CHEMBL625103,,
10961,Intermediate,,,,Compound was tested for in vivo bioavailability in hamsters,100712,Cricetinae,13249,BAO_0000218,,1,1,,CHEMBL625104,,
10962,Autocuration,,,,Compound was tested for in vivo bioavailability in monkey,22224,Simiiformes,13249,BAO_0000218,,0,1,,CHEMBL625105,,
10963,Intermediate,,,,Compound was tested for in vivo bioavailability in rat,50597,Rattus norvegicus,13249,BAO_0000218,,1,1,,CHEMBL625106,,
10964,Autocuration,,,,Oral bioavailability in mouse,22224,Mus musculus,9552,BAO_0000218,,0,1,,CHEMBL625107,,
10965,Intermediate,,,,Compound was tested for percent of oral bioavailability in mice; 56-74,50594,Mus musculus,9552,BAO_0000218,,1,1,,CHEMBL625108,,
10966,Autocuration,,,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),22224,Mus musculus,14839,BAO_0000218,,0,1,,CHEMBL625109,,
10967,Autocuration,,,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),22224,Macaca fascicularis,14839,BAO_0000218,,0,1,,CHEMBL625110,,
10968,Autocuration,,,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),22224,Macaca fascicularis,14839,BAO_0000218,,0,1,,CHEMBL625111,,
10969,Intermediate,,,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL625112,,
10970,Intermediate,,,,Oral bioavailability in nude mice,50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL875334,,
10971,Autocuration,,,,Bioavailability in monkey (i.d. dosing),22224,Primates,11219,BAO_0000218,,0,1,,CHEMBL628617,,
10972,Autocuration,,,,Bioavailability in rat,22224,Rattus norvegicus,9552,BAO_0000218,,0,1,,CHEMBL628618,,
10973,Autocuration,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,22224,,11732,BAO_0000218,,0,1,,CHEMBL628619,,
10974,Autocuration,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,22224,,11732,BAO_0000218,,0,1,,CHEMBL628620,,
10975,Intermediate,,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL628621,,
10976,Intermediate,,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL628622,,
10977,Intermediate,,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL628623,,
10978,Intermediate,,Plasma,1969.0,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL628624,,
10979,Intermediate,,Plasma,1969.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL628625,,
10980,Intermediate,,Plasma,1969.0,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,100710,Macaca fascicularis,14839,BAO_0000218,,1,1,,CHEMBL628626,,
10981,Intermediate,,Plasma,1969.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL627041,,
10982,Intermediate,,Plasma,1969.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL627042,,
10983,Intermediate,,Plasma,1969.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL627043,,
10984,Autocuration,,Plasma,1969.0,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,22224,,13932,BAO_0000218,,0,1,,CHEMBL627044,,
10985,Intermediate,,Plasma,1969.0,Cmax in mouse plasma,50594,Mus musculus,11637,BAO_0000218,,1,1,,CHEMBL627045,,
10986,Autocuration,,Plasma,1969.0,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,22224,,11637,BAO_0000218,,0,1,,CHEMBL627046,,
10987,Intermediate,,Plasma,1969.0,Maximal plasma concentration in rat,50597,Rattus norvegicus,13960,BAO_0000218,,1,1,,CHEMBL627047,,
10988,Intermediate,,Plasma,1969.0,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,50597,Rattus norvegicus,15905,BAO_0000218,,1,1,,CHEMBL627048,,
10989,Intermediate,,,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,50597,Rattus norvegicus,14062,BAO_0000218,,1,1,,CHEMBL627049,,
10990,Intermediate,,,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,50597,Rattus norvegicus,14062,BAO_0000218,,1,1,,CHEMBL627050,,
10991,Intermediate,,,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,50597,Rattus norvegicus,14062,BAO_0000218,,1,1,,CHEMBL627051,,
10992,Intermediate,,,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,50597,Rattus norvegicus,14062,BAO_0000218,,1,1,,CHEMBL627052,,
10993,Intermediate,,,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,50597,Rattus norvegicus,14062,BAO_0000218,,1,1,,CHEMBL627053,,
10994,Intermediate,,,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,50597,Rattus norvegicus,14062,BAO_0000218,,1,1,,CHEMBL627054,,
10995,Intermediate,,,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,50594,Mus musculus,15011,BAO_0000218,,1,1,,CHEMBL627055,,
10996,Intermediate,,,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,50594,Mus musculus,15011,BAO_0000218,,1,1,,CHEMBL627056,,
10997,Intermediate,,,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),50594,Mus musculus,15011,BAO_0000218,,1,1,,CHEMBL627057,,
10998,Intermediate,,,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,50594,Mus musculus,15011,BAO_0000218,,1,1,,CHEMBL627058,,
10999,Intermediate,,,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,50594,Mus musculus,15011,BAO_0000218,,1,1,,CHEMBL626211,,
11000,Autocuration,,,,Maximum Concentration of the compound.,22224,,10291,BAO_0000218,,0,1,,CHEMBL626212,,
11001,Intermediate,,,,Maximum Concentration was measured after iv administration into Beagle dog,50588,Canis lupus familiaris,14599,BAO_0000218,,1,1,,CHEMBL626213,,
11002,Intermediate,,,,Maximum Concentration was measured after iv administration into Beagle dog.,50588,Canis lupus familiaris,14599,BAO_0000218,,1,1,,CHEMBL626214,,
11003,Intermediate,,,,Maximum Concentration was measured after po administration into Beagle dog,50588,Canis lupus familiaris,14599,BAO_0000218,,1,1,,CHEMBL626215,,
11004,Intermediate,,,,Maximum Concentration was measured after po administration into Beagle dog.,50588,Canis lupus familiaris,14599,BAO_0000218,,1,1,,CHEMBL626216,,
11005,Autocuration,,Blood,178.0,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,22224,,12767,BAO_0000218,,0,1,,CHEMBL626217,,
11006,Autocuration,,Blood,178.0,Maximum blood level reached after an iv dose of 12.2 uM/kg,22224,,12767,BAO_0000218,,0,1,,CHEMBL626218,,
11007,Autocuration,,Blood,178.0,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,22224,,12767,BAO_0000218,,0,1,,CHEMBL626219,,
11008,Autocuration,,Blood,178.0,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,22224,,12767,BAO_0000218,,0,1,,CHEMBL626220,,
11009,Autocuration,,Blood,178.0,Maximum blood level reached after an oral dose of 5.0 mg/kg,22224,,12767,BAO_0000218,,0,1,,CHEMBL626221,,
11010,Autocuration,,Blood,178.0,Maximum blood level reached at dose of 10.6 uM/kg orally,22224,,12767,BAO_0000218,,0,1,,CHEMBL626222,,
11011,Intermediate,,,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,50512,Cavia porcellus,14706,BAO_0000218,,1,1,,CHEMBL626223,,
11012,Intermediate,,,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,50512,Cavia porcellus,14706,BAO_0000218,,1,1,,CHEMBL626224,,
11013,Intermediate,,Brain,955.0,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL626225,,
11014,Intermediate,,Brain,955.0,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL626226,,
11015,Intermediate,,Brain,955.0,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL626227,,
11016,Intermediate,,Brain,955.0,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL626228,,
11017,Intermediate,,,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL626229,,
11018,Intermediate,,,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL626921,,
11019,Intermediate,,,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL876793,,
11020,Intermediate,,,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL625309,,
11021,Intermediate,,,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),50278,Bacillus subtilis,10524,BAO_0000218,,1,1,,CHEMBL625310,,
11022,Autocuration,,,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,22224,Simiiformes,11871,BAO_0000218,,0,1,,CHEMBL625311,,
11023,Intermediate,,,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,50597,Rattus norvegicus,11871,BAO_0000218,,1,1,,CHEMBL625312,,
11024,Autocuration,,,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,22224,,3437,BAO_0000218,,0,1,,CHEMBL625313,,
11025,Intermediate,,,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,50594,Mus musculus,12038,BAO_0000218,,1,1,,CHEMBL625314,,
11026,Intermediate,,,,Maximum concentration in male rats after iv administration of 20 mg/kg,50597,Rattus norvegicus,12038,BAO_0000218,,1,1,,CHEMBL625315,,
11027,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625316,,
11028,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625317,,
11029,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625318,,
11030,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625319,,
11031,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625320,,
11032,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625321,,
11033,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625322,,
11034,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL876801,,
11035,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625323,,
11036,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625324,,
11037,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625325,,
11038,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625326,,
11039,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625327,,
11040,Intermediate,,Liver,2107.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625328,,
11041,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625329,,
11042,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL625330,,
11043,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627774,,
11044,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627775,,
11045,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627949,,
11046,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627950,,
11047,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627951,,
11048,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627952,,
11049,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627953,,
11050,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627954,,
11051,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627955,,
11052,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627956,,
11053,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL876802,,
11054,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627957,,
11055,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627958,,
11056,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627959,,
11057,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627960,,
11058,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627961,,
11059,Intermediate,,Lung,2048.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL627962,,
11060,Intermediate,,,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL627963,,
11061,Intermediate,,,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL624759,,
11062,Intermediate,,,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL624760,,
11063,Intermediate,,,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL624761,,
11064,Intermediate,,,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL877607,,
11065,Intermediate,,Liver,2107.0,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL624762,,
11066,Intermediate,,Liver,2107.0,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL624763,,
11067,Intermediate,,Liver,2107.0,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL624764,,
11068,Intermediate,,Liver,2107.0,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL624765,,
11069,Intermediate,,Liver,2107.0,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL624766,,
11070,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624767,,
11071,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624768,,
11072,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624769,,
11073,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624770,,
11074,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624771,,
11075,Intermediate,,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624772,,
11076,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL624773,,
11077,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL624774,,
11078,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL624775,,
11079,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL624776,,
11080,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL624777,,
11081,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL624778,,
11082,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL624779,,
11083,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL624780,,
11084,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL624781,,
11085,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL877608,,
11086,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL624782,,
11087,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL624783,,
11088,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL624784,,
11089,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL624785,,
11090,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL624786,,
11091,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL624787,,
11092,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL628676,,
11093,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL621842,,
11094,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL621843,,
11095,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL623873,,
11096,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL623874,,
11097,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL623875,,
11098,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL623876,,
11099,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL623877,,
11100,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL623878,,
11101,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL623879,,
11102,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL623880,,
11103,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL623881,,
11104,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL623957,,
11105,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL623958,,
11106,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL623959,,
11107,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL623960,,
11108,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL623961,,
11109,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL623962,,
11110,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624676,,
11111,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624677,,
11112,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624678,,
11113,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624679,,
11114,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624680,,
11115,Autocuration,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,22224,,11732,BAO_0000218,,0,1,,CHEMBL624849,,
11116,Autocuration,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,22224,,11732,BAO_0000218,,0,1,,CHEMBL624850,,
11117,Autocuration,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,22224,,11732,BAO_0000218,,0,1,,CHEMBL874399,,
11118,Autocuration,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,22224,,11732,BAO_0000218,,0,1,,CHEMBL624851,,
11119,Autocuration,,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,22224,,11732,BAO_0000218,,0,1,,CHEMBL624852,,
11120,Autocuration,,,,Oral bioavailability in rat (dose 10 mg/kg),22224,Rattus norvegicus,13359,BAO_0000218,,0,1,,CHEMBL624853,,
11121,Autocuration,,,,Oral bioavailability in rat (Sprague-Dawley),22224,Rattus norvegicus,16618,BAO_0000218,,0,1,,CHEMBL624854,,
11122,Autocuration,,,,Oral bioavailability in rat,22224,Rattus norvegicus,13960,BAO_0000218,,0,1,,CHEMBL624855,,
11123,Autocuration,,,,Oral bioavailability in rats was determined in vivo,22224,Rattus norvegicus,13917,BAO_0000218,,0,1,,CHEMBL624856,,
11124,Autocuration,,,,Oral bioavailability in dog,22224,Canis lupus familiaris,14266,BAO_0000218,,0,1,,CHEMBL882957,,
11125,Autocuration,,,,Oral bioavailability of compound in monkey,22224,Simiiformes,12359,BAO_0000218,,0,1,,CHEMBL624857,,
11126,Intermediate,,,,Oral bioavailability of compound in rat,50597,Rattus norvegicus,12359,BAO_0000218,,1,1,,CHEMBL622202,,
11127,Autocuration,,,,Bioavailability in rat of PMEA prodrug,22224,Rattus norvegicus,12359,BAO_0000218,,0,1,,CHEMBL622203,,
11128,Intermediate,,,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,50597,Rattus norvegicus,12359,BAO_0000218,,1,1,,CHEMBL625522,,
11129,Autocuration,,,,Serum conc at 3 hours following 25 mg/kg dose,22224,Macaca mulatta,10791,BAO_0000218,,0,1,,CHEMBL622868,,
11130,Autocuration,,Urine,1088.0,Urine conc 0-5 hours following 25 mg/kg dose,22224,Macaca mulatta,10791,BAO_0000218,,0,1,,CHEMBL622869,,
11131,Autocuration,,Urine,1088.0,Urine conc 0-24 hours following 25 mg/kg dose,22224,Macaca mulatta,10791,BAO_0000218,,0,1,,CHEMBL622870,,
11132,Autocuration,,,,Oral bioavailability in African green monkeys; 20-25,22224,Chlorocebus aethiops,138,BAO_0000218,,0,1,,CHEMBL622871,,
11133,Intermediate,,,,Oral bioavailability in cynomolgus monkey.,100710,Macaca fascicularis,14521,BAO_0000218,,1,1,,CHEMBL620560,,
11134,Autocuration,,,,Oral bioavailability in dog,22224,Canis lupus familiaris,13953,BAO_0000218,,0,1,,CHEMBL620561,,
11135,Intermediate,,,,Oral bioavailability in dog at 10 mg/kg oral dose,50588,Canis lupus familiaris,12836,BAO_0000218,,1,1,,CHEMBL620562,,
11136,Intermediate,,,,Oral bioavailability in hamster at 10 mg/kg oral dose,100712,Cricetinae,12836,BAO_0000218,,1,1,,CHEMBL620563,,
11137,Intermediate,,,,Oral bioavailability in rat at 10 mg/kg oral dose,50597,Rattus norvegicus,12836,BAO_0000218,,1,1,,CHEMBL620564,,
11138,Autocuration,,,,Oral bioavailability in rat,22224,Rattus norvegicus,14521,BAO_0000218,,0,1,,CHEMBL872265,,
11139,Autocuration,,,,Oral bioavailability in rat,22224,Rattus norvegicus,13953,BAO_0000218,,0,1,,CHEMBL620565,,
11140,Autocuration,,,,Oral bioavailability,22224,Eutheria,6799,BAO_0000218,,0,1,,CHEMBL620566,,
11141,Autocuration,,,,Oral bioavailability was determined; range 49-102%,22224,,11311,BAO_0000218,,0,1,,CHEMBL620567,,
11142,Intermediate,,,,Oral bioavailability was determined in dogs,50588,Canis lupus familiaris,4013,BAO_0000218,,1,1,,CHEMBL620568,,
11143,Autocuration,,,,Oral bioavailability in rat,22224,Rattus norvegicus,4013,BAO_0000218,,0,1,,CHEMBL620569,,
11144,Autocuration,,,,Oral bioavailability,22224,Eutheria,17591,BAO_0000218,,0,1,,CHEMBL620570,,
11145,Autocuration,,,,Oral bioavailability was determined; Not orally available,22224,,17591,BAO_0000218,,0,1,,CHEMBL620571,,
11146,Intermediate,,,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),50594,Mus musculus,15011,BAO_0000218,,1,1,,CHEMBL620572,,
11147,Autocuration,,,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),22224,Mus musculus,15011,BAO_0000218,,0,1,,CHEMBL620573,,
11148,Autocuration,,,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,22224,Mus musculus,15011,BAO_0000218,,0,1,,CHEMBL620574,,
11149,Autocuration,,,,Oral bioavailability in Rhesus monkey,22224,Macaca mulatta,9552,BAO_0000218,,0,1,,CHEMBL620575,,
11150,Autocuration,,,,Oral bioavailability in dog (female mongrel),22224,Canis lupus familiaris,9552,BAO_0000218,,0,1,,CHEMBL620576,,
11151,Autocuration,,,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,22224,,3639,BAO_0000218,,0,1,,CHEMBL875846,,
11152,Autocuration,,,,Oral bioavailability in dog,22224,Canis lupus familiaris,13397,BAO_0000218,,0,1,,CHEMBL620577,,
11153,Autocuration,,,,Percentage Bioavailability was evaluated.,22224,,3031,BAO_0000218,,0,1,,CHEMBL620578,,
11154,Autocuration,,,,Bioavailability in rat administered i.d.,22224,Rattus norvegicus,12818,BAO_0000218,,0,1,,CHEMBL620579,,
11155,Autocuration,,,,Bioavailability,22224,Eutheria,4847,BAO_0000218,,0,1,,CHEMBL621248,,
11156,Autocuration,,,,Bioavailability in dog (male Beagle) i.v. administration,22224,Canis lupus familiaris,12421,BAO_0000218,,0,1,,CHEMBL625390,,
11157,Autocuration,,,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",22224,Rattus norvegicus,11966,BAO_0000218,,0,1,,CHEMBL625391,,
11158,Autocuration,,,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),22224,Primates,11218,BAO_0000218,,0,1,,CHEMBL872266,,
11159,Autocuration,,,,Oral bioavailability in rat (Sprague-Dawley) (male),22224,Rattus norvegicus,13129,BAO_0000218,,0,1,,CHEMBL625392,,
11160,Intermediate,,,,The oral bioavailability was measured on rats after oral administration,50597,Rattus norvegicus,12350,BAO_0000218,,1,1,,CHEMBL625393,,
11161,Intermediate,,,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,50597,Rattus norvegicus,2231,BAO_0000218,,1,1,,CHEMBL625394,,
11162,Intermediate,,,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,50797,Macaca mulatta,2231,BAO_0000218,,1,1,,CHEMBL625395,,
11163,Autocuration,,,,Bioavailability in rat (dose 10 mg/kg i.d.),22224,Rattus norvegicus,12187,BAO_0000218,,0,1,,CHEMBL625396,,
11164,Autocuration,,,,Bioavailability in dog (male Beagle) i.v. administration,22224,Canis lupus familiaris,12421,BAO_0000218,,0,1,,CHEMBL625397,,
11165,Intermediate,,,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL625398,,
11166,Intermediate,,Blood,178.0,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL625399,,
11167,Intermediate,,Cerebellum,2037.0,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL626074,,
11168,Intermediate,,,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL626075,,
11169,Intermediate,,Plasma,1969.0,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,50597,Rattus norvegicus,2231,BAO_0000218,,1,1,,CHEMBL626076,,
11170,Intermediate,,Plasma,1969.0,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,50797,Macaca mulatta,2231,BAO_0000218,,1,1,,CHEMBL626077,,
11171,Intermediate,,Blood,178.0,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),50597,Rattus norvegicus,12178,BAO_0000218,,1,1,,CHEMBL626078,,
11172,Autocuration,,Blood,178.0,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),22224,,12178,BAO_0000218,,0,1,,CHEMBL625846,,
11173,Autocuration,,Blood,178.0,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),22224,,12178,BAO_0000218,,0,1,,CHEMBL625847,,
11174,Expert,,,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,50597,Rattus norvegicus,15633,BAO_0000218,,1,1,,CHEMBL625848,,
11175,Intermediate,,Plasma,1969.0,Maximum concentration of compound in plasma administered orally to rats,50597,Rattus norvegicus,14258,BAO_0000218,,1,1,,CHEMBL625849,,
11176,Intermediate,,Plasma,1969.0,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",50588,Canis lupus familiaris,14224,BAO_0000218,,1,1,,CHEMBL626023,,
11177,Intermediate,,Plasma,1969.0,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",50588,Canis lupus familiaris,14224,BAO_0000218,,1,1,,CHEMBL626024,,
11178,Intermediate,,Plasma,1969.0,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",50588,Canis lupus familiaris,14224,BAO_0000218,,1,1,,CHEMBL626025,,
11179,Autocuration,,,,Maximum concentration after 10 mg/kg by oral administration,22224,,5566,BAO_0000218,,0,1,,CHEMBL626026,,
11180,Autocuration,,,,Maximum concentration at a dose of 1.5 mg/kg,22224,,16935,BAO_0000218,,0,1,,CHEMBL626027,,
11181,Autocuration,,,,Maximum concentration at a dose of 2.0 mg/kg,22224,,16935,BAO_0000218,,0,1,,CHEMBL626028,,
11182,Intermediate,,Plasma,1969.0,Maximum concentration in dog plasma,50588,Canis lupus familiaris,14224,BAO_0000218,,1,1,,CHEMBL626029,,
11183,Autocuration,,Plasma,1969.0,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,22224,,12536,BAO_0000218,,0,1,,CHEMBL626030,,
11184,Autocuration,,Plasma,1969.0,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,22224,,12536,BAO_0000218,,0,1,,CHEMBL626031,,
11185,Autocuration,,Plasma,1969.0,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,22224,,12536,BAO_0000218,,0,1,,CHEMBL626032,,
11186,Autocuration,,Plasma,1969.0,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,22224,,12536,BAO_0000218,,0,1,,CHEMBL626033,,
11187,Autocuration,,Plasma,1969.0,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,22224,,12536,BAO_0000218,,0,1,,CHEMBL626034,,
11188,Intermediate,,Plasma,1969.0,Maximum concentration in plasma after oral administration in dog (25 mg/kg),50588,Canis lupus familiaris,9994,BAO_0000218,,1,1,,CHEMBL626035,,
11189,Autocuration,,Plasma,1969.0,Maximum concentration in plasma at Tmax,22224,,1434,BAO_0000218,,0,1,,CHEMBL626036,,
11190,Expert,,Plasma,1969.0,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,50588,Canis lupus familiaris,12836,BAO_0000218,,1,1,,CHEMBL626037,,
11191,Intermediate,,Plasma,1969.0,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,100712,Cricetinae,12836,BAO_0000218,,1,1,,CHEMBL626038,,
11192,Intermediate,,Plasma,1969.0,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,50597,Rattus norvegicus,12836,BAO_0000218,,1,1,,CHEMBL626039,,
11193,Intermediate,,Plasma,1969.0,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,50597,Rattus norvegicus,12545,BAO_0000218,,1,1,,CHEMBL626040,,
11194,Intermediate,,Plasma,1969.0,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,50592,Oryctolagus cuniculus,13856,BAO_0000218,,1,1,,CHEMBL626041,,
11195,Autocuration,,,,Maximum concentration was calculated,22224,,3550,BAO_0000218,,0,1,,CHEMBL626042,,
11196,Autocuration,,,,Maximum concentration was calculated.,22224,,2632,BAO_0000218,,0,1,,CHEMBL626043,,
11197,Autocuration,,,,Maximum concentration at a peroral dose of 10 mg/kg,22224,,5566,BAO_0000218,,0,1,,CHEMBL626044,,
11198,Autocuration,,,,Maximum concentration of the drug at 10 uM/dg administered perorally,22224,,11883,BAO_0000218,,0,1,,CHEMBL626045,,
11199,Autocuration,,,,Maximum concentration of the drug at 2 uM/dg administered intravenously,22224,,11883,BAO_0000218,,0,1,,CHEMBL626046,,
11200,Intermediate,,Plasma,1969.0,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",50588,Canis lupus familiaris,14122,BAO_0000218,,1,1,,CHEMBL626047,,
11201,Intermediate,,Plasma,1969.0,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",100712,Cricetinae,14122,BAO_0000218,,1,1,,CHEMBL626048,,
11202,Intermediate,,Plasma,1969.0,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",50597,Rattus norvegicus,14122,BAO_0000218,,1,1,,CHEMBL626049,,
11203,Intermediate,,Plasma,1969.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,50597,Rattus norvegicus,12542,BAO_0000218,,1,1,,CHEMBL626050,,
11204,Intermediate,,Plasma,1969.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,50588,Canis lupus familiaris,12542,BAO_0000218,,1,1,,CHEMBL874541,,
11205,Intermediate,,Plasma,1969.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,100712,Cricetinae,12542,BAO_0000218,,1,1,,CHEMBL622826,,
11206,Intermediate,,Plasma,1969.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,100712,Cricetinae,12542,BAO_0000218,,1,1,,CHEMBL622827,,
11207,Intermediate,,Plasma,1969.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,50597,Rattus norvegicus,12542,BAO_0000218,,1,1,,CHEMBL622828,,
11208,Intermediate,,Plasma,1969.0,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,50597,Rattus norvegicus,14080,BAO_0000218,,1,1,,CHEMBL622829,,
11209,Intermediate,,,,Maximum concentration reached following intravenous administration in male rat,50597,Rattus norvegicus,11911,BAO_0000218,,1,1,,CHEMBL876806,,
11210,Intermediate,,,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,50588,Canis lupus familiaris,13204,BAO_0000218,,1,1,,CHEMBL622830,,
11211,Intermediate,,,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,50597,Rattus norvegicus,13204,BAO_0000218,,1,1,,CHEMBL622831,,
11212,Intermediate,,,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,50588,Canis lupus familiaris,14346,BAO_0000218,,1,1,,CHEMBL626794,,
11213,Intermediate,,,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL626795,,
11214,Intermediate,,,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL626796,,
11215,Intermediate,,,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL626797,,
11216,Intermediate,,,,Maximum drug concentration is determined after oral dosing in rats.,50597,Rattus norvegicus,14127,BAO_0000218,,1,1,,CHEMBL626798,,
11217,Intermediate,,,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,50588,Canis lupus familiaris,14339,BAO_0000218,,1,1,,CHEMBL626799,,
11218,Intermediate,,,,Maximum observed concentration in oral (5 mg/kg) fed dogs,50588,Canis lupus familiaris,14339,BAO_0000218,,1,1,,CHEMBL626800,,
11219,Autocuration,,Plasma,1969.0,Maximum plasma concentration,22224,,13494,BAO_0000218,,0,1,,CHEMBL626801,,
11220,Intermediate,,Plasma,1969.0,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,50597,Rattus norvegicus,14925,BAO_0000218,,1,1,,CHEMBL876816,,
11221,Intermediate,,Plasma,1969.0,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,50597,Rattus norvegicus,14474,BAO_0000218,,1,1,,CHEMBL626802,,
11222,Intermediate,,Plasma,1969.0,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,50588,Canis lupus familiaris,14474,BAO_0000218,,1,1,,CHEMBL626803,,
11223,Autocuration,,Plasma,1969.0,Maximum plasma concentration following oral administration of 30 umol/kg,22224,,13917,BAO_0000218,,0,1,,CHEMBL626804,,
11224,Intermediate,,Plasma,1969.0,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL626805,,
11225,Intermediate,,Plasma,1969.0,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL626309,,
11226,Intermediate,,Plasma,1969.0,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL626310,,
11227,Intermediate,,Plasma,1969.0,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL626311,,
11228,Intermediate,,Plasma,1969.0,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL626312,,
11229,Intermediate,,Uterus,995.0,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL626313,,
11230,Intermediate,,Uterus,995.0,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL626314,,
11231,Intermediate,,Uterus,995.0,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL626315,,
11232,Intermediate,,Uterus,995.0,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL626316,,
11233,Intermediate,,Uterus,995.0,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,50597,Rattus norvegicus,9796,BAO_0000218,,1,1,,CHEMBL626317,,
11234,Intermediate,,,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),50597,Rattus norvegicus,8363,BAO_0000218,,1,1,,CHEMBL626318,,
11235,Intermediate,,,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),50597,Rattus norvegicus,8363,BAO_0000218,,1,1,,CHEMBL626319,,
11236,Intermediate,,,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),50597,Rattus norvegicus,8363,BAO_0000218,,1,1,,CHEMBL626320,,
11237,Intermediate,,,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),50597,Rattus norvegicus,8363,BAO_0000218,,1,1,,CHEMBL875053,,
11238,Intermediate,,,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),50597,Rattus norvegicus,8363,BAO_0000218,,1,1,,CHEMBL626321,,
11239,Intermediate,,,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),50597,Rattus norvegicus,8363,BAO_0000218,,1,1,,CHEMBL626322,,
11240,Intermediate,,,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),50597,Rattus norvegicus,8363,BAO_0000218,,1,1,,CHEMBL626323,,
11241,Intermediate,,,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),50597,Rattus norvegicus,8363,BAO_0000218,,1,1,,CHEMBL626324,,
11242,Intermediate,,,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),50597,Rattus norvegicus,8363,BAO_0000218,,1,1,,CHEMBL626325,,
11243,Intermediate,,,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),50597,Rattus norvegicus,8363,BAO_0000218,,1,1,,CHEMBL626326,,
11244,Intermediate,,,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),50597,Rattus norvegicus,8363,BAO_0000218,,1,1,,CHEMBL626327,,
11245,Intermediate,,,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),50597,Rattus norvegicus,8363,BAO_0000218,,1,1,,CHEMBL626328,,
11246,Intermediate,,Blood,178.0,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL626329,,
11247,Intermediate,,Blood,178.0,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL626330,,
11248,Intermediate,,Blood,178.0,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL626331,,
11249,Intermediate,,Blood,178.0,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL626332,,
11250,Intermediate,,Blood,178.0,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL626333,,
11251,Intermediate,,Blood,178.0,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL626334,,
11252,Intermediate,,Blood,178.0,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL626335,,
11253,Intermediate,,Blood,178.0,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624798,,
11254,Intermediate,,Brain,955.0,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624799,,
11255,Intermediate,,Brain,955.0,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624800,,
11256,Intermediate,,Brain,955.0,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624801,,
11257,Intermediate,,Brain,955.0,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624802,,
11258,Intermediate,,Brain,955.0,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624803,,
11259,Intermediate,,Brain,955.0,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624804,,
11260,Intermediate,,Brain,955.0,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624805,,
11261,Intermediate,,Brain,955.0,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624806,,
11262,Intermediate,,,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624807,,
11263,Intermediate,,,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624808,,
11264,Intermediate,,,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624809,,
11265,Intermediate,,,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624810,,
11266,Intermediate,,,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL877618,,
11267,Intermediate,,,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624811,,
11268,Intermediate,,,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624812,,
11269,Intermediate,,,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624813,,
11270,Intermediate,,,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624814,,
11271,Intermediate,,,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624815,,
11272,Intermediate,,,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624816,,
11273,Intermediate,,,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624817,,
11274,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624818,,
11275,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624819,,
11276,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624820,,
11277,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624821,,
11278,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624822,,
11279,Intermediate,,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624823,,
11280,Intermediate,,,,Observed diffusion coefficient in organic solvent for Escherichia coli,50212,Escherichia coli,15599,BAO_0000218,,1,1,,CHEMBL624824,,
11281,Intermediate,,Blood,178.0,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",50597,Rattus norvegicus,9614,BAO_0000218,,1,1,,CHEMBL624825,,
11282,Intermediate,,Blood,178.0,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",50597,Rattus norvegicus,9614,BAO_0000218,,1,1,,CHEMBL624826,,
11283,Intermediate,,Cardiac atrium,2081.0,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",50597,Rattus norvegicus,9614,BAO_0000218,,1,1,,CHEMBL876817,,
11284,Intermediate,,Cardiac atrium,2081.0,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",50597,Rattus norvegicus,9614,BAO_0000218,,1,1,,CHEMBL624827,,
11285,Intermediate,,,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",50597,Rattus norvegicus,9614,BAO_0000218,,1,1,,CHEMBL624828,,
11286,Intermediate,,,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",50597,Rattus norvegicus,9614,BAO_0000218,,1,1,,CHEMBL624829,,
11287,Intermediate,,Liver,2107.0,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",50597,Rattus norvegicus,9614,BAO_0000218,,1,1,,CHEMBL624830,,
11288,Intermediate,,Liver,2107.0,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",50597,Rattus norvegicus,9614,BAO_0000218,,1,1,,CHEMBL624831,,
11289,Intermediate,,Cardiac atrium,2081.0,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",50597,Rattus norvegicus,9614,BAO_0000218,,1,1,,CHEMBL624832,,
11290,Intermediate,,Cardiac atrium,2081.0,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",50597,Rattus norvegicus,9614,BAO_0000218,,1,1,,CHEMBL624833,,
11291,Intermediate,,,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",50597,Rattus norvegicus,9614,BAO_0000218,,1,1,,CHEMBL624834,,
11292,Intermediate,,,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",50597,Rattus norvegicus,9614,BAO_0000218,,1,1,,CHEMBL624835,,
11293,Intermediate,,Spleen,2106.0,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",50597,Rattus norvegicus,9614,BAO_0000218,,1,1,,CHEMBL624836,,
11294,Intermediate,,Spleen,2106.0,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",50597,Rattus norvegicus,9614,BAO_0000218,,1,1,,CHEMBL624837,,
11295,Intermediate,,Blood,178.0,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,50597,Rattus norvegicus,9071,BAO_0000218,,1,1,,CHEMBL624838,,
11296,Intermediate,,Blood,178.0,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,50597,Rattus norvegicus,9071,BAO_0000218,,1,1,,CHEMBL622188,,
11297,Intermediate,,Heart,948.0,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,50597,Rattus norvegicus,9071,BAO_0000218,,1,1,,CHEMBL622189,,
11298,Intermediate,,Heart,948.0,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,50597,Rattus norvegicus,9071,BAO_0000218,,1,1,,CHEMBL622190,,
11299,Intermediate,,Heart,948.0,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,50597,Rattus norvegicus,9071,BAO_0000218,,1,1,,CHEMBL625170,,
11300,Intermediate,,Kidney,2113.0,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,50597,Rattus norvegicus,9071,BAO_0000218,,1,1,,CHEMBL625171,,
11301,Intermediate,,Kidney,2113.0,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,50597,Rattus norvegicus,9071,BAO_0000218,,1,1,,CHEMBL625172,,
11302,Intermediate,,Kidney,2113.0,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,50597,Rattus norvegicus,9071,BAO_0000218,,1,1,,CHEMBL625173,,
11303,Intermediate,,Liver,2107.0,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,50597,Rattus norvegicus,9071,BAO_0000218,,1,1,,CHEMBL625174,,
11304,Intermediate,,Liver,2107.0,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,50597,Rattus norvegicus,9071,BAO_0000218,,1,1,,CHEMBL625175,,
11305,Intermediate,,Liver,2107.0,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,50597,Rattus norvegicus,9071,BAO_0000218,,1,1,,CHEMBL625176,,
11306,Intermediate,,Lung,2048.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,50597,Rattus norvegicus,9071,BAO_0000218,,1,1,,CHEMBL625177,,
11307,Intermediate,,Lung,2048.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,50597,Rattus norvegicus,9071,BAO_0000218,,1,1,,CHEMBL625178,,
11308,Intermediate,,Lung,2048.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,50597,Rattus norvegicus,9071,BAO_0000218,,1,1,,CHEMBL625179,,
11309,Intermediate,,Lung,2048.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,50597,Rattus norvegicus,9071,BAO_0000218,,1,1,,CHEMBL625180,,
11310,Autocuration,,,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",22224,,10677,BAO_0000218,,0,1,,CHEMBL625181,,
11311,Intermediate,,Urine,1088.0,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,50594,Mus musculus,9750,BAO_0000218,,1,1,,CHEMBL625182,,
11312,Intermediate,,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL625183,,
11313,Intermediate,,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL875848,,
11314,Intermediate,,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL622260,,
11315,Intermediate,,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL622261,,
11316,Intermediate,,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL622262,,
11317,Intermediate,,Kidney,2113.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL622263,,
11318,Intermediate,,Kidney,2113.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL622418,,
11319,Intermediate,,Liver,2107.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL622419,,
11320,Intermediate,,,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL623388,,
11321,Intermediate,,Liver,2107.0,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL623389,,
11322,Intermediate,,,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL623390,,
11323,Intermediate,,,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL623391,,
11324,Intermediate,,Blood,178.0,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL623392,,
11325,Intermediate,,Cerebellum,2037.0,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL623393,,
11326,Intermediate,,,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL623394,,
11327,Intermediate,,,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL618885,,
11328,Intermediate,,Liver,2107.0,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL618886,,
11329,Intermediate,,,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL618887,,
11330,Intermediate,,,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL619535,,
11331,Intermediate,,Blood,178.0,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL619536,,
11332,Intermediate,,Cerebellum,2037.0,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL619537,,
11333,Intermediate,,,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL619705,,
11334,Intermediate,,,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL619706,,
11335,Intermediate,,Liver,2107.0,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL619707,,
11336,Intermediate,,,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL619708,,
11337,Intermediate,,,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL625219,,
11338,Intermediate,,Blood,178.0,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL625220,,
11339,Intermediate,,Cerebellum,2037.0,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL625221,,
11340,Intermediate,,,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL625222,,
11341,Intermediate,,,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL625223,,
11342,Intermediate,,Liver,2107.0,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL625224,,
11343,Intermediate,,,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),50594,Mus musculus,13256,BAO_0000218,,1,1,,CHEMBL625225,,
11344,Intermediate,,Blood,178.0,Biodistribution in Rat blood after 24 hours of iv administration,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL625226,,
11345,Intermediate,,Blood,178.0,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL625227,,
11346,Intermediate,,Blood,178.0,Biodistribution in Rat blood after 30 minutes of iv administration,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL625228,,
11347,Intermediate,,Blood,178.0,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL875354,,
11348,Intermediate,,Blood,178.0,Biodistribution in Rat blood after 5 minutes of iv administration,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL625229,,
11349,Intermediate,,Blood,178.0,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL625230,,
11350,Intermediate,,Heart,948.0,Biodistribution in Rat heart after 24 hours of iv administration,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL625231,,
11351,Intermediate,,Heart,948.0,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL625900,,
11352,Intermediate,,Heart,948.0,Biodistribution in Rat heart after 30 minutes of iv administration,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL625901,,
11353,Intermediate,,Heart,948.0,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL625902,,
11354,Intermediate,,Heart,948.0,Biodistribution in Rat heart after 5 minutes of iv administration,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL625903,,
11355,Intermediate,,Heart,948.0,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL625904,,
11356,Intermediate,,Liver,2107.0,Biodistribution in Rat liver after 24 hours of iv administration,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL625905,,
11357,Intermediate,,Liver,2107.0,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL627861,,
11358,Intermediate,,Liver,2107.0,Biodistribution in Rat liver after 30 minutes of iv administration,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL627862,,
11359,Intermediate,,Liver,2107.0,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL627863,,
11360,Intermediate,,Liver,2107.0,Biodistribution in Rat liver after 30 minutes of iv administration,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL627769,,
11361,Intermediate,,Plasma,1969.0,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,50588,Canis lupus familiaris,13249,BAO_0000218,,1,1,,CHEMBL627770,,
11362,Intermediate,,,,Cmax in cynomolgus monkey (PO dose),100710,Macaca fascicularis,13622,BAO_0000218,,1,1,,CHEMBL627771,,
11363,Intermediate,,,,Cmax in rat (PO dose),50597,Rattus norvegicus,13622,BAO_0000218,,1,1,,CHEMBL627772,,
11364,Intermediate,,,,Cmax in rat (PO dose),50597,Rattus norvegicus,13622,BAO_0000218,,1,1,,CHEMBL627773,,
11365,Intermediate,,Plasma,1969.0,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,50597,Rattus norvegicus,13494,BAO_0000218,,1,1,,CHEMBL621922,,
11366,Intermediate,,Plasma,1969.0,Cmax in rat plasma after oral dose (10 mg/kg),50597,Rattus norvegicus,12170,BAO_0000218,,1,1,,CHEMBL621923,,
11367,Autocuration,,Plasma,1969.0,Cmax in plasma after oral dose (10 mg/kg),22224,,12170,BAO_0000218,,0,1,,CHEMBL621924,,
11368,Intermediate,,Plasma,1969.0,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,50588,Canis lupus familiaris,17025,BAO_0000218,,1,1,,CHEMBL621925,,
11369,Autocuration,,Plasma,1969.0,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,22224,Simiiformes,17025,BAO_0000218,,0,1,,CHEMBL621926,,
11370,Intermediate,,Plasma,1969.0,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,50592,Oryctolagus cuniculus,17025,BAO_0000218,,1,1,,CHEMBL621927,,
11371,Intermediate,,Plasma,1969.0,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,50597,Rattus norvegicus,17025,BAO_0000218,,1,1,,CHEMBL621928,,
11372,Intermediate,,Plasma,1969.0,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,50597,Rattus norvegicus,14187,BAO_0000218,,1,1,,CHEMBL621929,,
11373,Intermediate,,Plasma,1969.0,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,50594,Mus musculus,14816,BAO_0000218,,1,1,,CHEMBL621930,,
11374,Intermediate,,Plasma,1969.0,Maximum plasma concentration after oral dosing in rat,50597,Rattus norvegicus,17820,BAO_0000218,,1,1,,CHEMBL621931,,
11375,Autocuration,,Plasma,1969.0,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL621932,,
11376,Autocuration,,Plasma,1969.0,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL621933,,
11377,Intermediate,,Plasma,1969.0,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,50588,Canis lupus familiaris,14691,BAO_0000218,,1,1,,CHEMBL621934,,
11378,Intermediate,,Plasma,1969.0,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,50588,Canis lupus familiaris,14691,BAO_0000218,,1,1,,CHEMBL621935,,
11379,Intermediate,,Plasma,1969.0,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,50597,Rattus norvegicus,13375,BAO_0000218,,1,1,,CHEMBL621936,,
11380,Autocuration,,Plasma,1969.0,Maximum plasma concentration was determined,22224,,6236,BAO_0000218,,0,1,,CHEMBL621937,,
11381,Autocuration,,Plasma,1969.0,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL621938,,
11382,Autocuration,,Plasma,1969.0,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL621939,,
11383,Autocuration,,Plasma,1969.0,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL621940,,
11384,Autocuration,,Plasma,1969.0,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL621941,,
11385,Autocuration,,Plasma,1969.0,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL621942,,
11386,Autocuration,,Plasma,1969.0,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL626178,,
11387,Autocuration,,Plasma,1969.0,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL626179,,
11388,Autocuration,,Plasma,1969.0,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL626180,,
11389,Intermediate,,Plasma,1969.0,Plasma Cmax in rat (PO dose),50597,Rattus norvegicus,13622,BAO_0000218,,1,1,,CHEMBL626181,,
11390,Intermediate,,,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL626182,,
11391,Intermediate,,,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL626183,,
11392,Intermediate,,,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL626184,,
11393,Intermediate,,,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL626185,,
11394,Intermediate,,Plasma,1969.0,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,50588,Canis lupus familiaris,14925,BAO_0000218,,1,1,,CHEMBL626186,,
11395,Intermediate,,Plasma,1969.0,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,50588,Canis lupus familiaris,14925,BAO_0000218,,1,1,,CHEMBL877589,,
11396,Autocuration,,,,Maximum concentration of the drug at 1 uM/dg administered intravenously,22224,,11883,BAO_0000218,,0,1,,CHEMBL626187,,
11397,Autocuration,,,,Maximum concentration of the drug at 20 uM/dg administered perorally,22224,,11883,BAO_0000218,,0,1,,CHEMBL626188,,
11398,Autocuration,,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,22224,,13391,BAO_0000218,,0,1,,CHEMBL626189,,
11399,Autocuration,,Blood,178.0,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,22224,,13391,BAO_0000218,,0,1,,CHEMBL626855,,
11400,Autocuration,,Blood,178.0,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,22224,,13391,BAO_0000218,,0,1,,CHEMBL623781,,
11401,Autocuration,,Blood,178.0,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,22224,,13391,BAO_0000218,,0,1,,CHEMBL623782,,
11402,Intermediate,,Plasma,1969.0,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,50597,Rattus norvegicus,16360,BAO_0000218,,1,1,,CHEMBL623783,,
11403,Intermediate,,Plasma,1969.0,Cmax in dog plasma after 1mg/kg oral dose,50588,Canis lupus familiaris,3673,BAO_0000218,,1,1,,CHEMBL623784,,
11404,Intermediate,,Plasma,1969.0,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,50588,Canis lupus familiaris,14431,BAO_0000218,,1,1,,CHEMBL623785,,
11405,Intermediate,,Plasma,1969.0,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,50597,Rattus norvegicus,14431,BAO_0000218,,1,1,,CHEMBL623786,,
11406,Intermediate,,,,Oral maximum concentration in rat,50597,Rattus norvegicus,14964,BAO_0000218,,1,1,,CHEMBL623787,,
11407,Intermediate,,,,Oral maximum concentration in rat,50597,Rattus norvegicus,14964,BAO_0000218,,1,1,,CHEMBL623788,,
11408,Intermediate,,Plasma,1969.0,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,50594,Mus musculus,14209,BAO_0000218,,1,1,,CHEMBL623789,,
11409,Intermediate,,Blood,178.0,Peak concentration in blood after intravenous administration to mice,50594,Mus musculus,11355,BAO_0000218,,1,1,,CHEMBL623790,,
11410,Intermediate,,Blood,178.0,Peak concentration in blood after peroral administration to mice,50594,Mus musculus,11355,BAO_0000218,,1,1,,CHEMBL623791,,
11411,Intermediate,,Plasma,1969.0,Peak concentration in rat plasma was determined,50597,Rattus norvegicus,11966,BAO_0000218,,1,1,,CHEMBL623792,,
11412,Autocuration,,Plasma,1969.0,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,22224,Simiiformes,8918,BAO_0000218,,0,1,,CHEMBL623793,,
11413,Intermediate,,Plasma,1969.0,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,50594,Mus musculus,8918,BAO_0000218,,1,1,,CHEMBL623794,,
11414,Intermediate,,Plasma,1969.0,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,50597,Rattus norvegicus,8918,BAO_0000218,,1,1,,CHEMBL623795,,
11415,Intermediate,,,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623796,,
11416,Intermediate,,,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623797,,
11417,Intermediate,,,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623798,,
11418,Intermediate,,,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623799,,
11419,Intermediate,,Intestine,160.0,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624490,,
11420,Intermediate,,Intestine,160.0,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624491,,
11421,Intermediate,,Intestine,160.0,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624492,,
11422,Intermediate,,Intestine,160.0,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624493,,
11423,Intermediate,,Intestine,160.0,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL877595,,
11424,Intermediate,,Intestine,160.0,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624494,,
11425,Intermediate,,Intestine,160.0,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624495,,
11426,Intermediate,,Intestine,160.0,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624681,,
11427,Intermediate,,,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624682,,
11428,Intermediate,,,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624683,,
11429,Intermediate,,,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624684,,
11430,Intermediate,,,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624685,,
11431,Intermediate,,,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624686,,
11432,Intermediate,,,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624687,,
11433,Intermediate,,,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624688,,
11434,Intermediate,,,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL627161,,
11435,Intermediate,,,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL622127,,
11436,Intermediate,,,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL622128,,
11437,Intermediate,,,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL874384,,
11438,Intermediate,,,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624898,,
11439,Intermediate,,,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624899,,
11440,Intermediate,,,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624900,,
11441,Intermediate,,,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624901,,
11442,Intermediate,,,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624902,,
11443,Intermediate,,,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624903,,
11444,Intermediate,,,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624904,,
11445,Intermediate,,,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624905,,
11446,Intermediate,,,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624906,,
11447,Intermediate,,,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624907,,
11448,Intermediate,,,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624908,,
11449,Intermediate,,,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624909,,
11450,Intermediate,,,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624910,,
11451,Intermediate,,Muscle tissue,2385.0,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624911,,
11452,Intermediate,,Muscle tissue,2385.0,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL874388,,
11453,Intermediate,,Muscle tissue,2385.0,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL624912,,
11454,Intermediate,,Muscle tissue,2385.0,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL622930,,
11455,Intermediate,,Muscle tissue,2385.0,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623121,,
11456,Intermediate,,Muscle tissue,2385.0,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623122,,
11457,Intermediate,,Muscle tissue,2385.0,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623123,,
11458,Intermediate,,Muscle tissue,2385.0,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623124,,
11459,Intermediate,,,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623125,,
11460,Intermediate,,,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623126,,
11461,Intermediate,,,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623127,,
11462,Intermediate,,,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623128,,
11463,Intermediate,,,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623129,,
11464,Intermediate,,,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623130,,
11465,Intermediate,,,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623131,,
11466,Intermediate,,,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL623132,,
11467,Intermediate,,Liver,2107.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL623133,,
11468,Intermediate,,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL623134,,
11469,Intermediate,,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL874389,,
11470,Intermediate,,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL623135,,
11471,Intermediate,,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL623136,,
11472,Intermediate,,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL623137,,
11473,Intermediate,,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL623138,,
11474,Intermediate,,Kidney,2113.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL623139,,
11475,Intermediate,,Kidney,2113.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL623140,,
11476,Intermediate,,Liver,2107.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL623141,,
11477,Intermediate,,Liver,2107.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL623142,,
11478,Intermediate,,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL623143,,
11479,Intermediate,,Urine,1088.0,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,50594,Mus musculus,14571,BAO_0000218,,1,1,,CHEMBL623144,,
11480,Intermediate,,Urine,1088.0,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,50597,Rattus norvegicus,14571,BAO_0000218,,1,1,,CHEMBL623405,,
11481,Intermediate,,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624074,,
11482,Intermediate,,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624075,,
11483,Intermediate,,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624076,,
11484,Intermediate,,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624077,,
11485,Intermediate,,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624078,,
11486,Intermediate,,Kidney,2113.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624079,,
11487,Intermediate,,Kidney,2113.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624261,,
11488,Intermediate,,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624262,,
11489,Intermediate,,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624263,,
11490,Intermediate,,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624264,,
11491,Intermediate,,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624265,,
11492,Intermediate,,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624266,,
11493,Intermediate,,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624267,,
11494,Intermediate,,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624268,,
11495,Intermediate,,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL875227,,
11496,Intermediate,,Kidney,2113.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624269,,
11497,Intermediate,,Kidney,2113.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624270,,
11498,Intermediate,,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624271,,
11499,Intermediate,,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624272,,
11500,Intermediate,,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,50597,Rattus norvegicus,8319,BAO_0000218,,1,1,,CHEMBL624273,,
11501,Intermediate,,Urine,1088.0,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,50597,Rattus norvegicus,12064,BAO_0000218,,1,1,,CHEMBL624274,,
11502,Intermediate,,Urine,1088.0,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,50597,Rattus norvegicus,12064,BAO_0000218,,1,1,,CHEMBL624275,,
11503,Intermediate,,Urine,1088.0,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,50597,Rattus norvegicus,12064,BAO_0000218,,1,1,,CHEMBL624276,,
11504,Intermediate,,Urine,1088.0,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,50597,Rattus norvegicus,12038,BAO_0000218,,1,1,,CHEMBL624277,,
11505,Autocuration,,,,% dose converted to 2-amino-5-chlorophenyl sulfate,22224,,14314,BAO_0000019,,0,1,,CHEMBL624278,,
11506,Autocuration,,,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),22224,,14314,BAO_0000019,,0,1,,CHEMBL624279,,
11507,Intermediate,,Feces,1988.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL624280,,
11508,Intermediate,,Feces,1988.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL624281,,
11509,Intermediate,,Feces,1988.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL622933,,
11510,Intermediate,,Feces,1988.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL622934,,
11511,Intermediate,,Liver,2107.0,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL622935,,
11512,Intermediate,,Liver,2107.0,Biodistribution in Rat liver after 5 minutes of iv administration,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL622936,,
11513,Intermediate,,Liver,2107.0,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL875228,,
11514,Intermediate,,Lung,2048.0,Biodistribution in Rat lung after 24 hours of iv administration,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL622937,,
11515,Intermediate,,Lung,2048.0,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL622938,,
11516,Intermediate,,Lung,2048.0,Biodistribution in Rat lung after 30 minutes of iv administration,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL619736,,
11517,Intermediate,,Lung,2048.0,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL625117,,
11518,Intermediate,,Lung,2048.0,Biodistribution in Rat lung after 5 minutes of iv administration,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL625118,,
11519,Intermediate,,Lung,2048.0,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,50597,Rattus norvegicus,8829,BAO_0000218,,1,1,,CHEMBL625119,,
11520,Intermediate,,Cerebellum,2037.0,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",50597,Rattus norvegicus,14972,BAO_0000218,,1,1,,CHEMBL625120,,
11521,Intermediate,,,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",50597,Rattus norvegicus,14972,BAO_0000218,,1,1,,CHEMBL625121,,
11522,Intermediate,,Thalamus,10000006.0,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",50597,Rattus norvegicus,14972,BAO_0000218,,1,1,,CHEMBL625122,,
11523,Intermediate,,Blood,178.0,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL622204,,
11524,Intermediate,,Blood,178.0,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL877503,,
11525,Intermediate,,Blood,178.0,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL627127,,
11526,Autocuration,,Hippocampus,10000000.0,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,22224,,14608,BAO_0000218,,0,1,,CHEMBL627128,,
11527,Autocuration,,Hippocampus,10000000.0,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,22224,,14608,BAO_0000218,,0,1,,CHEMBL627129,,
11528,Autocuration,,Hippocampus,10000000.0,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,22224,,14608,BAO_0000218,,0,1,,CHEMBL627130,,
11529,Intermediate,,Brain,955.0,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL627131,,
11530,Intermediate,,Brain,955.0,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL627132,,
11531,Intermediate,,Brain,955.0,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL627133,,
11532,Intermediate,,Cerebellum,2037.0,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL627134,,
11533,Intermediate,,Cerebellum,2037.0,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL627135,,
11534,Intermediate,,Cerebellum,2037.0,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL627136,,
11535,Intermediate,,,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL628435,,
11536,Intermediate,,,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL628436,,
11537,Intermediate,,,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL628437,,
11538,Intermediate,,Heart,948.0,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL628438,,
11539,Intermediate,,Heart,948.0,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL628439,,
11540,Intermediate,,Heart,948.0,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL628440,,
11541,Intermediate,,Hippocampus,10000000.0,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL628441,,
11542,Intermediate,,Hippocampus,10000000.0,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL628442,,
11543,Intermediate,,Hippocampus,10000000.0,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL628443,,
11544,Intermediate,,Kidney,2113.0,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL628444,,
11545,Intermediate,,Kidney,2113.0,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL628445,,
11546,Intermediate,,Kidney,2113.0,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL877504,,
11547,Intermediate,,Liver,2107.0,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL628446,,
11548,Intermediate,,Liver,2107.0,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL626874,,
11549,Intermediate,,Liver,2107.0,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL626875,,
11550,Intermediate,,Lung,2048.0,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL626876,,
11551,Intermediate,,Lung,2048.0,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL626877,,
11552,Intermediate,,Lung,2048.0,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL626878,,
11553,Intermediate,,Muscle tissue,2385.0,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL626879,,
11554,Autocuration,,Plasma,1969.0,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,22224,Simiiformes,8918,BAO_0000218,,0,1,,CHEMBL626880,,
11555,Intermediate,,Plasma,1969.0,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,50594,Mus musculus,8918,BAO_0000218,,1,1,,CHEMBL626881,,
11556,Intermediate,,Plasma,1969.0,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,50597,Rattus norvegicus,8918,BAO_0000218,,1,1,,CHEMBL626882,,
11557,Intermediate,,Plasma,1969.0,Peak plasma concentration was measured in dogs,50588,Canis lupus familiaris,14470,BAO_0000218,,1,1,,CHEMBL626883,,
11558,Intermediate,,,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,50597,Rattus norvegicus,14393,BAO_0000218,,1,1,,CHEMBL626884,,
11559,Intermediate,,,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,50597,Rattus norvegicus,14886,BAO_0000218,,1,1,,CHEMBL626885,,
11560,Intermediate,,,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,50597,Rattus norvegicus,14886,BAO_0000218,,1,1,,CHEMBL626886,,
11561,Intermediate,,,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,50597,Rattus norvegicus,14886,BAO_0000218,,1,1,,CHEMBL626887,,
11562,Intermediate,,,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,50597,Rattus norvegicus,14393,BAO_0000218,,1,1,,CHEMBL626888,,
11563,Intermediate,,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,50588,Canis lupus familiaris,13465,BAO_0000218,,1,1,,CHEMBL626889,,
11564,Autocuration,,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,22224,Simiiformes,13465,BAO_0000218,,0,1,,CHEMBL626761,,
11565,Intermediate,,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,50588,Canis lupus familiaris,13465,BAO_0000218,,1,1,,CHEMBL626762,,
11566,Intermediate,,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,50588,Canis lupus familiaris,13465,BAO_0000218,,1,1,,CHEMBL626763,,
11567,Intermediate,,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,50597,Rattus norvegicus,13465,BAO_0000218,,1,1,,CHEMBL626764,,
11568,Intermediate,,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,50597,Rattus norvegicus,13465,BAO_0000218,,1,1,,CHEMBL626765,,
11569,Intermediate,,,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,50588,Canis lupus familiaris,13465,BAO_0000218,,1,1,,CHEMBL626766,,
11570,Intermediate,,,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,50597,Rattus norvegicus,13465,BAO_0000218,,1,1,,CHEMBL626767,,
11571,Intermediate,,,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,50597,Rattus norvegicus,13465,BAO_0000218,,1,1,,CHEMBL626768,,
11572,Intermediate,,,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,50588,Canis lupus familiaris,13465,BAO_0000218,,1,1,,CHEMBL626769,,
11573,Intermediate,,,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,50588,Canis lupus familiaris,13465,BAO_0000218,,1,1,,CHEMBL874463,,
11574,Autocuration,,,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,22224,Simiiformes,13465,BAO_0000218,,0,1,,CHEMBL626770,,
11575,Autocuration,,,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,22224,Simiiformes,13465,BAO_0000218,,0,1,,CHEMBL626771,,
11576,Intermediate,,,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,50597,Rattus norvegicus,13465,BAO_0000218,,1,1,,CHEMBL626772,,
11577,Intermediate,,,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,100710,Macaca fascicularis,14731,BAO_0000218,,1,1,,CHEMBL626773,,
11578,Intermediate,,,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,50594,Mus musculus,14731,BAO_0000218,,1,1,,CHEMBL626774,,
11579,Intermediate,,,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,50588,Canis lupus familiaris,13376,BAO_0000218,,1,1,,CHEMBL626775,,
11580,Intermediate,,,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,50588,Canis lupus familiaris,13376,BAO_0000218,,1,1,,CHEMBL626776,,
11581,Intermediate,,,,Maximum concentration (Cmax) in rat when administered orally,50597,Rattus norvegicus,14443,BAO_0000218,,1,1,,CHEMBL626777,,
11582,Autocuration,,Plasma,1969.0,Maximal concentration in monkey plasma after 25 mg/kg oral dose,22224,Simiiformes,13465,BAO_0000218,,0,1,,CHEMBL626778,,
11583,Autocuration,,,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",22224,Rattus norvegicus,16359,BAO_0000218,,0,1,,CHEMBL626779,,
11584,Autocuration,,,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",22224,Rattus norvegicus,16359,BAO_0000218,,0,1,,CHEMBL626780,,
11585,Autocuration,,Plasma,1969.0,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,22224,,15618,BAO_0000218,,0,1,,CHEMBL626781,,
11586,Intermediate,,,,Pharmacokinetic profile Cmax was evaluated in rats,50597,Rattus norvegicus,14554,BAO_0000218,,1,1,,CHEMBL632164,,
11587,Intermediate,,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),50588,Canis lupus familiaris,11537,BAO_0000218,,1,1,,CHEMBL632165,,
11588,Intermediate,,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),50594,Mus musculus,11537,BAO_0000218,,1,1,,CHEMBL632166,,
11589,Intermediate,,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),50588,Canis lupus familiaris,11537,BAO_0000218,,1,1,,CHEMBL632167,,
11590,Intermediate,,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),50594,Mus musculus,11537,BAO_0000218,,1,1,,CHEMBL632168,,
11591,Autocuration,,Plasma,1969.0,Cmax in rat plasma,22224,Rattus norvegicus,2021,BAO_0000218,,0,1,,CHEMBL632169,,
11592,Intermediate,,Plasma,1969.0,Cmax in dog plasma after 30mg/kg oral dose,50588,Canis lupus familiaris,5932,BAO_0000218,,1,1,,CHEMBL632170,,
11593,Intermediate,,Plasma,1969.0,Cmax in rat plasma after 30mg/kg oral dose,50597,Rattus norvegicus,5932,BAO_0000218,,1,1,,CHEMBL632171,,
11594,Intermediate,,Plasma,1969.0,Plasma level in rats at 30 mg/kg,50597,Rattus norvegicus,17320,BAO_0000218,,1,1,,CHEMBL632172,,
11595,Intermediate,,Plasma,1969.0,Tested for maximum plasma concentration in mice,50594,Mus musculus,15831,BAO_0000218,,1,1,,CHEMBL632173,,
11596,Intermediate,,,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL632174,,
11597,Intermediate,,,,The Cmax values in female wistar rats.,50597,Rattus norvegicus,14941,BAO_0000218,,1,1,,CHEMBL632175,,
11598,Intermediate,,Plasma,1969.0,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,50588,Canis lupus familiaris,15343,BAO_0000218,,1,1,,CHEMBL632176,,
11599,Intermediate,,Plasma,1969.0,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,50597,Rattus norvegicus,15343,BAO_0000218,,1,1,,CHEMBL632177,,
11600,Intermediate,,Plasma,1969.0,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,50597,Rattus norvegicus,14856,BAO_0000218,,1,1,,CHEMBL632178,,
11601,Intermediate,,,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,50597,Rattus norvegicus,13129,BAO_0000218,,1,1,,CHEMBL632179,,
11602,Intermediate,,Blood,178.0,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,50597,Rattus norvegicus,13098,BAO_0000218,,1,1,,CHEMBL632180,,
11603,Intermediate,,Blood,178.0,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,50597,Rattus norvegicus,13098,BAO_0000218,,1,1,,CHEMBL632181,,
11604,Intermediate,,Blood,178.0,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,50597,Rattus norvegicus,13098,BAO_0000218,,1,1,,CHEMBL632182,,
11605,Autocuration,,Blood,178.0,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,22224,Mus musculus,15478,BAO_0000218,,0,1,,CHEMBL632183,,
11606,Intermediate,,,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,50588,Canis lupus familiaris,15341,BAO_0000218,,1,1,,CHEMBL632184,,
11607,Intermediate,,,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,50597,Rattus norvegicus,15341,BAO_0000218,,1,1,,CHEMBL874470,,
11608,Intermediate,,,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL631302,,
11609,Intermediate,,,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL631303,,
11610,Intermediate,,,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL631304,,
11611,Intermediate,,,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL631305,,
11612,Intermediate,,,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL631306,,
11613,Intermediate,,,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL631307,,
11614,Intermediate,,,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL631308,,
11615,Intermediate,,,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL625557,,
11616,Intermediate,,Spleen,2106.0,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL625558,,
11617,Intermediate,,Spleen,2106.0,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL625559,,
11618,Intermediate,,Spleen,2106.0,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL625560,,
11619,Intermediate,,Spleen,2106.0,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL625561,,
11620,Intermediate,,Spleen,2106.0,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL625562,,
11621,Intermediate,,Spleen,2106.0,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL875320,,
11622,Intermediate,,Spleen,2106.0,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL625563,,
11623,Intermediate,,Spleen,2106.0,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL625564,,
11624,Intermediate,,Uterus,995.0,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL625565,,
11625,Intermediate,,Uterus,995.0,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL625566,,
11626,Intermediate,,Uterus,995.0,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL625567,,
11627,Intermediate,,Uterus,995.0,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL625568,,
11628,Intermediate,,Uterus,995.0,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL628217,,
11629,Intermediate,,Uterus,995.0,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL628218,,
11630,Intermediate,,Uterus,995.0,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL628219,,
11631,Intermediate,,Uterus,995.0,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",50597,Rattus norvegicus,8684,BAO_0000218,,1,1,,CHEMBL628220,,
11632,Autocuration,,,,Distribution in the blood after 120 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628221,,
11633,Autocuration,,,,Distribution in the blood after 15 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628222,,
11634,Autocuration,,,,Distribution in the blood after 30 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628223,,
11635,Autocuration,,,,Distribution in the blood after 5 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628224,,
11636,Autocuration,,,,Distribution in the blood after 60 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628225,,
11637,Autocuration,,,,Distribution in the blood after 90 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628226,,
11638,Autocuration,,,,Distribution in the bone after 120 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628227,,
11639,Autocuration,,,,Distribution in the bone after 15 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL875481,,
11640,Autocuration,,,,Distribution in the bone after 30 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628228,,
11641,Autocuration,,,,Distribution in the bone after 5 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628229,,
11642,Autocuration,,,,Distribution in the bone after 60 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628230,,
11643,Autocuration,,,,Distribution in the bone after 90 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628231,,
11644,Autocuration,,,,Distribution in the heart after 120 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628232,,
11645,Autocuration,,,,Distribution in the heart after 15 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628233,,
11646,Autocuration,,,,Distribution in the heart after 30 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628234,,
11647,Autocuration,,,,Distribution in the heart after 5 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628235,,
11648,Autocuration,,,,Distribution in the heart after 60 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628236,,
11649,Autocuration,,,,Distribution in the heart after 90 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628237,,
11650,Autocuration,,,,Distribution in the kidneys after 120 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628238,,
11651,Autocuration,,,,Distribution in the kidneys after 15 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628239,,
11652,Autocuration,,,,Distribution in the kidneys after 30 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628240,,
11653,Autocuration,,,,Distribution in the kidneys after 5 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628241,,
11654,Autocuration,,,,Distribution in the kidneys after 60 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628242,,
11655,Autocuration,,,,Distribution in the kidneys after 90 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL875482,,
11656,Autocuration,,,,Distribution in the liver after 120 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628243,,
11657,Autocuration,,,,Distribution in the liver after 15 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628244,,
11658,Autocuration,,,,Distribution in the liver after 30 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628245,,
11659,Autocuration,,,,Distribution in the liver after 5 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628246,,
11660,Autocuration,,,,Distribution in the liver after 60 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628247,,
11661,Autocuration,,,,Distribution in the liver after 90 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628248,,
11662,Autocuration,,,,Distribution in the lung after 120 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628249,,
11663,Intermediate,,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL625452,,
11664,Intermediate,,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL625453,,
11665,Intermediate,,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL625454,,
11666,Intermediate,,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",50594,Mus musculus,14839,BAO_0000218,,1,1,,CHEMBL623844,,
11667,Intermediate,,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,50597,Rattus norvegicus,12178,BAO_0000218,,1,1,,CHEMBL623845,,
11668,Intermediate,,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,50597,Rattus norvegicus,12178,BAO_0000218,,1,1,,CHEMBL623846,,
11669,Autocuration,,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,22224,,12178,BAO_0000218,,0,1,,CHEMBL623847,,
11670,Intermediate,,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,100710,Macaca fascicularis,12186,BAO_0000218,,1,1,,CHEMBL623848,,
11671,Intermediate,,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,100710,Macaca fascicularis,12186,BAO_0000218,,1,1,,CHEMBL623849,,
11672,Intermediate,,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,100710,Macaca fascicularis,12186,BAO_0000218,,1,1,,CHEMBL623850,,
11673,Intermediate,,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,100710,Macaca fascicularis,12186,BAO_0000218,,1,1,,CHEMBL623851,,
11674,Autocuration,,,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,22224,Simiiformes,12187,BAO_0000218,,0,1,,CHEMBL623852,,
11675,Intermediate,,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,50506,Mustela putorius furo,12187,BAO_0000218,,1,1,,CHEMBL624551,,
11676,Intermediate,,,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",50506,Mustela putorius furo,12187,BAO_0000218,,1,1,,CHEMBL624552,,
11677,Autocuration,,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,22224,Simiiformes,12187,BAO_0000218,,0,1,,CHEMBL624553,,
11678,Autocuration,,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,22224,Simiiformes,12187,BAO_0000218,,0,1,,CHEMBL624554,,
11679,Intermediate,,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,50597,Rattus norvegicus,12187,BAO_0000218,,1,1,,CHEMBL624555,,
11680,Intermediate,,,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",50597,Rattus norvegicus,12187,BAO_0000218,,1,1,,CHEMBL624741,,
11681,Intermediate,,,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",50588,Canis lupus familiaris,14122,BAO_0000218,,1,1,,CHEMBL624742,,
11682,Intermediate,,,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",100712,Cricetinae,14122,BAO_0000218,,1,1,,CHEMBL624743,,
11683,Intermediate,,,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",50597,Rattus norvegicus,14122,BAO_0000218,,1,1,,CHEMBL877606,,
11684,Autocuration,,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,22224,,13391,BAO_0000218,,0,1,,CHEMBL624744,,
11685,Autocuration,,Blood,178.0,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,22224,,13391,BAO_0000218,,0,1,,CHEMBL624745,,
11686,Autocuration,,Blood,178.0,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,22224,,13391,BAO_0000218,,0,1,,CHEMBL624746,,
11687,Autocuration,,Blood,178.0,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,22224,,13391,BAO_0000218,,0,1,,CHEMBL624747,,
11688,Autocuration,,,,Oral absorption expressed as Area under curve was determined,22224,,16360,BAO_0000019,,0,1,,CHEMBL624748,,
11689,Intermediate,,,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,50588,Canis lupus familiaris,3673,BAO_0000218,,1,1,,CHEMBL622504,,
11690,Intermediate,,,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",50588,Canis lupus familiaris,14122,BAO_0000218,,1,1,,CHEMBL622505,,
11691,Intermediate,,,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",100712,Cricetinae,14122,BAO_0000218,,1,1,,CHEMBL622506,,
11692,Intermediate,,,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",100712,Cricetinae,14122,BAO_0000218,,1,1,,CHEMBL622507,,
11693,Intermediate,,,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",50597,Rattus norvegicus,14122,BAO_0000218,,1,1,,CHEMBL622508,,
11694,Autocuration,,,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,22224,,13889,BAO_0000019,,0,1,,CHEMBL622509,,
11695,Intermediate,,,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,50597,Rattus norvegicus,14393,BAO_0000218,,1,1,,CHEMBL622510,,
11696,Intermediate,,,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),50597,Rattus norvegicus,17279,BAO_0000218,,1,1,,CHEMBL622511,,
11697,Intermediate,,,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,100710,Macaca fascicularis,14548,BAO_0000218,,1,1,,CHEMBL622512,,
11698,Intermediate,,,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,100710,Macaca fascicularis,14548,BAO_0000218,,1,1,,CHEMBL622513,,
11699,Intermediate,,,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,100710,Macaca fascicularis,14548,BAO_0000218,,1,1,,CHEMBL622514,,
11700,Intermediate,,,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,50588,Canis lupus familiaris,14548,BAO_0000218,,1,1,,CHEMBL622515,,
11701,Intermediate,,,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,50588,Canis lupus familiaris,14548,BAO_0000218,,1,1,,CHEMBL622516,,
11702,Intermediate,,,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,50597,Rattus norvegicus,14548,BAO_0000218,,1,1,,CHEMBL622517,,
11703,Intermediate,,,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,50597,Rattus norvegicus,14548,BAO_0000218,,1,1,,CHEMBL622518,,
11704,Intermediate,,,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,50597,Rattus norvegicus,14548,BAO_0000218,,1,1,,CHEMBL622519,,
11705,Intermediate,,Muscle tissue,2385.0,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL622520,,
11706,Intermediate,,Muscle tissue,2385.0,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL622521,,
11707,Intermediate,,Zone of skin,14.0,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,50594,Mus musculus,14608,BAO_0000218,,1,1,,CHEMBL625113,,
11708,Intermediate,,Zone of skin,14.0,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL625114,,
11709,Intermediate,,Zone of skin,14.0,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL874397,,
11710,Intermediate,,Spleen,2106.0,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL625115,,
11711,Intermediate,,Spleen,2106.0,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL625116,,
11712,Intermediate,,Spleen,2106.0,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL623932,,
11713,Intermediate,,Striatum,2435.0,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL623933,,
11714,Intermediate,,Striatum,2435.0,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL623934,,
11715,Intermediate,,Striatum,2435.0,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL623935,,
11716,Intermediate,,Thyroid gland,2046.0,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL623936,,
11717,Intermediate,,Thyroid gland,2046.0,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL623937,,
11718,Intermediate,,Thyroid gland,2046.0,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,50597,Rattus norvegicus,14608,BAO_0000218,,1,1,,CHEMBL623938,,
11719,Intermediate,,,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL623939,,
11720,Intermediate,,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL623940,,
11721,Intermediate,,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL623941,,
11722,Intermediate,,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL627216,,
11723,Intermediate,,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL623942,,
11724,Intermediate,,Brain,955.0,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618793,,
11725,Intermediate,,Brain,955.0,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618794,,
11726,Intermediate,,Brain,955.0,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618795,,
11727,Intermediate,,,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618796,,
11728,Intermediate,,,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618797,,
11729,Intermediate,,Kidney,2113.0,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618798,,
11730,Intermediate,,Kidney,2113.0,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618799,,
11731,Intermediate,,Kidney,2113.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618800,,
11732,Intermediate,,Kidney,2113.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618801,,
11733,Intermediate,,Kidney,2113.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618802,,
11734,Intermediate,,Kidney,2113.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618803,,
11735,Intermediate,,Liver,2107.0,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618804,,
11736,Intermediate,,Liver,2107.0,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618805,,
11737,Intermediate,,Liver,2107.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618806,,
11738,Intermediate,,Liver,2107.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618807,,
11739,Intermediate,,Liver,2107.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618808,,
11740,Intermediate,,Liver,2107.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618809,,
11741,Intermediate,,Muscle tissue,2385.0,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618810,,
11742,Intermediate,,Muscle tissue,2385.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618811,,
11743,Intermediate,,Muscle tissue,2385.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL875844,,
11744,Intermediate,,Muscle tissue,2385.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618812,,
11745,Intermediate,,Muscle tissue,2385.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618813,,
11746,Intermediate,,,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618814,,
11747,Intermediate,,,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618815,,
11748,Intermediate,,,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618816,,
11749,Intermediate,,,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL618817,,
11750,Intermediate,,,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL620544,,
11751,Intermediate,,,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,50597,Rattus norvegicus,15341,BAO_0000218,,1,1,,CHEMBL626230,,
11752,Intermediate,,,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,50597,Rattus norvegicus,15341,BAO_0000218,,1,1,,CHEMBL626231,,
11753,Intermediate,,,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,50597,Rattus norvegicus,15341,BAO_0000218,,1,1,,CHEMBL626232,,
11754,Intermediate,,Plasma,1969.0,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,50588,Canis lupus familiaris,14906,BAO_0000218,,1,1,,CHEMBL626233,,
11755,Intermediate,,Plasma,1969.0,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,50597,Rattus norvegicus,14906,BAO_0000218,,1,1,,CHEMBL626234,,
11756,Intermediate,,Plasma,1969.0,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,50597,Rattus norvegicus,14906,BAO_0000218,,1,1,,CHEMBL875341,,
11757,Intermediate,,Plasma,1969.0,The maximum plasma concentration (100 mg/kg) administered orally in human,50587,Homo sapiens,14215,BAO_0000218,,1,1,,CHEMBL626235,,
11758,Autocuration,,Plasma,1969.0,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,22224,Callithrix,14215,BAO_0000218,,0,1,,CHEMBL626236,,
11759,Autocuration,,Plasma,1969.0,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,22224,Simiiformes,14215,BAO_0000218,,0,1,,CHEMBL626237,,
11760,Intermediate,,Plasma,1969.0,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,50588,Canis lupus familiaris,14215,BAO_0000218,,1,1,,CHEMBL626238,,
11761,Intermediate,,Plasma,1969.0,The maximum plasma concentration (200 mg/kg) administered orally in human,50587,Homo sapiens,14215,BAO_0000218,,1,1,,CHEMBL622412,,
11762,Intermediate,,Plasma,1969.0,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,50597,Rattus norvegicus,14215,BAO_0000218,,1,1,,CHEMBL623114,,
11763,Autocuration,,Plasma,1969.0,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,22224,Callithrix,14215,BAO_0000218,,0,1,,CHEMBL623115,,
11764,Autocuration,,Plasma,1969.0,The maximum plasma concentration (25 mg/kg) administered orally in monkey,22224,Simiiformes,14215,BAO_0000218,,0,1,,CHEMBL623116,,
11765,Autocuration,,Plasma,1969.0,The maximum plasma concentration (30 mg/kg) administered orally in dog,22224,Canis lupus familiaris,14215,BAO_0000218,,0,1,,CHEMBL623117,,
11766,Intermediate,,Plasma,1969.0,The maximum plasma concentration (400 mg/kg) administered orally in human,50587,Homo sapiens,14215,BAO_0000218,,1,1,,CHEMBL623118,,
11767,Intermediate,,Plasma,1969.0,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,50597,Rattus norvegicus,14215,BAO_0000218,,1,1,,CHEMBL623119,,
11768,Intermediate,,Plasma,1969.0,The maximum plasma concentration (50 mg/kg) administered orally in rat,50597,Rattus norvegicus,14215,BAO_0000218,,1,1,,CHEMBL623120,,
11769,Intermediate,,Plasma,1969.0,The maximum plasma concentration (800 mg/kg) administered orally in human,50587,Homo sapiens,14215,BAO_0000218,,1,1,,CHEMBL623286,,
11770,Intermediate,,Plasma,1969.0,The maximum plasma concentration was measured on rats,50597,Rattus norvegicus,14067,BAO_0000218,,1,1,,CHEMBL623287,,
11771,Intermediate,,Plasma,1969.0,The maximum plasma concentration was measured on rats after oral administration,50597,Rattus norvegicus,12350,BAO_0000218,,1,1,,CHEMBL623288,,
11772,Intermediate,,Plasma,1969.0,Plasma drug Cmax in rat (PO dose),50597,Rattus norvegicus,14813,BAO_0000218,,1,1,,CHEMBL623289,,
11773,Autocuration,,,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,22224,,12536,BAO_0000218,,0,1,,CHEMBL623290,,
11774,Intermediate,,Plasma,1969.0,maximum Plasma concentration in Dog was determined after Peroral administration,50588,Canis lupus familiaris,14169,BAO_0000218,,1,1,,CHEMBL623291,,
11775,Intermediate,,Plasma,1969.0,maximum Plasma concentration in Rats was determined after Peroral administration,50597,Rattus norvegicus,14169,BAO_0000218,,1,1,,CHEMBL623292,,
11776,Intermediate,,Plasma,1969.0,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,50588,Canis lupus familiaris,15604,BAO_0000218,,1,1,,CHEMBL623293,,
11777,Autocuration,,Plasma,1969.0,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,22224,Simiiformes,15604,BAO_0000218,,0,1,,CHEMBL623294,,
11778,Intermediate,,Plasma,1969.0,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,50597,Rattus norvegicus,15604,BAO_0000218,,1,1,,CHEMBL623295,,
11779,Intermediate,,,,maximum concentration was measured when administered through oral route in mice,50594,Mus musculus,14387,BAO_0000218,,1,1,,CHEMBL623296,,
11780,Intermediate,,,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,50594,Mus musculus,15115,BAO_0000218,,1,1,,CHEMBL875349,,
11781,Autocuration,,,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,22224,Simiiformes,15115,BAO_0000019,,0,1,,CHEMBL623297,,
11782,Autocuration,,,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,22224,Simiiformes,15115,BAO_0000019,,0,1,,CHEMBL623298,,
11783,Autocuration,,,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,22224,Simiiformes,15115,BAO_0000019,,0,1,,CHEMBL623299,,
11784,Intermediate,,,,Pharmacokinetic parameter was evaluated in rats,50597,Rattus norvegicus,16359,BAO_0000218,,1,1,,CHEMBL623300,,
11785,Intermediate,,,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,50594,Mus musculus,12829,BAO_0000218,,1,1,,CHEMBL623301,,
11786,Intermediate,,,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,50594,Mus musculus,12829,BAO_0000218,,1,1,,CHEMBL623302,,
11787,Intermediate,,,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,50594,Mus musculus,12829,BAO_0000218,,1,1,,CHEMBL623303,,
11788,Intermediate,,,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,50594,Mus musculus,12829,BAO_0000218,,1,1,,CHEMBL623304,,
11789,Intermediate,,,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,50594,Mus musculus,12829,BAO_0000218,,1,1,,CHEMBL623305,,
11790,Intermediate,,Plasma,1969.0,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,50597,Rattus norvegicus,15137,BAO_0000218,,1,1,,CHEMBL623306,,
11791,Intermediate,,Plasma,1969.0,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,50597,Rattus norvegicus,15137,BAO_0000218,,1,1,,CHEMBL623307,,
11792,Intermediate,,Plasma,1969.0,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,50597,Rattus norvegicus,15137,BAO_0000218,,1,1,,CHEMBL623308,,
11793,Intermediate,,Plasma,1969.0,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,50594,Mus musculus,15137,BAO_0000218,,1,1,,CHEMBL623309,,
11794,Intermediate,,,,Plasma Concentration after 120 min of oral administration to mice,50594,Mus musculus,13509,BAO_0000218,,1,1,,CHEMBL623310,,
11795,Intermediate,,,,Plasma Concentration after 30 min of oral administration to mice,50594,Mus musculus,13509,BAO_0000218,,1,1,,CHEMBL623311,,
11796,Intermediate,,,,Plasma Concentration after 60 min of oral administration to mice,100710,Macaca fascicularis,13509,BAO_0000218,,1,1,,CHEMBL623312,,
11797,Intermediate,,,,Plasma Concentration after 60 min of oral administration to mice; Not determined,50594,Mus musculus,13509,BAO_0000218,,1,1,,CHEMBL875350,,
11798,Intermediate,,,,Plasma Concentration after 90 min of oral administration to mice,50594,Mus musculus,13509,BAO_0000218,,1,1,,CHEMBL628635,,
11799,Intermediate,,,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,50597,Rattus norvegicus,12064,BAO_0000218,,1,1,,CHEMBL628636,,
11800,Intermediate,,,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,50597,Rattus norvegicus,12064,BAO_0000218,,1,1,,CHEMBL628637,,
11801,Intermediate,,,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,50597,Rattus norvegicus,12064,BAO_0000218,,1,1,,CHEMBL628058,,
11802,Intermediate,,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,50597,Rattus norvegicus,10677,BAO_0000218,,1,1,,CHEMBL628059,,
11803,Intermediate,,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,50597,Rattus norvegicus,10677,BAO_0000218,,1,1,,CHEMBL628060,,
11804,Autocuration,,,,Distribution in the lung after 15 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628061,,
11805,Autocuration,,,,Distribution in the lung after 30 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628062,,
11806,Autocuration,,,,Distribution in the lung after 5 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628063,,
11807,Autocuration,,,,Distribution in the lung after 60 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628064,,
11808,Autocuration,,,,Distribution in the lung after 90 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628065,,
11809,Autocuration,,Muscle tissue,2385.0,Distribution in the muscle after 120 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628066,,
11810,Autocuration,,Muscle tissue,2385.0,Distribution in the muscle after 15 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628067,,
11811,Intermediate,,Muscle tissue,2385.0,Distribution in the muscle after 30 min of intravenous administration,50594,Mus musculus,8926,BAO_0000218,,1,1,,CHEMBL874646,,
11812,Autocuration,,Muscle tissue,2385.0,Distribution in the muscle after 5 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628068,,
11813,Autocuration,,Muscle tissue,2385.0,Distribution in the muscle after 60 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628069,,
11814,Autocuration,,Muscle tissue,2385.0,Distribution in the muscle after 90 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628070,,
11815,Autocuration,,Spleen,2106.0,Distribution in the spleen after 120 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628071,,
11816,Autocuration,,Spleen,2106.0,Distribution in the spleen after 15 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628072,,
11817,Autocuration,,Spleen,2106.0,Distribution in the spleen after 30 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628073,,
11818,Autocuration,,Spleen,2106.0,Distribution in the spleen after 5 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628074,,
11819,Autocuration,,Spleen,2106.0,Distribution in the spleen after 60 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628075,,
11820,Autocuration,,Spleen,2106.0,Distribution in the spleen after 90 min of intravenous administration,22224,,8926,BAO_0000019,,0,1,,CHEMBL628076,,
11821,Intermediate,,Adrenal cortex,1235.0,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,50597,Rattus norvegicus,7570,BAO_0000218,,1,1,,CHEMBL628077,,
11822,Intermediate,,Blood,178.0,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,50597,Rattus norvegicus,7570,BAO_0000218,,1,1,,CHEMBL628078,,
11823,Intermediate,,Liver,2107.0,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,50597,Rattus norvegicus,7570,BAO_0000218,,1,1,,CHEMBL628079,,
11824,Intermediate,,Female gonad,992.0,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,50597,Rattus norvegicus,7570,BAO_0000218,,1,1,,CHEMBL628080,,
11825,Intermediate,,Thyroid gland,2046.0,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,50597,Rattus norvegicus,7570,BAO_0000218,,1,1,,CHEMBL628081,,
11826,Intermediate,,Adrenal cortex,1235.0,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,50597,Rattus norvegicus,7570,BAO_0000218,,1,1,,CHEMBL628082,,
11827,Intermediate,,Blood,178.0,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,50597,Rattus norvegicus,7570,BAO_0000218,,1,1,,CHEMBL874647,,
11828,Intermediate,,Liver,2107.0,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,50597,Rattus norvegicus,7570,BAO_0000218,,1,1,,CHEMBL626406,,
11829,Intermediate,,Female gonad,992.0,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,50597,Rattus norvegicus,7570,BAO_0000218,,1,1,,CHEMBL626407,,
11830,Intermediate,,Thyroid gland,2046.0,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,50597,Rattus norvegicus,7570,BAO_0000218,,1,1,,CHEMBL626408,,
11831,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626409,,
11832,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626410,,
11833,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626411,,
11834,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626412,,
11835,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626413,,
11836,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626414,,
11837,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626415,,
11838,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626416,,
11839,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627062,,
11840,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627063,,
11841,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627064,,
11842,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627227,,
11843,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627228,,
11844,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627229,,
11845,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL625792,,
11846,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL625793,,
11847,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL625794,,
11848,Intermediate,,Blood,178.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL625795,,
11849,Intermediate,,,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,50594,Mus musculus,13792,BAO_0000218,,1,1,,CHEMBL625796,,
11850,Intermediate,,,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,50588,Canis lupus familiaris,13376,BAO_0000218,,1,1,,CHEMBL625797,,
11851,Intermediate,,,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,50588,Canis lupus familiaris,13376,BAO_0000218,,1,1,,CHEMBL625798,,
11852,Autocuration,,,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL875613,,
11853,Autocuration,,,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL625799,,
11854,Autocuration,,,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL625800,,
11855,Autocuration,,,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL625801,,
11856,Autocuration,,,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL625802,,
11857,Autocuration,,,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL625803,,
11858,Autocuration,,,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,22224,,14380,BAO_0000019,,0,1,,CHEMBL625804,,
11859,Autocuration,,,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,22224,,14380,BAO_0000218,,0,1,,CHEMBL622530,,
11860,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL622531,,
11861,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL622532,,
11862,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL623176,,
11863,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL623177,,
11864,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL623178,,
11865,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL623179,,
11866,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL623180,,
11867,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL623181,,
11868,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL624131,,
11869,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL624132,,
11870,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL624133,,
11871,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL624846,,
11872,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL624847,,
11873,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL624848,,
11874,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL625012,,
11875,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL625013,,
11876,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL625014,,
11877,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL625015,,
11878,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL625016,,
11879,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL625017,,
11880,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL625018,,
11881,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL625019,,
11882,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL625020,,
11883,Intermediate,,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL625021,,
11884,Intermediate,,,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,50597,Rattus norvegicus,14393,BAO_0000218,,1,1,,CHEMBL625022,,
11885,Intermediate,,,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,50594,Mus musculus,14731,BAO_0000218,,1,1,,CHEMBL625023,,
11886,Intermediate,,,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,100710,Macaca fascicularis,14731,BAO_0000218,,1,1,,CHEMBL625024,,
11887,Intermediate,,,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,100710,Macaca fascicularis,14731,BAO_0000218,,1,1,,CHEMBL627626,,
11888,Autocuration,,Brain,955.0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,22224,,13758,BAO_0000218,,0,1,,CHEMBL627627,,
11889,Autocuration,,Serum,1977.0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,22224,,13758,BAO_0000218,,0,1,,CHEMBL627628,,
11890,Autocuration,,Brain,955.0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,22224,,13758,BAO_0000218,,0,1,,CHEMBL627629,,
11891,Autocuration,,Serum,1977.0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,22224,,13758,BAO_0000218,,0,1,,CHEMBL627630,,
11892,Autocuration,,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),22224,,16359,BAO_0000019,,0,1,,CHEMBL627631,,
11893,Autocuration,,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),22224,,16359,BAO_0000218,,0,1,,CHEMBL629515,,
11894,Intermediate,,Spleen,2106.0,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL629516,,
11895,Intermediate,,Spleen,2106.0,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL629517,,
11896,Intermediate,,Spleen,2106.0,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL629518,,
11897,Intermediate,,,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL877499,,
11898,Intermediate,,,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL629519,,
11899,Intermediate,,,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL629520,,
11900,Intermediate,,,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,50594,Mus musculus,15383,BAO_0000218,,1,1,,CHEMBL629521,,
11901,Intermediate,,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL629522,,
11902,Intermediate,,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL629523,,
11903,Intermediate,,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL629524,,
11904,Intermediate,,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL629525,,
11905,Intermediate,,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL629526,,
11906,Intermediate,,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL629527,,
11907,Intermediate,,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL629528,,
11908,Intermediate,,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL629529,,
11909,Intermediate,,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL629530,,
11910,Intermediate,,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL629531,,
11911,Intermediate,,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL628656,,
11912,Intermediate,,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL628657,,
11913,Intermediate,,,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL628658,,
11914,Intermediate,,,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL628659,,
11915,Intermediate,,,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL877500,,
11916,Intermediate,,,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL628660,,
11917,Intermediate,,,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL628661,,
11918,Intermediate,,,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL628662,,
11919,Intermediate,,,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL628663,,
11920,Intermediate,,,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL628664,,
11921,Intermediate,,Blood,178.0,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL628665,,
11922,Intermediate,,Blood,178.0,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL628666,,
11923,Intermediate,,Blood,178.0,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL628667,,
11924,Intermediate,,Blood,178.0,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL628668,,
11925,Intermediate,,Blood,178.0,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL628669,,
11926,Intermediate,,Blood,178.0,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL628670,,
11927,Intermediate,,Blood,178.0,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL628671,,
11928,Intermediate,,Bone,10000001.0,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL628672,,
11929,Intermediate,,Bone,10000001.0,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL630300,,
11930,Intermediate,,Bone,10000001.0,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629787,,
11931,Intermediate,,Bone,10000001.0,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629788,,
11932,Intermediate,,Brain,955.0,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629789,,
11933,Intermediate,,Brain,955.0,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629790,,
11934,Intermediate,,Brain,955.0,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629791,,
11935,Intermediate,,Brain,955.0,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629792,,
11936,Intermediate,,Brain,955.0,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629793,,
11937,Intermediate,,Brain,955.0,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629794,,
11938,Intermediate,,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,50597,Rattus norvegicus,10677,BAO_0000218,,1,1,,CHEMBL874459,,
11939,Intermediate,,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,50597,Rattus norvegicus,10677,BAO_0000218,,1,1,,CHEMBL629795,,
11940,Intermediate,,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,50597,Rattus norvegicus,10677,BAO_0000218,,1,1,,CHEMBL629796,,
11941,Intermediate,,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,50597,Rattus norvegicus,10677,BAO_0000218,,1,1,,CHEMBL629797,,
11942,Intermediate,,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,50597,Rattus norvegicus,10677,BAO_0000218,,1,1,,CHEMBL629798,,
11943,Intermediate,,Adrenal gland,2369.0,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629799,,
11944,Intermediate,,Adrenal gland,2369.0,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629800,,
11945,Intermediate,,Adrenal gland,2369.0,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629801,,
11946,Intermediate,,Adrenal gland,2369.0,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629802,,
11947,Intermediate,,Adrenal gland,2369.0,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629803,,
11948,Intermediate,,Blood,178.0,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629804,,
11949,Intermediate,,Blood,178.0,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629805,,
11950,Intermediate,,Blood,178.0,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629806,,
11951,Intermediate,,Blood,178.0,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629807,,
11952,Intermediate,,Blood,178.0,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629808,,
11953,Intermediate,,Brain,955.0,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629809,,
11954,Intermediate,,Brain,955.0,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629810,,
11955,Intermediate,,Brain,955.0,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629811,,
11956,Intermediate,,Brain,955.0,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629812,,
11957,Intermediate,,Brain,955.0,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629813,,
11958,Intermediate,,Brain,955.0,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL874460,,
11959,Intermediate,,,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629814,,
11960,Intermediate,,,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629815,,
11961,Intermediate,,,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629816,,
11962,Intermediate,,,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL629817,,
11963,Intermediate,,Kidney,2113.0,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL626643,,
11964,Intermediate,,Kidney,2113.0,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL626644,,
11965,Intermediate,,Kidney,2113.0,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL626806,,
11966,Intermediate,,Kidney,2113.0,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL626807,,
11967,Intermediate,,Liver,2107.0,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627261,,
11968,Intermediate,,Liver,2107.0,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627262,,
11969,Intermediate,,Liver,2107.0,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627263,,
11970,Intermediate,,Liver,2107.0,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627264,,
11971,Intermediate,,Lung,2048.0,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627265,,
11972,Intermediate,,Lung,2048.0,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627266,,
11973,Intermediate,,Lung,2048.0,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627267,,
11974,Intermediate,,Lung,2048.0,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627268,,
11975,Intermediate,,Muscle tissue,2385.0,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627269,,
11976,Intermediate,,Muscle tissue,2385.0,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627270,,
11977,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627271,,
11978,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627946,,
11979,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL875472,,
11980,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627947,,
11981,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627948,,
11982,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628113,,
11983,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628114,,
11984,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628115,,
11985,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628116,,
11986,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628117,,
11987,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628118,,
11988,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628119,,
11989,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628120,,
11990,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628121,,
11991,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628122,,
11992,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627297,,
11993,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627298,,
11994,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627299,,
11995,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627300,,
11996,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627301,,
11997,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627302,,
11998,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627303,,
11999,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627304,,
12000,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627305,,
12001,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627306,,
12002,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL623982,,
12003,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL623983,,
12004,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL623984,,
12005,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL623985,,
12006,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL623986,,
12007,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL623987,,
12008,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL623988,,
12009,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL623989,,
12010,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL622215,,
12011,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL622216,,
12012,Intermediate,,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL877481,,
12013,Autocuration,,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),22224,,16359,BAO_0000218,,0,1,,CHEMBL622217,,
12014,Intermediate,,,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),50594,Mus musculus,13701,BAO_0000218,,1,1,,CHEMBL622218,,
12015,Intermediate,,,,Pharmacokinetic profile AUC was evaluated in rats,50597,Rattus norvegicus,14554,BAO_0000218,,1,1,,CHEMBL622219,,
12016,Autocuration,,,,Pharmacokinetic property (Area under curve),22224,,6241,BAO_0000019,,0,1,,CHEMBL622220,,
12017,Intermediate,,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",50588,Canis lupus familiaris,11537,BAO_0000218,,1,1,,CHEMBL622221,,
12018,Intermediate,,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",50594,Mus musculus,11537,BAO_0000218,,1,1,,CHEMBL622222,,
12019,Intermediate,,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",50588,Canis lupus familiaris,11537,BAO_0000218,,1,1,,CHEMBL622223,,
12020,Intermediate,,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",50594,Mus musculus,11537,BAO_0000218,,1,1,,CHEMBL622224,,
12021,Autocuration,,,,Plasma concentration (AUC) was determined,22224,,13118,BAO_0000019,,0,1,,CHEMBL622225,,
12022,Autocuration,,,,Plasma concentration (AUC) was determined; Not detectable,22224,,13118,BAO_0000019,,0,1,,CHEMBL622226,,
12023,Intermediate,,,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),50512,Cavia porcellus,9562,BAO_0000218,,1,1,,CHEMBL624154,,
12024,Intermediate,,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,50597,Rattus norvegicus,10363,BAO_0000218,,1,1,,CHEMBL624155,,
12025,Intermediate,,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,50597,Rattus norvegicus,10363,BAO_0000218,,1,1,,CHEMBL624156,,
12026,Intermediate,,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,50597,Rattus norvegicus,10363,BAO_0000218,,1,1,,CHEMBL624157,,
12027,Intermediate,,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,50597,Rattus norvegicus,10363,BAO_0000218,,1,1,,CHEMBL624158,,
12028,Intermediate,,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,50597,Rattus norvegicus,12504,BAO_0000218,,1,1,,CHEMBL624159,,
12029,Intermediate,,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,50597,Rattus norvegicus,12504,BAO_0000218,,1,1,,CHEMBL624160,,
12030,Intermediate,,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,50597,Rattus norvegicus,12504,BAO_0000218,,1,1,,CHEMBL624161,,
12031,Intermediate,,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,50597,Rattus norvegicus,12504,BAO_0000218,,1,1,,CHEMBL624162,,
12032,Intermediate,,,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,50588,Canis lupus familiaris,13317,BAO_0000218,,1,1,,CHEMBL624163,,
12033,Intermediate,,,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL624164,,
12034,Intermediate,,,,The AUC(0-infinity) values in female wistar rats.,50597,Rattus norvegicus,14941,BAO_0000218,,1,1,,CHEMBL624165,,
12035,Intermediate,,,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL624166,,
12036,Intermediate,,,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL624167,,
12037,Intermediate,,,,The AUC(0-t)values in female wistar rats.,50597,Rattus norvegicus,14941,BAO_0000218,,1,1,,CHEMBL624168,,
12038,Intermediate,,,,The Area under the concentration time curve of compound was measured on rats,50597,Rattus norvegicus,14067,BAO_0000218,,1,1,,CHEMBL624169,,
12039,Intermediate,,,,The area under curve (100 mg/kg) administered orally in humans,50587,Homo sapiens,14215,BAO_0000218,,1,1,,CHEMBL624170,,
12040,Autocuration,,,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,22224,Callithrix,14215,BAO_0000218,,0,1,,CHEMBL624171,,
12041,Autocuration,,,,The area under curve (12.5 mg/kg) administered intravenously in monkey,22224,Simiiformes,14215,BAO_0000218,,0,1,,CHEMBL624172,,
12042,Intermediate,,,,The area under curve (15 mg/kg) administered intravenously in dog,50588,Canis lupus familiaris,14215,BAO_0000218,,1,1,,CHEMBL624173,,
12043,Intermediate,,,,The area under curve (200 mg/kg) administered orally in humans,50587,Homo sapiens,14215,BAO_0000218,,1,1,,CHEMBL877488,,
12044,Intermediate,,,,The area under curve (25 mg/kg) administered intravenously in rat,50597,Rattus norvegicus,14215,BAO_0000218,,1,1,,CHEMBL624174,,
12045,Autocuration,,,,The area under curve (25 mg/kg) administered orally in marmoset,22224,Callithrix,14215,BAO_0000218,,0,1,,CHEMBL624175,,
12046,Autocuration,,,,The area under curve (25 mg/kg) administered orally in monkey,22224,Simiiformes,14215,BAO_0000218,,0,1,,CHEMBL624176,,
12047,Intermediate,,,,The area under curve (30 mg/kg) administered orally in dog,50588,Canis lupus familiaris,14215,BAO_0000218,,1,1,,CHEMBL624177,,
12048,Intermediate,,,,The area under curve (400 mg/kg) administered orally in humans,50587,Homo sapiens,14215,BAO_0000218,,1,1,,CHEMBL624178,,
12049,Intermediate,,,,The area under curve (50 mg/kg) administered orally in fasted rat,50597,Rattus norvegicus,14215,BAO_0000218,,1,1,,CHEMBL624179,,
12050,Intermediate,,,,The area under curve (50 mg/kg) administered orally in rat,50597,Rattus norvegicus,14215,BAO_0000218,,1,1,,CHEMBL627689,,
12051,Intermediate,,,,The area under curve (800 mg/kg) administered orally in humans,50587,Homo sapiens,14215,BAO_0000218,,1,1,,CHEMBL627690,,
12052,Autocuration,,,,The compound was evaluated for area under the curve,22224,,11324,BAO_0000019,,0,1,,CHEMBL627691,,
12053,Autocuration,,,,The compound was evaluated for area under the curve in marmosets,22224,Callithrix,11324,BAO_0000019,,0,1,,CHEMBL627692,,
12054,Autocuration,,,,The compound was evaluated for area under the curve in marmosets,22224,Callithrix,11324,BAO_0000019,,0,1,,CHEMBL627693,,
12055,Intermediate,,,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,50597,Rattus norvegicus,13875,BAO_0000218,,1,1,,CHEMBL627694,,
12056,Intermediate,,,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,50597,Rattus norvegicus,13875,BAO_0000218,,1,1,,CHEMBL627695,,
12057,Autocuration,,,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),22224,,13875,BAO_0000218,,0,1,,CHEMBL627696,,
12058,Intermediate,,,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,50597,Rattus norvegicus,13875,BAO_0000218,,1,1,,CHEMBL627697,,
12059,Intermediate,,,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,50597,Rattus norvegicus,13875,BAO_0000218,,1,1,,CHEMBL627698,,
12060,Intermediate,,,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,50597,Rattus norvegicus,13875,BAO_0000218,,1,1,,CHEMBL627699,,
12061,Intermediate,,,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,50597,Rattus norvegicus,13807,BAO_0000218,,1,1,,CHEMBL627700,,
12062,Intermediate,,,,Total drug exposure is determined after oral dosing in rats.,50597,Rattus norvegicus,14127,BAO_0000218,,1,1,,CHEMBL627701,,
12063,Autocuration,,,,Total drug exposure (5 mg/kg) when administered intravenously,22224,,15116,BAO_0000218,,0,1,,CHEMBL627702,,
12064,Autocuration,,,,Total drug exposure (5 mg/kg) when administered orally,22224,,15116,BAO_0000218,,0,1,,CHEMBL627703,,
12065,Autocuration,,,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,22224,Simiiformes,15604,BAO_0000218,,0,1,,CHEMBL626873,,
12066,Intermediate,,,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,50597,Rattus norvegicus,15604,BAO_0000218,,1,1,,CHEMBL629583,,
12067,Intermediate,,,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,50588,Canis lupus familiaris,15604,BAO_0000218,,1,1,,CHEMBL629584,,
12068,Intermediate,,,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,50588,Canis lupus familiaris,15604,BAO_0000218,,1,1,,CHEMBL629585,,
12069,Intermediate,,Brain,955.0,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629586,,
12070,Intermediate,,Brain,955.0,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629587,,
12071,Intermediate,,,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629588,,
12072,Intermediate,,,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629589,,
12073,Intermediate,,,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629590,,
12074,Intermediate,,,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629591,,
12075,Intermediate,,,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629592,,
12076,Intermediate,,,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629593,,
12077,Intermediate,,,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629594,,
12078,Intermediate,,Heart,948.0,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL629595,,
12079,Intermediate,,Heart,948.0,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL630290,,
12080,Intermediate,,Heart,948.0,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627137,,
12081,Intermediate,,Heart,948.0,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627138,,
12082,Intermediate,,Heart,948.0,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627139,,
12083,Intermediate,,Heart,948.0,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627140,,
12084,Intermediate,,Heart,948.0,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627141,,
12085,Intermediate,,Kidney,2113.0,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627142,,
12086,Intermediate,,Kidney,2113.0,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627143,,
12087,Intermediate,,Kidney,2113.0,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL874449,,
12088,Intermediate,,Kidney,2113.0,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627144,,
12089,Intermediate,,Kidney,2113.0,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627145,,
12090,Intermediate,,Kidney,2113.0,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627146,,
12091,Intermediate,,Kidney,2113.0,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627147,,
12092,Intermediate,,Liver,2107.0,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627148,,
12093,Intermediate,,Lung,2048.0,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627149,,
12094,Intermediate,,Lung,2048.0,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL632160,,
12095,Intermediate,,Lung,2048.0,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL632161,,
12096,Intermediate,,Lung,2048.0,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL632162,,
12097,Intermediate,,Lung,2048.0,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL632163,,
12098,Intermediate,,Lung,2048.0,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL874469,,
12099,Intermediate,,Lung,2048.0,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627182,,
12100,Intermediate,,Muscle tissue,2385.0,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627183,,
12101,Intermediate,,Muscle tissue,2385.0,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627184,,
12102,Intermediate,,Muscle tissue,2385.0,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627185,,
12103,Intermediate,,Muscle tissue,2385.0,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627186,,
12104,Intermediate,,Muscle tissue,2385.0,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627187,,
12105,Intermediate,,Muscle tissue,2385.0,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627188,,
12106,Intermediate,,Muscle tissue,2385.0,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627189,,
12107,Intermediate,,,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627190,,
12108,Intermediate,,Liver,2107.0,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627191,,
12109,Intermediate,,Liver,2107.0,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627192,,
12110,Intermediate,,Liver,2107.0,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL627193,,
12111,Intermediate,,Muscle tissue,2385.0,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL874590,,
12112,Intermediate,,Muscle tissue,2385.0,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627194,,
12113,Intermediate,,Muscle tissue,2385.0,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627195,,
12114,Intermediate,,Female gonad,992.0,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627196,,
12115,Intermediate,,Female gonad,992.0,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627197,,
12116,Intermediate,,Female gonad,992.0,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627198,,
12117,Intermediate,,Female gonad,992.0,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627199,,
12118,Intermediate,,Female gonad,992.0,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627200,,
12119,Intermediate,,Plasma,1969.0,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627201,,
12120,Intermediate,,Plasma,1969.0,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627202,,
12121,Intermediate,,Plasma,1969.0,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627203,,
12122,Intermediate,,Plasma,1969.0,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627204,,
12123,Intermediate,,Spleen,2106.0,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627205,,
12124,Intermediate,,Spleen,2106.0,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627206,,
12125,Intermediate,,Spleen,2106.0,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627207,,
12126,Intermediate,,Spleen,2106.0,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627208,,
12127,Intermediate,,Thyroid gland,2046.0,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627209,,
12128,Intermediate,,Thyroid gland,2046.0,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627210,,
12129,Intermediate,,Thyroid gland,2046.0,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627211,,
12130,Intermediate,,Thyroid gland,2046.0,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627212,,
12131,Intermediate,,Uterus,995.0,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL627213,,
12132,Intermediate,,Uterus,995.0,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL626599,,
12133,Intermediate,,Uterus,995.0,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL626600,,
12134,Intermediate,,Uterus,995.0,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,50597,Rattus norvegicus,10911,BAO_0000218,,1,1,,CHEMBL626601,,
12135,Autocuration,,,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,22224,,8081,BAO_0000019,,0,1,,CHEMBL627484,,
12136,Intermediate,,Plasma,1969.0,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),100710,Macaca fascicularis,17248,BAO_0000218,,1,1,,CHEMBL627485,,
12137,Intermediate,,Plasma,1969.0,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,100710,Macaca fascicularis,17248,BAO_0000218,,1,1,,CHEMBL628147,,
12138,Intermediate,,Plasma,1969.0,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,100710,Macaca fascicularis,17248,BAO_0000218,,1,1,,CHEMBL628148,,
12139,Intermediate,,Plasma,1969.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),50588,Canis lupus familiaris,17248,BAO_0000218,,1,1,,CHEMBL628149,,
12140,Intermediate,,Plasma,1969.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,50588,Canis lupus familiaris,17248,BAO_0000218,,1,1,,CHEMBL628150,,
12141,Intermediate,,Plasma,1969.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,50588,Canis lupus familiaris,17248,BAO_0000218,,1,1,,CHEMBL628318,,
12142,Intermediate,,Plasma,1969.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,50588,Canis lupus familiaris,17248,BAO_0000218,,1,1,,CHEMBL628319,,
12143,Intermediate,,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",50588,Canis lupus familiaris,15592,BAO_0000218,,1,1,,CHEMBL875609,,
12144,Autocuration,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,22224,,7040,BAO_0000019,,0,1,,CHEMBL628320,,
12145,Autocuration,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,22224,,7040,BAO_0000019,,0,1,,CHEMBL628321,,
12146,Autocuration,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,22224,,7040,BAO_0000019,,0,1,,CHEMBL628322,,
12147,Autocuration,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,22224,,7040,BAO_0000019,,0,1,,CHEMBL628323,,
12148,Autocuration,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,22224,,7040,BAO_0000019,,0,1,,CHEMBL628324,,
12149,Autocuration,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,22224,,7040,BAO_0000019,,0,1,,CHEMBL628325,,
12150,Autocuration,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,22224,,7040,BAO_0000019,,0,1,,CHEMBL628326,,
12151,Intermediate,,Adrenal medulla,1236.0,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",50588,Canis lupus familiaris,9614,BAO_0000218,,1,1,,CHEMBL628327,,
12152,Intermediate,,Adrenal medulla,1236.0,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",50588,Canis lupus familiaris,9614,BAO_0000218,,1,1,,CHEMBL628328,,
12153,Intermediate,,Blood,178.0,"Concentration of compound in blood of dog 1, after administering intravenously",50588,Canis lupus familiaris,9614,BAO_0000218,,1,1,,CHEMBL628329,,
12154,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628330,,
12155,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628331,,
12156,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628332,,
12157,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628333,,
12158,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628334,,
12159,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628335,,
12160,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628336,,
12161,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628337,,
12162,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628338,,
12163,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL875610,,
12164,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628339,,
12165,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628340,,
12166,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL628341,,
12167,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL622214,,
12168,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL623167,,
12169,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL623168,,
12170,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL623169,,
12171,Intermediate,,Liver,2107.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL623170,,
12172,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627224,,
12173,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL875634,,
12174,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627225,,
12175,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627226,,
12176,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626083,,
12177,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626084,,
12178,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626085,,
12179,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626086,,
12180,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626087,,
12181,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626088,,
12182,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626089,,
12183,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626090,,
12184,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626091,,
12185,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626092,,
12186,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626093,,
12187,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626094,,
12188,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626095,,
12189,Intermediate,,Lung,2048.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626096,,
12190,Autocuration,,,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,22224,Simiiformes,15604,BAO_0000218,,0,1,,CHEMBL626097,,
12191,Intermediate,,,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,50597,Rattus norvegicus,15604,BAO_0000218,,1,1,,CHEMBL626098,,
12192,Autocuration,,Plasma,1969.0,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,22224,,1806,BAO_0000218,,0,1,,CHEMBL626099,,
12193,Autocuration,,Plasma,1969.0,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,22224,,1806,BAO_0000218,,0,1,,CHEMBL626100,,
12194,Intermediate,,Plasma,1969.0,AUC 0-inf in dog,50588,Canis lupus familiaris,17237,BAO_0000218,,1,1,,CHEMBL626101,,
12195,Intermediate,,Plasma,1969.0,AUC 0-inf in guinea pig,50512,Cavia porcellus,17237,BAO_0000218,,1,1,,CHEMBL626102,,
12196,Intermediate,,Plasma,1969.0,AUC 0-t in dog,50588,Canis lupus familiaris,17237,BAO_0000218,,1,1,,CHEMBL626103,,
12197,Intermediate,,Plasma,1969.0,AUC 0-t in guinea pig,50512,Cavia porcellus,17237,BAO_0000218,,1,1,,CHEMBL628391,,
12198,Intermediate,,,,The compound was tested for brain to plasma partition in rat,50597,Rattus norvegicus,15194,BAO_0000218,,1,1,,CHEMBL628392,,
12199,Intermediate,,,,The compound was tested for brain to plasma partition in rat.,50597,Rattus norvegicus,15194,BAO_0000218,,1,1,,CHEMBL628393,,
12200,Autocuration,,Blood,178.0,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,22224,,8787,BAO_0000019,,0,1,,CHEMBL628394,,
12201,Intermediate,,,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,50588,Canis lupus familiaris,17025,BAO_0000218,,1,1,,CHEMBL628395,,
12202,Autocuration,,,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,22224,Simiiformes,17025,BAO_0000218,,0,1,,CHEMBL628396,,
12203,Intermediate,,,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,50592,Oryctolagus cuniculus,17025,BAO_0000218,,1,1,,CHEMBL628397,,
12204,Intermediate,,,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,50597,Rattus norvegicus,17025,BAO_0000218,,1,1,,CHEMBL628398,,
12205,Intermediate,,,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,50797,Macaca mulatta,4236,BAO_0000218,,1,1,,CHEMBL628399,,
12206,Intermediate,,,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,50588,Canis lupus familiaris,15343,BAO_0000218,,1,1,,CHEMBL628400,,
12207,Intermediate,,,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,50597,Rattus norvegicus,15343,BAO_0000218,,1,1,,CHEMBL874907,,
12208,Autocuration,,,,Area under curve of the compound was determined,22224,,17720,BAO_0000019,,0,1,,CHEMBL628401,,
12209,Autocuration,,Plasma,1969.0,AUC in monkeys at a dose of 1 mg/kg,22224,Simiiformes,17788,BAO_0000218,,0,1,,CHEMBL628402,,
12210,Intermediate,,Plasma,1969.0,AUC in rats at a dose of 1 mg/kg,50597,Rattus norvegicus,17788,BAO_0000218,,1,1,,CHEMBL628403,,
12211,Autocuration,,,,Compound was evaluated for the overall absorbance loss at pH of 2,22224,,8778,BAO_0000019,,0,1,,CHEMBL628404,,
12212,Autocuration,,,,Compound was evaluated for the overall absorbance loss at pH of 4,22224,,8778,BAO_0000019,,0,1,,CHEMBL628405,,
12213,Autocuration,,,,Compound was evaluated for the overall absorbance loss at pH of 7,22224,,8778,BAO_0000019,,0,1,,CHEMBL628406,,
12214,Intermediate,,,,Compound was evaluated for its absorption in the rats,50597,Rattus norvegicus,2249,BAO_0000218,,1,1,,CHEMBL628407,,
12215,Intermediate,,Urine,1088.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,50597,Rattus norvegicus,8881,BAO_0000218,,1,1,,CHEMBL628408,,
12216,Intermediate,,Urine,1088.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,50597,Rattus norvegicus,8881,BAO_0000218,,1,1,,CHEMBL629171,,
12217,Intermediate,,Urine,1088.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,50597,Rattus norvegicus,8881,BAO_0000218,,1,1,,CHEMBL629172,,
12218,Intermediate,,Urine,1088.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,50597,Rattus norvegicus,8881,BAO_0000218,,1,1,,CHEMBL629173,,
12219,Intermediate,,,,In vitro percent permeability into rat ileum,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL629174,,
12220,Intermediate,,,,In vitro percent permeability into rat ileum; Range is 10-17,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL629175,,
12221,Intermediate,,,,In vitro percent permeability into rat ileum; Range is 10-18,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL629176,,
12222,Intermediate,,,,In vitro percent permeability into rat ileum; Range is 10-19,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL629177,,
12223,Intermediate,,,,In vitro percent permeability into rat ileum; Range is 12-15,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL629178,,
12224,Intermediate,,,,In vitro percent permeability into rat ileum; Range is 13-19,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL631869,,
12225,Intermediate,,,,In vitro percent permeability into rat ileum; Range is 14-17,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL631870,,
12226,Intermediate,,,,In vitro percent permeability into rat ileum; Range is 15-18,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL631871,,
12227,Intermediate,,,,In vitro percent permeability into rat ileum; Range is 2-5,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL631872,,
12228,Autocuration,,Ileum,2116.0,In vitro percent permeability into rat ileum; Range is 23-42,22224,,15286,BAO_0000221,,0,1,,CHEMBL875775,,
12229,Intermediate,,,,In vitro percent permeability into rat ileum; Range is 28-36,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL631873,,
12230,Intermediate,,,,In vitro percent permeability into rat ileum; Range is 29-35,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL631874,,
12231,Intermediate,,,,In vitro percent permeability into rat ileum; Range is 46-66,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL631875,,
12232,Intermediate,,,,In vitro percent permeability into rat ileum; Range is 50-68,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL631876,,
12233,Intermediate,,,,In vitro percent permeability into rat ileum; Range is 78-81,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL631877,,
12234,Intermediate,,,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL631878,,
12235,Intermediate,,,,In vitro percent permeability into rat ileum; nd indicates not detected,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL631879,,
12236,Intermediate,,,,In vitro percent permeability into rat ileum; nt indicates not detected,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL631880,,
12237,Intermediate,,,,In vitro percent permeability into rat ileum; nt indicates not tested,50597,Rattus norvegicus,15286,BAO_0000218,,1,1,,CHEMBL631881,,
12238,Intermediate,,,,Compound was tested for oral absorption in bile-duct cannulated rats,50597,Rattus norvegicus,13770,BAO_0000218,,1,1,,CHEMBL631882,,
12239,Intermediate,,,,Compound was tested for oral absorption in bile-duct cannulated rats.,50597,Rattus norvegicus,13770,BAO_0000218,,1,1,,CHEMBL630749,,
12240,Intermediate,,,,Oral absorption using Caco-2 cell monolayers.,50587,Homo sapiens,5202,BAO_0000218,,1,1,,CHEMBL630750,,
12241,Intermediate,,,,Percent of the drug absorbed after administration to humans was determined,50587,Homo sapiens,14920,BAO_0000218,,1,1,,CHEMBL630253,,
12242,Intermediate,,Plasma,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL630254,,
12243,Intermediate,,Plasma,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL630255,,
12244,Intermediate,,Plasma,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL630256,,
12245,Intermediate,,Liver,2107.0,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL875781,,
12246,Intermediate,,Liver,2107.0,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL630257,,
12247,Intermediate,,Liver,2107.0,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",50597,Rattus norvegicus,13751,BAO_0000218,,1,1,,CHEMBL630258,,
12248,Intermediate,,,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",50597,Rattus norvegicus,15807,BAO_0000218,,1,1,,CHEMBL630259,,
12249,Intermediate,,Striatum,2435.0,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",50597,Rattus norvegicus,15807,BAO_0000218,,1,1,,CHEMBL630260,,
12250,Intermediate,,Striatum,2435.0,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",50597,Rattus norvegicus,15807,BAO_0000218,,1,1,,CHEMBL630261,,
12251,Intermediate,,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630262,,
12252,Intermediate,,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630263,,
12253,Intermediate,,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630264,,
12254,Intermediate,,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630265,,
12255,Intermediate,,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630266,,
12256,Intermediate,,Kidney,2113.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630267,,
12257,Intermediate,,Kidney,2113.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630268,,
12258,Intermediate,,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630269,,
12259,Intermediate,,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630270,,
12260,Intermediate,,Lung,2048.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630141,,
12261,Intermediate,,Lung,2048.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630142,,
12262,Intermediate,,Muscle tissue,2385.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630143,,
12263,Intermediate,,Muscle tissue,2385.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630144,,
12264,Intermediate,,Prostate gland,2367.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630145,,
12265,Intermediate,,Prostate gland,2367.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630146,,
12266,Intermediate,,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630147,,
12267,Intermediate,,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630148,,
12268,Intermediate,,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630149,,
12269,Intermediate,,Spleen,2106.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630150,,
12270,Intermediate,,Spleen,2106.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL630151,,
12271,Intermediate,,Thyroid gland,2046.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL632031,,
12272,Intermediate,,Thyroid gland,2046.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL632032,,
12273,Intermediate,,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL632033,,
12274,Intermediate,,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL632034,,
12275,Intermediate,,Muscle tissue,2385.0,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL632035,,
12276,Intermediate,,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL632036,,
12277,Intermediate,,Thyroid gland,2046.0,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,50597,Rattus norvegicus,14950,BAO_0000218,,1,1,,CHEMBL632037,,
12278,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL632038,,
12279,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL632039,,
12280,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL632040,,
12281,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL632041,,
12282,Intermediate,,Blood,178.0,"Concentration of compound in blood of dog 2, after administering intravenously",50588,Canis lupus familiaris,9614,BAO_0000218,,1,1,,CHEMBL632042,,
12283,Intermediate,,,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",50588,Canis lupus familiaris,9614,BAO_0000218,,1,1,,CHEMBL632043,,
12284,Intermediate,,,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",50588,Canis lupus familiaris,9614,BAO_0000218,,1,1,,CHEMBL632044,,
12285,Intermediate,,Liver,2107.0,"Concentration of compound in liver of dog 1, after administering intravenously",50588,Canis lupus familiaris,9614,BAO_0000218,,1,1,,CHEMBL632045,,
12286,Intermediate,,Liver,2107.0,"Concentration of compound in liver of dog 2, after administering intravenously",50588,Canis lupus familiaris,9614,BAO_0000218,,1,1,,CHEMBL632046,,
12287,Intermediate,,Lung,2048.0,"Concentration of compound in lung of dog 1, after administering intravenously",50588,Canis lupus familiaris,9614,BAO_0000218,,1,1,,CHEMBL632047,,
12288,Intermediate,,Lung,2048.0,"Concentration of compound in lung of dog 2, after administering intravenously",50588,Canis lupus familiaris,9614,BAO_0000218,,1,1,,CHEMBL632048,,
12289,Intermediate,,Muscle tissue,2385.0,"Concentration of compound in muscle of dog 1, after administering intravenously",50588,Canis lupus familiaris,9614,BAO_0000218,,1,1,,CHEMBL632049,,
12290,Intermediate,,Muscle tissue,2385.0,"Concentration of compound in muscle of dog 2, after administering intravenously",50588,Canis lupus familiaris,9614,BAO_0000218,,1,1,,CHEMBL876418,,
12291,Intermediate,,Spleen,2106.0,"Concentration of compound in spleen of dog 1,after administering intravenously",50588,Canis lupus familiaris,9614,BAO_0000218,,1,1,,CHEMBL632050,,
12292,Intermediate,,Spleen,2106.0,"Concentration of compound in spleen of dog 2, after administering intravenously",50588,Canis lupus familiaris,9614,BAO_0000218,,1,1,,CHEMBL632051,,
12293,Autocuration,,,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,22224,,10353,BAO_0000218,,0,1,,CHEMBL632052,,
12294,Autocuration,,,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,22224,,10353,BAO_0000218,,0,1,,CHEMBL632053,,
12295,Autocuration,,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,22224,,10353,BAO_0000218,,0,1,,CHEMBL632054,,
12296,Autocuration,,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,22224,,10353,BAO_0000218,,0,1,,CHEMBL632055,,
12297,Autocuration,,,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,22224,,10353,BAO_0000218,,0,1,,CHEMBL631181,,
12298,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL631182,,
12299,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL631183,,
12300,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL631184,,
12301,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL629774,,
12302,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL629775,,
12303,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL876549,,
12304,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628172,,
12305,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628173,,
12306,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628174,,
12307,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628175,,
12308,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628176,,
12309,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628177,,
12310,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628178,,
12311,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628179,,
12312,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,22224,,9196,BAO_0000218,,0,1,,CHEMBL628180,,
12313,Autocuration,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628181,,
12314,Autocuration,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628182,,
12315,Autocuration,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628183,,
12316,Autocuration,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,22224,,9196,BAO_0000218,,0,1,,CHEMBL628184,,
12317,Autocuration,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628185,,
12318,Autocuration,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL875617,,
12319,Autocuration,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,22224,,9196,BAO_0000218,,0,1,,CHEMBL628186,,
12320,Autocuration,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628187,,
12321,Autocuration,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628188,,
12322,Autocuration,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628189,,
12323,Autocuration,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,22224,,9196,BAO_0000218,,0,1,,CHEMBL628190,,
12324,Autocuration,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628191,,
12325,Autocuration,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,22224,,9196,BAO_0000218,,0,1,,CHEMBL626513,,
12326,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626514,,
12327,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626515,,
12328,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626516,,
12329,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626517,,
12330,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626518,,
12331,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626519,,
12332,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626520,,
12333,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626521,,
12334,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626522,,
12335,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626523,,
12336,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626524,,
12337,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626688,,
12338,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626689,,
12339,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626690,,
12340,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL626691,,
12341,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL627319,,
12342,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL624052,,
12343,Intermediate,,Thyroid gland,2046.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",50597,Rattus norvegicus,8608,BAO_0000218,,1,1,,CHEMBL624053,,
12344,Intermediate,,,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,50597,Rattus norvegicus,8085,BAO_0000218,,1,1,,CHEMBL624054,,
12345,Intermediate,,,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,50597,Rattus norvegicus,8085,BAO_0000218,,1,1,,CHEMBL624055,,
12346,Intermediate,,,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,50597,Rattus norvegicus,8085,BAO_0000218,,1,1,,CHEMBL624056,,
12347,Intermediate,,Uterus,995.0,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,50597,Rattus norvegicus,8085,BAO_0000218,,1,1,,CHEMBL624057,,
12348,Intermediate,,Uterus,995.0,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,50597,Rattus norvegicus,8085,BAO_0000218,,1,1,,CHEMBL622281,,
12349,Intermediate,,Uterus,995.0,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,50597,Rattus norvegicus,8085,BAO_0000218,,1,1,,CHEMBL622282,,
12350,Intermediate,,Uterus,995.0,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,50597,Rattus norvegicus,8085,BAO_0000218,,1,1,,CHEMBL622283,,
12351,Intermediate,,Uterus,995.0,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,50597,Rattus norvegicus,8085,BAO_0000218,,1,1,,CHEMBL622284,,
12352,Intermediate,,Uterus,995.0,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,50597,Rattus norvegicus,8085,BAO_0000218,,1,1,,CHEMBL622285,,
12353,Intermediate,,Uterus,995.0,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,50597,Rattus norvegicus,8085,BAO_0000218,,1,1,,CHEMBL622286,,
12354,Autocuration,,,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,22224,,7657,BAO_0000100,,0,1,,CHEMBL622287,,
12355,Intermediate,,,,Partition coefficient (logD7.4),50594,Mus musculus,8935,BAO_0000218,,1,1,,CHEMBL622288,,
12356,Intermediate,,,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",50594,Mus musculus,13792,BAO_0000218,,1,1,,CHEMBL622289,,
12357,Intermediate,,Brain,955.0,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",50594,Mus musculus,13792,BAO_0000218,,1,1,,CHEMBL622290,,
12358,Intermediate,,,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,50594,Mus musculus,13792,BAO_0000218,,1,1,,CHEMBL622291,,
12359,Intermediate,,Brain,955.0,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,50594,Mus musculus,13792,BAO_0000218,,1,1,,CHEMBL622292,,
12360,Intermediate,,,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",50594,Mus musculus,13792,BAO_0000218,,1,1,,CHEMBL622293,,
12361,Intermediate,,Brain,955.0,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",50594,Mus musculus,13792,BAO_0000218,,1,1,,CHEMBL622294,,
12362,Intermediate,,,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,50594,Mus musculus,13792,BAO_0000218,,1,1,,CHEMBL622295,,
12363,Intermediate,,Brain,955.0,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,50597,Rattus norvegicus,13792,BAO_0000218,,1,1,,CHEMBL622296,,
12364,Intermediate,,Plasma,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL874409,,
12365,Intermediate,,Plasma,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL622297,,
12366,Intermediate,,Plasma,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL622298,,
12367,Intermediate,,Plasma,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL622299,,
12368,Intermediate,,Plasma,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL622300,,
12369,Intermediate,,Plasma,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL622301,,
12370,Intermediate,,Plasma,1969.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL622302,,
12371,Intermediate,,Plasma,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL622303,,
12372,Intermediate,,Plasma,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL622304,,
12373,Intermediate,,Plasma,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL622305,,
12374,Intermediate,,Plasma,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL622306,,
12375,Intermediate,,Plasma,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL626864,,
12376,Intermediate,,Plasma,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL626865,,
12377,Intermediate,,Plasma,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL626866,,
12378,Intermediate,,Plasma,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL626867,,
12379,Intermediate,,Plasma,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL626868,,
12380,Intermediate,,Plasma,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL626869,,
12381,Intermediate,,Plasma,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL626870,,
12382,Intermediate,,Plasma,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL626871,,
12383,Intermediate,,Plasma,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL626872,,
12384,Intermediate,,Plasma,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL632185,,
12385,Intermediate,,Plasma,1969.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,50597,Rattus norvegicus,14103,BAO_0000218,,1,1,,CHEMBL632186,,
12386,Autocuration,,,,Amount of acetic acid produced by the compound,22224,,12904,BAO_0000019,,0,1,,CHEMBL629310,,
12387,Autocuration,,,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,22224,,12904,BAO_0000019,,0,1,,CHEMBL629311,,
12388,Intermediate,,,,Log of (Cbrain/Cblood) in rats,50597,Rattus norvegicus,9663,BAO_0000218,,1,1,,CHEMBL629312,,
12389,Autocuration,,,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),22224,,7652,BAO_0000221,,0,1,,CHEMBL629313,,
12390,Autocuration,,,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),22224,,7652,BAO_0000221,,0,1,,CHEMBL629314,,
12391,Autocuration,,,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),22224,,7652,BAO_0000221,,0,1,,CHEMBL629315,,
12392,Autocuration,,,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),22224,,7652,BAO_0000219,,0,1,,CHEMBL629316,,
12393,Autocuration,,,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),22224,,7652,BAO_0000221,,0,1,,CHEMBL629317,,
12394,Autocuration,,,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),22224,,7652,BAO_0000019,,0,1,,CHEMBL629318,,
12395,Autocuration,,,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),22224,,7652,BAO_0000019,,0,1,,CHEMBL877497,,
12396,Autocuration,,,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),22224,,7652,BAO_0000019,,0,1,,CHEMBL629319,,
12397,Autocuration,,,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),22224,,7652,BAO_0000019,,0,1,,CHEMBL629320,,
12398,Autocuration,,,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),22224,,7652,BAO_0000019,,0,1,,CHEMBL629496,,
12399,Autocuration,,,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),22224,,7652,BAO_0000019,,0,1,,CHEMBL629497,,
12400,Autocuration,,,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),22224,,7652,BAO_0000019,,0,1,,CHEMBL629498,,
12401,Autocuration,,,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),22224,,7652,BAO_0000019,,0,1,,CHEMBL629499,,
12402,Autocuration,,,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),22224,,7652,BAO_0000019,,0,1,,CHEMBL629500,,
12403,Autocuration,,,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),22224,,7652,BAO_0000019,,0,1,,CHEMBL629501,,
12404,Autocuration,,,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),22224,,7652,BAO_0000019,,0,1,,CHEMBL629502,,
12405,Autocuration,,,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,22224,,8267,BAO_0000218,,0,1,,CHEMBL629503,,
12406,Intermediate,,,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,50588,Canis lupus familiaris,8267,BAO_0000218,,1,1,,CHEMBL629504,,
12407,Autocuration,,,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,22224,,14479,BAO_0000019,,0,1,,CHEMBL629505,,
12408,Autocuration,,,,Compound was evaluated for total body clearance,22224,,17515,BAO_0000019,,0,1,,CHEMBL629506,,
12409,Autocuration,,,,Compound was evaluated for volume of distribution at steady state,22224,,17515,BAO_0000019,,0,1,,CHEMBL629507,,
12410,Autocuration,,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,22224,,8142,BAO_0000019,,0,1,,CHEMBL877498,,
12411,Autocuration,,,,Percentage of the diamine which is monoprotonated at pH 7.4,22224,,14849,BAO_0000019,,0,1,,CHEMBL629508,,
12412,Autocuration,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,22224,,7653,BAO_0000019,,0,1,,CHEMBL629509,,
12413,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL629510,,
12414,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL629511,,
12415,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL629512,,
12416,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL629513,,
12417,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL629514,,
12418,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL628447,,
12419,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL628448,,
12420,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL628449,,
12421,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL631119,,
12422,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL631120,,
12423,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL631121,,
12424,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL874458,,
12425,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL631122,,
12426,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL631123,,
12427,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL631124,,
12428,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL631125,,
12429,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL631290,,
12430,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL631291,,
12431,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL631292,,
12432,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL631293,,
12433,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL631294,,
12434,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL631295,,
12435,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL631296,,
12436,Intermediate,,Blood,178.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,50597,Rattus norvegicus,8631,BAO_0000218,,1,1,,CHEMBL631297,,
12437,Autocuration,,,,Maximum biodistribution (Bmax) was determined.,22224,,10263,BAO_0000218,,0,1,,CHEMBL631298,,
12438,Intermediate,,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,50594,Mus musculus,12364,BAO_0000218,,1,1,,CHEMBL631299,,
12439,Intermediate,,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,50594,Mus musculus,12364,BAO_0000218,,1,1,,CHEMBL631300,,
12440,Intermediate,,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,50594,Mus musculus,12364,BAO_0000218,,1,1,,CHEMBL631301,,
12441,Intermediate,,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,50594,Mus musculus,12364,BAO_0000218,,1,1,,CHEMBL630291,,
12442,Autocuration,,,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,22224,,14793,BAO_0000218,,0,1,,CHEMBL630292,,
12443,Autocuration,,,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,22224,,14793,BAO_0000218,,0,1,,CHEMBL630293,,
12444,Autocuration,,,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,22224,,14793,BAO_0000218,,0,1,,CHEMBL630294,,
12445,Autocuration,,,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,22224,,14793,BAO_0000218,,0,1,,CHEMBL630295,,
12446,Autocuration,,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,22224,,14793,BAO_0000218,,0,1,,CHEMBL630296,,
12447,Autocuration,,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,22224,,14793,BAO_0000218,,0,1,,CHEMBL626782,,
12448,Autocuration,,,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,22224,,14793,BAO_0000218,,0,1,,CHEMBL626783,,
12449,Autocuration,,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,22224,,14793,BAO_0000218,,0,1,,CHEMBL626784,,
12450,Autocuration,,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,22224,,14793,BAO_0000218,,0,1,,CHEMBL626785,,
12451,Autocuration,,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,22224,,14793,BAO_0000218,,0,1,,CHEMBL626786,,
12452,Autocuration,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL626787,,
12453,Autocuration,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,22224,,9196,BAO_0000218,,0,1,,CHEMBL626788,,
12454,Autocuration,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL625927,,
12455,Intermediate,,Blood,178.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL625928,,
12456,Intermediate,,Blood,178.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL625929,,
12457,Intermediate,,Blood,178.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL625930,,
12458,Intermediate,,Blood,178.0,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL625931,,
12459,Intermediate,,Blood,178.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627230,,
12460,Intermediate,,Blood,178.0,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627231,,
12461,Intermediate,,Blood,178.0,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627232,,
12462,Intermediate,,Blood,178.0,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627233,,
12463,Intermediate,,Blood,178.0,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL875470,,
12464,Intermediate,,Blood,178.0,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627234,,
12465,Intermediate,,Blood,178.0,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627235,,
12466,Intermediate,,Blood,178.0,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627236,,
12467,Intermediate,,Blood,178.0,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627237,,
12468,Intermediate,,Blood,178.0,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627238,,
12469,Intermediate,,Blood,178.0,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627239,,
12470,Intermediate,,Blood,178.0,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627240,,
12471,Intermediate,,Blood,178.0,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627241,,
12472,Intermediate,,Blood,178.0,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627242,,
12473,Intermediate,,Blood,178.0,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627243,,
12474,Intermediate,,Blood,178.0,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627244,,
12475,Intermediate,,Blood,178.0,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627245,,
12476,Intermediate,,Blood,178.0,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627246,,
12477,Intermediate,,Blood,178.0,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627247,,
12478,Intermediate,,Blood,178.0,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627248,,
12479,Intermediate,,Blood,178.0,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627249,,
12480,Intermediate,,Blood,178.0,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL625569,,
12481,Intermediate,,Blood,178.0,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL625570,,
12482,Intermediate,,Blood,178.0,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL625571,,
12483,Intermediate,,Blood,178.0,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL625572,,
12484,Intermediate,,Blood,178.0,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL625573,,
12485,Intermediate,,Blood,178.0,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL625574,,
12486,Intermediate,,Blood,178.0,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL626245,,
12487,Intermediate,,Blood,178.0,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL626246,,
12488,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL626247,,
12489,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL626248,,
12490,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL626249,,
12491,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL626420,,
12492,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL626421,,
12493,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL626422,,
12494,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL626423,,
12495,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL626424,,
12496,Intermediate,,,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,50588,Canis lupus familiaris,12023,BAO_0000218,,1,1,,CHEMBL626425,,
12497,Intermediate,,,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,50597,Rattus norvegicus,12023,BAO_0000218,,1,1,,CHEMBL875476,,
12498,Intermediate,,,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,100710,Macaca fascicularis,12023,BAO_0000218,,1,1,,CHEMBL626426,,
12499,Autocuration,,,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,22224,,10580,BAO_0000100,,0,1,,CHEMBL626427,,
12500,Autocuration,,,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,22224,,10580,BAO_0000100,,0,1,,CHEMBL626428,,
12501,Autocuration,,,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,22224,,16032,BAO_0000019,,0,1,,CHEMBL626429,,
12502,Autocuration,,Urine,1088.0,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,22224,,16032,BAO_0000019,,0,1,,CHEMBL625025,,
12503,Intermediate,,Blood,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL625026,,
12504,Intermediate,,Blood,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL625027,,
12505,Intermediate,,Blood,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL874410,,
12506,Intermediate,,Blood,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL625028,,
12507,Intermediate,,Blood,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL625029,,
12508,Intermediate,,Blood,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL625030,,
12509,Intermediate,,Blood,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL625031,,
12510,Intermediate,,Blood,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL625032,,
12511,Intermediate,,Blood,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL625033,,
12512,Intermediate,,Blood,178.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL625034,,
12513,Intermediate,,Heart,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624872,,
12514,Intermediate,,Heart,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624873,,
12515,Intermediate,,Heart,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624874,,
12516,Intermediate,,Heart,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624875,,
12517,Intermediate,,Heart,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624876,,
12518,Intermediate,,Heart,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624877,,
12519,Intermediate,,Heart,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624878,,
12520,Intermediate,,Heart,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624879,,
12521,Intermediate,,Heart,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624880,,
12522,Intermediate,,Heart,948.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624881,,
12523,Intermediate,,Heart,948.0,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624882,,
12524,Intermediate,,Kidney,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624883,,
12525,Intermediate,,Kidney,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624884,,
12526,Intermediate,,Kidney,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624885,,
12527,Intermediate,,Kidney,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624886,,
12528,Intermediate,,Kidney,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624887,,
12529,Intermediate,,Kidney,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624888,,
12530,Intermediate,,Kidney,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624889,,
12531,Intermediate,,Kidney,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624890,,
12532,Intermediate,,Kidney,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL621964,,
12533,Intermediate,,Kidney,2113.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL621965,,
12534,Intermediate,,Liver,2107.0,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL621966,,
12535,Intermediate,,Liver,2107.0,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL621967,,
12536,Intermediate,,Liver,2107.0,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL622164,,
12537,Autocuration,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),22224,,7653,BAO_0000019,,0,1,,CHEMBL623097,,
12538,Autocuration,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),22224,,7653,BAO_0000019,,0,1,,CHEMBL623098,,
12539,Autocuration,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,22224,,7653,BAO_0000019,,0,1,,CHEMBL623099,,
12540,Autocuration,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,22224,,7653,BAO_0000019,,0,1,,CHEMBL623100,,
12541,Intermediate,,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",50597,Rattus norvegicus,9104,BAO_0000218,,1,1,,CHEMBL628673,,
12542,Intermediate,,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",50597,Rattus norvegicus,9104,BAO_0000218,,1,1,,CHEMBL628674,,
12543,Intermediate,,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",50597,Rattus norvegicus,9104,BAO_0000218,,1,1,,CHEMBL628675,,
12544,Intermediate,,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",50597,Rattus norvegicus,9104,BAO_0000218,,1,1,,CHEMBL627644,,
12545,Intermediate,,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",50597,Rattus norvegicus,9104,BAO_0000218,,1,1,,CHEMBL627645,,
12546,Intermediate,,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",50597,Rattus norvegicus,9104,BAO_0000218,,1,1,,CHEMBL627646,,
12547,Intermediate,,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",50597,Rattus norvegicus,9104,BAO_0000218,,1,1,,CHEMBL627647,,
12548,Intermediate,,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",50597,Rattus norvegicus,9104,BAO_0000218,,1,1,,CHEMBL627648,,
12549,Intermediate,,,,Free level in rat plasma,50597,Rattus norvegicus,12902,BAO_0000218,,1,1,,CHEMBL627649,,
12550,Autocuration,,,,Level reaching in blood plasma of rat or human was determined,22224,,6614,BAO_0000019,,0,1,,CHEMBL628313,,
12551,Intermediate,,,,Log (Cbrain/Cblood) in rats,50597,Rattus norvegicus,9663,BAO_0000218,,1,1,,CHEMBL628314,,
12552,Autocuration,,,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,22224,,17658,BAO_0000019,,0,1,,CHEMBL628315,,
12553,Autocuration,,,,Mean percentage of compound transport through membrane; expressed as membrane transport,22224,,17658,BAO_0000019,,0,1,,CHEMBL628316,,
12554,Autocuration,,,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,22224,,14314,BAO_0000218,,0,1,,CHEMBL628317,,
12555,Autocuration,,,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,22224,,7385,BAO_0000019,,0,1,,CHEMBL628473,,
12556,Autocuration,,,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",22224,,7385,BAO_0000019,,0,1,,CHEMBL628474,,
12557,Autocuration,,,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,22224,,7385,BAO_0000019,,0,1,,CHEMBL628475,,
12558,Autocuration,,,,Net water uptake by a carrier mediated transport (%cm) mechanism,22224,,1329,BAO_0000019,,0,1,,CHEMBL628476,,
12559,Autocuration,,,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,22224,Simiiformes,12187,BAO_0000218,,0,1,,CHEMBL628477,,
12560,Intermediate,,,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,50506,Mustela putorius furo,12187,BAO_0000218,,1,1,,CHEMBL628478,,
12561,Intermediate,,,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",50506,Mustela putorius furo,12187,BAO_0000218,,1,1,,CHEMBL628479,,
12562,Autocuration,,,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,22224,Simiiformes,12187,BAO_0000218,,0,1,,CHEMBL628480,,
12563,Autocuration,,,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",22224,Simiiformes,12187,BAO_0000218,,0,1,,CHEMBL628481,,
12564,Intermediate,,,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,50597,Rattus norvegicus,12187,BAO_0000218,,1,1,,CHEMBL628482,,
12565,Intermediate,,,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",50597,Rattus norvegicus,12187,BAO_0000218,,1,1,,CHEMBL628483,,
12566,Intermediate,,Plasma,1969.0,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",50597,Rattus norvegicus,9278,BAO_0000218,,1,1,,CHEMBL628484,,
12567,Intermediate,,Plasma,1969.0,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",50597,Rattus norvegicus,9278,BAO_0000218,,1,1,,CHEMBL628485,,
12568,Intermediate,,Plasma,1969.0,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",100710,Macaca fascicularis,9278,BAO_0000218,,1,1,,CHEMBL628486,,
12569,Intermediate,,Plasma,1969.0,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",50587,Homo sapiens,9278,BAO_0000218,,1,1,,CHEMBL628487,,
12570,Intermediate,,Plasma,1969.0,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",50597,Rattus norvegicus,9278,BAO_0000218,,1,1,,CHEMBL628488,,
12571,Intermediate,,Plasma,1969.0,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",50597,Rattus norvegicus,9278,BAO_0000218,,1,1,,CHEMBL628489,,
12572,Intermediate,,Plasma,1969.0,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",50597,Rattus norvegicus,9278,BAO_0000218,,1,1,,CHEMBL628490,,
12573,Intermediate,,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,100710,Macaca fascicularis,12186,BAO_0000218,,1,1,,CHEMBL628491,,
12574,Intermediate,,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,100710,Macaca fascicularis,12186,BAO_0000218,,1,1,,CHEMBL877507,,
12575,Autocuration,,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,22224,,12186,BAO_0000218,,0,1,,CHEMBL628492,,
12576,Autocuration,,,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),22224,Simiiformes,12041,BAO_0000019,,0,1,,CHEMBL628493,,
12577,Autocuration,,,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),22224,Simiiformes,12041,BAO_0000019,,0,1,,CHEMBL628494,,
12578,Autocuration,,,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),22224,Simiiformes,12041,BAO_0000019,,0,1,,CHEMBL628495,,
12579,Intermediate,,,,Permeability in Caco-2 assay at 10E-6,50587,Homo sapiens,6737,BAO_0000218,,1,1,,CHEMBL628496,,
12580,Autocuration,,Brain,955.0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,22224,,13758,BAO_0000218,,0,1,,CHEMBL628497,,
12581,Autocuration,,Brain,955.0,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,22224,,13758,BAO_0000218,,0,1,,CHEMBL628498,,
12582,Autocuration,,,,Plasma protein binding was determined,22224,,5676,BAO_0000019,,0,1,,CHEMBL628499,,
12583,Autocuration,,,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,22224,,14793,BAO_0000218,,0,1,,CHEMBL627656,,
12584,Autocuration,,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,22224,,14793,BAO_0000218,,0,1,,CHEMBL627657,,
12585,Autocuration,,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,22224,,14793,BAO_0000218,,0,1,,CHEMBL626808,,
12586,Autocuration,,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,22224,,14793,BAO_0000218,,0,1,,CHEMBL626809,,
12587,Autocuration,,,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,22224,,14793,BAO_0000218,,0,1,,CHEMBL626810,,
12588,Autocuration,,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,22224,,14793,BAO_0000218,,0,1,,CHEMBL626811,,
12589,Autocuration,,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,22224,,14793,BAO_0000218,,0,1,,CHEMBL874465,,
12590,Autocuration,,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,22224,,14793,BAO_0000218,,0,1,,CHEMBL626812,,
12591,Autocuration,,,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,22224,,14793,BAO_0000218,,0,1,,CHEMBL626813,,
12592,Autocuration,,,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,22224,,14793,BAO_0000218,,0,1,,CHEMBL626814,,
12593,Autocuration,,,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,22224,,14000,BAO_0000019,,0,1,,CHEMBL626815,,
12594,Autocuration,,,,Partition coefficient (logP),22224,,5948,BAO_0000019,,0,1,,CHEMBL628566,,
12595,Autocuration,,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),22229,,13824,BAO_0000100,,0,1,,CHEMBL628567,,
12596,Autocuration,,,,Calculated partition coefficient (clogP),22229,,10778,BAO_0000100,,0,1,,CHEMBL628568,,
12597,Intermediate,,,,C max in dog,50588,Canis lupus familiaris,17237,BAO_0000218,,1,1,,CHEMBL628569,,
12598,Intermediate,,,,C max in guinea pig,50512,Cavia porcellus,17237,BAO_0000218,,1,1,,CHEMBL628570,,
12599,Autocuration,,,,C max value was evaluated,22224,,2809,BAO_0000218,,0,1,,CHEMBL628571,,
12600,Autocuration,,,,Cmax value after oral dose of 0.1 mg//kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL628572,,
12601,Autocuration,,,,Cmax value after oral dose of 0.3 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL628573,,
12602,Autocuration,,,,Cmax value after oral dose of 1 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL628574,,
12603,Autocuration,,,,Cmax value after oral dose of 10 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL628575,,
12604,Autocuration,,,,Cmax value after oral dose of 23.4 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL628576,,
12605,Autocuration,,,,Cmax value after oral dose of 3 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL628577,,
12606,Autocuration,,,,Cmax value after oral dose of 3.87 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL628578,,
12607,Intermediate,,,,Cmax value in female Beagle dogs,50588,Canis lupus familiaris,12768,BAO_0000218,,1,1,,CHEMBL874466,,
12608,Intermediate,,,,Cmax value in male rats,50597,Rattus norvegicus,12768,BAO_0000218,,1,1,,CHEMBL628579,,
12609,Intermediate,,Plasma,1969.0,Cmax value in rat plasma when administered 20 mg/kg perorally,50597,Rattus norvegicus,12780,BAO_0000218,,1,1,,CHEMBL628580,,
12610,Intermediate,,Plasma,1969.0,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,50588,Canis lupus familiaris,15592,BAO_0000218,,1,1,,CHEMBL628581,,
12611,Intermediate,,Plasma,1969.0,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,50588,Canis lupus familiaris,15592,BAO_0000218,,1,1,,CHEMBL628582,,
12612,Intermediate,,,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,50588,Canis lupus familiaris,17025,BAO_0000218,,1,1,,CHEMBL628583,,
12613,Autocuration,,,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,22224,Simiiformes,17025,BAO_0000218,,0,1,,CHEMBL625782,,
12614,Intermediate,,,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,50592,Oryctolagus cuniculus,17025,BAO_0000218,,1,1,,CHEMBL625783,,
12615,Intermediate,,,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,50597,Rattus norvegicus,17025,BAO_0000218,,1,1,,CHEMBL625784,,
12616,Intermediate,,Plasma,1969.0,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,50797,Macaca mulatta,4236,BAO_0000218,,1,1,,CHEMBL625785,,
12617,Intermediate,,,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,50597,Rattus norvegicus,15791,BAO_0000218,,1,1,,CHEMBL625786,,
12618,Autocuration,,,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,22224,,11149,BAO_0000019,,0,1,,CHEMBL874467,,
12619,Intermediate,,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",50588,Canis lupus familiaris,15592,BAO_0000218,,1,1,,CHEMBL625787,,
12620,Intermediate,,,,cytotoxicity against HIV protease enzyme.,50677,Human immunodeficiency virus,15778,BAO_0000218,,1,1,,CHEMBL625964,,
12621,Intermediate,,,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,50594,Mus musculus,12745,BAO_0000218,,1,1,,CHEMBL625965,,
12622,Intermediate,,,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,50594,Mus musculus,12745,BAO_0000218,,1,1,,CHEMBL625966,,
12623,Intermediate,,Plasma,1969.0,The plasma clearance in dog.,50588,Canis lupus familiaris,13941,BAO_0000218,,1,1,,CHEMBL625967,,
12624,Intermediate,,Plasma,1969.0,The plasma clearance in rat.,50597,Rattus norvegicus,13941,BAO_0000218,,1,1,,CHEMBL625968,,
12625,Intermediate,,Plasma,1969.0,Clearance from plasma in male Sprague-Dawley rats,50597,Rattus norvegicus,16449,BAO_0000218,,1,1,,CHEMBL625969,,
12626,Intermediate,,Plasma,1969.0,Clearance from plasma in male cynomolgus monkeys,100710,Macaca fascicularis,16449,BAO_0000218,,1,1,,CHEMBL625970,,
12627,Intermediate,,Plasma,1969.0,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",50588,Canis lupus familiaris,14224,BAO_0000218,,1,1,,CHEMBL625971,,
12628,Intermediate,,Plasma,1969.0,Clearance of compound in dog plasma,50588,Canis lupus familiaris,14224,BAO_0000218,,1,1,,CHEMBL625972,,
12629,Intermediate,,Plasma,1969.0,Clearance of compound in human plasma,50587,Homo sapiens,14224,BAO_0000218,,1,1,,CHEMBL625973,,
12630,Intermediate,,,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,50588,Canis lupus familiaris,14317,BAO_0000218,,1,1,,CHEMBL625974,,
12631,Intermediate,,,,Clearance of compound when administered intravenously as an individual dose to a single dog.,50588,Canis lupus familiaris,14317,BAO_0000218,,1,1,,CHEMBL625975,,
12632,Intermediate,,Plasma,1969.0,"Clearance (10 mg/kg, intravenously) in dog plasma",50588,Canis lupus familiaris,14224,BAO_0000218,,1,1,,CHEMBL625976,,
12633,Intermediate,,,,Clearance value in dog,50588,Canis lupus familiaris,17237,BAO_0000218,,1,1,,CHEMBL625977,,
12634,Intermediate,,,,Clearance value in guinea pig,50512,Cavia porcellus,17237,BAO_0000218,,1,1,,CHEMBL625978,,
12635,Intermediate,,,,Clearance values in rats after iv administration.,50597,Rattus norvegicus,14187,BAO_0000218,,1,1,,CHEMBL874468,,
12636,Autocuration,,Plasma,1969.0,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,22224,,4806,BAO_0000218,,0,1,,CHEMBL625421,,
12637,Intermediate,,,,In vivo clearance (5 mg/kg) was determined in rabbits,50592,Oryctolagus cuniculus,15025,BAO_0000218,,1,1,,CHEMBL625422,,
12638,Intermediate,,,,Plasma Clearance rate was determined for the compound in rats,50597,Rattus norvegicus,13197,BAO_0000218,,1,1,,CHEMBL625423,,
12639,Autocuration,,,,Plasma Clearance rate was determined for the compound in squirrel monkeys,22224,Saimiri,13197,BAO_0000218,,0,1,,CHEMBL625424,,
12640,Intermediate,,,,Plasma clearance in rat,50597,Rattus norvegicus,13960,BAO_0000218,,1,1,,CHEMBL625425,,
12641,Autocuration,,,,Plasma clearance of the compound,22224,,17820,BAO_0000218,,0,1,,CHEMBL625426,,
12642,Intermediate,,,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,50512,Cavia porcellus,14706,BAO_0000218,,1,1,,CHEMBL625427,,
12643,Intermediate,,,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,50512,Cavia porcellus,14706,BAO_0000218,,1,1,,CHEMBL625428,,
12644,Autocuration,,,,Plasma clearance was determined,22224,,6504,BAO_0000218,,0,1,,CHEMBL625429,,
12645,Intermediate,,,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,50588,Canis lupus familiaris,14925,BAO_0000218,,1,1,,CHEMBL625430,,
12646,Intermediate,,,,Plasma clearance rate was determined for the compound in rats,50597,Rattus norvegicus,13197,BAO_0000218,,1,1,,CHEMBL625431,,
12647,Autocuration,,,,Plasma clearance rate was determined for the compound in squirrel monkeys,22224,Saimiri,13197,BAO_0000218,,0,1,,CHEMBL627307,,
12648,Autocuration,,,,Slow clearance (CL) was determined,22224,,3437,BAO_0000218,,0,1,,CHEMBL627308,,
12649,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL627309,,
12650,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,22224,,9196,BAO_0000218,,0,1,,CHEMBL627310,,
12651,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL627311,,
12652,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL627312,,
12653,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL627313,,
12654,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL627314,,
12655,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL627315,,
12656,Autocuration,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL627316,,
12657,Autocuration,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL627317,,
12658,Autocuration,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL627318,,
12659,Autocuration,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL627999,,
12660,Autocuration,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628000,,
12661,Autocuration,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628001,,
12662,Autocuration,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL628002,,
12663,Autocuration,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL625610,,
12664,Autocuration,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL625611,,
12665,Autocuration,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL625612,,
12666,Autocuration,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL625613,,
12667,Autocuration,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL875479,,
12668,Autocuration,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL625614,,
12669,Autocuration,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL625615,,
12670,Autocuration,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,22224,,9196,BAO_0000218,,0,1,,CHEMBL626302,,
12671,Intermediate,,Blood,178.0,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL626303,,
12672,Intermediate,,Blood,178.0,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,50597,Rattus norvegicus,8374,BAO_0000218,,1,1,,CHEMBL627420,,
12673,Intermediate,,,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL627421,,
12674,Intermediate,,,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL625695,,
12675,Intermediate,,,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL625696,,
12676,Intermediate,,Brain,955.0,Distribution of compound in mice brain was measured after 1 hr,50594,Mus musculus,10009,BAO_0000218,,1,1,,CHEMBL875606,,
12677,Intermediate,,Brain,955.0,Distribution of compound in mice brain was measured after 24 hr r,50594,Mus musculus,10009,BAO_0000218,,1,1,,CHEMBL625697,,
12678,Intermediate,,Brain,955.0,Distribution of compound in mice brain was measured after 2 hr,50594,Mus musculus,10009,BAO_0000218,,1,1,,CHEMBL625698,,
12679,Intermediate,,Brain,955.0,Distribution of compound in mice brain was measured after 3 hr,50594,Mus musculus,10009,BAO_0000218,,1,1,,CHEMBL625699,,
12680,Intermediate,,Brain,955.0,Distribution of compound in mice brain was measured after 6 hr,50594,Mus musculus,10009,BAO_0000218,,1,1,,CHEMBL625700,,
12681,Intermediate,,,,Distribution of compound in mice liver was measured after 1 hr,50594,Mus musculus,10009,BAO_0000218,,1,1,,CHEMBL625701,,
12682,Intermediate,,,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,50594,Mus musculus,10009,BAO_0000218,,1,1,,CHEMBL625702,,
12683,Intermediate,,,,Distribution of compound in mice liver was measured after 2 hr,50594,Mus musculus,10009,BAO_0000218,,1,1,,CHEMBL625703,,
12684,Intermediate,,,,Distribution of compound in mice liver was measured after 3 hr,50594,Mus musculus,10009,BAO_0000218,,1,1,,CHEMBL625704,,
12685,Intermediate,,,,Distribution of compound in mice liver was measured after 6 hr,50594,Mus musculus,10009,BAO_0000218,,1,1,,CHEMBL625705,,
12686,Intermediate,,Adrenal medulla,1236.0,Distribution in dog adrenal medulla 30 min after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL625706,,
12687,Intermediate,,Adrenal medulla,1236.0,Distribution in dog adrenal medulla 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL625707,,
12688,Intermediate,,,,Distribution in female dog Ovary 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL625708,,
12689,Intermediate,,,,Distribution in female dog Ovary 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL625709,,
12690,Intermediate,,,,Distribution in female dog adipose 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624180,,
12691,Intermediate,,,,Distribution in female dog adipose 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624181,,
12692,Intermediate,,Adrenal cortex,1235.0,Distribution in female dog adrenal cortex 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624182,,
12693,Intermediate,,Adrenal cortex,1235.0,Distribution in female dog adrenal cortex 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624183,,
12694,Intermediate,,Liver,2107.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624184,,
12695,Intermediate,,Liver,2107.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL877489,,
12696,Intermediate,,Liver,2107.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624185,,
12697,Intermediate,,Liver,2107.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624186,,
12698,Intermediate,,Liver,2107.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624187,,
12699,Intermediate,,Liver,2107.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624188,,
12700,Intermediate,,Lung,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624189,,
12701,Intermediate,,Lung,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624190,,
12702,Intermediate,,Lung,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624191,,
12703,Intermediate,,Lung,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624192,,
12704,Intermediate,,Lung,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624193,,
12705,Intermediate,,Lung,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624194,,
12706,Intermediate,,Lung,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624891,,
12707,Intermediate,,Lung,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624892,,
12708,Intermediate,,Lung,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL624893,,
12709,Intermediate,,Lung,2048.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL627632,,
12710,Intermediate,,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL627633,,
12711,Intermediate,,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL627634,,
12712,Intermediate,,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL627635,,
12713,Intermediate,,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL627636,,
12714,Intermediate,,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626816,,
12715,Intermediate,,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626817,,
12716,Intermediate,,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626818,,
12717,Intermediate,,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626819,,
12718,Intermediate,,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626820,,
12719,Intermediate,,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626821,,
12720,Intermediate,,Thyroid gland,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626822,,
12721,Intermediate,,Thyroid gland,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626823,,
12722,Intermediate,,Thyroid gland,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626824,,
12723,Intermediate,,Thyroid gland,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626825,,
12724,Intermediate,,Thyroid gland,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626826,,
12725,Intermediate,,Thyroid gland,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626827,,
12726,Intermediate,,Thyroid gland,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626828,,
12727,Intermediate,,Thyroid gland,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626829,,
12728,Intermediate,,Thyroid gland,2046.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626830,,
12729,Intermediate,,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL627150,,
12730,Intermediate,,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL627151,,
12731,Intermediate,,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL627152,,
12732,Intermediate,,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL627153,,
12733,Autocuration,,,,Rate of acetate production by the compound was determined,22224,,12904,BAO_0000019,,0,1,,CHEMBL627154,,
12734,Autocuration,,,,Rate of acetate production by the compound was determined; Not determined,22224,,12904,BAO_0000019,,0,1,,CHEMBL627155,,
12735,Autocuration,,,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,22224,,3730,BAO_0000019,,0,1,,CHEMBL627156,,
12736,Autocuration,,,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,22224,,3627,BAO_0000019,,0,1,,CHEMBL627157,,
12737,Intermediate,,,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,50592,Oryctolagus cuniculus,13799,BAO_0000218,,1,1,,CHEMBL627158,,
12738,Intermediate,,Plasma,1969.0,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,50592,Oryctolagus cuniculus,13799,BAO_0000218,,1,1,,CHEMBL627159,,
12739,Intermediate,,,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,50594,Mus musculus,13799,BAO_0000218,,1,1,,CHEMBL627160,,
12740,Intermediate,,,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,50597,Rattus norvegicus,13799,BAO_0000218,,1,1,,CHEMBL628540,,
12741,Intermediate,,Plasma,1969.0,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,50597,Rattus norvegicus,13799,BAO_0000218,,1,1,,CHEMBL628541,,
12742,Intermediate,,Plasma,1969.0,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,50597,Rattus norvegicus,13799,BAO_0000218,,1,1,,CHEMBL628542,,
12743,Autocuration,,,,Solubility after at a pH 1.2,22229,,6629,BAO_0000100,,0,1,,CHEMBL628543,,
12744,Autocuration,,,,Solubility after at pH 1.2,22229,,6629,BAO_0000100,,0,1,,CHEMBL628544,,
12745,Autocuration,,,,Solubility after injection of water,22229,,6629,BAO_0000100,,0,1,,CHEMBL628545,,
12746,Autocuration,,,,Statistical significance of IC 50 values; Expressed as R value,22224,,14000,BAO_0000019,,0,1,,CHEMBL628546,,
12747,Autocuration,,,,Systemic availability with respect to methyldopa was determined,22224,,8267,BAO_0000019,,0,1,,CHEMBL874455,,
12748,Intermediate,,,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,50597,Rattus norvegicus,13799,BAO_0000218,,1,1,,CHEMBL628547,,
12749,Intermediate,,Plasma,1969.0,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,50597,Rattus norvegicus,13799,BAO_0000218,,1,1,,CHEMBL628548,,
12750,Intermediate,,Feces,1988.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628549,,
12751,Intermediate,,Feces,1988.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628550,,
12752,Intermediate,,Feces,1988.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628551,,
12753,Intermediate,,Urine,1088.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628552,,
12754,Intermediate,,Urine,1088.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628553,,
12755,Intermediate,,Urine,1088.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628554,,
12756,Intermediate,,Urine,1088.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628555,,
12757,Intermediate,,Urine,1088.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628556,,
12758,Intermediate,,Kidney,2113.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628557,,
12759,Intermediate,,Feces,1988.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628558,,
12760,Intermediate,,Feces,1988.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628559,,
12761,Intermediate,,Feces,1988.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628560,,
12762,Intermediate,,Urine,1088.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL874456,,
12763,Intermediate,,Feces,1988.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628561,,
12764,Intermediate,,Feces,1988.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628562,,
12765,Intermediate,,Urine,1088.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628563,,
12766,Intermediate,,Urine,1088.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628564,,
12767,Intermediate,,Urine,1088.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL628565,,
12768,Intermediate,,Urine,1088.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL631248,,
12769,Intermediate,,Urine,1088.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL631249,,
12770,Intermediate,,Kidney,2113.0,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL627214,,
12771,Intermediate,,Feces,1988.0,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL874591,,
12772,Intermediate,,Feces,1988.0,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL627215,,
12773,Intermediate,,Feces,1988.0,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL625471,,
12774,Intermediate,,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL625472,,
12775,Intermediate,,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL625473,,
12776,Intermediate,,,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,50588,Canis lupus familiaris,13317,BAO_0000218,,1,1,,CHEMBL625474,,
12777,Intermediate,,,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,50588,Canis lupus familiaris,15341,BAO_0000218,,1,1,,CHEMBL625475,,
12778,Intermediate,,,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,50597,Rattus norvegicus,15341,BAO_0000218,,1,1,,CHEMBL625476,,
12779,Intermediate,,,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,50597,Rattus norvegicus,15341,BAO_0000218,,1,1,,CHEMBL625477,,
12780,Intermediate,,,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,50597,Rattus norvegicus,15341,BAO_0000218,,1,1,,CHEMBL625478,,
12781,Intermediate,,esophageal tunica muscularis mucosae,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,50597,Rattus norvegicus,12801,BAO_0000218,,1,1,,CHEMBL625479,,
12782,Intermediate,,esophageal tunica muscularis mucosae,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,50597,Rattus norvegicus,12801,BAO_0000218,,1,1,,CHEMBL625480,,
12783,Intermediate,,Plasma,1969.0,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,50597,Rattus norvegicus,14856,BAO_0000218,,1,1,,CHEMBL625481,,
12784,Intermediate,,,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,50597,Rattus norvegicus,14062,BAO_0000218,,1,1,,CHEMBL625482,,
12785,Intermediate,,,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,50597,Rattus norvegicus,14062,BAO_0000218,,1,1,,CHEMBL625483,,
12786,Intermediate,,,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,50597,Rattus norvegicus,14062,BAO_0000218,,1,1,,CHEMBL625484,,
12787,Intermediate,,,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,50597,Rattus norvegicus,14062,BAO_0000218,,1,1,,CHEMBL625485,,
12788,Intermediate,,Plasma,1969.0,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,50588,Canis lupus familiaris,14346,BAO_0000218,,1,1,,CHEMBL625486,,
12789,Intermediate,,Plasma,1969.0,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL625487,,
12790,Intermediate,,Plasma,1969.0,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL625488,,
12791,Intermediate,,Plasma,1969.0,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL625489,,
12792,Intermediate,,Plasma,1969.0,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL625490,,
12793,Intermediate,,Plasma,1969.0,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,50588,Canis lupus familiaris,14346,BAO_0000218,,1,1,,CHEMBL625491,,
12794,Intermediate,,Plasma,1969.0,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,50597,Rattus norvegicus,14346,BAO_0000218,,1,1,,CHEMBL625492,,
12795,Intermediate,,Plasma,1969.0,plasma clearance in human,50587,Homo sapiens,15711,BAO_0000218,,1,1,,CHEMBL625493,,
12796,Intermediate,,,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,50597,Rattus norvegicus,14886,BAO_0000218,,1,1,,CHEMBL625494,,
12797,Intermediate,,,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,50597,Rattus norvegicus,14886,BAO_0000218,,1,1,,CHEMBL625495,,
12798,Intermediate,,,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,50597,Rattus norvegicus,14886,BAO_0000218,,1,1,,CHEMBL625496,,
12799,Autocuration,,,,1-Octanol/water partition coefficient measured at 7.4,22229,,4115,BAO_0000100,,0,1,,CHEMBL625497,,
12800,Autocuration,,,,Calculated partition coefficient (clogP),22229,,13733,BAO_0000100,,0,1,,CHEMBL625498,,
12801,Autocuration,,,,Partition coefficient (logP),22224,,12102,BAO_0000019,,0,1,,CHEMBL625499,,
12802,Autocuration,,,,Calculated partition coefficient (clogP),22229,,12676,BAO_0000100,,0,1,,CHEMBL625500,,
12803,Autocuration,,,,Calculated partition coefficient (clogP),22229,,13733,BAO_0000100,,0,1,,CHEMBL625501,,
12804,Autocuration,,,,Calculated partition coefficient (clogP),22229,,13740,BAO_0000100,,0,1,,CHEMBL625502,,
12805,Autocuration,,,,Calculated partition coefficient (clogP) (relative to BAY K 8644),22229,,12766,BAO_0000100,,0,1,,CHEMBL625503,,
12806,Autocuration,,,,Calculated partition coefficient (clogP),22229,,2764,BAO_0000100,,0,1,,CHEMBL625504,,
12807,Autocuration,,,,Calculated partition coefficient (clogP),22229,,12355,BAO_0000100,,0,1,,CHEMBL625505,,
12808,Autocuration,,,,Calculated partition coefficient of the compound,22229,,11314,BAO_0000100,,0,1,,CHEMBL625506,,
12809,Autocuration,,,,Partition coefficient (logP),22224,,12706,BAO_0000019,,0,1,,CHEMBL625507,,
12810,Autocuration,,,,Calculated partition coefficient (clogP),22229,,12645,BAO_0000100,,0,1,,CHEMBL625508,,
12811,Autocuration,,,,Calculated partition coefficient (clogP),22229,,13668,BAO_0000100,,0,1,,CHEMBL625509,,
12812,Autocuration,,,,Calculated partition coefficient (clogP),22229,,12819,BAO_0000100,,0,1,,CHEMBL625510,,
12813,Autocuration,,,,Calculated partition coefficient (clogP),22229,,13668,BAO_0000100,,0,1,,CHEMBL883125,,
12814,Autocuration,,,,Calculated partition coefficient (clogP),22229,,13017,BAO_0000100,,0,1,,CHEMBL625511,,
12815,Autocuration,,,,Partition coefficient of the compound,22224,,2448,BAO_0000019,,0,1,,CHEMBL874650,,
12816,Autocuration,,,,Partition coefficient of the compound,22224,,11526,BAO_0000019,,0,1,,CHEMBL625512,,
12817,Autocuration,,,,Partition coefficient of compound was determined,22224,,12426,BAO_0000019,,0,1,,CHEMBL625513,,
12818,Autocuration,,,,Partition coefficient was determined,22224,,2448,BAO_0000019,,0,1,,CHEMBL625514,,
12819,Autocuration,,,,Calculated partition coefficient (clogP),22229,,12001,BAO_0000100,,0,1,,CHEMBL625515,,
12820,Autocuration,,,,partition coefficient of compound was determined,22229,,12426,BAO_0000100,,0,1,,CHEMBL625516,,
12821,Intermediate,,,,The total body administered intravenously in dog,50588,Canis lupus familiaris,13204,BAO_0000218,,1,1,,CHEMBL625517,,
12822,Intermediate,,,,The total body administered intravenously in rats,50597,Rattus norvegicus,13204,BAO_0000218,,1,1,,CHEMBL625518,,
12823,Intermediate,,,,Time taken for the administration to female NIH mice weighing 25-30 g.,50594,Mus musculus,13889,BAO_0000218,,1,1,,CHEMBL625519,,
12824,Autocuration,,,,Time taken for the administration,22224,,13889,BAO_0000019,,0,1,,CHEMBL625520,,
12825,Intermediate,,,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,50588,Canis lupus familiaris,17025,BAO_0000218,,1,1,,CHEMBL874651,,
12826,Autocuration,,,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,22224,Simiiformes,17025,BAO_0000218,,0,1,,CHEMBL625521,,
12827,Intermediate,,,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,50592,Oryctolagus cuniculus,17025,BAO_0000218,,1,1,,CHEMBL623171,,
12828,Intermediate,,,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,50597,Rattus norvegicus,17025,BAO_0000218,,1,1,,CHEMBL623853,,
12829,Autocuration,,,,Plasma clearance for the compound was determined.,22224,,15067,BAO_0000019,,0,1,,CHEMBL623854,,
12830,Autocuration,,,,CLog P value of the compound,22224,,3091,BAO_0000100,,0,1,,CHEMBL874405,,
12831,Autocuration,,,,Calculated partition coefficient (clogP),22229,,15592,BAO_0000100,,0,1,,CHEMBL623855,,
12832,Autocuration,,,,Calculated partition coefficient (clogP),22229,,14738,BAO_0000100,,0,1,,CHEMBL623856,,
12833,Autocuration,,,,ClogP value of the compound; nd ='no data',22224,,14738,BAO_0000100,,0,1,,CHEMBL623857,,
12834,Autocuration,,,,ClogP value of the compound; nd ='not determined',22224,,14738,BAO_0000100,,0,1,,CHEMBL623858,,
12835,Autocuration,,,,CLog P was determined,22224,,6076,BAO_0000100,,0,1,,CHEMBL623859,,
12836,Autocuration,,,,Calculated partition coefficient (clogP),22229,,17840,BAO_0000100,,0,1,,CHEMBL839829,,
12837,Autocuration,,,,CLogP was calculated,22224,,13589,BAO_0000019,,0,1,,CHEMBL623860,,
12838,Autocuration,,,,CLogP value was determined,22224,,17655,BAO_0000019,,0,1,,CHEMBL623861,,
12839,Autocuration,,,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,22224,,5867,BAO_0000019,,0,1,,CHEMBL623862,,
12840,Autocuration,,,,Calculated partition coefficient (clogP),22229,,5867,BAO_0000100,,0,1,,CHEMBL874406,,
12841,Autocuration,,,,Calculated partition coefficient (clogP),22229,,10783,BAO_0000100,,0,1,,CHEMBL623863,,
12842,Autocuration,,,,Calculated partition coefficient (clogP),22229,,14849,BAO_0000100,,0,1,,CHEMBL624021,,
12843,Intermediate,,Adrenal medulla,1236.0,Distribution in female dog adrenal medulla 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624022,,
12844,Intermediate,,Adrenal medulla,1236.0,Distribution in female dog adrenal medulla 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624023,,
12845,Intermediate,,,,Distribution in female dog bile 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624024,,
12846,Intermediate,,,,Distribution in female dog bile 72 hr after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624025,,
12847,Intermediate,,,,Distribution in female dog blood 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624026,,
12848,Intermediate,,,,Distribution in female dog blood 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624027,,
12849,Intermediate,,,,Distribution in female dog heart 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624028,,
12850,Intermediate,,,,Distribution in female dog heart 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624029,,
12851,Intermediate,,,,Distribution in female dog kidney 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624030,,
12852,Intermediate,,,,Distribution in female dog kidney 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624031,,
12853,Intermediate,,Intestine,160.0,Distribution in female dog large intestine 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624032,,
12854,Intermediate,,Intestine,160.0,Distribution in female dog large intestine 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL874407,,
12855,Intermediate,,,,Distribution in female dog liver 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624033,,
12856,Intermediate,,,,Distribution in female dog liver 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624034,,
12857,Intermediate,,,,Distribution in female dog lung 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624035,,
12858,Intermediate,,,,Distribution in female dog lung 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624036,,
12859,Intermediate,,Muscle tissue,2385.0,Distribution in female dog muscle 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624037,,
12860,Intermediate,,Muscle tissue,2385.0,Distribution in female dog muscle 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624038,,
12861,Intermediate,,,,Distribution in female dog pancreas 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624039,,
12862,Intermediate,,,,Distribution in female dog pancreas 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624040,,
12863,Intermediate,,Intestine,160.0,Distribution in female dog small intestine 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624041,,
12864,Intermediate,,Intestine,160.0,Distribution in female dog small intestine 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624042,,
12865,Intermediate,,Spleen,2106.0,Distribution in female dog spleen 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624043,,
12866,Intermediate,,Spleen,2106.0,Distribution in female dog spleen 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624044,,
12867,Intermediate,,Stomach,945.0,Distribution in female dog stomach 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624045,,
12868,Intermediate,,Stomach,945.0,Distribution in female dog stomach 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624046,,
12869,Intermediate,,Thyroid gland,2046.0,Distribution in female dog thyroid 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624047,,
12870,Intermediate,,Thyroid gland,2046.0,Distribution in female dog thyroid 72 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624048,,
12871,Intermediate,,Urine,1088.0,Distribution in female dog urine 24 hours after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL874408,,
12872,Intermediate,,Urine,1088.0,Distribution in female dog urine 72 hr after administration.,50588,Canis lupus familiaris,8170,BAO_0000218,,1,1,,CHEMBL624049,,
12873,Autocuration,,Plasma,1969.0,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,22224,,14283,BAO_0000218,,0,1,,CHEMBL624050,,
12874,Autocuration,,,,Plasma concentration at 7 hr after intravenous dosing,22224,,5623,BAO_0000019,,0,1,,CHEMBL624051,,
12875,Intermediate,,,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL623278,,
12876,Intermediate,,,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL623279,,
12877,Intermediate,,,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL623280,,
12878,Intermediate,,,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL623963,,
12879,Intermediate,,,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL623964,,
12880,Intermediate,,,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL623965,,
12881,Intermediate,,,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL623966,,
12882,Intermediate,,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL874415,,
12883,Intermediate,,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL623967,,
12884,Intermediate,,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL623968,,
12885,Intermediate,,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL623969,,
12886,Intermediate,,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL628409,,
12887,Intermediate,,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL628410,,
12888,Intermediate,,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL628411,,
12889,Intermediate,,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL628412,,
12890,Autocuration,,,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,22224,,12553,BAO_0000019,,0,1,,CHEMBL628413,,
12891,Autocuration,,Plasma,1969.0,The concentration in plasmat; Not determined,22224,,14548,BAO_0000019,,0,1,,CHEMBL628414,,
12892,Intermediate,,,,Tissue level at 10 mg/kg/po in wistar rats in blood,50597,Rattus norvegicus,14393,BAO_0000218,,1,1,,CHEMBL628415,,
12893,Intermediate,,,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,50597,Rattus norvegicus,14393,BAO_0000218,,1,1,,CHEMBL628416,,
12894,Intermediate,,,,Tissue level at 10 mg/kg/po in wistar rats in heart,50597,Rattus norvegicus,14393,BAO_0000218,,1,1,,CHEMBL628417,,
12895,Intermediate,,Liver,2107.0,Tissue level at 10 mg/kg/po in wistar rats in liver,50597,Rattus norvegicus,14393,BAO_0000218,,1,1,,CHEMBL874908,,
12896,Intermediate,,,,Tissue level at 10 mg/kg/po in wistar rats in plasma,50597,Rattus norvegicus,14393,BAO_0000218,,1,1,,CHEMBL628418,,
12897,Intermediate,,Muscle tissue,2385.0,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,50597,Rattus norvegicus,14393,BAO_0000218,,1,1,,CHEMBL628419,,
12898,Intermediate,,,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,50597,Rattus norvegicus,14393,BAO_0000218,,1,1,,CHEMBL628420,,
12899,Autocuration,,,,Water solubility at 37 degree C.,22224,,1629,BAO_0000019,,0,1,,CHEMBL628421,,
12900,Autocuration,,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,22229,,8194,BAO_0000100,,0,1,,CHEMBL626726,,
12901,Autocuration,,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,22229,,8194,BAO_0000100,,0,1,,CHEMBL626727,,
12902,Intermediate,,Blood,178.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626728,,
12903,Intermediate,,Blood,178.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626729,,
12904,Intermediate,,Blood,178.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626730,,
12905,Intermediate,,Blood,178.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626731,,
12906,Intermediate,,Blood,178.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626732,,
12907,Intermediate,,Heart,948.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626733,,
12908,Intermediate,,Heart,948.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626734,,
12909,Intermediate,,Heart,948.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626735,,
12910,Intermediate,,Heart,948.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL874909,,
12911,Intermediate,,Heart,948.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626736,,
12912,Intermediate,,Kidney,2113.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL626737,,
12913,Intermediate,,Kidney,2113.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL630999,,
12914,Intermediate,,Kidney,2113.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL631000,,
12915,Intermediate,,Kidney,2113.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL631001,,
12916,Intermediate,,Kidney,2113.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL631002,,
12917,Intermediate,,Liver,2107.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL631003,,
12918,Intermediate,,Liver,2107.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL631004,,
12919,Intermediate,,Liver,2107.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL631005,,
12920,Intermediate,,Liver,2107.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL631006,,
12921,Intermediate,,Liver,2107.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL631007,,
12922,Intermediate,,Lung,2048.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL631008,,
12923,Intermediate,,Lung,2048.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL631009,,
12924,Intermediate,,Lung,2048.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL631010,,
12925,Intermediate,,Lung,2048.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL631011,,
12926,Intermediate,,Lung,2048.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL631012,,
12927,Intermediate,,Thyroid gland,2046.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL630271,,
12928,Intermediate,,Thyroid gland,2046.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL630272,,
12929,Intermediate,,Thyroid gland,2046.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL630273,,
12930,Intermediate,,Thyroid gland,2046.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL630274,,
12931,Intermediate,,Thyroid gland,2046.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL630275,,
12932,Intermediate,,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL875782,,
12933,Intermediate,,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL630276,,
12934,Intermediate,,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL630277,,
12935,Intermediate,,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL630278,,
12936,Intermediate,,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,50597,Rattus norvegicus,8594,BAO_0000218,,1,1,,CHEMBL630279,,
12937,Autocuration,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,22224,,8151,BAO_0000019,,0,1,,CHEMBL630280,,
12938,Autocuration,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,22224,,8151,BAO_0000019,,0,1,,CHEMBL630281,,
12939,Intermediate,,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL630282,,
12940,Intermediate,,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL630283,,
12941,Autocuration,,,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),22224,,5797,BAO_0000019,,0,1,,CHEMBL630284,,
12942,Autocuration,,,,Alkylating activity was determined,22224,,7849,BAO_0000019,,0,1,,CHEMBL630285,,
12943,Autocuration,Microsomes,,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),22224,,14220,BAO_0000251,,0,1,,CHEMBL630286,,
12944,Intermediate,,,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",50592,Oryctolagus cuniculus,8650,BAO_0000218,,1,1,,CHEMBL630069,,
12945,Intermediate,,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",50592,Oryctolagus cuniculus,8650,BAO_0000218,,1,1,,CHEMBL630070,,
12946,Intermediate,,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",50592,Oryctolagus cuniculus,8650,BAO_0000218,,1,1,,CHEMBL630071,,
12947,Intermediate,,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",50592,Oryctolagus cuniculus,8650,BAO_0000218,,1,1,,CHEMBL630072,,
12948,Intermediate,,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",50592,Oryctolagus cuniculus,8650,BAO_0000218,,1,1,,CHEMBL875110,,
12949,Intermediate,,,,Compound was tested for antidiuretic activity in rats,50597,Rattus norvegicus,7116,BAO_0000218,,1,1,,CHEMBL630073,,
12950,Autocuration,,,,Compound was tested for inactivation kinetic values,22224,,14131,BAO_0000019,,0,1,,CHEMBL630074,,
12951,Autocuration,,,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,22224,,7415,BAO_0000218,,0,1,,CHEMBL630075,,
12952,Autocuration,,,,Dissociation rate calculated from the first-order equation using the t1/2 value,22224,,13178,BAO_0000019,,0,1,,CHEMBL630076,,
12953,Autocuration,,,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,22229,,8815,BAO_0000100,,0,1,,CHEMBL630077,,
12954,Autocuration,,,,Aqueous solubility was measured,22229,,1450,BAO_0000100,,0,1,,CHEMBL630078,,
12955,Autocuration,,,,Aqueous solubility was measured at a pH 4,22229,,1450,BAO_0000100,,0,1,,CHEMBL630079,,
12956,Autocuration,,,,Aqueous solubility (pH 7),22229,,1450,BAO_0000100,,0,1,,CHEMBL630080,,
12957,Autocuration,,,,Aqueous solubility was measured at a pH 9,22229,,1450,BAO_0000100,,0,1,,CHEMBL630081,,
12958,Autocuration,,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",22224,,12711,BAO_0000019,,0,1,,CHEMBL630082,,
12959,Autocuration,,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",22224,,12711,BAO_0000019,,0,1,,CHEMBL630083,,
12960,Autocuration,,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",22224,,12711,BAO_0000019,,0,1,,CHEMBL630084,,
12961,Autocuration,,,,Aqueous solubility of the compound,22229,,15032,BAO_0000100,,0,1,,CHEMBL629198,,
12962,Autocuration,,,,Aqueous solubility at 37 degree Celsius at pH 7.38,22229,,9964,BAO_0000100,,0,1,,CHEMBL629199,,
12963,Autocuration,,,,Aqueous solubility in pH 7.4 phosphate buffer,22229,,14962,BAO_0000100,,0,1,,CHEMBL629200,,
12964,Intermediate,,,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,50588,Canis lupus familiaris,12487,BAO_0000218,,1,1,,CHEMBL629201,,
12965,Intermediate,,,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,50588,Canis lupus familiaris,12487,BAO_0000218,,1,1,,CHEMBL629202,,
12966,Intermediate,,,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,50587,Homo sapiens,10026,BAO_0000218,,1,1,,CHEMBL875111,,
12967,Intermediate,,,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,50587,Homo sapiens,10026,BAO_0000218,,1,1,,CHEMBL629203,,
12968,Intermediate,,,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,50587,Homo sapiens,10026,BAO_0000218,,1,1,,CHEMBL629204,,
12969,Intermediate,,,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,50587,Homo sapiens,10026,BAO_0000218,,1,1,,CHEMBL629205,,
12970,Intermediate,,,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,50587,Homo sapiens,10026,BAO_0000218,,1,1,,CHEMBL629206,,
12971,Autocuration,,,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,22224,,10026,BAO_0000019,,0,1,,CHEMBL631185,,
12972,Intermediate,,,,Compound was evaluated for the average bile flow rat in rats,50597,Rattus norvegicus,7415,BAO_0000218,,1,1,,CHEMBL631186,,
12973,Intermediate,,,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",50592,Oryctolagus cuniculus,17025,BAO_0000218,,1,1,,CHEMBL631187,,
12974,Intermediate,,,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",50592,Oryctolagus cuniculus,17025,BAO_0000218,,1,1,,CHEMBL631188,,
12975,Autocuration,,,,Average half life period was determined,22224,,10184,BAO_0000019,,0,1,,CHEMBL876419,,
12976,Autocuration,,,,Average half life period was determined,22224,,10184,BAO_0000019,,0,1,,CHEMBL631189,,
12977,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL631190,,
12978,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL631191,,
12979,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL631192,,
12980,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL632400,,
12981,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL630564,,
12982,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL630565,,
12983,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL630566,,
12984,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL631229,,
12985,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL631230,,
12986,Autocuration,,,,Calculated partition coefficient (clogP),22229,,6030,BAO_0000100,,0,1,,CHEMBL876428,,
12987,Autocuration,,,,Calculated partition coefficient (clogP),22229,,6147,BAO_0000100,,0,1,,CHEMBL631231,,
12988,Autocuration,,,,Calculated partition coefficient (clogP) (MacLogP),22229,,14556,BAO_0000100,,0,1,,CHEMBL631232,,
12989,Autocuration,,,,Hydrophilicity was determined,22224,,768,BAO_0000019,,0,1,,CHEMBL631233,,
12990,Autocuration,,,,Calculated partition coefficient (clogP),22229,,14452,BAO_0000100,,0,1,,CHEMBL631234,,
12991,Autocuration,,,,Increased absorption was determined,22224,,5237,BAO_0000019,,0,1,,CHEMBL883126,,
12992,Autocuration,,,,Lipophilicity value was evaluated,22224,,14378,BAO_0000100,,0,1,,CHEMBL631235,,
12993,Autocuration,,,,Log P value of the compound.,22224,,14418,BAO_0000100,,0,1,,CHEMBL631236,,
12994,Autocuration,,,,Partition coefficient of compound was determined,22224,,5249,BAO_0000019,,0,1,,CHEMBL631237,,
12995,Autocuration,,,,Calculated partition coefficient (clogP),22229,,14621,BAO_0000100,,0,1,,CHEMBL631238,,
12996,Autocuration,,,,Calculated partition coefficient (clogP),22229,,12542,BAO_0000100,,0,1,,CHEMBL876429,,
12997,Autocuration,,,,Partition coefficient was measured by medchem software; Not calculated,22224,,12542,BAO_0000019,,0,1,,CHEMBL631414,,
12998,Autocuration,,,,Partition coefficient was measured by octanol-water using standard shake-flask method,22224,,12542,BAO_0000100,,0,1,,CHEMBL631415,,
12999,Autocuration,,,,Calculated partition coefficient (clogP),22229,,15462,BAO_0000100,,0,1,,CHEMBL631416,,
13000,Autocuration,,,,Partition coefficient (logP),22224,,14884,BAO_0000019,,0,1,,CHEMBL631417,,
13001,Autocuration,,,,Calculated partition coefficient (clogP),22229,,16526,BAO_0000100,,0,1,,CHEMBL631418,,
13002,Autocuration,,,,The Octanol/Water partition coefficient CLogP,22229,,13693,BAO_0000100,,0,1,,CHEMBL631419,,
13003,Autocuration,,,,The pharmacokinetic parameter C Log p was reported,22224,,13693,BAO_0000019,,0,1,,CHEMBL631420,,
13004,Autocuration,,,,Calculated partition coefficient (clogP),22229,,13779,BAO_0000100,,0,1,,CHEMBL631421,,
13005,Autocuration,,,,Calculated partition coefficient (clogP),22229,,14772,BAO_0000100,,0,1,,CHEMBL631422,,
13006,Autocuration,,,,Calculated partition coefficient (clogP),22229,,14393,BAO_0000100,,0,1,,CHEMBL631423,,
13007,Intermediate,,Plasma,1969.0,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL876430,,
13008,Intermediate,,Plasma,1969.0,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL631424,,
13009,Intermediate,,Plasma,1969.0,Compound was administered intravenously in dog to evaluate plasma clearance values,50588,Canis lupus familiaris,13744,BAO_0000218,,1,1,,CHEMBL631425,,
13010,Autocuration,,Plasma,1969.0,Compound was administered intravenously in monkey to evaluate plasma clearance values,22224,Simiiformes,13744,BAO_0000218,,0,1,,CHEMBL631426,,
13011,Intermediate,,Plasma,1969.0,Compound was administered intravenously in mouse to evaluate plasma clearance values,50594,Mus musculus,13744,BAO_0000218,,1,1,,CHEMBL631427,,
13012,Intermediate,,Plasma,1969.0,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,50588,Canis lupus familiaris,13207,BAO_0000218,,1,1,,CHEMBL631428,,
13013,Intermediate,Microsomes,Liver,2107.0,Intrinsic clearance in Rhesus liver microsome,50797,Macaca mulatta,5669,BAO_0000218,,1,1,,CHEMBL631429,,
13014,Intermediate,Microsomes,Liver,2107.0,Intrinsic clearance in dog liver microsome,50588,Canis lupus familiaris,5669,BAO_0000218,,1,1,,CHEMBL631430,,
13015,Intermediate,Microsomes,Liver,2107.0,Intrinsic clearance in rat liver microsome,50597,Rattus norvegicus,5669,BAO_0000218,,1,1,,CHEMBL631431,,
13016,Intermediate,,Plasma,1969.0,Low plasma clearance was calculated in rhesus monkey,50797,Macaca mulatta,4853,BAO_0000218,,1,1,,CHEMBL631432,,
13017,Intermediate,,,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,50588,Canis lupus familiaris,16452,BAO_0000218,,1,1,,CHEMBL631433,,
13018,Autocuration,,,,Plasma clearance after intravenous dose of 0.3 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL631434,,
13019,Autocuration,,,,Plasma clearance after intravenous dose of 1 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL631435,,
13020,Autocuration,,,,Plasma clearance after intravenous dose of 3 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL631436,,
13021,Autocuration,,,,Plasma clearance after intravenous dose of 3.87 mg/kg,22224,,11954,BAO_0000218,,0,1,,CHEMBL631437,,
13022,Intermediate,,,,Plasma clearance after peroral administration at 10 mpk in Rat,50597,Rattus norvegicus,5669,BAO_0000218,,1,1,,CHEMBL631438,,
13023,Intermediate,,,,Plasma clearance after peroral administration at 10 mpk in Rhesus,50797,Macaca mulatta,5669,BAO_0000218,,1,1,,CHEMBL876431,,
13024,Intermediate,,,,Plasma clearance after peroral administration at 10 mpk in dog,50588,Canis lupus familiaris,5669,BAO_0000218,,1,1,,CHEMBL631439,,
13025,Intermediate,,,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,50597,Rattus norvegicus,13662,BAO_0000218,,1,1,,CHEMBL631440,,
13026,Autocuration,,,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),22224,,8272,BAO_0000019,,0,1,,CHEMBL631441,,
13027,Autocuration,,,,Critical Micellar concentration was determined,22224,,13410,BAO_0000019,,0,1,,CHEMBL631442,,
13028,Autocuration,,,,Critical Micellar concentration of the compound. was determined,22224,,13410,BAO_0000019,,0,1,,CHEMBL626525,,
13029,Autocuration,,,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,22224,,12628,BAO_0000019,,0,1,,CHEMBL627168,,
13030,Autocuration,,,,Critical micellar concentration was measured in water by the dye solubilization method,22224,,9675,BAO_0000019,,0,1,,CHEMBL875618,,
13031,Autocuration,,,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,22224,,12628,BAO_0000019,,0,1,,CHEMBL626612,,
13032,Autocuration,,,,CMR value (relative to BAY K 8644),22224,,12766,BAO_0000019,,0,1,,CHEMBL626613,,
13033,Autocuration,,,,Carbamoylating activity was determined,22224,,7849,BAO_0000019,,0,1,,CHEMBL626614,,
13034,Autocuration,,,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,22224,Simiiformes,12187,BAO_0000218,,0,1,,CHEMBL626615,,
13035,Autocuration,,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,22224,,2040,BAO_0000019,,0,1,,CHEMBL626616,,
13036,Autocuration,,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,22224,,2040,BAO_0000019,,0,1,,CHEMBL626617,,
13037,Intermediate,,Plasma,1969.0,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,50588,Canis lupus familiaris,14180,BAO_0000218,,1,1,,CHEMBL626618,,
13038,Intermediate,,Plasma,1969.0,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,50597,Rattus norvegicus,14180,BAO_0000218,,1,1,,CHEMBL626619,,
13039,Intermediate,,,,"Clearance rate at 0.46 mg/kg, iv, in dogs",50588,Canis lupus familiaris,14474,BAO_0000218,,1,1,,CHEMBL626620,,
13040,Intermediate,,,,"Clearance rate at 5.5 mg/kg, iv, in rat",50597,Rattus norvegicus,14474,BAO_0000218,,1,1,,CHEMBL626621,,
13041,Intermediate,,,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,100710,Macaca fascicularis,14548,BAO_0000218,,1,1,,CHEMBL626622,,
13042,Intermediate,,,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,100710,Macaca fascicularis,14548,BAO_0000218,,1,1,,CHEMBL626623,,
13043,Intermediate,,,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,50588,Canis lupus familiaris,14548,BAO_0000218,,1,1,,CHEMBL626624,,
13044,Intermediate,,,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,50597,Rattus norvegicus,14548,BAO_0000218,,1,1,,CHEMBL626625,,
13045,Intermediate,,Liver,2107.0,Clearance rate constant using isolated perfused rat liver (IPRL) assay,50597,Rattus norvegicus,6125,BAO_0000218,,1,1,,CHEMBL626626,,
13046,Autocuration,,,,Tested for the total clearance of the compound,22224,,6874,BAO_0000218,,0,1,,CHEMBL626627,,
13047,Intermediate,,,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,50588,Canis lupus familiaris,15343,BAO_0000218,,1,1,,CHEMBL626628,,
13048,Autocuration,,,,Total body clearance was determined,22224,,6236,BAO_0000218,,0,1,,CHEMBL626629,,
13049,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626630,,
13050,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626631,,
13051,Autocuration,,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,22229,,8194,BAO_0000100,,0,1,,CHEMBL626632,,
13052,Autocuration,,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,22229,,8194,BAO_0000100,,0,1,,CHEMBL626633,,
13053,Autocuration,,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,22229,,8194,BAO_0000100,,0,1,,CHEMBL626634,,
13054,Autocuration,,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,22229,,8194,BAO_0000100,,0,1,,CHEMBL626635,,
13055,Autocuration,,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,22229,,8194,BAO_0000100,,0,1,,CHEMBL626636,,
13056,Autocuration,,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,22229,,8194,BAO_0000100,,0,1,,CHEMBL626637,,
13057,Intermediate,,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),50339,Pneumocystis carinii,13273,BAO_0000218,,1,1,,CHEMBL626638,,
13058,Intermediate,,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,50339,Pneumocystis carinii,13273,BAO_0000218,,1,1,,CHEMBL626639,,
13059,Intermediate,,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,50339,Pneumocystis carinii,13273,BAO_0000218,,1,1,,CHEMBL626640,,
13060,Intermediate,,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,50339,Pneumocystis carinii,13273,BAO_0000218,,1,1,,CHEMBL626641,,
13061,Intermediate,,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,50339,Pneumocystis carinii,13273,BAO_0000218,,1,1,,CHEMBL627272,,
13062,Intermediate,,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,50339,Pneumocystis carinii,13273,BAO_0000218,,1,1,,CHEMBL627273,,
13063,Intermediate,,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),50339,Pneumocystis carinii,13273,BAO_0000218,,1,1,,CHEMBL627441,,
13064,Intermediate,,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),50339,Pneumocystis carinii,13273,BAO_0000218,,1,1,,CHEMBL628355,,
13065,Intermediate,,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),50339,Pneumocystis carinii,13273,BAO_0000218,,1,1,,CHEMBL628356,,
13066,Intermediate,,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),50339,Pneumocystis carinii,13273,BAO_0000218,,1,1,,CHEMBL628357,,
13067,Intermediate,,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),50339,Pneumocystis carinii,13273,BAO_0000218,,1,1,,CHEMBL628358,,
13068,Intermediate,,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),50339,Pneumocystis carinii,13273,BAO_0000218,,1,1,,CHEMBL622307,,
13069,Autocuration,,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,22224,,13118,BAO_0000019,,0,1,,CHEMBL622527,,
13070,Autocuration,,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,22224,,13118,BAO_0000019,,0,1,,CHEMBL622528,,
13071,Autocuration,,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,22224,,13118,BAO_0000019,,0,1,,CHEMBL622529,,
13072,Autocuration,,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,22224,,13118,BAO_0000019,,0,1,,CHEMBL622992,,
13073,Autocuration,,,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,22224,,13118,BAO_0000019,,0,1,,CHEMBL622993,,
13074,Autocuration,,,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,22224,,13118,BAO_0000019,,0,1,,CHEMBL622994,,
13075,Intermediate,,,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",50597,Rattus norvegicus,10633,BAO_0000218,,1,1,,CHEMBL622995,,
13076,Intermediate,,,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",50597,Rattus norvegicus,10633,BAO_0000218,,1,1,,CHEMBL622996,,
13077,Intermediate,,,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",50597,Rattus norvegicus,10633,BAO_0000218,,1,1,,CHEMBL622997,,
13078,Intermediate,,,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",50597,Rattus norvegicus,10633,BAO_0000218,,1,1,,CHEMBL622998,,
13079,Autocuration,,,,Cp max following ip administration at 1 mg/kg,22224,,5767,BAO_0000218,,0,1,,CHEMBL622999,,
13080,Autocuration,,Plasma,1969.0,Maximum concentration in plasma was reported at 0.5 hour,22224,,3302,BAO_0000218,,0,1,,CHEMBL623000,,
13081,Autocuration,,Plasma,1969.0,Maximum concentration in plasma was reported at 2 hour,22224,,3302,BAO_0000218,,0,1,,CHEMBL623001,,
13082,Intermediate,,,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,50594,Mus musculus,12467,BAO_0000218,,1,1,,CHEMBL623002,,
13083,Autocuration,,,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),22229,,11778,BAO_0000100,,0,1,,CHEMBL623003,,
13084,Autocuration,,,,Steady state concentration was evaluated,22224,,4321,BAO_0000019,,0,1,,CHEMBL623004,,
13085,Autocuration,,,,Partition coefficient (logP),22224,,14884,BAO_0000019,,0,1,,CHEMBL623005,,
13086,Autocuration,,,,Partition coefficient (logD7.4),22224,,15234,BAO_0000019,,0,1,,CHEMBL623006,,
13087,Intermediate,,Liver,2107.0,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623007,,
13088,Intermediate,,Bone,10000001.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623008,,
13089,Intermediate,,Cerebellum,2037.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL876654,,
13090,Intermediate,,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623009,,
13091,Intermediate,,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623010,,
13092,Intermediate,,Heart,948.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623011,,
13093,Intermediate,,Intestine,160.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623012,,
13094,Autocuration,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,22224,,8151,BAO_0000019,,0,1,,CHEMBL623013,,
13095,Autocuration,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,22224,,8151,BAO_0000019,,0,1,,CHEMBL623014,,
13096,Autocuration,,Urine,1088.0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,22224,,8151,BAO_0000019,,0,1,,CHEMBL623015,,
13097,Autocuration,,Urine,1088.0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,22224,,8151,BAO_0000019,,0,1,,CHEMBL623016,,
13098,Autocuration,,Urine,1088.0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,22224,,8151,BAO_0000019,,0,1,,CHEMBL624858,,
13099,Intermediate,,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,50597,Rattus norvegicus,8151,BAO_0000218,,1,1,,CHEMBL624859,,
13100,Intermediate,,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,50597,Rattus norvegicus,8151,BAO_0000218,,1,1,,CHEMBL624860,,
13101,Intermediate,,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,50597,Rattus norvegicus,8151,BAO_0000218,,1,1,,CHEMBL624861,,
13102,Intermediate,,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,50597,Rattus norvegicus,8151,BAO_0000218,,1,1,,CHEMBL624862,,
13103,Intermediate,,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,50597,Rattus norvegicus,8151,BAO_0000218,,1,1,,CHEMBL624863,,
13104,Intermediate,,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,50597,Rattus norvegicus,8151,BAO_0000218,,1,1,,CHEMBL876655,,
13105,Intermediate,,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624864,,
13106,Intermediate,,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624865,,
13107,Intermediate,,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624866,,
13108,Expert,,,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624867,,
13109,Intermediate,,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL624868,,
13110,Intermediate,,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL628450,,
13111,Intermediate,,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL628451,,
13112,Intermediate,,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL628452,,
13113,Intermediate,,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL628453,,
13114,Intermediate,,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL628454,,
13115,Intermediate,,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL628455,,
13116,Intermediate,,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL628456,,
13117,Intermediate,,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL628457,,
13118,Intermediate,,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL877505,,
13119,Intermediate,,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL628458,,
13120,Intermediate,,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL628459,,
13121,Intermediate,,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL628460,,
13122,Intermediate,,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL628461,,
13123,Autocuration,,,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",22224,,6996,BAO_0000218,,0,1,,CHEMBL628462,,
13124,Intermediate,,,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL628463,,
13125,Expert,,,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625666,,
13126,Autocuration,,,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,22224,,6996,BAO_0000218,,0,1,,CHEMBL625667,,
13127,Expert,,,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625668,,
13128,Intermediate,,,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL625669,,
13129,Autocuration,,,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,22224,,7114,BAO_0000019,,0,1,,CHEMBL625670,,
13130,Intermediate,,,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,50597,Rattus norvegicus,7114,BAO_0000218,,1,1,,CHEMBL625671,,
13131,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL625672,,
13132,Intermediate,,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL625673,,
13133,Intermediate,,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL625674,,
13134,Intermediate,,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL625675,,
13135,Intermediate,,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL627637,,
13136,Intermediate,,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL627638,,
13137,Intermediate,,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL627639,,
13138,Intermediate,,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL627640,,
13139,Intermediate,,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL627641,,
13140,Intermediate,,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL627642,,
13141,Intermediate,,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL877506,,
13142,Intermediate,,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,50594,Mus musculus,8613,BAO_0000218,,1,1,,CHEMBL627275,,
13143,Intermediate,,,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",50506,Mustela putorius furo,11219,BAO_0000218,,1,1,,CHEMBL627643,,
13144,Intermediate,,,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",50506,Mustela putorius furo,11219,BAO_0000218,,1,1,,CHEMBL631246,,
13145,Intermediate,,,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",50506,Mustela putorius furo,11219,BAO_0000218,,1,1,,CHEMBL631247,,
13146,Intermediate,,,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,50506,Mustela putorius furo,11219,BAO_0000218,,1,1,,CHEMBL629532,,
13147,Intermediate,,,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,50506,Mustela putorius furo,11219,BAO_0000218,,1,1,,CHEMBL629533,,
13148,Intermediate,,,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,50506,Mustela putorius furo,11219,BAO_0000218,,1,1,,CHEMBL629534,,
13149,Intermediate,,,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,50506,Mustela putorius furo,11219,BAO_0000218,,1,1,,CHEMBL629535,,
13150,Autocuration,,,,Pharmacokinetic parameter :drug bound to plasma was reported,22224,,14837,BAO_0000019,,0,1,,CHEMBL625932,,
13151,Autocuration,,,,compound was evaluated for drug bound in plasma,22224,,14837,BAO_0000019,,0,1,,CHEMBL625933,,
13152,Intermediate,,,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,50597,Rattus norvegicus,15343,BAO_0000218,,1,1,,CHEMBL625934,,
13153,Autocuration,,,,Bioavailability,22224,Eutheria,13761,BAO_0000218,,0,1,,CHEMBL625935,,
13154,Intermediate,,,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,50597,Rattus norvegicus,14810,BAO_0000218,,1,1,,CHEMBL625936,,
13155,Intermediate,,,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,50597,Rattus norvegicus,14810,BAO_0000218,,1,1,,CHEMBL625937,,
13156,Intermediate,,,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,50588,Canis lupus familiaris,13249,BAO_0000218,,1,1,,CHEMBL625938,,
13157,Intermediate,,Bile,1970.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,50597,Rattus norvegicus,9267,BAO_0000218,,1,1,,CHEMBL625939,,
13158,Intermediate,,Bile,1970.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,50597,Rattus norvegicus,9267,BAO_0000218,,1,1,,CHEMBL625940,,
13159,Intermediate,,Bile,1970.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,50597,Rattus norvegicus,9267,BAO_0000218,,1,1,,CHEMBL874464,,
13160,Intermediate,,Bile,1970.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,50597,Rattus norvegicus,9267,BAO_0000218,,1,1,,CHEMBL625941,,
13161,Intermediate,,Bile,1970.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,50597,Rattus norvegicus,9267,BAO_0000218,,1,1,,CHEMBL625942,,
13162,Intermediate,,Bile,1970.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,50597,Rattus norvegicus,9267,BAO_0000218,,1,1,,CHEMBL625943,,
13163,Intermediate,,Serum,1977.0,In vitro protein binding in human serum at 5 ug/ml,50587,Homo sapiens,15549,BAO_0000218,,1,1,,CHEMBL625944,,
13164,Autocuration,,,,Serum protein binding ability was measured,22224,,10929,BAO_0000019,,0,1,,CHEMBL625945,,
13165,Autocuration,,,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),22224,,15444,BAO_0000019,,0,1,,CHEMBL625946,,
13166,Autocuration,,,,Oral bioavailability in dog,22224,Canis lupus familiaris,12860,BAO_0000218,,0,1,,CHEMBL625947,,
13167,Intermediate,,,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,50597,Rattus norvegicus,12170,BAO_0000218,,1,1,,CHEMBL625948,,
13168,Autocuration,,,,Absolute oral bioavailability at an iv dose of 14 mg/kg,22224,,15173,BAO_0000218,,0,1,,CHEMBL625949,,
13169,Autocuration,,,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,22224,,15173,BAO_0000218,,0,1,,CHEMBL625950,,
13170,Autocuration,,,,Oral bioavailability (dose 15 mg/kg i.v.),22224,Eutheria,15173,BAO_0000218,,0,1,,CHEMBL625951,,
13171,Autocuration,,,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,22224,,15173,BAO_0000218,,0,1,,CHEMBL625952,,
13172,Autocuration,,,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,22224,,15173,BAO_0000218,,0,1,,CHEMBL625953,,
13173,Autocuration,,,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,22224,,15173,BAO_0000218,,0,1,,CHEMBL625954,,
13174,Autocuration,,,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,22224,,15173,BAO_0000218,,0,1,,CHEMBL882959,,
13175,Intermediate,,,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,50588,Canis lupus familiaris,11767,BAO_0000218,,1,1,,CHEMBL625955,,
13176,Autocuration,,,,Bioavailability in ferret,22224,Mustela putorius furo,11219,BAO_0000218,,0,1,,CHEMBL625956,,
13177,Intermediate,,,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,100710,Macaca fascicularis,12186,BAO_0000218,,1,1,,CHEMBL625957,,
13178,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL625958,,
13179,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL625959,,
13180,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626642,,
13181,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL631330,,
13182,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL631331,,
13183,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL631332,,
13184,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL631333,,
13185,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL632018,,
13186,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL632019,,
13187,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL632020,,
13188,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL632021,,
13189,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL632022,,
13190,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL632023,,
13191,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL632024,,
13192,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL874472,,
13193,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL632025,,
13194,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL632026,,
13195,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL632027,,
13196,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL632028,,
13197,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626430,,
13198,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626431,,
13199,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626432,,
13200,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626433,,
13201,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626434,,
13202,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627280,,
13203,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627281,,
13204,Intermediate,,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627282,,
13205,Autocuration,,,,Total body clearance was measured at given dose,22224,,7199,BAO_0000019,,0,1,,CHEMBL627283,,
13206,Autocuration,,,,Total body clearance was measured at given dose.,22224,,7199,BAO_0000218,,0,1,,CHEMBL627284,,
13207,Intermediate,,,,Metabolic clearance from the body in rat,50597,Rattus norvegicus,7095,BAO_0000218,,1,1,,CHEMBL627285,,
13208,Autocuration,,,,Renal clearance from the body,22224,,7095,BAO_0000218,,0,1,,CHEMBL627286,,
13209,Intermediate,,,,Renal clearance from the body in rat,50597,Rattus norvegicus,7095,BAO_0000218,,1,1,,CHEMBL875477,,
13210,Intermediate,,,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,50597,Rattus norvegicus,12528,BAO_0000218,,1,1,,CHEMBL627287,,
13211,Intermediate,,,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,50588,Canis lupus familiaris,12528,BAO_0000218,,1,1,,CHEMBL627288,,
13212,Intermediate,,,,Total clearance from the body in rat,50597,Rattus norvegicus,7095,BAO_0000218,,1,1,,CHEMBL627289,,
13213,Intermediate,,Plasma,1969.0,Clearance into cortex from rat plasma or PBS,50597,Rattus norvegicus,14223,BAO_0000218,,1,1,,CHEMBL627290,,
13214,Autocuration,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,22224,,13569,BAO_0000218,,0,1,,CHEMBL627291,,
13215,Autocuration,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,22224,,13569,BAO_0000218,,0,1,,CHEMBL627292,,
13216,Autocuration,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,22224,,13569,BAO_0000218,,0,1,,CHEMBL627293,,
13217,Autocuration,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,22224,,13569,BAO_0000218,,0,1,,CHEMBL627294,,
13218,Autocuration,,,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,22224,,13569,BAO_0000218,,0,1,,CHEMBL875478,,
13219,Autocuration,,,,Clearance was determined,22224,,13979,BAO_0000218,,0,1,,CHEMBL627295,,
13220,Intermediate,,,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,50594,Mus musculus,14315,BAO_0000218,,1,1,,CHEMBL627296,,
13221,Intermediate,,,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,50592,Oryctolagus cuniculus,14315,BAO_0000218,,1,1,,CHEMBL626119,,
13222,Intermediate,,,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,50597,Rattus norvegicus,14315,BAO_0000218,,1,1,,CHEMBL626120,,
13223,Intermediate,,,,Clearance in rat after iv dose (100 ug/kg),50597,Rattus norvegicus,12174,BAO_0000218,,1,1,,CHEMBL626121,,
13224,Autocuration,,,,Clearance in guinea pig,22224,Cavia porcellus,12797,BAO_0000218,,0,1,,CHEMBL626122,,
13225,Intermediate,,,,Compound was evaluated for clearance in rat,50597,Rattus norvegicus,12797,BAO_0000218,,1,1,,CHEMBL626123,,
13226,Intermediate,,,,Compound was evaluated for the clearance in dog,50588,Canis lupus familiaris,12797,BAO_0000218,,1,1,,CHEMBL623456,,
13227,Intermediate,,,,Compound was evaluated for the clearance in rat,50597,Rattus norvegicus,12797,BAO_0000218,,1,1,,CHEMBL623457,,
13228,Intermediate,,,,Compound was tested in vivo for clearance after iv administration in the rat,50597,Rattus norvegicus,11500,BAO_0000218,,1,1,,CHEMBL623458,,
13229,Autocuration,,,,IV clearance determined at an iv dose of 14 mg/kg,22224,,15173,BAO_0000218,,0,1,,CHEMBL623459,,
13230,Autocuration,,,,IV clearance determined at an iv dose of 15.2 mg/kg,22224,,15173,BAO_0000218,,0,1,,CHEMBL875484,,
13231,Autocuration,,,,IV clearance determined at an iv dose of 15 mg/kg,22224,,15173,BAO_0000218,,0,1,,CHEMBL623460,,
13232,Autocuration,,,,IV clearance determined at an peroral dose of 30 mg/kg.,22224,,15173,BAO_0000218,,0,1,,CHEMBL623461,,
13233,Autocuration,,,,IV clearance determined at an peroral dose of 30.2 mg/kg.,22224,,15173,BAO_0000218,,0,1,,CHEMBL623462,,
13234,Autocuration,,,,IV clearance determined at an peroral dose of 30.3 mg/kg.,22224,,15173,BAO_0000218,,0,1,,CHEMBL627386,,
13235,Intermediate,,Kidney,2113.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627387,,
13236,Intermediate,,Liver,2107.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627388,,
13237,Intermediate,,Lung,2048.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627389,,
13238,Intermediate,,Muscle tissue,2385.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627390,,
13239,Intermediate,,Plasma,1969.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627391,,
13240,Intermediate,,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627392,,
13241,Intermediate,,Spleen,2106.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627393,,
13242,Intermediate,,Trachea,3126.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627394,,
13243,Intermediate,,Bone,10000001.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627395,,
13244,Intermediate,,Cerebellum,2037.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL875485,,
13245,Intermediate,,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627396,,
13246,Intermediate,,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627397,,
13247,Intermediate,,Heart,948.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627398,,
13248,Intermediate,,Bone,10000001.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627399,,
13249,Intermediate,,Kidney,2113.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627400,,
13250,Intermediate,,Liver,2107.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627401,,
13251,Intermediate,,Lung,2048.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627402,,
13252,Intermediate,,Muscle tissue,2385.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627403,,
13253,Intermediate,,Plasma,1969.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL627404,,
13254,Intermediate,,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623101,,
13255,Intermediate,,Spleen,2106.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL877480,,
13256,Intermediate,,Trachea,3126.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623102,,
13257,Intermediate,,Bone,10000001.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623103,,
13258,Intermediate,,Cerebellum,2037.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623104,,
13259,Intermediate,,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623105,,
13260,Intermediate,,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623106,,
13261,Intermediate,,Heart,948.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623107,,
13262,Intermediate,,Intestine,160.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623108,,
13263,Intermediate,,Kidney,2113.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623109,,
13264,Intermediate,,Liver,2107.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623110,,
13265,Intermediate,,Lung,2048.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL623111,,
13266,Intermediate,,Muscle tissue,2385.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL625060,,
13267,Intermediate,,Plasma,1969.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL625061,,
13268,Intermediate,,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL625062,,
13269,Intermediate,,Spleen,2106.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL625063,,
13270,Intermediate,,Trachea,3126.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL625064,,
13271,Intermediate,,Bone,10000001.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL625065,,
13272,Intermediate,,Cerebellum,2037.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL625066,,
13273,Intermediate,,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL625067,,
13274,Intermediate,,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL625068,,
13275,Intermediate,,Heart,948.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL622159,,
13276,Intermediate,,Intestine,160.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL622160,,
13277,Intermediate,,Kidney,2113.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL622161,,
13278,Intermediate,,Lung,2048.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL622162,,
13279,Intermediate,,Muscle tissue,2385.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL622163,,
13280,Intermediate,,Plasma,1969.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL622313,,
13281,Intermediate,,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL622314,,
13282,Intermediate,,Spleen,2106.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL622315,,
13283,Intermediate,,Trachea,3126.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,50597,Rattus norvegicus,14198,BAO_0000218,,1,1,,CHEMBL622316,,
13284,Intermediate,,,,Normal diffusion coefficient in water for Escherichia coli,50212,Escherichia coli,15599,BAO_0000218,,1,1,,CHEMBL877486,,
13285,Autocuration,,,,Average max percent decrease in RVR (renal vascular resistance) was determined,22224,,8204,BAO_0000019,,0,1,,CHEMBL622317,,
13286,Autocuration,,,,Average max percent decrease in RVR (renal vascular resistance) was determined.,22224,,8204,BAO_0000019,,0,1,,CHEMBL622318,,
13287,Autocuration,,,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,22224,,6154,BAO_0000019,,0,1,,CHEMBL622319,,
13288,Autocuration,,,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,22224,,6154,BAO_0000019,,0,1,,CHEMBL622320,,
13289,Autocuration,,,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,22224,,6154,BAO_0000019,,0,1,,CHEMBL622321,,
13290,Autocuration,,,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,22224,,6154,BAO_0000019,,0,1,,CHEMBL622322,,
13291,Autocuration,,,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,22224,,7114,BAO_0000019,,0,1,,CHEMBL622323,,
13292,Intermediate,,,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,50597,Rattus norvegicus,7114,BAO_0000218,,1,1,,CHEMBL622324,,
13293,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL622325,,
13294,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL622326,,
13295,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL877487,,
13296,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL622327,,
13297,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL622328,,
13298,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL622329,,
13299,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL622330,,
13300,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL622331,,
13301,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL622332,,
13302,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL622333,,
13303,Autocuration,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",22224,Simiiformes,8133,BAO_0000218,,0,1,,CHEMBL627658,,
13304,Autocuration,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",22224,Simiiformes,8133,BAO_0000218,,0,1,,CHEMBL630428,,
13305,Autocuration,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",22224,Simiiformes,8133,BAO_0000218,,0,1,,CHEMBL630429,,
13306,Autocuration,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",22224,Simiiformes,8133,BAO_0000218,,0,1,,CHEMBL630430,,
13307,Autocuration,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",22224,Simiiformes,8133,BAO_0000218,,0,1,,CHEMBL630431,,
13308,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL630432,,
13309,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL630433,,
13310,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL630434,,
13311,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL629372,,
13312,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL629553,,
13313,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL629554,,
13314,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL874447,,
13315,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL629555,,
13316,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL629556,,
13317,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL629557,,
13318,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL629558,,
13319,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL629559,,
13320,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL629560,,
13321,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL629561,,
13322,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL629562,,
13323,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL629563,,
13324,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL629564,,
13325,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL629565,,
13326,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL629566,,
13327,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL629567,,
13328,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL629568,,
13329,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL629569,,
13330,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL629570,,
13331,Autocuration,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",22224,Simiiformes,8133,BAO_0000218,,0,1,,CHEMBL629571,,
13332,Autocuration,,,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,22224,Rattus norvegicus,12170,BAO_0000218,,0,1,,CHEMBL629572,,
13333,Autocuration,,,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,22224,Rattus norvegicus,12170,BAO_0000218,,0,1,,CHEMBL629573,,
13334,Autocuration,,,,Bioavailability (dose 20 mg/kg),22224,Eutheria,4985,BAO_0000218,,0,1,,CHEMBL629574,,
13335,Autocuration,,,,Bioavailability in dog,22224,Canis lupus familiaris,15145,BAO_0000218,,0,1,,CHEMBL629575,,
13336,Autocuration,,,,Bioavailability in rat (Sprague-Dawley) (male),22224,Rattus norvegicus,14080,BAO_0000218,,0,1,,CHEMBL874448,,
13337,Autocuration,,,,Bioavailability in monkey (dose 10 mg/kg i.d.),22224,Primates,11219,BAO_0000218,,0,1,,CHEMBL629576,,
13338,Autocuration,,,,Bioavailability in rat,22224,Rattus norvegicus,15145,BAO_0000218,,0,1,,CHEMBL629577,,
13339,Autocuration,,,,Bioavailability in rat,22224,Rattus norvegicus,15145,BAO_0000218,,0,1,,CHEMBL629578,,
13340,Autocuration,,,,Bioavailability in dog (dose 3.0 mg/kg p.o.),22224,Canis lupus familiaris,1202,BAO_0000218,,0,1,,CHEMBL629579,,
13341,Autocuration,,,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,22224,Canis lupus familiaris,1202,BAO_0000218,,0,1,,CHEMBL882958,,
13342,Intermediate,,,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,50505,Pan troglodytes,1202,BAO_0000218,,1,1,,CHEMBL629580,,
13343,Autocuration,,,,Bioavailability,22224,Eutheria,4026,BAO_0000218,,0,1,,CHEMBL629581,,
13344,Autocuration,,,,Bioavailability in squirrel monkey,22224,Saimiri,1492,BAO_0000218,,0,1,,CHEMBL629582,,
13345,Intermediate,,,,Bioavailability was evaluated in dog,50588,Canis lupus familiaris,12793,BAO_0000218,,1,1,,CHEMBL628522,,
13346,Intermediate,,,,Bioavailability was evaluated in hamster,100712,Cricetinae,12793,BAO_0000218,,1,1,,CHEMBL625432,,
13347,Autocuration,,,,Bioavailability in rat,22224,Rattus norvegicus,12793,BAO_0000218,,0,1,,CHEMBL625433,,
13348,Intermediate,,Plasma,1969.0,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL625434,,
13349,Intermediate,,Plasma,1969.0,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,50597,Rattus norvegicus,14793,BAO_0000218,,1,1,,CHEMBL625435,,
13350,Autocuration,,,,Bioavailability in rat (dose 10 mg/kg p.o.),22224,Rattus norvegicus,14793,BAO_0000218,,0,1,,CHEMBL625436,,
13351,Intermediate,,,,Bioavailability was measured in cynomolgus monkeys.,100710,Macaca fascicularis,14731,BAO_0000218,,1,1,,CHEMBL874588,,
13352,Intermediate,,,,Bioavailability was measured in nude mice.,50594,Mus musculus,14731,BAO_0000218,,1,1,,CHEMBL625437,,
13353,Autocuration,,,,Bioavailability in ferret (dose 10 mg/kg i.d.),22224,Mustela putorius furo,12187,BAO_0000218,,0,1,,CHEMBL625438,,
13354,Autocuration,,,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),22224,Simiiformes,12187,BAO_0000218,,0,1,,CHEMBL625439,,
13355,Autocuration,,,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",22224,Simiiformes,12187,BAO_0000218,,0,1,,CHEMBL625440,,
13356,Autocuration,,,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),22224,Simiiformes,12187,BAO_0000218,,0,1,,CHEMBL625441,,
13357,Autocuration,,,,Bioavailability in rat (dose 10 mg/kg i.d.),22224,Rattus norvegicus,12187,BAO_0000218,,0,1,,CHEMBL625442,,
13358,Intermediate,,,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",50597,Rattus norvegicus,12187,BAO_0000218,,1,1,,CHEMBL625443,,
13359,Autocuration,,,,Bioavailability was determined; extremely poor,22224,,17431,BAO_0000218,,0,1,,CHEMBL625444,,
13360,Intermediate,,,,% bioavailability in mice after oral administration of prodrug,50594,Mus musculus,13318,BAO_0000218,,1,1,,CHEMBL625445,,
13361,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625446,,
13362,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL882960,,
13363,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625447,,
13364,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625448,,
13365,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625449,,
13366,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL874589,,
13367,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625450,,
13368,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625451,,
13369,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL626584,,
13370,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL626585,,
13371,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL626586,,
13372,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL626587,,
13373,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL626588,,
13374,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL626589,,
13375,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL626590,,
13376,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL626591,,
13377,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL627181,,
13378,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628083,,
13379,Autocuration,,,,IV clearance determined at an peroral dose of 15 mg/kg.,22224,,15173,BAO_0000218,,0,1,,CHEMBL628084,,
13380,Expert,,,,Mouse oral clearance was measured against Hymenolepiasis nana.,50064,Hymenolepis nana,7732,BAO_0000218,,1,1,,CHEMBL628085,,
13381,Expert,,,,Mouse oral clearance was measured against Nematospiroides dubius,50545,Heligmosomoides polygyrus,7732,BAO_0000218,,1,1,,CHEMBL628086,,
13382,Autocuration,,,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,22224,,7732,BAO_0000218,,0,1,,CHEMBL628087,,
13383,Intermediate,,,,Mouse oral clearance was measured against N. nana; NT is Not Tested,50594,Mus musculus,7732,BAO_0000218,,1,1,,CHEMBL628088,,
13384,Autocuration,,,,Mouse oral clearance was measured against N. nana; NT is Not Tested,22224,,7732,BAO_0000218,,0,1,,CHEMBL628089,,
13385,Autocuration,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,22224,,8328,BAO_0000218,,0,1,,CHEMBL628090,,
13386,Autocuration,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,22224,,8328,BAO_0000218,,0,1,,CHEMBL628091,,
13387,Autocuration,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,22224,,8328,BAO_0000218,,0,1,,CHEMBL628092,,
13388,Autocuration,,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,22224,,8328,BAO_0000218,,0,1,,CHEMBL628093,,
13389,Autocuration,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,22224,,8328,BAO_0000218,,0,1,,CHEMBL875607,,
13390,Autocuration,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,22224,,8328,BAO_0000218,,0,1,,CHEMBL625710,,
13391,Autocuration,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,22224,,8328,BAO_0000218,,0,1,,CHEMBL625711,,
13392,Autocuration,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,22224,,8328,BAO_0000218,,0,1,,CHEMBL625712,,
13393,Autocuration,,,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,22224,,8328,BAO_0000218,,0,1,,CHEMBL625713,,
13394,Intermediate,,,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,50588,Canis lupus familiaris,13376,BAO_0000218,,1,1,,CHEMBL625714,,
13395,Intermediate,,,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,50797,Macaca mulatta,13477,BAO_0000218,,1,1,,CHEMBL625715,,
13396,Intermediate,,,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL625716,,
13397,Intermediate,,,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,50597,Rattus norvegicus,13477,BAO_0000218,,1,1,,CHEMBL625717,,
13398,Intermediate,,,,Plasma clearance was determined for the compound in rats,50597,Rattus norvegicus,13313,BAO_0000218,,1,1,,CHEMBL625718,,
13399,Intermediate,,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,50597,Rattus norvegicus,12504,BAO_0000218,,1,1,,CHEMBL625719,,
13400,Intermediate,,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,50597,Rattus norvegicus,12504,BAO_0000218,,1,1,,CHEMBL625720,,
13401,Intermediate,,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,50597,Rattus norvegicus,12504,BAO_0000218,,1,1,,CHEMBL625721,,
13402,Intermediate,,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,50597,Rattus norvegicus,12504,BAO_0000218,,1,1,,CHEMBL625722,,
13403,Intermediate,,,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,50597,Rattus norvegicus,13129,BAO_0000218,,1,1,,CHEMBL625723,,
13404,Intermediate,,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,50545,Heligmosomoides polygyrus,7732,BAO_0000218,,1,1,,CHEMBL625724,,
13405,Intermediate,,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,50545,Heligmosomoides polygyrus,7732,BAO_0000218,,1,1,,CHEMBL625725,,
13406,Intermediate,,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,50545,Heligmosomoides polygyrus,7732,BAO_0000218,,1,1,,CHEMBL625726,,
13407,Intermediate,,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,50545,Heligmosomoides polygyrus,7732,BAO_0000218,,1,1,,CHEMBL875608,,
13408,Intermediate,,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,50545,Heligmosomoides polygyrus,7732,BAO_0000218,,1,1,,CHEMBL625727,,
13409,Autocuration,,Urine,1088.0,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,22224,Rattus norvegicus,9278,BAO_0000218,,0,1,,CHEMBL625728,,
13410,Autocuration,,,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,22224,Rattus norvegicus,9278,BAO_0000218,,0,1,,CHEMBL625729,,
13411,Autocuration,,,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,22224,Rattus norvegicus,9278,BAO_0000218,,0,1,,CHEMBL625730,,
13412,Autocuration,,Urine,1088.0,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,22224,Rattus norvegicus,9278,BAO_0000218,,0,1,,CHEMBL625731,,
13413,Autocuration,,Urine,1088.0,Urinary clearance was determined in rat at 25 mg/kg os dosage,22224,Rattus norvegicus,9278,BAO_0000218,,0,1,,CHEMBL626417,,
13414,Intermediate,,Urine,1088.0,Urinary clearance was determined at 100 mg/kg oral dosage in human,50587,Homo sapiens,9278,BAO_0000218,,1,1,,CHEMBL626418,,
13415,Intermediate,,Urine,1088.0,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,50588,Canis lupus familiaris,9278,BAO_0000218,,1,1,,CHEMBL626419,,
13416,Intermediate,,Plasma,1969.0,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,50588,Canis lupus familiaris,5932,BAO_0000218,,1,1,,CHEMBL626592,,
13417,Intermediate,,Plasma,1969.0,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,50597,Rattus norvegicus,5932,BAO_0000218,,1,1,,CHEMBL626593,,
13418,Intermediate,,,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,50597,Rattus norvegicus,5182,BAO_0000218,,1,1,,CHEMBL626594,,
13419,Intermediate,,,,Clearance rate in dogs,50588,Canis lupus familiaris,10499,BAO_0000218,,1,1,,CHEMBL625035,,
13420,Autocuration,,,,Compound was measured for intrinsic clearance,22224,,6051,BAO_0000019,,0,1,,CHEMBL625036,,
13421,Autocuration,,,,Calculated partition coefficient (clogP),22229,,17508,BAO_0000100,,0,1,,CHEMBL625037,,
13422,Autocuration,,,,Calculated partition coefficient (clogP),22229,,6228,BAO_0000100,,0,1,,CHEMBL625038,,
13423,Autocuration,,,,Calculated partition coefficient (clogP),22229,,6231,BAO_0000100,,0,1,,CHEMBL625039,,
13424,Autocuration,,,,Calculated partition coefficient (clogP),22229,,17740,BAO_0000100,,0,1,,CHEMBL625040,,
13425,Autocuration,,,,Calculated partition coefficient (clogP),22229,,6495,BAO_0000100,,0,1,,CHEMBL625041,,
13426,Autocuration,,,,Calculated partition coefficient (clogP),22229,,2171,BAO_0000100,,0,1,,CHEMBL625042,,
13427,Autocuration,,,,Partition coefficient of the compound,22224,,3255,BAO_0000019,,0,1,,CHEMBL874411,,
13428,Autocuration,,,,Permeability,22224,,6821,BAO_0000019,,0,1,,CHEMBL625043,,
13429,Autocuration,,,,Calculated partition coefficient (clogP),22229,,2685,BAO_0000100,,0,1,,CHEMBL625044,,
13430,Autocuration,,,,Partition coefficient (logD),22224,,17584,BAO_0000019,,0,1,,CHEMBL625045,,
13431,Autocuration,,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),22229,,13824,BAO_0000100,,0,1,,CHEMBL625046,,
13432,Autocuration,,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),22229,,13824,BAO_0000100,,0,1,,CHEMBL625047,,
13433,Autocuration,,,,Calculated partition coefficient (clogP),22229,,16479,BAO_0000100,,0,1,,CHEMBL625048,,
13434,Autocuration,,,,Calculated partition coefficient (clogP),22229,,11997,BAO_0000100,,0,1,,CHEMBL625049,,
13435,Autocuration,,,,Calculated logarithm of partition coefficient (P) was determined,22229,,2988,BAO_0000100,,0,1,,CHEMBL625050,,
13436,Autocuration,,,,Calculated partition coefficient (clogP),22229,,931,BAO_0000100,,0,1,,CHEMBL625051,,
13437,Autocuration,,,,Calculated partition coefficient (clogP),22229,,4381,BAO_0000100,,0,1,,CHEMBL874412,,
13438,Autocuration,,,,Calculated partition coefficient (clogP),22229,,4397,BAO_0000100,,0,1,,CHEMBL625052,,
13439,Autocuration,,,,Calculated partition coefficient (clogP),22229,,5889,BAO_0000100,,0,1,,CHEMBL625053,,
13440,Autocuration,,,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,22224,,6154,BAO_0000019,,0,1,,CHEMBL623250,,
13441,Autocuration,,,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,22224,,6154,BAO_0000019,,0,1,,CHEMBL623251,,
13442,Autocuration,,,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,22224,,6154,BAO_0000019,,0,1,,CHEMBL623252,,
13443,Autocuration,,,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,22224,,6154,BAO_0000019,,0,1,,CHEMBL623253,,
13444,Autocuration,,,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,22224,,6154,BAO_0000019,,0,1,,CHEMBL623254,,
13445,Autocuration,,,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,22224,,6154,BAO_0000019,,0,1,,CHEMBL623255,,
13446,Autocuration,,,,Percent degradation of compound at a pH of 1 over a 18 hr period,22224,,6887,BAO_0000019,,0,1,,CHEMBL626831,,
13447,Autocuration,,,,Percent degradation of compound at pH of 1 over an 18 hr period,22224,,6887,BAO_0000019,,0,1,,CHEMBL877494,,
13448,Autocuration,,,,Delta Logarithm of Partition Coefficient value was determined.,22224,,14116,BAO_0000019,,0,1,,CHEMBL626832,,
13449,Autocuration,,,,Delta logPoct-cyc,22224,,11137,BAO_0000019,,0,1,,CHEMBL626833,,
13450,Autocuration,,,,Lipophilicity estimated on reversed phase TLC,22224,,7230,BAO_0000100,,0,1,,CHEMBL626834,,
13451,Autocuration,,,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,22224,,15741,BAO_0000019,,0,1,,CHEMBL626835,,
13452,Autocuration,,,,Delta logPoct-cyc,22224,,9663,BAO_0000019,,0,1,,CHEMBL626836,,
13453,Autocuration,,,,Change in logarithm of partition coefficient of the compound,22229,,9663,BAO_0000100,,0,1,,CHEMBL626837,,
13454,Autocuration,,,,Delta logD (pH 6.5),22224,,13807,BAO_0000019,,0,1,,CHEMBL626838,,
13455,Autocuration,,,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",22224,,13807,BAO_0000100,,0,1,,CHEMBL626839,,
13456,Autocuration,,,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,22224,,17425,BAO_0000019,,0,1,,CHEMBL626840,,
13457,Autocuration,,,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),22224,,12143,BAO_0000019,,0,1,,CHEMBL626841,,
13458,Autocuration,,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,22224,,12608,BAO_0000219,,0,1,,CHEMBL626842,,
13459,Autocuration,,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,22224,,12608,BAO_0000219,,0,1,,CHEMBL626843,,
13460,Intermediate,,,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,50597,Rattus norvegicus,8649,BAO_0000218,,1,1,,CHEMBL626844,,
13461,Intermediate,,,,Amount of deuterium retained was reported after normal workup in rats,50597,Rattus norvegicus,8649,BAO_0000218,,1,1,,CHEMBL877495,,
13462,Intermediate,,,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,50597,Rattus norvegicus,8649,BAO_0000218,,1,1,,CHEMBL626845,,
13463,Intermediate,,,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,50597,Rattus norvegicus,8649,BAO_0000218,,1,1,,CHEMBL626846,,
13464,Intermediate,,,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,50597,Rattus norvegicus,8649,BAO_0000218,,1,1,,CHEMBL626847,,
13465,Intermediate,,,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,50597,Rattus norvegicus,8649,BAO_0000218,,1,1,,CHEMBL628677,,
13466,Intermediate,,,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,50597,Rattus norvegicus,8649,BAO_0000218,,1,1,,CHEMBL628678,,
13467,Autocuration,,,,Compound was subjected to electrochemical oxidation,22224,,9659,BAO_0000019,,0,1,,CHEMBL628679,,
13468,Autocuration,,,,Compound was subjected to photochemical oxidation,22224,,9659,BAO_0000019,,0,1,,CHEMBL628680,,
13469,Autocuration,,,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,22224,,9659,BAO_0000019,,0,1,,CHEMBL628681,,
13470,Autocuration,,,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,22224,,9659,BAO_0000019,,0,1,,CHEMBL628682,,
13471,Autocuration,,,,Oxidation of compound by methemoglobin in presence of hydroperoxide,22224,,9659,BAO_0000019,,0,1,,CHEMBL628683,,
13472,Intermediate,,,,Percent diffusion through fuzzy rat skin after 48 h of incubation,50597,Rattus norvegicus,9607,BAO_0000218,,1,1,,CHEMBL628684,,
13473,Autocuration,,,,Dissociation constant (pKa),22229,,7057,BAO_0000100,,0,1,,CHEMBL877501,,
13474,Autocuration,,,,Dissociation constant value of the compound; ND means not determined.,22224,,7057,BAO_0000100,,0,1,,CHEMBL628685,,
13475,Intermediate,,Blood,178.0,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,50597,Rattus norvegicus,7911,BAO_0000218,,1,1,,CHEMBL628686,,
13476,Intermediate,,Blood,178.0,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,50597,Rattus norvegicus,7911,BAO_0000218,,1,1,,CHEMBL628687,,
13477,Intermediate,,,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,50597,Rattus norvegicus,7911,BAO_0000218,,1,1,,CHEMBL628688,,
13478,Intermediate,,,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,50597,Rattus norvegicus,7911,BAO_0000218,,1,1,,CHEMBL628689,,
13479,Intermediate,,Liver,2107.0,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,50597,Rattus norvegicus,7911,BAO_0000218,,1,1,,CHEMBL628690,,
13480,Intermediate,,Liver,2107.0,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,50597,Rattus norvegicus,7911,BAO_0000218,,1,1,,CHEMBL629363,,
13481,Intermediate,,Spleen,2106.0,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,50597,Rattus norvegicus,7911,BAO_0000218,,1,1,,CHEMBL629364,,
13482,Intermediate,,Spleen,2106.0,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,50597,Rattus norvegicus,7911,BAO_0000218,,1,1,,CHEMBL629365,,
13483,Intermediate,,,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,50597,Rattus norvegicus,7911,BAO_0000218,,1,1,,CHEMBL629366,,
13484,Intermediate,,Urine,1088.0,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,50597,Rattus norvegicus,7911,BAO_0000218,,1,1,,CHEMBL629367,,
13485,Intermediate,,Feces,1988.0,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,50597,Rattus norvegicus,7911,BAO_0000218,,1,1,,CHEMBL629368,,
13486,Intermediate,,Urine,1088.0,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,50597,Rattus norvegicus,7911,BAO_0000218,,1,1,,CHEMBL877502,,
13487,Intermediate,,Cerebellum,2037.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,50594,Mus musculus,13792,BAO_0000218,,1,1,,CHEMBL629369,,
13488,Intermediate,,Brain,955.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,50594,Mus musculus,13792,BAO_0000218,,1,1,,CHEMBL629370,,
13489,Autocuration,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",22224,Simiiformes,8133,BAO_0000218,,0,1,,CHEMBL629371,,
13490,Autocuration,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",22224,Simiiformes,8133,BAO_0000218,,0,1,,CHEMBL626276,,
13491,Autocuration,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",22224,Simiiformes,8133,BAO_0000218,,0,1,,CHEMBL626277,,
13492,Autocuration,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",22224,Simiiformes,8133,BAO_0000218,,0,1,,CHEMBL631250,,
13493,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL631251,,
13494,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL631252,,
13495,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL631253,,
13496,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL631254,,
13497,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL631255,,
13498,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL631256,,
13499,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL631257,,
13500,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL628009,,
13501,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL628010,,
13502,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL628011,,
13503,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL628012,,
13504,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL628013,,
13505,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL628014,,
13506,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL628015,,
13507,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL628016,,
13508,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL874461,,
13509,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL628017,,
13510,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL628018,,
13511,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL628019,,
13512,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL628020,,
13513,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL628021,,
13514,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL628022,,
13515,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",50588,Canis lupus familiaris,8133,BAO_0000218,,1,1,,CHEMBL628023,,
13516,Autocuration,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",22224,Simiiformes,8133,BAO_0000218,,0,1,,CHEMBL628024,,
13517,Autocuration,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",22224,Simiiformes,8133,BAO_0000218,,0,1,,CHEMBL628025,,
13518,Autocuration,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",22224,Simiiformes,8133,BAO_0000218,,0,1,,CHEMBL628026,,
13519,Autocuration,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",22224,Simiiformes,8133,BAO_0000218,,0,1,,CHEMBL628027,,
13520,Autocuration,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",22224,Simiiformes,8133,BAO_0000218,,0,1,,CHEMBL628028,,
13521,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL628029,,
13522,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL628030,,
13523,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL628031,,
13524,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL628032,,
13525,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL628033,,
13526,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL628034,,
13527,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL628035,,
13528,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL628036,,
13529,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL874462,,
13530,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628037,,
13531,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628123,,
13532,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628124,,
13533,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628125,,
13534,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628126,,
13535,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628127,,
13536,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628128,,
13537,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628129,,
13538,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628130,,
13539,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628131,,
13540,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628132,,
13541,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628133,,
13542,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628134,,
13543,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628135,,
13544,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628136,,
13545,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628137,,
13546,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628138,,
13547,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628139,,
13548,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628140,,
13549,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628141,,
13550,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628142,,
13551,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628143,,
13552,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628144,,
13553,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628145,,
13554,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL628146,,
13555,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625355,,
13556,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625356,,
13557,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625357,,
13558,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625527,,
13559,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL875473,,
13560,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL625528,,
13561,Intermediate,,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,50597,Rattus norvegicus,9025,BAO_0000218,,1,1,,CHEMBL626304,,
13562,Intermediate,,Artery,1637.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,50588,Canis lupus familiaris,9025,BAO_0000218,,1,1,,CHEMBL624138,,
13563,Autocuration,,,,Calculated partition coefficient (clogP),22229,,6448,BAO_0000100,,0,1,,CHEMBL624139,,
13564,Autocuration,,,,Calculated partition coefficient (clogP),22229,,17221,BAO_0000100,,0,1,,CHEMBL624140,,
13565,Autocuration,,,,Calculated partition coefficient (clogP),22229,,6545,BAO_0000100,,0,1,,CHEMBL624141,,
13566,Autocuration,,,,Calculated partition coefficient (clogP),22229,,577,BAO_0000100,,0,1,,CHEMBL624142,,
13567,Autocuration,,,,Calculated partition coefficient (clogP),22229,,6285,BAO_0000100,,0,1,,CHEMBL624143,,
13568,Autocuration,,,,Calculated partition coefficient (clogP),22229,,6500,BAO_0000100,,0,1,,CHEMBL624144,,
13569,Autocuration,,,,Calculated partition coefficient (clogP),22229,,6716,BAO_0000100,,0,1,,CHEMBL624145,,
13570,Autocuration,,,,Calculated partition coefficient (clogP),22229,,13658,BAO_0000100,,0,1,,CHEMBL624146,,
13571,Autocuration,,,,Calculated partition coefficient (clogP),22229,,6549,BAO_0000100,,0,1,,CHEMBL624147,,
13572,Autocuration,,,,Calculated partition coefficient (clogP) (MacLogP),22229,,14685,BAO_0000100,,0,1,,CHEMBL883123,,
13573,Autocuration,,,,Partition coefficient (logP),22224,,6893,BAO_0000019,,0,1,,CHEMBL624148,,
13574,Autocuration,,,,Kinetic parameter was determined,22224,,3687,BAO_0000019,,0,1,,CHEMBL874416,,
13575,Autocuration,,,,Calculated partition coefficient (clogP),22229,,4207,BAO_0000100,,0,1,,CHEMBL624149,,
13576,Autocuration,,,,Calculated partition coefficient (clogP),22229,,4626,BAO_0000100,,0,1,,CHEMBL624150,,
13577,Autocuration,,,,Lipophilicity was determined,22224,,1021,BAO_0000100,,0,1,,CHEMBL624151,,
13578,Autocuration,,,,Lipophilicity was determined,22224,,3777,BAO_0000100,,0,1,,CHEMBL624152,,
13579,Autocuration,,,,Lipophilicity was determined,22224,,17533,BAO_0000100,,0,1,,CHEMBL622139,,
13580,Autocuration,,,,Calculated partition coefficient (clogP),22229,,6524,BAO_0000100,,0,1,,CHEMBL622140,,
13581,Autocuration,,,,Lipophilicity was determined,22224,,17533,BAO_0000100,,0,1,,CHEMBL622141,,
13582,Autocuration,,,,Lipophilicity in octanol-water,22224,,6480,BAO_0000100,,0,1,,CHEMBL622142,,
13583,Autocuration,,,,Calculated partition coefficient (clogP),22229,,17606,BAO_0000100,,0,1,,CHEMBL622143,,
13584,Autocuration,,,,Octanol-water partition coefficient was determined,22229,,6863,BAO_0000100,,0,1,,CHEMBL622144,,
13585,Autocuration,,,,Partition coefficient (logP),22224,,1356,BAO_0000019,,0,1,,CHEMBL877473,,
13586,Autocuration,,,,Calculated partition coefficient (clogP),22229,,3326,BAO_0000100,,0,1,,CHEMBL622145,,
13587,Autocuration,,,,Partition coefficient was determined; ND means not determined,22224,,1356,BAO_0000019,,0,1,,CHEMBL622146,,
13588,Autocuration,,,,Calculated partition coefficient (clogP),22229,,12984,BAO_0000100,,0,1,,CHEMBL622147,,
13589,Autocuration,,,,Partition coefficient of the compound,22224,,17363,BAO_0000019,,0,1,,CHEMBL622148,,
13590,Autocuration,,,,Permeability was determined,22224,,6827,BAO_0000019,,0,1,,CHEMBL883124,,
13591,Autocuration,,,,The compound was evaluated for the partition coefficient,22229,,261,BAO_0000100,,0,1,,CHEMBL622149,,
13592,Autocuration,,,,Partition coefficient (logP),22224,,2685,BAO_0000019,,0,1,,CHEMBL622150,,
13593,Autocuration,,,,The lipophilicity was reported,22224,,414,BAO_0000100,,0,1,,CHEMBL622151,,
13594,Autocuration,,,,logarithm of the octanol-water partition coefficient for the compound,22229,,15769,BAO_0000100,,0,1,,CHEMBL622152,,
13595,Autocuration,,,,Clogp value was determined,22224,,17248,BAO_0000019,,0,1,,CHEMBL622153,,
13596,Autocuration,,,,Clp at a dose of 1.5 mg/kg,22224,,16935,BAO_0000218,,0,1,,CHEMBL877474,,
13597,Autocuration,,,,Clp at a dose of 2.0 mg/kg,22224,,16935,BAO_0000218,,0,1,,CHEMBL622154,,
13598,Autocuration,,Plasma,1969.0,"Clp, plasma clearance at a dose of 10 mg/kg",22224,,14832,BAO_0000218,,0,1,,CHEMBL622155,,
13599,Autocuration,,Plasma,1969.0,"Clp, plasma clearance at a dose of 50 mg/kg",22224,,14832,BAO_0000218,,0,1,,CHEMBL622156,,
13600,Intermediate,,Plasma,1969.0,Compound was tested for plasma clearance in rat,50597,Rattus norvegicus,2399,BAO_0000218,,1,1,,CHEMBL622157,,
13601,Intermediate,,Plasma,1969.0,Compound was tested for plasma clearance in rat; Not determined,50597,Rattus norvegicus,2399,BAO_0000218,,1,1,,CHEMBL622158,,
13602,Intermediate,,,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,50597,Rattus norvegicus,6227,BAO_0000218,,1,1,,CHEMBL622807,,
13603,Intermediate,,,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,50797,Macaca mulatta,6227,BAO_0000218,,1,1,,CHEMBL622808,,
13604,Autocuration,,,,Plasma clearance by iv administration at a dose 0.003 ug/mL,22224,,5623,BAO_0000218,,0,1,,CHEMBL622809,,
13605,Autocuration,,,,Plasma clearance determined,22224,,4854,BAO_0000218,,0,1,,CHEMBL622810,,
13606,Intermediate,,,,Plasma clearance after iv administration at 3 mg/kg in hamster,100712,Cricetinae,4493,BAO_0000218,,1,1,,CHEMBL876653,,
13607,Intermediate,,,,Plasma clearance after iv administration at 4 mg/kg in hamster,100712,Cricetinae,4493,BAO_0000218,,1,1,,CHEMBL622811,,
13608,Intermediate,,,,Rate of clearance in rat was determined,50597,Rattus norvegicus,14956,BAO_0000218,,1,1,,CHEMBL622986,,
13609,Intermediate,,Plasma,1969.0,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL622987,,
13610,Intermediate,,Plasma,1969.0,Total plasma clearance after iv dose of 5.10 mg/kg in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL622988,,
13611,Intermediate,,Plasma,1969.0,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL622989,,
13612,Intermediate,,Plasma,1969.0,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,50597,Rattus norvegicus,15372,BAO_0000218,,1,1,,CHEMBL622990,,
13613,Autocuration,,Plasma,1969.0,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,22224,Simiiformes,15604,BAO_0000218,,0,1,,CHEMBL622991,,
13614,Intermediate,,Plasma,1969.0,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,50597,Rattus norvegicus,15604,BAO_0000218,,1,1,,CHEMBL622227,,
13615,Intermediate,,Plasma,1969.0,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,50588,Canis lupus familiaris,15604,BAO_0000218,,1,1,,CHEMBL622228,,
13616,Intermediate,,,,Clpl value in rat,50597,Rattus norvegicus,14964,BAO_0000218,,1,1,,CHEMBL622229,,
13617,Intermediate,,,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,50512,Cavia porcellus,15240,BAO_0000218,,1,1,,CHEMBL622230,,
13618,Intermediate,,,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,50597,Rattus norvegicus,16449,BAO_0000218,,1,1,,CHEMBL622231,,
13619,Intermediate,,,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,100710,Macaca fascicularis,16449,BAO_0000218,,1,1,,CHEMBL622232,,
13620,Autocuration,,,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,22224,,12902,BAO_0000218,,0,1,,CHEMBL622233,,
13621,Autocuration,,,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,22224,,12902,BAO_0000218,,0,1,,CHEMBL622234,,
13622,Autocuration,,,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,22224,,12902,BAO_0000218,,0,1,,CHEMBL622235,,
13623,Autocuration,,,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,22224,,12902,BAO_0000218,,0,1,,CHEMBL622236,,
13624,Autocuration,,,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,22224,,12902,BAO_0000218,,0,1,,CHEMBL622237,,
13625,Autocuration,,,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,22224,,12902,BAO_0000218,,0,1,,CHEMBL877482,,
13626,Autocuration,,,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,22224,,12902,BAO_0000218,,0,1,,CHEMBL622238,,
13627,Autocuration,,,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,22224,,12902,BAO_0000218,,0,1,,CHEMBL622239,,
13628,Autocuration,,Blood,178.0,Cmax was calculated as maximum concentration reached in the blood,22224,,11149,BAO_0000218,,0,1,,CHEMBL622240,,
13629,Autocuration,,Blood,178.0,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,22224,,11149,BAO_0000218,,0,1,,CHEMBL622241,,
13630,Intermediate,,,,Cmax was determine after peroral administration at 10 mpk in Rat,50597,Rattus norvegicus,5669,BAO_0000218,,1,1,,CHEMBL631013,,
13631,Intermediate,,,,Cmax was determine after peroral administration at 10 mpk in Rhesus,50797,Macaca mulatta,5669,BAO_0000218,,1,1,,CHEMBL631014,,
13632,Intermediate,,,,Cmax was determine after peroral administration at 10 mpk in dog,50588,Canis lupus familiaris,5669,BAO_0000218,,1,1,,CHEMBL631015,,
13633,Intermediate,,,,Cmax was determine after peroral administration at 160 mpk in Rat,50597,Rattus norvegicus,5669,BAO_0000218,,1,1,,CHEMBL631016,,
13634,Intermediate,,,,Cmax was determine after peroral administration at 20 mpk in Rat,50597,Rattus norvegicus,5669,BAO_0000218,,1,1,,CHEMBL631017,,
13635,Intermediate,,,,Cmax was determine after peroral administration at 50 mpk in Rat,50597,Rattus norvegicus,5669,BAO_0000218,,1,1,,CHEMBL631018,,
13636,Autocuration,,,,Cmax was determined,22224,,4236,BAO_0000218,,0,1,,CHEMBL631019,,
13637,Intermediate,,Brain,955.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,50594,Mus musculus,13792,BAO_0000218,,1,1,,CHEMBL875761,,
13638,Intermediate,,Brain,955.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,50594,Mus musculus,13792,BAO_0000218,,1,1,,CHEMBL631020,,
13639,Intermediate,,Brain,955.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,50594,Mus musculus,13792,BAO_0000218,,1,1,,CHEMBL631669,,
13640,Intermediate,,Brain,955.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,50594,Mus musculus,13792,BAO_0000218,,1,1,,CHEMBL631670,,
13641,Intermediate,,Striatum,2435.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,50594,Mus musculus,13792,BAO_0000218,,1,1,,CHEMBL631671,,
13642,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631672,,
13643,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631673,,
13644,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631856,,
13645,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631857,,
13646,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631858,,
13647,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631859,,
13648,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631860,,
13649,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631861,,
13650,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631862,,
13651,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631863,,
13652,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631864,,
13653,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631865,,
13654,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL631866,,
13655,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL629360,,
13656,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL629361,,
13657,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL629362,,
13658,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630740,,
13659,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630741,,
13660,Intermediate,,Blood,178.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630742,,
13661,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630743,,
13662,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630744,,
13663,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630745,,
13664,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630746,,
13665,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630747,,
13666,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL630748,,
13667,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL632056,,
13668,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL632057,,
13669,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL632058,,
13670,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL632059,,
13671,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL632060,,
13672,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL632061,,
13673,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL629207,,
13674,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL629208,,
13675,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL629209,,
13676,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL629210,,
13677,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL629211,,
13678,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL629212,,
13679,Intermediate,,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,50597,Rattus norvegicus,8418,BAO_0000218,,1,1,,CHEMBL629213,,
13680,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL629214,,
13681,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL629215,,
13682,Intermediate,,Urine,1088.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",50597,Rattus norvegicus,8133,BAO_0000218,,1,1,,CHEMBL635154,,
13683,Intermediate,,,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL629216,,
13684,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL629217,,
13685,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL629218,,
13686,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL629219,,
13687,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL629220,,
13688,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL629221,,
13689,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631127,,
13690,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631128,,
13691,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631129,,
13692,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631130,,
13693,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631131,,
13694,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631132,,
13695,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631133,,
13696,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631134,,
13697,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL875120,,
13698,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631135,,
13699,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631136,,
13700,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631137,,
13701,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631138,,
13702,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631139,,
13703,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631140,,
13704,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631141,,
13705,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631142,,
13706,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631143,,
13707,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),50597,Rattus norvegicus,6996,BAO_0000218,,1,1,,CHEMBL631144,,
13708,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631145,,
13709,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631146,,
13710,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631147,,
13711,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631148,,
13712,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631149,,
13713,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631150,,
13714,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631151,,
13715,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631152,,
13716,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631443,,
13717,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631444,,
13718,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631445,,
13719,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631446,,
13720,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631447,,
13721,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631448,,
13722,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631449,,
13723,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL631450,,
13724,Intermediate,,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),50588,Canis lupus familiaris,6996,BAO_0000218,,1,1,,CHEMBL629724,,
13725,Intermediate,,Zone of skin,14.0,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",50594,Mus musculus,9716,BAO_0000218,,1,1,,CHEMBL629725,,
13726,Intermediate,,Zone of skin,14.0,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",50594,Mus musculus,9716,BAO_0000218,,1,1,,CHEMBL629726,,
13727,Intermediate,,Spleen,2106.0,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",50594,Mus musculus,9716,BAO_0000218,,1,1,,CHEMBL629727,,
13728,Intermediate,,Spleen,2106.0,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",50594,Mus musculus,9716,BAO_0000218,,1,1,,CHEMBL630404,,
13729,Intermediate,,Spleen,2106.0,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",50594,Mus musculus,9716,BAO_0000218,,1,1,,CHEMBL630405,,
13730,Intermediate,,Spleen,2106.0,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",50594,Mus musculus,9716,BAO_0000218,,1,1,,CHEMBL630406,,
13731,Intermediate,,Stomach,945.0,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",50594,Mus musculus,9716,BAO_0000218,,1,1,,CHEMBL630407,,
13732,Intermediate,,Stomach,945.0,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",50594,Mus musculus,9716,BAO_0000218,,1,1,,CHEMBL630573,,
13733,Intermediate,,Stomach,945.0,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",50594,Mus musculus,9716,BAO_0000218,,1,1,,CHEMBL630574,,
13734,Intermediate,,Stomach,945.0,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",50594,Mus musculus,9716,BAO_0000218,,1,1,,CHEMBL630575,,
13735,Intermediate,,,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",50594,Mus musculus,9716,BAO_0000218,,1,1,,CHEMBL630576,,
13736,Intermediate,,,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",50594,Mus musculus,9716,BAO_0000218,,1,1,,CHEMBL630577,,
13737,Intermediate,,,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",50594,Mus musculus,9716,BAO_0000218,,1,1,,CHEMBL630578,,
13738,Intermediate,,,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",50594,Mus musculus,9716,BAO_0000218,,1,1,,CHEMBL630579,,
13739,Intermediate,,Kidney,2113.0,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),50594,Mus musculus,12192,BAO_0000218,,1,1,,CHEMBL630580,,
13740,Intermediate,,Kidney,2113.0,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,50594,Mus musculus,12192,BAO_0000218,,1,1,,CHEMBL630581,,
13741,Intermediate,,Kidney,2113.0,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),50594,Mus musculus,12192,BAO_0000218,,1,1,,CHEMBL630582,,
13742,Intermediate,,,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,50594,Mus musculus,12192,BAO_0000218,,1,1,,CHEMBL630583,,
13743,Intermediate,,,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),50594,Mus musculus,12192,BAO_0000218,,1,1,,CHEMBL630584,,
13744,Intermediate,,,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,50594,Mus musculus,12192,BAO_0000218,,1,1,,CHEMBL630585,,
13745,Intermediate,,,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),50594,Mus musculus,12192,BAO_0000218,,1,1,,CHEMBL630586,,
13746,Intermediate,,,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,50594,Mus musculus,12192,BAO_0000218,,1,1,,CHEMBL630587,,
13747,Intermediate,,,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),50594,Mus musculus,12192,BAO_0000218,,1,1,,CHEMBL630588,,
13748,Intermediate,,,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,50594,Mus musculus,12192,BAO_0000218,,1,1,,CHEMBL630589,,
13749,Intermediate,,,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),50594,Mus musculus,12192,BAO_0000218,,1,1,,CHEMBL630590,,
13750,Autocuration,,Feces,1988.0,Removal of 238-Plutonium(IV) in feces at 24 h,22224,,12192,BAO_0000019,,0,1,,CHEMBL630591,,
13751,Autocuration,,Feces,1988.0,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),22224,,12192,BAO_0000019,,0,1,,CHEMBL630592,,
13752,Autocuration,,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,22224,,12192,BAO_0000019,,0,1,,CHEMBL630593,,
13753,Autocuration,,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),22224,,12192,BAO_0000019,,0,1,,CHEMBL630594,,
13754,Autocuration,,Urine,1088.0,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),22224,,12192,BAO_0000019,,0,1,,CHEMBL630595,,
13755,Autocuration,,Urine,1088.0,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),22224,,12192,BAO_0000019,,0,1,,CHEMBL630596,,
13756,Autocuration,,Urine,1088.0,Removal of 238-Plutonium(IV) in urine after 0-24 h,22224,,12192,BAO_0000019,,0,1,,CHEMBL630597,,
13757,Autocuration,,Urine,1088.0,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),22224,,12192,BAO_0000019,,0,1,,CHEMBL630598,,
13758,Autocuration,,Urine,1088.0,Removal of 238-Plutonium(IV) in urine after 0-4 h,22224,,12192,BAO_0000019,,0,1,,CHEMBL630599,,
13759,Autocuration,,Urine,1088.0,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),22224,,12192,BAO_0000019,,0,1,,CHEMBL630600,,
13760,Autocuration,,Urine,1088.0,Removal of 238-Plutonium(IV) in urine after 4-24 h,22224,,12192,BAO_0000019,,0,1,,CHEMBL630601,,
13761,Autocuration,,Urine,1088.0,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),22224,,12192,BAO_0000019,,0,1,,CHEMBL630602,,
13762,Autocuration,,Urine,1088.0,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),22224,,12192,BAO_0000019,,0,1,,CHEMBL630603,,
13763,Autocuration,,Urine,1088.0,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),22224,,12192,BAO_0000019,,0,1,,CHEMBL630604,,
13764,Intermediate,,Blood,178.0,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL624869,,
13765,Intermediate,,Blood,178.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL624870,,
13766,Intermediate,,Blood,178.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL623189,,
13767,Intermediate,,Blood,178.0,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL623190,,
13768,Intermediate,,Blood,178.0,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL623191,,
13769,Intermediate,,,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL623192,,
13770,Intermediate,,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL623193,,
13771,Intermediate,,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL623194,,
13772,Intermediate,,,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL623195,,
13773,Intermediate,,,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL623196,,
13774,Intermediate,,,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623197,,
13775,Intermediate,,,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623198,,
13776,Intermediate,,,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623199,,
13777,Intermediate,,Muscle tissue,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623200,,
13778,Intermediate,,Muscle tissue,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623201,,
13779,Intermediate,,Muscle tissue,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623202,,
13780,Intermediate,,Muscle tissue,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623203,,
13781,Intermediate,,Muscle tissue,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623204,,
13782,Intermediate,,Muscle tissue,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623205,,
13783,Intermediate,,Muscle tissue,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623206,,
13784,Intermediate,,Muscle tissue,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623207,,
13785,Intermediate,,Muscle tissue,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623208,,
13786,Intermediate,,Muscle tissue,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623209,,
13787,Intermediate,,Muscle tissue,2385.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623210,,
13788,Intermediate,,,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623211,,
13789,Intermediate,,Uterus,995.0,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,50597,Rattus norvegicus,11836,BAO_0000218,,1,1,,CHEMBL623212,,
13790,Autocuration,,,,Tested in vitro for intrinsic activity relative to quinpirole,22224,,12640,BAO_0000019,,0,1,,CHEMBL623213,,
13791,Autocuration,,,,"Relative ion enhancement, determined in pulsed ultrafiltration",22224,,14218,BAO_0000019,,0,1,,CHEMBL623214,,
13792,Autocuration,,,,% ionization at the pH 7.4 at 37 degree Centigrade,22224,,11296,BAO_0000019,,0,1,,CHEMBL623215,,
13793,Autocuration,,,,Percentage ionization was measured,22224,,10929,BAO_0000019,,0,1,,CHEMBL623216,,
13794,Intermediate,,,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,50591,Bos taurus,13841,BAO_0000218,,1,1,,CHEMBL623217,,
13795,Autocuration,,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,22224,,10431,BAO_0000019,,0,1,,CHEMBL623218,,
13796,Autocuration,,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,22224,,10431,BAO_0000019,,0,1,,CHEMBL623913,,
13797,Autocuration,,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,22224,,10431,BAO_0000019,,0,1,,CHEMBL623914,,
13798,Autocuration,,,,Compound was evaluated for the partition coefficient in octanol/water,22229,,8826,BAO_0000100,,0,1,,CHEMBL623915,,
13799,Autocuration,,,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),22229,,8826,BAO_0000100,,0,1,,CHEMBL624080,,
13800,Autocuration,,,,Equilibrium constant measured by the pulse radiolysis at pH 7,22224,,9884,BAO_0000019,,0,1,,CHEMBL624081,,
13801,Intermediate,,,,In vitro hydrolytic rate constant determined in human blood,50587,Homo sapiens,9827,BAO_0000218,,1,1,,CHEMBL624082,,
13802,Intermediate,,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,50587,Homo sapiens,10009,BAO_0000218,,1,1,,CHEMBL625054,,
13803,Autocuration,,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,22224,,10009,BAO_0000019,,0,1,,CHEMBL877485,,
13804,Intermediate,,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,50594,Mus musculus,10009,BAO_0000218,,1,1,,CHEMBL625055,,
13805,Intermediate,,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,50594,Mus musculus,10009,BAO_0000218,,1,1,,CHEMBL625056,,
13806,Intermediate,,,,In vitro oxidation of compound in presence of human plasma,50587,Homo sapiens,10009,BAO_0000218,,1,1,,CHEMBL625057,,
13807,Autocuration,,,,In vitro oxidation of compound in presence of hydrogen peroxide,22224,,10009,BAO_0000019,,0,1,,CHEMBL625058,,
13808,Intermediate,,,,In vitro oxidation of compound in presence of mouse brain homogenate,50594,Mus musculus,10009,BAO_0000218,,1,1,,CHEMBL625059,,
13809,Intermediate,,,,In vitro oxidation of compound in presence of mouse liver homogenate,50594,Mus musculus,10009,BAO_0000218,,1,1,,CHEMBL629536,,
13810,Intermediate,,,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629537,,
13811,Intermediate,,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629538,,
13812,Intermediate,,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629539,,
13813,Intermediate,,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL874445,,
13814,Intermediate,,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629540,,
13815,Intermediate,,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629541,,
13816,Intermediate,,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629542,,
13817,Intermediate,,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL630243,,
13818,Intermediate,,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL630244,,
13819,Intermediate,,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL630245,,
13820,Intermediate,,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL630246,,
13821,Intermediate,,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL630247,,
13822,Intermediate,,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL630248,,
13823,Intermediate,,Blood,178.0,Biodistribution in rat blood at 240 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630249,,
13824,Intermediate,,Blood,178.0,Biodistribution in rat blood at 30 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630250,,
13825,Intermediate,,Blood,178.0,Biodistribution in rat blood at 360 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630251,,
13826,Intermediate,,Blood,178.0,Biodistribution in rat blood at 3 hr after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630252,,
13827,Intermediate,,Blood,178.0,Biodistribution in rat blood at 60 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630408,,
13828,Intermediate,,Cerebellum,2037.0,Biodistribution in rat cerebellum at 120 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630409,,
13829,Intermediate,,Cerebellum,2037.0,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL874446,,
13830,Intermediate,,Cerebellum,2037.0,Biodistribution in rat cerebellum at 15 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630410,,
13831,Intermediate,,Cerebellum,2037.0,Biodistribution in rat cerebellum at 240 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630411,,
13832,Intermediate,,Cerebellum,2037.0,Biodistribution in rat cerebellum at 30 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630412,,
13833,Intermediate,,Cerebellum,2037.0,Biodistribution in rat cerebellum at 360 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630413,,
13834,Intermediate,,Cerebellum,2037.0,Biodistribution in rat cerebellum at 3 hr after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630414,,
13835,Intermediate,,Cerebellum,2037.0,Biodistribution in rat cerebellum at 60 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630415,,
13836,Intermediate,,,,Biodistribution in rat cortex at 120 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630416,,
13837,Intermediate,,,,Biodistribution in rat cortex at 1440 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630417,,
13838,Intermediate,,,,Biodistribution in rat cortex at 15 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630418,,
13839,Intermediate,,,,Biodistribution in rat cortex at 240 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630419,,
13840,Intermediate,,,,Biodistribution in rat cortex at 30 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630420,,
13841,Intermediate,,,,Biodistribution in rat cortex at 360 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630421,,
13842,Intermediate,,,,Biodistribution in rat cortex at 3 hr after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630422,,
13843,Intermediate,,,,Biodistribution in rat cortex at 60 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630423,,
13844,Intermediate,,Heart,948.0,Biodistribution in rat heart at 120 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630424,,
13845,Intermediate,,Heart,948.0,Biodistribution in rat heart at 15 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630425,,
13846,Intermediate,,Heart,948.0,Biodistribution in rat heart at 240 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL629462,,
13847,Intermediate,,Heart,948.0,Biodistribution in rat heart at 30 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630426,,
13848,Intermediate,,Heart,948.0,Biodistribution in rat heart at 360 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630427,,
13849,Intermediate,,Heart,948.0,Biodistribution in rat heart at 3 hr after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625877,,
13850,Intermediate,,Heart,948.0,Biodistribution in rat heart at 60 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625878,,
13851,Intermediate,,Hippocampus,10000000.0,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625879,,
13852,Intermediate,,Hippocampus,10000000.0,Biodistribution in rat hippocampus at 240 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625880,,
13853,Intermediate,,Hippocampus,10000000.0,Biodistribution in rat hippocampus at 30 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625881,,
13854,Intermediate,,Hippocampus,10000000.0,Biodistribution in rat hippocampus at 360 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625882,,
13855,Intermediate,,Hippocampus,10000000.0,Biodistribution in rat hippocampus at 15 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625883,,
13856,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney at 120 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625884,,
13857,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney at 1440 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625885,,
13858,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney at 15 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628649,,
13859,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney at 240 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628650,,
13860,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney at 30 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628651,,
13861,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney at 360 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628652,,
13862,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney at 60 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628653,,
13863,Intermediate,,Liver,2107.0,Biodistribution in rat liver at 120 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628654,,
13864,Intermediate,,Liver,2107.0,Biodistribution in rat liver at 1440 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628655,,
13865,Intermediate,,Liver,2107.0,Biodistribution in rat liver at 15 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625238,,
13866,Intermediate,,Liver,2107.0,Biodistribution in rat liver at 240 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625239,,
13867,Intermediate,,Liver,2107.0,Biodistribution in rat liver at 30 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625240,,
13868,Intermediate,,Liver,2107.0,Biodistribution in rat liver at 360 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625241,,
13869,Intermediate,,Liver,2107.0,Biodistribution in rat liver at 60 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625242,,
13870,Intermediate,,Lung,2048.0,Biodistribution in rat lung at 120 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL874587,,
13871,Intermediate,,Lung,2048.0,Biodistribution in rat lung at 1440 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625405,,
13872,Intermediate,,Lung,2048.0,Biodistribution in rat lung at 15 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625406,,
13873,Intermediate,,Lung,2048.0,Biodistribution in rat lung at 240 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625407,,
13874,Intermediate,,Lung,2048.0,Biodistribution in rat lung at 30 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625408,,
13875,Intermediate,,Lung,2048.0,Biodistribution in rat lung at 360 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL625409,,
13876,Intermediate,,Thoracic aorta,1515.0,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,50597,Rattus norvegicus,12361,BAO_0000218,,1,1,,CHEMBL625410,,
13877,Intermediate,,Thoracic aorta,1515.0,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,50597,Rattus norvegicus,12361,BAO_0000218,,1,1,,CHEMBL625411,,
13878,Intermediate,,Thoracic aorta,1515.0,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,50597,Rattus norvegicus,12361,BAO_0000218,,1,1,,CHEMBL625412,,
13879,Intermediate,,Thoracic aorta,1515.0,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,50597,Rattus norvegicus,12361,BAO_0000218,,1,1,,CHEMBL625413,,
13880,Intermediate,,Thoracic aorta,1515.0,Percent of maximal contractile response to compound in rat thoracic aorta strips v,50597,Rattus norvegicus,12361,BAO_0000218,,1,1,,CHEMBL625414,,
13881,Intermediate,,Thoracic aorta,1515.0,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,50597,Rattus norvegicus,12361,BAO_0000218,,1,1,,CHEMBL625415,,
13882,Intermediate,,Thoracic aorta,1515.0,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,50597,Rattus norvegicus,12361,BAO_0000218,,1,1,,CHEMBL625416,,
13883,Intermediate,,Urine,1088.0,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,50597,Rattus norvegicus,12712,BAO_0000218,,1,1,,CHEMBL625417,,
13884,Intermediate,,Feces,1988.0,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,50597,Rattus norvegicus,7415,BAO_0000218,,1,1,,CHEMBL625418,,
13885,Intermediate,,Urine,1088.0,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,50597,Rattus norvegicus,7415,BAO_0000218,,1,1,,CHEMBL625419,,
13886,Intermediate,,,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,50597,Rattus norvegicus,7415,BAO_0000218,,1,1,,CHEMBL625420,,
13887,Intermediate,,,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,50597,Rattus norvegicus,7415,BAO_0000218,,1,1,,CHEMBL626996,,
13888,Intermediate,,Feces,1988.0,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",50597,Rattus norvegicus,7415,BAO_0000218,,1,1,,CHEMBL626997,,
13889,Intermediate,,Urine,1088.0,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",50597,Rattus norvegicus,7415,BAO_0000218,,1,1,,CHEMBL626998,,
13890,Intermediate,,,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",50597,Rattus norvegicus,7415,BAO_0000218,,1,1,,CHEMBL626999,,
13891,Intermediate,,,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL627000,,
13892,Intermediate,,,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL627001,,
13893,Intermediate,,,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL627002,,
13894,Intermediate,,,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL627003,,
13895,Intermediate,,Urine,1088.0,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL627004,,
13896,Intermediate,,Urine,1088.0,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL627005,,
13897,Intermediate,,Urine,1088.0,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL874594,,
13898,Intermediate,,Urine,1088.0,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL627006,,
13899,Intermediate,,Urine,1088.0,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL627007,,
13900,Intermediate,,Urine,1088.0,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL627884,,
13901,Intermediate,,Urine,1088.0,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL627885,,
13902,Intermediate,,Urine,1088.0,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL627886,,
13903,Intermediate,,Urine,1088.0,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL627887,,
13904,Intermediate,,Urine,1088.0,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL627888,,
13905,Intermediate,,Urine,1088.0,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL628057,,
13906,Intermediate,,Urine,1088.0,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,50594,Mus musculus,8050,BAO_0000218,,1,1,,CHEMBL627405,,
13907,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627406,,
13908,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627407,,
13909,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627408,,
13910,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627409,,
13911,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL875486,,
13912,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627410,,
13913,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627411,,
13914,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627412,,
13915,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627413,,
13916,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627414,,
13917,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627415,,
13918,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627416,,
13919,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627417,,
13920,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627418,,
13921,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627419,,
13922,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627320,,
13923,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627321,,
13924,Intermediate,,Kidney,2113.0,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL627322,,
13925,Intermediate,,Kidney,2113.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL627323,,
13926,Intermediate,,Kidney,2113.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL627491,,
13927,Intermediate,,Kidney,2113.0,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL627492,,
13928,Intermediate,,Kidney,2113.0,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL627493,,
13929,Intermediate,,Liver,2107.0,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL627494,,
13930,Intermediate,,Liver,2107.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL627495,,
13931,Intermediate,,Liver,2107.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL627496,,
13932,Intermediate,,Liver,2107.0,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL627497,,
13933,Intermediate,,Liver,2107.0,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL627498,,
13934,Intermediate,,Lung,2048.0,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL627499,,
13935,Intermediate,,Lung,2048.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL627500,,
13936,Intermediate,,Lung,2048.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL627501,,
13937,Intermediate,,Lung,2048.0,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL625616,,
13938,Intermediate,,Lung,2048.0,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL625617,,
13939,Intermediate,,Muscle tissue,2385.0,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL625618,,
13940,Intermediate,,Muscle tissue,2385.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL625619,,
13941,Intermediate,,Muscle tissue,2385.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL625620,,
13942,Intermediate,,Muscle tissue,2385.0,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL625621,,
13943,Intermediate,,Muscle tissue,2385.0,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL625622,,
13944,Intermediate,,Spleen,2106.0,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL625788,,
13945,Intermediate,,Spleen,2106.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL625789,,
13946,Intermediate,,Spleen,2106.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL625790,,
13947,Intermediate,,Spleen,2106.0,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL625791,,
13948,Intermediate,,Spleen,2106.0,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL622334,,
13949,Intermediate,,Thyroid gland,2046.0,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL622335,,
13950,Intermediate,,Thyroid gland,2046.0,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL622336,,
13951,Intermediate,,Thyroid gland,2046.0,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL622337,,
13952,Intermediate,,Thyroid gland,2046.0,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL622338,,
13953,Intermediate,,Thyroid gland,2046.0,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL622339,,
13954,Intermediate,,,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL624153,,
13955,Intermediate,,,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL628430,,
13956,Intermediate,,,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL628431,,
13957,Intermediate,,,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL628432,,
13958,Intermediate,,,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL628433,,
13959,Intermediate,,Spleen,2106.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL628434,,
13960,Intermediate,,Spleen,2106.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL626789,,
13961,Intermediate,,Spleen,2106.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL626790,,
13962,Intermediate,,Spleen,2106.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL626791,,
13963,Intermediate,,Spleen,2106.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL626792,,
13964,Intermediate,,Spleen,2106.0,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL626793,,
13965,Intermediate,,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627436,,
13966,Intermediate,,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627437,,
13967,Intermediate,,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627438,,
13968,Intermediate,,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627439,,
13969,Intermediate,,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627440,,
13970,Intermediate,,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627602,,
13971,Intermediate,,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627603,,
13972,Intermediate,,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627604,,
13973,Intermediate,,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627605,,
13974,Intermediate,,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627606,,
13975,Intermediate,,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627607,,
13976,Intermediate,,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627608,,
13977,Intermediate,,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627609,,
13978,Intermediate,,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627610,,
13979,Intermediate,,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627611,,
13980,Intermediate,,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL627612,,
13981,Autocuration,,,,Octanol:water partition coefficient is evaluated,22229,,8362,BAO_0000100,,0,1,,CHEMBL627613,,
13982,Autocuration,,,,Partition coefficient in 1-octanol/water system,22224,,8257,BAO_0000100,,0,1,,CHEMBL627614,,
13983,Autocuration,,,,Partition coefficient in 1-octanol/water system measured using radio active compounds,22224,,8257,BAO_0000100,,0,1,,CHEMBL627615,,
13984,Autocuration,,,,Partition coefficient in octanol/water system was determined,22224,,9468,BAO_0000100,,0,1,,CHEMBL627616,,
13985,Autocuration,,,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,22224,,9468,BAO_0000100,,0,1,,CHEMBL627617,,
13986,Autocuration,,,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,22224,,10568,BAO_0000019,,0,1,,CHEMBL627618,,
13987,Autocuration,,,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",22224,,10568,BAO_0000019,,0,1,,CHEMBL627619,,
13988,Autocuration,,,,Pseudo-first-order rate constant of the compound,22224,,15359,BAO_0000019,,0,1,,CHEMBL627620,,
13989,Autocuration,,,,Pseudo-first-order rate constant with 1-min time point,22224,,15359,BAO_0000019,,0,1,,CHEMBL627621,,
13990,Autocuration,,,,Pseudo-first-order rate constant without 1-min time point,22224,,15359,BAO_0000019,,0,1,,CHEMBL627622,,
13991,Autocuration,,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,22224,,10431,BAO_0000019,,0,1,,CHEMBL627623,,
13992,Autocuration,,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,22224,,10431,BAO_0000019,,0,1,,CHEMBL627624,,
13993,Autocuration,,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,22224,,10431,BAO_0000019,,0,1,,CHEMBL627625,,
13994,Autocuration,,,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,22224,,15704,BAO_0000019,,0,1,,CHEMBL628523,,
13995,Autocuration,,,,The alkaline hydrolysis second order rate constant(K OH) of the compound,22224,,15287,BAO_0000019,,0,1,,CHEMBL628524,,
13996,Autocuration,,,,The efflux rate constant of the compound,22224,,7516,BAO_0000019,,0,1,,CHEMBL628525,,
13997,Autocuration,,,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,22224,,12973,BAO_0000019,,0,1,,CHEMBL625732,,
13998,Autocuration,,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,22224,,12973,BAO_0000019,,0,1,,CHEMBL625733,,
13999,Autocuration,,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,22224,,12973,BAO_0000019,,0,1,,CHEMBL625734,,
14000,Autocuration,,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,22224,,12973,BAO_0000019,,0,1,,CHEMBL625913,,
14001,Autocuration,,,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,22224,,8696,BAO_0000019,,0,1,,CHEMBL625914,,
14002,Autocuration,,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,22224,,15052,BAO_0000019,,0,1,,CHEMBL625915,,
14003,Autocuration,,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,22224,,15052,BAO_0000019,,0,1,,CHEMBL625916,,
14004,Autocuration,,,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),22224,,10503,BAO_0000019,,0,1,,CHEMBL625917,,
14005,Autocuration,,,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL625918,,
14006,Autocuration,,,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL625919,,
14007,Autocuration,,,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL625920,,
14008,Autocuration,,,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL874453,,
14009,Autocuration,,,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL625921,,
14010,Autocuration,,,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,22224,,10503,BAO_0000019,,0,1,,CHEMBL625922,,
14011,Autocuration,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL625923,,
14012,Autocuration,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL625924,,
14013,Autocuration,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL625925,,
14014,Autocuration,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL625926,,
14015,Intermediate,,Lung,2048.0,Biodistribution in rat lung at 60 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL627704,,
14016,Intermediate,,,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL627705,,
14017,Intermediate,,,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL627706,,
14018,Intermediate,,,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL627707,,
14019,Intermediate,,,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL627708,,
14020,Intermediate,,,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628361,,
14021,Intermediate,,,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628362,,
14022,Intermediate,,Striatum,2435.0,Biodistribution in rat striatum at 120 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628363,,
14023,Intermediate,,Striatum,2435.0,Biodistribution in rat striatum at 1440 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628364,,
14024,Intermediate,,Striatum,2435.0,Biodistribution in rat striatum at 15 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628365,,
14025,Intermediate,,Striatum,2435.0,Biodistribution in rat striatum at 240 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL874454,,
14026,Intermediate,,Striatum,2435.0,Biodistribution in rat striatum at 30 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628531,,
14027,Intermediate,,Striatum,2435.0,Biodistribution in rat striatum at 360 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628532,,
14028,Intermediate,,Striatum,2435.0,Biodistribution in rat striatum at 3 hr after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628533,,
14029,Intermediate,,Striatum,2435.0,Biodistribution in rat striatum at 60 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628534,,
14030,Intermediate,,Thyroid gland,2046.0,Biodistribution in rat thyroid at 120 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628535,,
14031,Intermediate,,Thyroid gland,2046.0,Biodistribution in rat thyroid at 1440 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628536,,
14032,Intermediate,,Thyroid gland,2046.0,Biodistribution in rat thyroid at 15 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628537,,
14033,Intermediate,,Thyroid gland,2046.0,Biodistribution in rat thyroid at 240 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628538,,
14034,Intermediate,,Thyroid gland,2046.0,Biodistribution in rat thyroid at 30 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628539,,
14035,Intermediate,,Thyroid gland,2046.0,Biodistribution in rat thyroid at 360 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630297,,
14036,Intermediate,,Thyroid gland,2046.0,Biodistribution in rat thyroid at 60 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630298,,
14037,Intermediate,,Brain,955.0,Biodistribution in rest of brain of rat 120 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL630299,,
14038,Intermediate,,Brain,955.0,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628094,,
14039,Intermediate,,Brain,955.0,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628095,,
14040,Intermediate,,Brain,955.0,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL874648,,
14041,Intermediate,,Brain,955.0,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628096,,
14042,Intermediate,,Brain,955.0,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628097,,
14043,Intermediate,,Brain,955.0,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,50597,Rattus norvegicus,13100,BAO_0000218,,1,1,,CHEMBL628098,,
14044,Autocuration,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",22224,,13331,BAO_0000019,,0,1,,CHEMBL628099,,
14045,Autocuration,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",22224,,13331,BAO_0000019,,0,1,,CHEMBL628100,,
14046,Autocuration,,,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),22224,,13331,BAO_0000019,,0,1,,CHEMBL628101,,
14047,Autocuration,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",22224,,13331,BAO_0000019,,0,1,,CHEMBL628102,,
14048,Autocuration,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",22224,,13331,BAO_0000019,,0,1,,CHEMBL628103,,
14049,Autocuration,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",22224,,13331,BAO_0000019,,0,1,,CHEMBL628104,,
14050,Autocuration,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",22224,,13331,BAO_0000019,,0,1,,CHEMBL628105,,
14051,Autocuration,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",22224,,13331,BAO_0000019,,0,1,,CHEMBL628106,,
14052,Intermediate,,Urine,1088.0,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,50597,Rattus norvegicus,10086,BAO_0000218,,1,1,,CHEMBL628107,,
14053,Autocuration,,Urine,1088.0,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,22224,,10086,BAO_0000218,,0,1,,CHEMBL628108,,
14054,Intermediate,,Urine,1088.0,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,50597,Rattus norvegicus,10086,BAO_0000218,,1,1,,CHEMBL628109,,
14055,Autocuration,,Urine,1088.0,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,22224,,10086,BAO_0000218,,0,1,,CHEMBL625299,,
14056,Intermediate,,Urine,1088.0,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,50597,Rattus norvegicus,10086,BAO_0000218,,1,1,,CHEMBL625300,,
14057,Intermediate,,Urine,1088.0,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,50597,Rattus norvegicus,10086,BAO_0000218,,1,1,,CHEMBL625301,,
14058,Intermediate,,Urine,1088.0,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,50597,Rattus norvegicus,10086,BAO_0000218,,1,1,,CHEMBL625302,,
14059,Intermediate,,Urine,1088.0,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,50597,Rattus norvegicus,10086,BAO_0000218,,1,1,,CHEMBL874649,,
14060,Intermediate,,,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,50597,Rattus norvegicus,13248,BAO_0000218,,1,1,,CHEMBL625303,,
14061,Intermediate,,,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,50597,Rattus norvegicus,13248,BAO_0000218,,1,1,,CHEMBL625463,,
14062,Intermediate,,Liver,2107.0,In vitro metabolism in human liver microsomes,50587,Homo sapiens,14527,BAO_0000218,,1,1,,CHEMBL625464,,
14063,Intermediate,,,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,50587,Homo sapiens,3008,BAO_0000218,,1,1,,CHEMBL625465,,
14064,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL625466,,
14065,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL625467,,
14066,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL625468,,
14067,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL625469,,
14068,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL625470,,
14069,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL632418,,
14070,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL627250,,
14071,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL627251,,
14072,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL627252,,
14073,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL627253,,
14074,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL627254,,
14075,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL875471,,
14076,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL627255,,
14077,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL627256,,
14078,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL627257,,
14079,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL627258,,
14080,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL627259,,
14081,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL627260,,
14082,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623256,,
14083,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL874413,,
14084,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623257,,
14085,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623258,,
14086,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623259,,
14087,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623260,,
14088,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623261,,
14089,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623262,,
14090,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623263,,
14091,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623264,,
14092,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623265,,
14093,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623266,,
14094,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623267,,
14095,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623268,,
14096,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623269,,
14097,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623270,,
14098,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623271,,
14099,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623272,,
14100,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623273,,
14101,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623274,,
14102,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL874414,,
14103,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623275,,
14104,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL629150,,
14105,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623276,,
14106,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623277,,
14107,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623112,,
14108,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623113,,
14109,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623800,,
14110,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623801,,
14111,Intermediate,,Spleen,2106.0,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL623802,,
14112,Intermediate,,Uterus,995.0,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL623803,,
14113,Intermediate,,Uterus,995.0,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL623970,,
14114,Intermediate,,Uterus,995.0,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL623971,,
14115,Intermediate,,Blood,178.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),50597,Rattus norvegicus,14045,BAO_0000218,,1,1,,CHEMBL623972,,
14116,Intermediate,,Blood,178.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),50597,Rattus norvegicus,14045,BAO_0000218,,1,1,,CHEMBL623973,,
14117,Intermediate,,Blood,178.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),50597,Rattus norvegicus,14045,BAO_0000218,,1,1,,CHEMBL623974,,
14118,Intermediate,,Blood,178.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),50597,Rattus norvegicus,14045,BAO_0000218,,1,1,,CHEMBL623975,,
14119,Intermediate,,Brain,955.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),50597,Rattus norvegicus,14045,BAO_0000218,,1,1,,CHEMBL623976,,
14120,Intermediate,,Brain,955.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),50597,Rattus norvegicus,14045,BAO_0000218,,1,1,,CHEMBL623977,,
14121,Intermediate,,Brain,955.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),50597,Rattus norvegicus,14045,BAO_0000218,,1,1,,CHEMBL623978,,
14122,Intermediate,,Brain,955.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),50597,Rattus norvegicus,14045,BAO_0000218,,1,1,,CHEMBL623979,,
14123,Intermediate,,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),50597,Rattus norvegicus,14045,BAO_0000218,,1,1,,CHEMBL623980,,
14124,Intermediate,,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),50597,Rattus norvegicus,14045,BAO_0000218,,1,1,,CHEMBL623981,,
14125,Intermediate,,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),50597,Rattus norvegicus,14045,BAO_0000218,,1,1,,CHEMBL626278,,
14126,Intermediate,,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),50597,Rattus norvegicus,14045,BAO_0000218,,1,1,,CHEMBL626279,,
14127,Intermediate,,,,Biodistribution in mice bladder plus excreted urine was determined,50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626280,,
14128,Intermediate,,,,"Percentage biodistribution in mouse blood, 10 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626281,,
14129,Intermediate,,,,"Percentage biodistribution in mouse blood, 30 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626282,,
14130,Intermediate,,,,"Percentage biodistribution in mouse blood, 5 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626283,,
14131,Intermediate,,,,"Percentage biodistribution in mouse blood, 60 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626284,,
14132,Intermediate,,Brain,955.0,"Percentage biodistribution in mouse brain, 10 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626285,,
14133,Intermediate,,Brain,955.0,"Percentage biodistribution in mouse brain, 30 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626286,,
14134,Intermediate,,Brain,955.0,"Percentage biodistribution in mouse brain, 5 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626287,,
14135,Intermediate,,Brain,955.0,"Percentage biodistribution in mouse brain, 60 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626288,,
14136,Intermediate,,,,"Percentage biodistribution in mouse heart, 10 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626289,,
14137,Intermediate,,,,"Percentage biodistribution in mouse heart, 30 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626290,,
14138,Intermediate,,,,"Percentage biodistribution in mouse heart, 5 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626291,,
14139,Intermediate,,,,"Percentage biodistribution in mouse heart, 60 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL839888,,
14140,Intermediate,,Intestine,160.0,"Percentage biodistribution in mouse intestine, 10 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626292,,
14141,Intermediate,,Intestine,160.0,"Percentage biodistribution in mouse intestine, 30 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626293,,
14142,Intermediate,,Intestine,160.0,"Percentage biodistribution in mouse intestine, 5 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626294,,
14143,Intermediate,,Intestine,160.0,"Percentage biodistribution in mouse intestine, 60 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL626295,,
14144,Intermediate,,Liver,2107.0,"Percentage biodistribution in mouse liver, 10 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL627659,,
14145,Intermediate,,Liver,2107.0,"Percentage biodistribution in mouse liver, 30 minutes of post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL627660,,
14146,Intermediate,,Liver,2107.0,"Percentage biodistribution in mouse liver, 5 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL627661,,
14147,Intermediate,,Liver,2107.0,Biodistribution in mice liver at 60 minutes of post injection,50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL627662,,
14148,Intermediate,,Lung,2048.0,Biodistribution in mice lungs at 10 min of post injection,50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL627663,,
14149,Intermediate,,,,"Percentage biodistribution in mouse lung, 30 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL627664,,
14150,Intermediate,,,,"Percentage biodistribution in mousee lung, 5 minutes post injection",50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL627665,,
14151,Intermediate,,Lung,2048.0,Biodistribution in mice lungs at 60 min of post injection,50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL627666,,
14152,Intermediate,,Spleen,2106.0,Percentage biodistribution in mouse spleen,50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL627667,,
14153,Intermediate,,Stomach,945.0,Percentage biodistribution in mouse stomach,50594,Mus musculus,14045,BAO_0000218,,1,1,,CHEMBL627668,,
14154,Intermediate,,Urine,1088.0,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,50594,Mus musculus,11745,BAO_0000218,,1,1,,CHEMBL627669,,
14155,Autocuration,,Urinary bladder,1255.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,22224,,13257,BAO_0000218,,0,1,,CHEMBL627670,,
14156,Autocuration,,Blood,178.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,22224,,13257,BAO_0000218,,0,1,,CHEMBL627671,,
14157,Autocuration,,Bone element,1474.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,22224,,13257,BAO_0000218,,0,1,,CHEMBL627672,,
14158,Autocuration,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,22224,,13257,BAO_0000218,,0,1,,CHEMBL627673,,
14159,Autocuration,,Kidney,2113.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,22224,,13257,BAO_0000218,,0,1,,CHEMBL627674,,
14160,Autocuration,,Liver,2107.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,22224,,13257,BAO_0000218,,0,1,,CHEMBL627675,,
14161,Autocuration,,Lung,2048.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,22224,,13257,BAO_0000218,,0,1,,CHEMBL627676,,
14162,Autocuration,,Muscle tissue,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,22224,,13257,BAO_0000218,,0,1,,CHEMBL627677,,
14163,Autocuration,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL627678,,
14164,Intermediate,,Serum,1977.0,Affinity for protein binding expressed as association constant in fresh rat serum,50597,Rattus norvegicus,7095,BAO_0000218,,1,1,,CHEMBL627679,,
14165,Autocuration,,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,22224,,12185,BAO_0000019,,0,1,,CHEMBL627680,,
14166,Autocuration,,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,22224,,12185,BAO_0000019,,0,1,,CHEMBL627681,,
14167,Autocuration,,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,22224,,12185,BAO_0000019,,0,1,,CHEMBL627682,,
14168,Autocuration,,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,22224,,12185,BAO_0000019,,0,1,,CHEMBL627683,,
14169,Autocuration,,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,22224,,12686,BAO_0000019,,0,1,,CHEMBL627684,,
14170,Autocuration,,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",22224,,12686,BAO_0000019,,0,1,,CHEMBL874441,,
14171,Autocuration,,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,22224,,12686,BAO_0000019,,0,1,,CHEMBL627685,,
14172,Autocuration,,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",22224,,12686,BAO_0000019,,0,1,,CHEMBL627686,,
14173,Autocuration,,,,Apparent rate constant Koff for inactivation of dTMP synthase.,22224,,8057,BAO_0000019,,0,1,,CHEMBL627687,,
14174,Autocuration,,,,The irreversible inhibitor activity by second order rate equation.,22224,,15778,BAO_0000019,,0,1,,CHEMBL627688,,
14175,Intermediate,,,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,50597,Rattus norvegicus,12375,BAO_0000218,,1,1,,CHEMBL628038,,
14176,Intermediate,,,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,50597,Rattus norvegicus,12375,BAO_0000218,,1,1,,CHEMBL628039,,
14177,Intermediate,,,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,50597,Rattus norvegicus,12375,BAO_0000218,,1,1,,CHEMBL628040,,
14178,Autocuration,,,,Dissociation rate calculated from the first-order equation using t1/2 value,22224,,13588,BAO_0000019,,0,1,,CHEMBL628041,,
14179,Autocuration,,,,The compound was tested for Binding constant against DNA,22224,,15039,BAO_0000019,,0,1,,CHEMBL630226,,
14180,Autocuration,,,,First order rate constant for cyclization of the compound,22224,,9500,BAO_0000019,,0,1,,CHEMBL628042,,
14181,Autocuration,,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,22224,,10014,BAO_0000019,,0,1,,CHEMBL625232,,
14182,Autocuration,,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,22224,,10014,BAO_0000019,,0,1,,CHEMBL625233,,
14183,Autocuration,,,,Hydrolysis rate constant was determined,22224,,568,BAO_0000019,,0,1,,CHEMBL625979,,
14184,Autocuration,,,,Observed first order rate constant,22224,,10026,BAO_0000019,,0,1,,CHEMBL625980,,
14185,Autocuration,,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,22224,,10281,BAO_0000019,,0,1,,CHEMBL625981,,
14186,Autocuration,,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,22224,,10281,BAO_0000019,,0,1,,CHEMBL625982,,
14187,Autocuration,,,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,22224,,9680,BAO_0000019,,0,1,,CHEMBL625983,,
14188,Autocuration,,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL625984,,
14189,Autocuration,,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL625985,,
14190,Autocuration,,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL625986,,
14191,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL625987,,
14192,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL625988,,
14193,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL625989,,
14194,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL625990,,
14195,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL625991,,
14196,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL625992,,
14197,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL625993,,
14198,Autocuration,,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL631973,,
14199,Autocuration,,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL632143,,
14200,Autocuration,,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL632144,,
14201,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL632145,,
14202,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL632146,,
14203,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL632147,,
14204,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL632148,,
14205,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL632149,,
14206,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL632150,,
14207,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL632151,,
14208,Intermediate,,,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,50587,Homo sapiens,3008,BAO_0000218,,1,1,,CHEMBL632152,,
14209,Intermediate,,,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,50587,Homo sapiens,4509,BAO_0000218,,1,1,,CHEMBL632153,,
14210,Intermediate,,,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,50587,Homo sapiens,4509,BAO_0000218,,1,1,,CHEMBL632154,,
14211,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL632155,,
14212,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL632156,,
14213,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL632157,,
14214,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL632158,,
14215,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL632159,,
14216,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL626305,,
14217,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL626306,,
14218,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL626307,,
14219,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL626308,,
14220,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL626479,,
14221,Intermediate,,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,50602,Human herpesvirus 1,8613,BAO_0000218,,1,1,,CHEMBL626480,,
14222,Autocuration,,,,Calculated partition coefficient (clogP) (MlogP),22229,,6021,BAO_0000100,,0,1,,CHEMBL626481,,
14223,Autocuration,,,,Equipotent potent ratio relative to carbachol (nicotinic activity),22224,,9348,BAO_0000019,,0,1,,CHEMBL626482,,
14224,Intermediate,,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",50588,Canis lupus familiaris,15592,BAO_0000218,,1,1,,CHEMBL626483,,
14225,Intermediate,,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",50588,Canis lupus familiaris,15592,BAO_0000218,,1,1,,CHEMBL626484,,
14226,Autocuration,,,,Solubility at pH 7.4 in micro g/mL;NA denotes available,22229,,15592,BAO_0000100,,0,1,,CHEMBL626485,,
14227,Autocuration,,,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,22229,,15592,BAO_0000100,,0,1,,CHEMBL626486,,
14228,Autocuration,,,,Solubility at pH 7.4 in ug/mL;NA denotes not available,22229,,15592,BAO_0000100,,0,1,,CHEMBL626487,,
14229,Intermediate,,Plasma,1969.0,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,50588,Canis lupus familiaris,15592,BAO_0000218,,1,1,,CHEMBL626488,,
14230,Intermediate,,Serum,1977.0,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,50597,Rattus norvegicus,7095,BAO_0000218,,1,1,,CHEMBL626489,,
14231,Autocuration,,,,Area under the MAP curve measured over 5 min; ND means Not determined,22224,,16618,BAO_0000019,,0,1,,CHEMBL626490,,
14232,Autocuration,,,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,22224,,16835,BAO_0000100,,0,1,,CHEMBL626491,,
14233,Autocuration,,,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,22229,,15284,BAO_0000100,,0,1,,CHEMBL626492,,
14234,Autocuration,,,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,22224,,15750,BAO_0000019,,0,1,,CHEMBL626493,,
14235,Intermediate,,,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,50597,Rattus norvegicus,16618,BAO_0000218,,1,1,,CHEMBL626494,,
14236,Autocuration,,,,Half life after oral tested,22224,,16618,BAO_0000218,,0,1,,CHEMBL626495,,
14237,Intermediate,,Plasma,1969.0,Half life was determined in plasma of rat; NT indicates not tested,50597,Rattus norvegicus,15812,BAO_0000218,,1,1,,CHEMBL626496,,
14238,Intermediate,,,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,50597,Rattus norvegicus,16618,BAO_0000218,,1,1,,CHEMBL626497,,
14239,Autocuration,,,,Oral bioavailability after oral tested,22224,,16618,BAO_0000218,,0,1,,CHEMBL626498,,
14240,Intermediate,,,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),50597,Rattus norvegicus,13098,BAO_0000218,,1,1,,CHEMBL626499,,
14241,Intermediate,,,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),50597,Rattus norvegicus,13098,BAO_0000218,,1,1,,CHEMBL626500,,
14242,Intermediate,,Plasma,1969.0,half life was determined in plasma of rat; NT indicates not tested,50597,Rattus norvegicus,15812,BAO_0000218,,1,1,,CHEMBL626501,,
14243,Intermediate,,Plasma,1969.0,half life was determined in plasma of rat; NT means not tested,50597,Rattus norvegicus,15812,BAO_0000218,,1,1,,CHEMBL626502,,
14244,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626503,,
14245,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626504,,
14246,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626505,,
14247,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626506,,
14248,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626507,,
14249,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626508,,
14250,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626509,,
14251,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL875480,,
14252,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626510,,
14253,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626511,,
14254,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL626512,,
14255,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL628208,,
14256,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL628209,,
14257,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL628210,,
14258,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL628211,,
14259,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL628212,,
14260,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL628213,,
14261,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628214,,
14262,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628215,,
14263,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628216,,
14264,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626595,,
14265,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626596,,
14266,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626597,,
14267,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626598,,
14268,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL622242,,
14269,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL622243,,
14270,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL622244,,
14271,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL622245,,
14272,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL622246,,
14273,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL622247,,
14274,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL622248,,
14275,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL877483,,
14276,Intermediate,,Urine,1088.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL622249,,
14277,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL622250,,
14278,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL622251,,
14279,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL622252,,
14280,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL622253,,
14281,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL622254,,
14282,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL622255,,
14283,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL622256,,
14284,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL622257,,
14285,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL622258,,
14286,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL622259,,
14287,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL622927,,
14288,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL622928,,
14289,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL622929,,
14290,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL623182,,
14291,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL623183,,
14292,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623184,,
14293,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623185,,
14294,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL877484,,
14295,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL627274,,
14296,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623186,,
14297,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623187,,
14298,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL623188,,
14299,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628055,,
14300,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628056,,
14301,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628200,,
14302,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628201,,
14303,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628202,,
14304,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628203,,
14305,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628204,,
14306,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628205,,
14307,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628206,,
14308,Autocuration,,Prostate gland,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),22224,,13257,BAO_0000218,,0,1,,CHEMBL628207,,
14309,Autocuration,,Prostate gland,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,22224,,13257,BAO_0000218,,0,1,,CHEMBL627220,,
14310,Autocuration,,Muscle tissue,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,22224,,13257,BAO_0000218,,0,1,,CHEMBL627221,,
14311,Autocuration,,Prostate gland,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),22224,,13257,BAO_0000218,,0,1,,CHEMBL627222,,
14312,Autocuration,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,22224,,13257,BAO_0000218,,0,1,,CHEMBL627223,,
14313,Autocuration,,Muscle tissue,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,22224,,13257,BAO_0000218,,0,1,,CHEMBL632062,,
14314,Autocuration,,Spleen,2106.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,22224,,13257,BAO_0000218,,0,1,,CHEMBL632063,,
14315,Autocuration,,Urinary bladder,1255.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,22224,,13257,BAO_0000218,,0,1,,CHEMBL632064,,
14316,Autocuration,,Blood,178.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,22224,,13257,BAO_0000218,,0,1,,CHEMBL632065,,
14317,Autocuration,,Bone element,1474.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,22224,,13257,BAO_0000218,,0,1,,CHEMBL632066,,
14318,Autocuration,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,22224,,13257,BAO_0000218,,0,1,,CHEMBL632067,,
14319,Autocuration,,Kidney,2113.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,22224,,13257,BAO_0000218,,0,1,,CHEMBL629188,,
14320,Autocuration,,Liver,2107.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,22224,,13257,BAO_0000218,,0,1,,CHEMBL629189,,
14321,Autocuration,,Lung,2048.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,22224,,13257,BAO_0000218,,0,1,,CHEMBL629190,,
14322,Autocuration,,Muscle tissue,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,22224,,13257,BAO_0000218,,0,1,,CHEMBL629191,,
14323,Autocuration,,Prostate gland,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),22224,,13257,BAO_0000218,,0,1,,CHEMBL629192,,
14324,Autocuration,,Muscle tissue,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,22224,,13257,BAO_0000218,,0,1,,CHEMBL629193,,
14325,Autocuration,,Prostate gland,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),22224,,13257,BAO_0000218,,0,1,,CHEMBL629194,,
14326,Autocuration,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,22224,,13257,BAO_0000218,,0,1,,CHEMBL629195,,
14327,Autocuration,,Muscle tissue,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,22224,,13257,BAO_0000218,,0,1,,CHEMBL629373,,
14328,Autocuration,,Spleen,2106.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,22224,,13257,BAO_0000218,,0,1,,CHEMBL629374,,
14329,Autocuration,,Prostate gland,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,22224,,13257,BAO_0000218,,0,1,,CHEMBL629375,,
14330,Autocuration,,Urinary bladder,1255.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,22224,,13257,BAO_0000218,,0,1,,CHEMBL629376,,
14331,Autocuration,,Blood,178.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,22224,,13257,BAO_0000218,,0,1,,CHEMBL629377,,
14332,Autocuration,,Bone element,1474.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,22224,,13257,BAO_0000218,,0,1,,CHEMBL629378,,
14333,Autocuration,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,22224,,13257,BAO_0000218,,0,1,,CHEMBL629379,,
14334,Autocuration,,Kidney,2113.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,22224,,13257,BAO_0000218,,0,1,,CHEMBL629151,,
14335,Autocuration,,Liver,2107.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,22224,,13257,BAO_0000218,,0,1,,CHEMBL629152,,
14336,Autocuration,,Lung,2048.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,22224,,13257,BAO_0000218,,0,1,,CHEMBL629153,,
14337,Autocuration,,Muscle tissue,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,22224,,13257,BAO_0000218,,0,1,,CHEMBL629154,,
14338,Autocuration,,Prostate gland,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),22224,,13257,BAO_0000218,,0,1,,CHEMBL629155,,
14339,Autocuration,,Prostate gland,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,22224,,13257,BAO_0000218,,0,1,,CHEMBL629156,,
14340,Autocuration,,Muscle tissue,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,22224,,13257,BAO_0000218,,0,1,,CHEMBL629157,,
14341,Autocuration,,Prostate gland,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),22224,,13257,BAO_0000218,,0,1,,CHEMBL629158,,
14342,Autocuration,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,22224,,13257,BAO_0000218,,0,1,,CHEMBL629159,,
14343,Autocuration,,Muscle tissue,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,22224,,13257,BAO_0000218,,0,1,,CHEMBL629160,,
14344,Autocuration,,Spleen,2106.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,22224,,13257,BAO_0000218,,0,1,,CHEMBL629161,,
14345,Autocuration,,Urinary bladder,1255.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,22224,,13257,BAO_0000218,,0,1,,CHEMBL629162,,
14346,Autocuration,,Blood,178.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,22224,,13257,BAO_0000218,,0,1,,CHEMBL629163,,
14347,Autocuration,,Bone element,1474.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,22224,,13257,BAO_0000218,,0,1,,CHEMBL629164,,
14348,Autocuration,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,22224,,13257,BAO_0000218,,0,1,,CHEMBL629165,,
14349,Autocuration,,Liver,2107.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,22224,,13257,BAO_0000218,,0,1,,CHEMBL629166,,
14350,Autocuration,,Lung,2048.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,22224,,13257,BAO_0000218,,0,1,,CHEMBL629167,,
14351,Autocuration,,Muscle tissue,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,22224,,13257,BAO_0000218,,0,1,,CHEMBL629168,,
14352,Autocuration,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,22224,,2193,BAO_0000019,,0,1,,CHEMBL629169,,
14353,Autocuration,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,22224,,2193,BAO_0000019,,0,1,,CHEMBL629170,,
14354,Autocuration,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,22224,,2193,BAO_0000019,,0,1,,CHEMBL631153,,
14355,Autocuration,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,22224,,2193,BAO_0000019,,0,1,,CHEMBL875121,,
14356,Autocuration,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,22224,,2193,BAO_0000019,,0,1,,CHEMBL631154,,
14357,Autocuration,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,22224,,2193,BAO_0000019,,0,1,,CHEMBL631155,,
14358,Autocuration,,,,Hydrolysis rate constant was determined,22224,,568,BAO_0000019,,0,1,,CHEMBL631156,,
14359,Autocuration,,,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",22224,,9680,BAO_0000019,,0,1,,CHEMBL631157,,
14360,Autocuration,,,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",22224,,9680,BAO_0000019,,0,1,,CHEMBL631158,,
14361,Autocuration,,,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",22224,,9680,BAO_0000019,,0,1,,CHEMBL631159,,
14362,Autocuration,,,,Observed second order rate constant,22224,,10026,BAO_0000019,,0,1,,CHEMBL631160,,
14363,Autocuration,,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,22224,,10281,BAO_0000019,,0,1,,CHEMBL631161,,
14364,Autocuration,,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,22224,,10014,BAO_0000019,,0,1,,CHEMBL631162,,
14365,Autocuration,,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,22224,,10014,BAO_0000019,,0,1,,CHEMBL630313,,
14366,Autocuration,,,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",22224,,9680,BAO_0000019,,0,1,,CHEMBL630314,,
14367,Autocuration,,,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",22224,,9680,BAO_0000019,,0,1,,CHEMBL630315,,
14368,Autocuration,,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL630316,,
14369,Autocuration,,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL630986,,
14370,Autocuration,,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL630987,,
14371,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL630988,,
14372,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL630989,,
14373,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL630990,,
14374,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL630991,,
14375,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL630992,,
14376,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL630993,,
14377,Autocuration,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,22224,,13028,BAO_0000019,,0,1,,CHEMBL630994,,
14378,Intermediate,,,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,50597,Rattus norvegicus,10014,BAO_0000218,,1,1,,CHEMBL630995,,
14379,Autocuration,,,,Association constant for compound at 31 degree C was determined,22224,,9962,BAO_0000019,,0,1,,CHEMBL629252,,
14380,Autocuration,,,,Calculated antagonist equilibrium dissociation constant of the compound,22224,,12029,BAO_0000019,,0,1,,CHEMBL629253,,
14381,Autocuration,,,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,22224,,12029,BAO_0000019,,0,1,,CHEMBL629944,,
14382,Intermediate,,Trachea,3126.0,Dissociation constants vs LTE4 on guinea pig trachea,50512,Cavia porcellus,10583,BAO_0000218,,1,1,,CHEMBL629945,,
14383,Autocuration,,,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",22224,,568,BAO_0000019,,0,1,,CHEMBL629946,,
14384,Autocuration,,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",22224,,568,BAO_0000019,,0,1,,CHEMBL629947,,
14385,Autocuration,,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",22224,,568,BAO_0000019,,0,1,,CHEMBL629948,,
14386,Autocuration,,,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",22224,,568,BAO_0000019,,0,1,,CHEMBL856024,,
14387,Autocuration,,,,Affinity constant KD value was derived from TMP,22224,,7493,BAO_0000019,,0,1,,CHEMBL629949,,
14388,Autocuration,,,,Apparent dissociation (binding) rate constant was evaluated,22224,,8371,BAO_0000019,,0,1,,CHEMBL629950,,
14389,Autocuration,,,,Dissociation constant (KD) of the compound,22224,,13114,BAO_0000100,,0,1,,CHEMBL630127,,
14390,Autocuration,,,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,22224,,15515,BAO_0000100,,0,1,,CHEMBL630128,,
14391,Autocuration,,,,Dissociation constant from ESR titration experiments,22224,,522,BAO_0000100,,0,1,,CHEMBL630129,,
14392,Autocuration,,,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),22224,,13888,BAO_0000019,,0,1,,CHEMBL630130,,
14393,Autocuration,,,,Dissociation constant was evaluated.,22224,,2616,BAO_0000100,,0,1,,CHEMBL875234,,
14394,Autocuration,,,,Dissociation constant was reported,22224,,3798,BAO_0000100,,0,1,,CHEMBL630131,,
14395,Intermediate,,,,Dissociation constant was determined in rat pituitary cells.,50597,Rattus norvegicus,8731,BAO_0000218,,1,1,,CHEMBL630132,,
14396,Autocuration,,,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,22224,,11892,BAO_0000019,,0,1,,CHEMBL630133,,
14397,Autocuration,,,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,22224,,11892,BAO_0000019,,0,1,,CHEMBL630134,,
14398,Autocuration,,,,Equilibrium dissociation constant of the compound,22224,,2582,BAO_0000019,,0,1,,CHEMBL630135,,
14399,Autocuration,,,,Equilibrium dissociation constant was determined,22224,,11892,BAO_0000019,,0,1,,CHEMBL630136,,
14400,Autocuration,,,,Kinetic constant KD was evaluated,22224,,13396,BAO_0000019,,0,1,,CHEMBL630137,,
14401,Autocuration,,,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,22224,,603,BAO_0000019,,0,1,,CHEMBL630138,,
14402,Autocuration,,,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,22224,,15673,BAO_0000019,,0,1,,CHEMBL630139,,
14403,Autocuration,,,,Rate constant for hydrolysis in aqueous acetone.,22224,,10368,BAO_0000019,,0,1,,CHEMBL630140,,
14404,Autocuration,,,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,22224,,14228,BAO_0000019,,0,1,,CHEMBL875235,,
14405,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL876439,,
14406,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL630605,,
14407,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL630606,,
14408,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL630607,,
14409,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL630608,,
14410,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL630609,,
14411,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL630610,,
14412,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL630611,,
14413,Intermediate,,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629552,,
14414,Intermediate,,,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629733,,
14415,Intermediate,,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629734,,
14416,Intermediate,,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629735,,
14417,Intermediate,,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629736,,
14418,Intermediate,,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629737,,
14419,Intermediate,,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629738,,
14420,Intermediate,,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629739,,
14421,Intermediate,,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629740,,
14422,Intermediate,,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629741,,
14423,Intermediate,,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629742,,
14424,Intermediate,,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629743,,
14425,Intermediate,,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629744,,
14426,Intermediate,,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629745,,
14427,Intermediate,,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629746,,
14428,Intermediate,,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629747,,
14429,Intermediate,,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629748,,
14430,Intermediate,,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629749,,
14431,Intermediate,,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629750,,
14432,Intermediate,,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629751,,
14433,Intermediate,,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629752,,
14434,Intermediate,,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629753,,
14435,Intermediate,,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629754,,
14436,Intermediate,,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629755,,
14437,Intermediate,,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629756,,
14438,Intermediate,,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629757,,
14439,Intermediate,,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629758,,
14440,Intermediate,,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629759,,
14441,Intermediate,,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL629760,,
14442,Intermediate,,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,50597,Rattus norvegicus,11510,BAO_0000218,,1,1,,CHEMBL876443,,
14443,Intermediate,,,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,50588,Canis lupus familiaris,8310,BAO_0000218,,1,1,,CHEMBL629761,,
14444,Intermediate,,,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,50588,Canis lupus familiaris,8310,BAO_0000218,,1,1,,CHEMBL629762,,
14445,Intermediate,,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,50594,Mus musculus,8310,BAO_0000218,,1,1,,CHEMBL629763,,
14446,Intermediate,,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,50594,Mus musculus,8310,BAO_0000218,,1,1,,CHEMBL629764,,
14447,Intermediate,,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,50594,Mus musculus,8310,BAO_0000218,,1,1,,CHEMBL629765,,
14448,Intermediate,,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,50594,Mus musculus,8310,BAO_0000218,,1,1,,CHEMBL629766,,
14449,Intermediate,,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,50594,Mus musculus,8310,BAO_0000218,,1,1,,CHEMBL629767,,
14450,Intermediate,,,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,50588,Canis lupus familiaris,8310,BAO_0000218,,1,1,,CHEMBL629768,,
14451,Intermediate,,,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,50594,Mus musculus,8310,BAO_0000218,,1,1,,CHEMBL629769,,
14452,Intermediate,,,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,50588,Canis lupus familiaris,8310,BAO_0000218,,1,1,,CHEMBL629770,,
14453,Intermediate,,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,50588,Canis lupus familiaris,8310,BAO_0000218,,1,1,,CHEMBL629771,,
14454,Intermediate,,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,50594,Mus musculus,8310,BAO_0000218,,1,1,,CHEMBL629772,,
14455,Intermediate,,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,50594,Mus musculus,8310,BAO_0000218,,1,1,,CHEMBL629773,,
14456,Intermediate,,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,50594,Mus musculus,8310,BAO_0000218,,1,1,,CHEMBL625455,,
14457,Intermediate,,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,50594,Mus musculus,8310,BAO_0000218,,1,1,,CHEMBL625456,,
14458,Intermediate,,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,50594,Mus musculus,8310,BAO_0000218,,1,1,,CHEMBL625457,,
14459,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL625458,,
14460,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL625459,,
14461,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL875483,,
14462,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL634779,,
14463,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL625460,,
14464,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626117,,
14465,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626118,,
14466,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628342,,
14467,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628343,,
14468,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628344,,
14469,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628345,,
14470,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628346,,
14471,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628347,,
14472,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628348,,
14473,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628349,,
14474,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL875611,,
14475,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628350,,
14476,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628351,,
14477,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628352,,
14478,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628353,,
14479,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628354,,
14480,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626667,,
14481,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626668,,
14482,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626669,,
14483,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626670,,
14484,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626671,,
14485,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626672,,
14486,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626673,,
14487,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626674,,
14488,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626675,,
14489,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626676,,
14490,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626677,,
14491,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626678,,
14492,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626679,,
14493,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL875612,,
14494,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626680,,
14495,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626681,,
14496,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626682,,
14497,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626683,,
14498,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626684,,
14499,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626685,,
14500,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626686,,
14501,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626687,,
14502,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL624978,,
14503,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL624979,,
14504,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL624980,,
14505,Intermediate,,Urine,1088.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL624981,,
14506,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL624982,,
14507,Autocuration,,Prostate gland,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),22224,,13257,BAO_0000218,,0,1,,CHEMBL627564,,
14508,Autocuration,,Prostate gland,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),22224,,13257,BAO_0000218,,0,1,,CHEMBL627565,,
14509,Autocuration,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,22224,,13257,BAO_0000218,,0,1,,CHEMBL627566,,
14510,Autocuration,,Muscle tissue,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,22224,,13257,BAO_0000218,,0,1,,CHEMBL627567,,
14511,Autocuration,,Spleen,2106.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,22224,,13257,BAO_0000218,,0,1,,CHEMBL627568,,
14512,Autocuration,,Kidney,2113.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,22224,,13257,BAO_0000218,,0,1,,CHEMBL627569,,
14513,Autocuration,,Urinary bladder,1255.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,22224,,13257,BAO_0000218,,0,1,,CHEMBL627570,,
14514,Autocuration,,Blood,178.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,22224,,13257,BAO_0000218,,0,1,,CHEMBL627571,,
14515,Autocuration,,Bone element,1474.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,22224,,13257,BAO_0000218,,0,1,,CHEMBL627572,,
14516,Autocuration,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,22224,,13257,BAO_0000218,,0,1,,CHEMBL627573,,
14517,Autocuration,,Kidney,2113.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,22224,,13257,BAO_0000218,,0,1,,CHEMBL627574,,
14518,Autocuration,,Liver,2107.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,22224,,13257,BAO_0000218,,0,1,,CHEMBL627575,,
14519,Autocuration,,Lung,2048.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,22224,,13257,BAO_0000218,,0,1,,CHEMBL627576,,
14520,Autocuration,,Muscle tissue,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,22224,,13257,BAO_0000218,,0,1,,CHEMBL627577,,
14521,Autocuration,,Prostate gland,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),22224,,13257,BAO_0000218,,0,1,,CHEMBL627578,,
14522,Autocuration,,Prostate gland,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,22224,,13257,BAO_0000218,,0,1,,CHEMBL627579,,
14523,Autocuration,,Muscle tissue,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,22224,,13257,BAO_0000218,,0,1,,CHEMBL627580,,
14524,Autocuration,,Prostate gland,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),22224,,13257,BAO_0000218,,0,1,,CHEMBL627581,,
14525,Autocuration,,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,22224,,13257,BAO_0000218,,0,1,,CHEMBL627582,,
14526,Autocuration,,Muscle tissue,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,22224,,13257,BAO_0000218,,0,1,,CHEMBL627583,,
14527,Autocuration,,Spleen,2106.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,22224,,13257,BAO_0000218,,0,1,,CHEMBL627584,,
14528,Autocuration,,Prostate gland,2367.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,22224,,13257,BAO_0000218,,0,1,,CHEMBL627585,,
14529,Autocuration,,Muscle tissue,2385.0,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,22224,,13257,BAO_0000218,,0,1,,CHEMBL627586,,
14530,Intermediate,,,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL627587,,
14531,Intermediate,,,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL627588,,
14532,Intermediate,,,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL628250,,
14533,Intermediate,,,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL628251,,
14534,Intermediate,,Hippocampus,10000000.0,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL628252,,
14535,Intermediate,,Hippocampus,10000000.0,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL628253,,
14536,Intermediate,,Hypothalamus,1898.0,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL628254,,
14537,Intermediate,,Hypothalamus,1898.0,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL877493,,
14538,Intermediate,,,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL628255,,
14539,Intermediate,,,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL628256,,
14540,Intermediate,,Hippocampus,10000000.0,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL628257,,
14541,Intermediate,,Hypothalamus,1898.0,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL628258,,
14542,Intermediate,,,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL628259,,
14543,Intermediate,,,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL628429,,
14544,Intermediate,,Hippocampus,10000000.0,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL626862,,
14545,Intermediate,,Hypothalamus,1898.0,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL626863,,
14546,Intermediate,,Cerebellum,2037.0,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL625886,,
14547,Intermediate,,Cerebellum,2037.0,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL625887,,
14548,Intermediate,,,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL625888,,
14549,Intermediate,,,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL625889,,
14550,Intermediate,,Hippocampus,10000000.0,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL625890,,
14551,Intermediate,,Hippocampus,10000000.0,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL625891,,
14552,Intermediate,,Hypothalamus,1898.0,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL625892,,
14553,Intermediate,,Hypothalamus,1898.0,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL625893,,
14554,Intermediate,,Cerebellum,2037.0,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL625894,,
14555,Intermediate,,,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL625895,,
14556,Autocuration,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,22224,,12404,BAO_0000019,,0,1,,CHEMBL625896,,
14557,Autocuration,,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",22224,,568,BAO_0000019,,0,1,,CHEMBL625897,,
14558,Autocuration,,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",22224,,568,BAO_0000019,,0,1,,CHEMBL625898,,
14559,Autocuration,,,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",22224,,568,BAO_0000019,,0,1,,CHEMBL625899,,
14560,Autocuration,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,22224,,12404,BAO_0000019,,0,1,,CHEMBL626124,,
14561,Intermediate,,,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,50212,Escherichia coli,7624,BAO_0000218,,1,1,,CHEMBL628500,,
14562,Intermediate,,,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",50597,Rattus norvegicus,7624,BAO_0000218,,1,1,,CHEMBL857856,,
14563,Intermediate,,,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",50597,Rattus norvegicus,7624,BAO_0000218,,1,1,,CHEMBL628501,,
14564,Autocuration,,,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",22224,,4643,BAO_0000019,,0,1,,CHEMBL628502,,
14565,Autocuration,,,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,22224,,11532,BAO_0000019,,0,1,,CHEMBL628503,,
14566,Autocuration,,,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,22224,,11018,BAO_0000019,,0,1,,CHEMBL628504,,
14567,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",22224,,2276,BAO_0000019,,0,1,,CHEMBL628505,,
14568,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",22224,,2276,BAO_0000019,,0,1,,CHEMBL874452,,
14569,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",22224,,2276,BAO_0000019,,0,1,,CHEMBL628506,,
14570,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",22224,,2276,BAO_0000019,,0,1,,CHEMBL628507,,
14571,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",22224,,2276,BAO_0000019,,0,1,,CHEMBL628508,,
14572,Autocuration,,,,Michaelis constant (KM) was evaluated,22224,,8949,BAO_0000019,,0,1,,CHEMBL628509,,
14573,Autocuration,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,22224,,12404,BAO_0000019,,0,1,,CHEMBL628510,,
14574,Autocuration,,,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,22224,,7625,BAO_0000019,,0,1,,CHEMBL628511,,
14575,Autocuration,,,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,22224,,7625,BAO_0000019,,0,1,,CHEMBL628512,,
14576,Autocuration,,,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,22224,,7625,BAO_0000019,,0,1,,CHEMBL628513,,
14577,Autocuration,,,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,22224,,7625,BAO_0000019,,0,1,,CHEMBL628514,,
14578,Autocuration,,,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,22224,,12908,BAO_0000019,,0,1,,CHEMBL628515,,
14579,Autocuration,,,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,22224,,10368,BAO_0000019,,0,1,,CHEMBL628516,,
14580,Autocuration,,,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),22224,,13108,BAO_0000019,,0,1,,CHEMBL628517,,
14581,Autocuration,,,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),22224,,13108,BAO_0000019,,0,1,,CHEMBL628518,,
14582,Autocuration,,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,22224,,15217,BAO_0000019,,0,1,,CHEMBL628519,,
14583,Autocuration,,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,22224,,15217,BAO_0000019,,0,1,,CHEMBL628520,,
14584,Autocuration,,,,Binding constant was determined,22224,,10933,BAO_0000019,,0,1,,CHEMBL628521,,
14585,Autocuration,,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,22224,,2363,BAO_0000019,,0,1,,CHEMBL630443,,
14586,Autocuration,,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,22224,,2363,BAO_0000019,,0,1,,CHEMBL630444,,
14587,Autocuration,,,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,22224,,2276,BAO_0000019,,0,1,,CHEMBL857732,,
14588,Autocuration,,,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,22224,,14915,BAO_0000100,,0,1,,CHEMBL630445,,
14589,Autocuration,,,,Catalytic rate constant of the compound,22224,,8847,BAO_0000019,,0,1,,CHEMBL630446,,
14590,Autocuration,,,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,22224,,15357,BAO_0000019,,0,1,,CHEMBL630447,,
14591,Autocuration,,,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),22224,,2869,BAO_0000019,,0,1,,CHEMBL630448,,
14592,Autocuration,,,,Catalytic rate constant against phospholipase A2 was determined,22224,,3484,BAO_0000019,,0,1,,CHEMBL630449,,
14593,Autocuration,,,,"Compound was evaluated for catalytic constant, Kcat",22224,,1373,BAO_0000019,,0,1,,CHEMBL630450,,
14594,Autocuration,,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,22224,,8142,BAO_0000019,,0,1,,CHEMBL630451,,
14595,Autocuration,,,,Kcat calculated from 0.693/T1/2,22224,,14131,BAO_0000019,,0,1,,CHEMBL630452,,
14596,Autocuration,,,,Kcat was determined,22224,,17269,BAO_0000019,,0,1,,CHEMBL630453,,
14597,Autocuration,,,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,22224,,3485,BAO_0000019,,0,1,,CHEMBL630454,,
14598,Autocuration,,,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,22224,,3485,BAO_0000019,,0,1,,CHEMBL630455,,
14599,Autocuration,,,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,22224,,3485,BAO_0000019,,0,1,,CHEMBL631487,,
14600,Autocuration,,,,Kcat value was determined,22224,,5962,BAO_0000019,,0,1,,CHEMBL631488,,
14601,Autocuration,,,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,22224,,3133,BAO_0000019,,0,1,,CHEMBL876440,,
14602,Autocuration,,,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,22224,,3133,BAO_0000019,,0,1,,CHEMBL631489,,
14603,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",22224,,2276,BAO_0000019,,0,1,,CHEMBL857742,,
14604,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",22224,,2276,BAO_0000019,,0,1,,CHEMBL631490,,
14605,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",22224,,2276,BAO_0000019,,0,1,,CHEMBL631491,,
14606,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",22224,,2276,BAO_0000019,,0,1,,CHEMBL631492,,
14607,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",22224,,2276,BAO_0000019,,0,1,,CHEMBL631493,,
14608,Autocuration,,,,Kinetic parameter for rate of conversion to PABA was determined,22224,,4892,BAO_0000019,,0,1,,CHEMBL631494,,
14609,Autocuration,,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,22224,,3133,BAO_0000019,,0,1,,CHEMBL631495,,
14610,Intermediate,,Feces,1988.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL631496,,
14611,Intermediate,,Urine,1088.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL631497,,
14612,Intermediate,,Urine,1088.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL631498,,
14613,Intermediate,,Urine,1088.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL629776,,
14614,Intermediate,,Urine,1088.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL629777,,
14615,Intermediate,,Urine,1088.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL629778,,
14616,Intermediate,,,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630456,,
14617,Intermediate,,,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630457,,
14618,Intermediate,,,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630458,,
14619,Intermediate,,,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630459,,
14620,Intermediate,,,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630460,,
14621,Intermediate,,,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL876550,,
14622,Intermediate,,,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630461,,
14623,Intermediate,,,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630462,,
14624,Intermediate,,,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630463,,
14625,Intermediate,,,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630464,,
14626,Intermediate,,,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630465,,
14627,Intermediate,,,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630466,,
14628,Intermediate,,,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630467,,
14629,Intermediate,,,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630633,,
14630,Intermediate,,,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630634,,
14631,Intermediate,,,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630635,,
14632,Intermediate,,,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630636,,
14633,Intermediate,,,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,50597,Rattus norvegicus,11488,BAO_0000218,,1,1,,CHEMBL630637,,
14634,Intermediate,,Feces,1988.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL630638,,
14635,Intermediate,,Feces,1988.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL630639,,
14636,Intermediate,,Feces,1988.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL630640,,
14637,Intermediate,,Feces,1988.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL876551,,
14638,Intermediate,,Urine,1088.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL630641,,
14639,Intermediate,,Urine,1088.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL630642,,
14640,Intermediate,,Urine,1088.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL630643,,
14641,Intermediate,,Urine,1088.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL630644,,
14642,Intermediate,,Urine,1088.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL630645,,
14643,Intermediate,,Feces,1988.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL625599,,
14644,Intermediate,,Feces,1988.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL625600,,
14645,Intermediate,,Feces,1988.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL625601,,
14646,Intermediate,,Feces,1988.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL625602,,
14647,Intermediate,,Urine,1088.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL627470,,
14648,Intermediate,,Urine,1088.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL627471,,
14649,Intermediate,,Urine,1088.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL627472,,
14650,Intermediate,,Urine,1088.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL627473,,
14651,Intermediate,,Urine,1088.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",50592,Oryctolagus cuniculus,7132,BAO_0000218,,1,1,,CHEMBL627474,,
14652,Intermediate,,Blood,178.0,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL627475,,
14653,Intermediate,,Blood,178.0,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL627476,,
14654,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627477,,
14655,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627478,,
14656,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627479,,
14657,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627480,,
14658,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627481,,
14659,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627482,,
14660,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL627483,,
14661,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL875636,,
14662,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL625764,,
14663,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL625765,,
14664,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL625766,,
14665,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL625767,,
14666,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL625768,,
14667,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL625769,,
14668,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL625770,,
14669,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL625771,,
14670,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL625772,,
14671,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,50588,Canis lupus familiaris,12582,BAO_0000218,,1,1,,CHEMBL625773,,
14672,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL625774,,
14673,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL625775,,
14674,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL625776,,
14675,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL625777,,
14676,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL625778,,
14677,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL625779,,
14678,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL625780,,
14679,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL625781,,
14680,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL875637,,
14681,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626473,,
14682,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626474,,
14683,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626475,,
14684,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626476,,
14685,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL634397,,
14686,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL626477,,
14687,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631069,,
14688,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631070,,
14689,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631071,,
14690,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631072,,
14691,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631073,,
14692,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631074,,
14693,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631075,,
14694,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631725,,
14695,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631726,,
14696,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631727,,
14697,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631728,,
14698,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631729,,
14699,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631730,,
14700,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631731,,
14701,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631910,,
14702,Intermediate,,Hippocampus,10000000.0,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL631911,,
14703,Intermediate,,Hypothalamus,1898.0,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL631912,,
14704,Intermediate,,Hypothalamus,1898.0,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,50597,Rattus norvegicus,15413,BAO_0000218,,1,1,,CHEMBL631913,,
14705,Intermediate,,Blood,178.0,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631914,,
14706,Intermediate,,Blood,178.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631915,,
14707,Intermediate,,Blood,178.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL875778,,
14708,Intermediate,,Blood,178.0,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631916,,
14709,Intermediate,,Blood,178.0,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631917,,
14710,Intermediate,,Blood,178.0,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631918,,
14711,Intermediate,,Blood,178.0,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631919,,
14712,Intermediate,,Blood,178.0,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631920,,
14713,Intermediate,,Blood,178.0,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631921,,
14714,Intermediate,,Blood,178.0,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631922,,
14715,Intermediate,,Blood,178.0,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631923,,
14716,Intermediate,,,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631924,,
14717,Intermediate,,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630234,,
14718,Intermediate,,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630235,,
14719,Intermediate,,,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630236,,
14720,Intermediate,,,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630237,,
14721,Intermediate,,,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630238,,
14722,Intermediate,,,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630239,,
14723,Intermediate,,,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630303,,
14724,Intermediate,,,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630304,,
14725,Intermediate,,,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630305,,
14726,Intermediate,,Kidney,2113.0,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630306,,
14727,Intermediate,,Kidney,2113.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630307,,
14728,Intermediate,,Kidney,2113.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630308,,
14729,Intermediate,,Kidney,2113.0,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630309,,
14730,Intermediate,,Kidney,2113.0,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL629309,,
14731,Intermediate,,Kidney,2113.0,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL629993,,
14732,Intermediate,,Kidney,2113.0,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL629994,,
14733,Intermediate,,Kidney,2113.0,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL629995,,
14734,Intermediate,,Kidney,2113.0,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631993,,
14735,Intermediate,,Kidney,2113.0,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631994,,
14736,Intermediate,,Kidney,2113.0,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631995,,
14737,Intermediate,,Liver,2107.0,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631996,,
14738,Intermediate,,Liver,2107.0,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631997,,
14739,Intermediate,,Liver,2107.0,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631998,,
14740,Intermediate,,Liver,2107.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631999,,
14741,Intermediate,,Liver,2107.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL632000,,
14742,Intermediate,,Liver,2107.0,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL632001,,
14743,Intermediate,,Liver,2107.0,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL874424,,
14744,Intermediate,,Liver,2107.0,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL632002,,
14745,Intermediate,,Liver,2107.0,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL632003,,
14746,Autocuration,,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,22224,,3133,BAO_0000019,,0,1,,CHEMBL632004,,
14747,Autocuration,,,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,22224,,2742,BAO_0000019,,0,1,,CHEMBL632005,,
14748,Autocuration,,,,Compound was tested for amidase rate in the presence of N62C screen enzyme,22224,,2742,BAO_0000019,,0,1,,CHEMBL632006,,
14749,Autocuration,,,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,22224,,2742,BAO_0000019,,0,1,,CHEMBL632007,,
14750,Autocuration,,,,Compound was tested for amidase rate in the presence of S166C screen enzyme,22224,,2742,BAO_0000019,,0,1,,CHEMBL632008,,
14751,Autocuration,,,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,22224,,2742,BAO_0000019,,0,1,,CHEMBL632009,,
14752,Autocuration,,,,Compound was tested for esterase rate in the presence of N62C screen enzyme,22224,,2742,BAO_0000019,,0,1,,CHEMBL632010,,
14753,Autocuration,,,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,22224,,2742,BAO_0000019,,0,1,,CHEMBL857750,,
14754,Autocuration,,,,Compound was tested for esterase rate in the presence of S166C screen enzyme,22224,,2742,BAO_0000019,,0,1,,CHEMBL632011,,
14755,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",22224,,2276,BAO_0000019,,0,1,,CHEMBL632012,,
14756,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",22224,,2276,BAO_0000019,,0,1,,CHEMBL632013,,
14757,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",22224,,2276,BAO_0000019,,0,1,,CHEMBL632014,,
14758,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",22224,,2276,BAO_0000019,,0,1,,CHEMBL629622,,
14759,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",22224,,2276,BAO_0000019,,0,1,,CHEMBL629623,,
14760,Autocuration,,,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",22224,,2276,BAO_0000019,,0,1,,CHEMBL629624,,
14761,Autocuration,,,,Ratio of Kcat to that of Km was determined,22224,,17269,BAO_0000019,,0,1,,CHEMBL629625,,
14762,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",22224,,2276,BAO_0000019,,0,1,,CHEMBL629626,,
14763,Autocuration,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",22224,,2276,BAO_0000019,,0,1,,CHEMBL629627,,
14764,Autocuration,,,,"Compound was evaluated for constant, Kd",22224,,15917,BAO_0000019,,0,1,,CHEMBL629628,,
14765,Autocuration,,,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,22224,,10933,BAO_0000019,,0,1,,CHEMBL629629,,
14766,Autocuration,,,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,22224,,10933,BAO_0000019,,0,1,,CHEMBL629630,,
14767,Autocuration,,,,Dissociation Constant of compound determined,22224,,14293,BAO_0000019,,0,1,,CHEMBL856030,,
14768,Autocuration,,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,22224,,6698,BAO_0000019,,0,1,,CHEMBL629631,,
14769,Autocuration,,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,22224,,6698,BAO_0000019,,0,1,,CHEMBL629632,,
14770,Autocuration,,,,Dissociation constant of compound with Fructose was determined,22224,,4318,BAO_0000100,,0,1,,CHEMBL629633,,
14771,Autocuration,,,,Dissociation constant of compound with Fructose was determined; Not determined,22224,,4318,BAO_0000100,,0,1,,CHEMBL629634,,
14772,Autocuration,,,,Dissociation constant of compound with Lactulose was determined,22224,,4318,BAO_0000100,,0,1,,CHEMBL629635,,
14773,Autocuration,,,,Dissociation constant of compound with Lactulose was determined; Not determined,22224,,4318,BAO_0000100,,0,1,,CHEMBL629636,,
14774,Autocuration,,,,Dissociation constant of the Compound,22224,,14959,BAO_0000100,,0,1,,CHEMBL629637,,
14775,Autocuration,,,,Dissociation constant by non-linear regression analysis,22224,,5913,BAO_0000100,,0,1,,CHEMBL629638,,
14776,Autocuration,,,,Dissociation constant was determined,22224,,14218,BAO_0000100,,0,1,,CHEMBL629639,,
14777,Autocuration,,,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,22224,,10689,BAO_0000100,,0,1,,CHEMBL629640,,
14778,Autocuration,,,,Dissociation constant was determined,22224,,13925,BAO_0000100,,0,1,,CHEMBL629641,,
14779,Autocuration,,,,Dissociation constant was determined,22224,,16359,BAO_0000100,,0,1,,CHEMBL631344,,
14780,Intermediate,,Muscle tissue,2385.0,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,50597,Rattus norvegicus,10944,BAO_0000218,,1,1,,CHEMBL631345,,
14781,Autocuration,,,,The dissociation constant determined by fluorescence displacement assay,22224,,11080,BAO_0000019,,0,1,,CHEMBL631346,,
14782,Autocuration,,,,kd value surface plasmon resonance (SPR) method,22224,,17805,BAO_0000019,,0,1,,CHEMBL631524,,
14783,Intermediate,,Muscle tissue,2385.0,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,50597,Rattus norvegicus,10944,BAO_0000218,,1,1,,CHEMBL631525,,
14784,Autocuration,,,,First dissociation constant of the binding of compound to V30M TTR,22224,,16645,BAO_0000019,,0,1,,CHEMBL631526,,
14785,Autocuration,,,,Second dissociation constant of the binding of compound to V30M TTR,22224,,16645,BAO_0000019,,0,1,,CHEMBL631527,,
14786,Autocuration,,,,"Compound was evaluated for equilibrium constant, Ke",22224,,7793,BAO_0000019,,0,1,,CHEMBL631528,,
14787,Autocuration,,Hypothalamus,1898.0,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,22224,,12199,BAO_0000019,,0,1,,CHEMBL631529,,
14788,Autocuration,,Hypothalamus,1898.0,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,22224,,12199,BAO_0000019,,0,1,,CHEMBL631530,,
14789,Autocuration,,,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,22224,,9680,BAO_0000019,,0,1,,CHEMBL631531,,
14790,Autocuration,,,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,22224,,9680,BAO_0000019,,0,1,,CHEMBL631532,,
14791,Autocuration,,,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,22224,,9680,BAO_0000019,,0,1,,CHEMBL631533,,
14792,Intermediate,,,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,50594,Mus musculus,13758,BAO_0000218,,1,1,,CHEMBL876552,,
14793,Intermediate,,,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,50594,Mus musculus,13758,BAO_0000218,,1,1,,CHEMBL631534,,
14794,Intermediate,,,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,50594,Mus musculus,13758,BAO_0000218,,1,1,,CHEMBL631535,,
14795,Intermediate,,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,50594,Mus musculus,13758,BAO_0000218,,1,1,,CHEMBL631536,,
14796,Intermediate,,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,50594,Mus musculus,13758,BAO_0000218,,1,1,,CHEMBL631537,,
14797,Intermediate,,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,50594,Mus musculus,13758,BAO_0000218,,1,1,,CHEMBL631538,,
14798,Intermediate,,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,50594,Mus musculus,13758,BAO_0000218,,1,1,,CHEMBL631539,,
14799,Intermediate,,,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,50594,Mus musculus,13758,BAO_0000218,,1,1,,CHEMBL631540,,
14800,Intermediate,,,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,50597,Rattus norvegicus,14393,BAO_0000218,,1,1,,CHEMBL625637,,
14801,Intermediate,,,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,50597,Rattus norvegicus,14393,BAO_0000218,,1,1,,CHEMBL625638,,
14802,Intermediate,,,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",50597,Rattus norvegicus,15078,BAO_0000218,,1,1,,CHEMBL625639,,
14803,Intermediate,,Brain,955.0,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625640,,
14804,Intermediate,,Brain,955.0,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625641,,
14805,Intermediate,,Heart,948.0,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625642,,
14806,Intermediate,,Heart,948.0,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625643,,
14807,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625644,,
14808,Intermediate,,Kidney,2113.0,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625645,,
14809,Intermediate,,Liver,2107.0,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625646,,
14810,Intermediate,,Liver,2107.0,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625647,,
14811,Intermediate,,Lung,2048.0,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625648,,
14812,Intermediate,,Lung,2048.0,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625649,,
14813,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625650,,
14814,Intermediate,,Muscle tissue,2385.0,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625651,,
14815,Intermediate,,Zone of skin,14.0,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625652,,
14816,Intermediate,,Zone of skin,14.0,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625653,,
14817,Intermediate,,Spleen,2106.0,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625654,,
14818,Intermediate,,Spleen,2106.0,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL625655,,
14819,Intermediate,,Blood,178.0,Biodistribution of Compound in rat blood after 15 minutes of administration,50597,Rattus norvegicus,9712,BAO_0000218,,1,1,,CHEMBL625656,,
14820,Intermediate,,Blood,178.0,Biodistribution of Compound in rat blood after 2 minutes of administration,50597,Rattus norvegicus,9712,BAO_0000218,,1,1,,CHEMBL625657,,
14821,Intermediate,,Brain,955.0,Biodistribution of Compound in rat brain after 15 minutes of administration,50597,Rattus norvegicus,9712,BAO_0000218,,1,1,,CHEMBL625658,,
14822,Intermediate,,Brain,955.0,Biodistribution of Compound in rat brain after 2 minutes of administration,50597,Rattus norvegicus,9712,BAO_0000218,,1,1,,CHEMBL625659,,
14823,Intermediate,,Heart,948.0,Biodistribution of Compound in rat heart after 15 minutes of administration,50597,Rattus norvegicus,9712,BAO_0000218,,1,1,,CHEMBL625660,,
14824,Intermediate,,Heart,948.0,Biodistribution of Compound in rat heart after 2 minutes of administration,50597,Rattus norvegicus,9712,BAO_0000218,,1,1,,CHEMBL625661,,
14825,Intermediate,,Liver,2107.0,Biodistribution of Compound in rat liver after 15 minutes of administration,50597,Rattus norvegicus,9712,BAO_0000218,,1,1,,CHEMBL625662,,
14826,Intermediate,,Liver,2107.0,Biodistribution of Compound in rat liver after 2 minutes of administration,50597,Rattus norvegicus,9712,BAO_0000218,,1,1,,CHEMBL625663,,
14827,Intermediate,,Lung,2048.0,Biodistribution of Compound in rat lung after 15 minutes of administration,50597,Rattus norvegicus,9712,BAO_0000218,,1,1,,CHEMBL875621,,
14828,Intermediate,,Lung,2048.0,Biodistribution of Compound in rat lung after 2 minutes of administration,50597,Rattus norvegicus,9712,BAO_0000218,,1,1,,CHEMBL628382,,
14829,Intermediate,,Muscle tissue,2385.0,Biodistribution of Compound in rat muscle after 15 minutes of administration,50597,Rattus norvegicus,9712,BAO_0000218,,1,1,,CHEMBL628383,,
14830,Intermediate,,Muscle tissue,2385.0,Biodistribution of Compound in rat muscle after 2 minutes of administration,50597,Rattus norvegicus,9712,BAO_0000218,,1,1,,CHEMBL628384,,
14831,Intermediate,,,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL628385,,
14832,Intermediate,,,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL875753,,
14833,Intermediate,,,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,50597,Rattus norvegicus,13925,BAO_0000218,,1,1,,CHEMBL628386,,
14834,Intermediate,,,,Organ distribution in rat blood 2 minutes after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL628387,,
14835,Intermediate,,,,Organ distribution in rat blood 2 hr after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL628388,,
14836,Intermediate,,,,Organ distribution in rat blood 30 minutes after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL628389,,
14837,Intermediate,,,,Organ distribution in rat blood 30 min after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL632756,,
14838,Intermediate,,,,Organ distribution in rat brain 2 minutes after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL628390,,
14839,Intermediate,,,,Organ distribution in rat brain 2 hr after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631811,,
14840,Intermediate,,,,Organ distribution in rat brain 30 minutes after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631812,,
14841,Intermediate,,,,Organ distribution in rat heart 2 minutes after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631813,,
14842,Intermediate,,,,Organ distribution in rat heart 2 hr after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631814,,
14843,Intermediate,,,,Organ distribution in rat heart 30 minutes after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631815,,
14844,Intermediate,,,,Organ distribution in rat kidney 2 minutes after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631816,,
14845,Intermediate,,,,Organ distribution in rat kidney 2 hr after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL875758,,
14846,Intermediate,,,,Organ distribution in rat kidney 30 minutes after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631817,,
14847,Intermediate,,Liver,2107.0,Organ distribution in rat liver 2 minutes after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631818,,
14848,Intermediate,,Liver,2107.0,Organ distribution in rat liver 2 hr after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631819,,
14849,Intermediate,,Liver,2107.0,Organ distribution in rat liver 30 minutes after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631820,,
14850,Intermediate,,,,Organ distribution in rat lung 2 minutes after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631821,,
14851,Intermediate,,,,Organ distribution in rat lung 2 hr after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631822,,
14852,Intermediate,,,,Organ distribution in rat lung 30 minutes after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631823,,
14853,Intermediate,,Muscle tissue,2385.0,Organ distribution in rat muscle 2 minutes after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631824,,
14854,Intermediate,,Muscle tissue,2385.0,Organ distribution in rat muscle 2 hr after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631825,,
14855,Intermediate,,Muscle tissue,2385.0,Organ distribution in rat muscle 30 minutes after intravenous injection,50597,Rattus norvegicus,6941,BAO_0000218,,1,1,,CHEMBL631826,,
14856,Intermediate,,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL631827,,
14857,Intermediate,,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL631828,,
14858,Intermediate,,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL631829,,
14859,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL875759,,
14860,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631830,,
14861,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631831,,
14862,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631832,,
14863,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631833,,
14864,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631834,,
14865,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631835,,
14866,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631836,,
14867,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631837,,
14868,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631838,,
14869,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631839,,
14870,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631840,,
14871,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631841,,
14872,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631842,,
14873,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631843,,
14874,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631844,,
14875,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631845,,
14876,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631846,,
14877,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL875760,,
14878,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL632199,,
14879,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631847,,
14880,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL631848,,
14881,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628707,,
14882,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628708,,
14883,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628709,,
14884,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628710,,
14885,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628711,,
14886,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628712,,
14887,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628713,,
14888,Intermediate,,Urine,1088.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,50597,Rattus norvegicus,12582,BAO_0000218,,1,1,,CHEMBL628714,,
14889,Intermediate,,,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",50597,Rattus norvegicus,7415,BAO_0000218,,1,1,,CHEMBL628715,,
14890,Autocuration,,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,22224,,7313,BAO_0000019,,0,1,,CHEMBL629179,,
14891,Autocuration,,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,22224,,7313,BAO_0000019,,0,1,,CHEMBL629180,,
14892,Autocuration,,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,22224,,7313,BAO_0000019,,0,1,,CHEMBL875108,,
14893,Autocuration,,Adrenal cortex,1235.0,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629181,,
14894,Autocuration,,Adrenal cortex,1235.0,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629182,,
14895,Autocuration,,,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629183,,
14896,Autocuration,,,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629184,,
14897,Autocuration,,Adrenal cortex,1235.0,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629185,,
14898,Autocuration,,Adrenal cortex,1235.0,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629186,,
14899,Autocuration,,,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629187,,
14900,Autocuration,,,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629887,,
14901,Autocuration,,,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629888,,
14902,Autocuration,,,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629889,,
14903,Autocuration,,Adrenal cortex,1235.0,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629890,,
14904,Autocuration,,,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629891,,
14905,Autocuration,,,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629892,,
14906,Autocuration,,Adrenal cortex,1235.0,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629893,,
14907,Autocuration,,,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629894,,
14908,Autocuration,,,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,22224,,7570,BAO_0000019,,0,1,,CHEMBL629895,,
14909,Autocuration,,,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",22224,Canis lupus familiaris,14122,BAO_0000218,,0,1,,CHEMBL875109,,
14910,Autocuration,,,,Absolute bioavailability in male cynomolgus monkeys,22224,Macaca fascicularis,16449,BAO_0000218,,0,1,,CHEMBL629896,,
14911,Autocuration,,,,Absolute bioavailability in maleSprague-Dawley rats,22224,Rattus norvegicus,16449,BAO_0000218,,0,1,,CHEMBL629897,,
14912,Intermediate,,Liver,2107.0,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL629898,,
14913,Intermediate,,Liver,2107.0,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630057,,
14914,Intermediate,,Liver,2107.0,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630058,,
14915,Intermediate,,Lung,2048.0,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630059,,
14916,Intermediate,,Lung,2048.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630060,,
14917,Intermediate,,Lung,2048.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630061,,
14918,Intermediate,,Lung,2048.0,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630062,,
14919,Intermediate,,Lung,2048.0,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630063,,
14920,Intermediate,,Lung,2048.0,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630064,,
14921,Intermediate,,Lung,2048.0,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630065,,
14922,Intermediate,,Lung,2048.0,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630066,,
14923,Intermediate,,Lung,2048.0,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630067,,
14924,Intermediate,,Lung,2048.0,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630068,,
14925,Intermediate,,Muscle tissue,2385.0,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631113,,
14926,Intermediate,,Muscle tissue,2385.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631114,,
14927,Intermediate,,Muscle tissue,2385.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631115,,
14928,Intermediate,,Muscle tissue,2385.0,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL631116,,
14929,Intermediate,,Muscle tissue,2385.0,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630528,,
14930,Intermediate,,Muscle tissue,2385.0,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630529,,
14931,Intermediate,,Muscle tissue,2385.0,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630530,,
14932,Intermediate,,Muscle tissue,2385.0,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630531,,
14933,Intermediate,,Muscle tissue,2385.0,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630532,,
14934,Intermediate,,Muscle tissue,2385.0,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630533,,
14935,Intermediate,,Blood,178.0,Biodistribution in normal mice blood after 120 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630534,,
14936,Intermediate,,Blood,178.0,Biodistribution in normal mice blood after 24 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630535,,
14937,Intermediate,,Blood,178.0,Biodistribution in normal mice blood after 4 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630536,,
14938,Intermediate,,Bone,10000001.0,Biodistribution in normal mice bone after 120 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630537,,
14939,Intermediate,,Bone,10000001.0,Biodistribution in normal mice bone after 24 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630538,,
14940,Intermediate,,Bone,10000001.0,Biodistribution in normal mice bone after 4 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630539,,
14941,Intermediate,,Heart,948.0,Biodistribution in normal mice heart after 120 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630540,,
14942,Intermediate,,Heart,948.0,Biodistribution in normal mice heart after 24 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630541,,
14943,Intermediate,,Heart,948.0,Biodistribution in normal mice heart after 4 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630542,,
14944,Intermediate,,Kidney,2113.0,Biodistribution in normal mice kidney after 120 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630543,,
14945,Intermediate,,Kidney,2113.0,Biodistribution in normal mice kidney after 24 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630544,,
14946,Intermediate,,Kidney,2113.0,Biodistribution in normal mice kidney after 4 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630545,,
14947,Intermediate,,Liver,2107.0,Biodistribution in normal mice liver after 120 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630546,,
14948,Intermediate,,Liver,2107.0,Biodistribution in normal mice liver after 24 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630547,,
14949,Intermediate,,Liver,2107.0,Biodistribution in normal mice liver after 4 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630548,,
14950,Intermediate,,Spleen,2106.0,Biodistribution in normal mice spleen after 120 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630549,,
14951,Intermediate,,Spleen,2106.0,Biodistribution in normal mice spleen after 24 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL630550,,
14952,Intermediate,,Spleen,2106.0,Biodistribution in normal mice spleen after 4 hr,50594,Mus musculus,15045,BAO_0000218,,1,1,,CHEMBL876426,,
14953,Intermediate,,Spleen,2106.0,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630551,,
14954,Intermediate,,Spleen,2106.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630552,,
14955,Intermediate,,Spleen,2106.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630553,,
14956,Intermediate,,Spleen,2106.0,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630554,,
14957,Intermediate,,Spleen,2106.0,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630555,,
14958,Intermediate,,Spleen,2106.0,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630556,,
14959,Intermediate,,Spleen,2106.0,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630557,,
14960,Intermediate,,Spleen,2106.0,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630558,,
14961,Intermediate,,Spleen,2106.0,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630559,,
14962,Intermediate,,Spleen,2106.0,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL630560,,
14963,Intermediate,,Thyroid gland,2046.0,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,50597,Rattus norvegicus,12017,BAO_0000218,,1,1,,CHEMBL876427,,
14964,Intermediate,,,,The Kel values in female wistar rats.,50597,Rattus norvegicus,14941,BAO_0000218,,1,1,,CHEMBL630561,,
14965,Autocuration,,,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,22224,,4646,BAO_0000019,,0,1,,CHEMBL630562,,
14966,Autocuration,,,,Hydrolysis rate constant of the compound,22224,,8847,BAO_0000019,,0,1,,CHEMBL630563,,
14967,Autocuration,,,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,22229,,11778,BAO_0000100,,0,1,,CHEMBL629673,,
14968,Autocuration,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",22224,,2363,BAO_0000019,,0,1,,CHEMBL629674,,
14969,Autocuration,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",22224,,2363,BAO_0000019,,0,1,,CHEMBL629675,,
14970,Autocuration,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",22224,,2363,BAO_0000019,,0,1,,CHEMBL629676,,
14971,Autocuration,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",22224,,2363,BAO_0000019,,0,1,,CHEMBL629677,,
14972,Autocuration,,,,Apparent inactivation rate constant was evaluated,22224,,8371,BAO_0000019,,0,1,,CHEMBL629678,,
14973,Autocuration,,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,22224,,14883,BAO_0000019,,0,1,,CHEMBL629679,,
14974,Autocuration,,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,22224,,14883,BAO_0000019,,0,1,,CHEMBL629680,,
14975,Autocuration,,,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,22224,,4643,BAO_0000019,,0,1,,CHEMBL629681,,
14976,Autocuration,,,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,22224,,3519,BAO_0000019,,0,1,,CHEMBL629682,,
14977,Autocuration,,,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,22224,,10600,BAO_0000019,,0,1,,CHEMBL629683,,
14978,Autocuration,,,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,22224,,8501,BAO_0000019,,0,1,,CHEMBL629684,,
14979,Autocuration,,,,Dissociation constant was determined,22224,,8505,BAO_0000100,,0,1,,CHEMBL629685,,
14980,Autocuration,,,,Dissociation constant was determined,22224,,9778,BAO_0000100,,0,1,,CHEMBL629686,,
14981,Autocuration,,,,Dissociation constant at pH 7.4,22224,,9778,BAO_0000100,,0,1,,CHEMBL872932,,
14982,Autocuration,,,,Dissociation constant in presence of 1 mM dithiothreitol,22224,,9778,BAO_0000100,,0,1,,CHEMBL629687,,
14983,Autocuration,,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,22224,,13007,BAO_0000019,,0,1,,CHEMBL872931,,
14984,Autocuration,,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,22224,,13007,BAO_0000019,,0,1,,CHEMBL628151,,
14985,Autocuration,,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,22224,,13007,BAO_0000019,,0,1,,CHEMBL628152,,
14986,Autocuration,,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,22224,,13007,BAO_0000019,,0,1,,CHEMBL628153,,
14987,Autocuration,,,,Kinetic constant for aromatization of androstenedione,22224,,11482,BAO_0000019,,0,1,,CHEMBL628154,,
14988,Autocuration,,,,Kinetic constant for aromatization of testosterone,22224,,11482,BAO_0000019,,0,1,,CHEMBL628155,,
14989,Autocuration,,,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,22224,,2303,BAO_0000019,,0,1,,CHEMBL628156,,
14990,Autocuration,,,,Local inhibition constant was determined,22224,,11964,BAO_0000019,,0,1,,CHEMBL628157,,
14991,Intermediate,,,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,50347,Saccharomyces cerevisiae,3140,BAO_0000218,,1,1,,CHEMBL857533,,
14992,Autocuration,,,,Dissociation constant value of the compound,22224,,10650,BAO_0000100,,0,1,,CHEMBL628158,,
14993,Autocuration,,Cornea,964.0,In vitro permeability through cornea without epithelium,22224,,4667,BAO_0000019,,0,1,,CHEMBL628159,,
14994,Autocuration,,Cornea,964.0,In vitro permeability through intact cornea,22224,,4667,BAO_0000019,,0,1,,CHEMBL875616,,
14995,Intermediate,,Cornea,964.0,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,50592,Oryctolagus cuniculus,9199,BAO_0000218,,1,1,,CHEMBL628160,,
14996,Autocuration,,,,Rate of enzyme inactivation for the compound was determined,22224,,11966,BAO_0000019,,0,1,,CHEMBL628161,,
14997,Autocuration,,Cornea,964.0,In vitro permeability through cornea without epithelium,22224,,4667,BAO_0000019,,0,1,,CHEMBL628162,,
14998,Autocuration,,Cornea,964.0,In vitro permeability through intact cornea,22224,,4667,BAO_0000019,,0,1,,CHEMBL628163,,
14999,Autocuration,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL628164,,
15000,Autocuration,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL628165,,
15001,Autocuration,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL628166,,
15002,Autocuration,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL628167,,
15003,Autocuration,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL628168,,
15004,Autocuration,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL628169,,
15005,Autocuration,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL628170,,
15006,Autocuration,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL628171,,
15007,Autocuration,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL627434,,
15008,Autocuration,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL627435,,
15009,Autocuration,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL628110,,
15010,Autocuration,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL628111,,
15011,Autocuration,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL628112,,
15012,Autocuration,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL628260,,
15013,Autocuration,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",22224,,8354,BAO_0000019,,0,1,,CHEMBL628261,,
15014,Intermediate,,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL628262,,
15015,Intermediate,,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,50587,Homo sapiens,14439,BAO_0000218,,1,1,,CHEMBL628263,,
15016,Intermediate,,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL628264,,
15017,Intermediate,,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL628265,,
15018,Intermediate,,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL628266,,
15019,Intermediate,,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL628267,,
15020,Intermediate,,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL628268,,
15021,Intermediate,,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL628269,,
15022,Intermediate,,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL628270,,
15023,Intermediate,,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL628271,,
15024,Intermediate,,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),50594,Mus musculus,14439,BAO_0000218,,1,1,,CHEMBL628272,,
